03.07.2013 Views

AGREEMENT AND PLAN OF MERGER by and among CLEMENT ...

AGREEMENT AND PLAN OF MERGER by and among CLEMENT ...

AGREEMENT AND PLAN OF MERGER by and among CLEMENT ...

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

16439551.17.BUSINESS<br />

____________________________________________________<br />

<strong>AGREEMENT</strong> <strong>AND</strong> <strong>PLAN</strong> <strong>OF</strong> <strong>MERGER</strong><br />

<strong>by</strong> <strong>and</strong> <strong>among</strong><br />

<strong>CLEMENT</strong> PAPPAS <strong>AND</strong> COMPANY, INC.,<br />

POMONA HOLDINGS, INC.,<br />

POMONA <strong>MERGER</strong> CORP.,<br />

<strong>and</strong><br />

EXECUTION VERSION<br />

<strong>CLEMENT</strong> DAVID PAPPAS <strong>and</strong><br />

<strong>CLEMENT</strong> DIMITRI PAPPAS<br />

as Representatives of Former Shareholders<br />

(for purposes of Sections 2.7, 5.10, 8.3, 8.4, 8.8, 8.9 <strong>and</strong> 9.1 <strong>and</strong> Article 10 only),<br />

<strong>and</strong><br />

LASSONDE INDUSTRIES, INC.<br />

(for purposes of Article 10 only)<br />

Dated June 17, 2011<br />

____________________________________________________


TABLE <strong>OF</strong> CONTENTS<br />

16439551.17.BUSINESS -i-<br />

Page<br />

ARTICLE 1 CERTAIN DEFINITIONS .............................................................................. 1<br />

1.1 Certain Definitions................................................................................................. 1<br />

1.2 Interpretation........................................................................................................ 14<br />

ARTICLE 2 THE <strong>MERGER</strong> .............................................................................................. 14<br />

2.1 The Merger; Effects of the Merger ...................................................................... 14<br />

2.2 Closing ................................................................................................................. 15<br />

2.3 Certificate of Merger............................................................................................ 15<br />

2.4 Organizational Documents................................................................................... 15<br />

2.5 Directors; Officers ............................................................................................... 15<br />

2.6 Conversion of Common Stock............................................................................. 15<br />

2.7 Purchase Price; Calculation of Estimated Purchase Price; Closing Date<br />

Payments; Adjustment to Estimated Purchase Price ........................................... 16<br />

2.8 Letters of Transmittal <strong>and</strong> Stock Certificates ...................................................... 20<br />

2.9 Dissenting Shares................................................................................................. 21<br />

ARTICLE 3 REPRESENTATIONS <strong>AND</strong> WARRANTIES <strong>OF</strong> THE COMPANY.......... 22<br />

3.1 Organization <strong>and</strong> Qualification............................................................................ 22<br />

3.2 Authorization ....................................................................................................... 22<br />

3.3 Non-contravention ............................................................................................... 22<br />

3.4 Governmental Consents....................................................................................... 23<br />

3.5 Capitalization; Subsidiaries ................................................................................. 23<br />

3.6 Financial Statements; Absence of Undisclosed Liabilities.................................. 24<br />

3.7 Absence of Certain Developments....................................................................... 25<br />

3.8 Compliance with Laws; Governmental Authorizations; Licenses; Etc ............... 25<br />

3.9 Litigation.............................................................................................................. 26<br />

3.10 Taxes.................................................................................................................... 26<br />

3.11 Environmental Matters......................................................................................... 28<br />

3.12 Employee Matters ................................................................................................ 29<br />

3.13 Employee Benefit Plans....................................................................................... 30<br />

3.14 Intellectual Property Rights ................................................................................. 31<br />

3.15 Contracts .............................................................................................................. 32


TABLE <strong>OF</strong> CONTENTS<br />

(continued)<br />

-ii-<br />

Page<br />

3.16 Insurance.............................................................................................................. 34<br />

3.17 Real Property ....................................................................................................... 35<br />

3.18 Title to Assets ...................................................................................................... 36<br />

3.19 Related-Party Transactions .................................................................................. 36<br />

3.20 Brokers................................................................................................................. 36<br />

3.21 Customers <strong>and</strong> Suppliers...................................................................................... 37<br />

3.22 Bank Accounts..................................................................................................... 37<br />

3.23 NO ADDITIONAL REPRESENTATIONS........................................................ 37<br />

ARTICLE 4 REPRESENTATIONS <strong>AND</strong> WARRANTIES <strong>OF</strong> PARENT <strong>AND</strong><br />

NEWCO......................................................................................................... 38<br />

4.1 Organization......................................................................................................... 38<br />

4.2 Authorization ....................................................................................................... 38<br />

4.3 Non-contravention ............................................................................................... 38<br />

4.4 No Consents......................................................................................................... 39<br />

4.5 Litigation.............................................................................................................. 39<br />

4.6 Financial Ability .................................................................................................. 39<br />

4.7 Acknowledgement <strong>by</strong> Parent <strong>and</strong> Newco............................................................ 40<br />

4.8 Brokers................................................................................................................. 41<br />

ARTICLE 5 COVENANTS <strong>AND</strong> <strong>AGREEMENT</strong>S.......................................................... 41<br />

5.1 Shareholder Matters............................................................................................. 41<br />

5.2 Access <strong>and</strong> Information ....................................................................................... 41<br />

5.3 Conduct of Business <strong>by</strong> the Company................................................................. 42<br />

5.4 Reasonable Best Efforts; Further Assurances...................................................... 44<br />

5.5 Financing.............................................................................................................. 46<br />

5.6 Public Announcements ........................................................................................ 48<br />

5.7 Employee Benefits............................................................................................... 48<br />

5.8 Indemnification of Directors <strong>and</strong> Officers........................................................... 50<br />

5.9 Obligations of Parent ........................................................................................... 51<br />

5.10 Tax Filings ........................................................................................................... 51<br />

5.11 Exclusive Dealing ................................................................................................ 55


TABLE <strong>OF</strong> CONTENTS<br />

(continued)<br />

-iii-<br />

Page<br />

5.12 Transactions with Former Shareholders .............................................................. 55<br />

5.13 Matters relating to the Additional Equity Contribution....................................... 55<br />

ARTICLE 6 CONDITIONS TO CLOSING ...................................................................... 56<br />

6.1 Mutual Conditions ............................................................................................... 56<br />

6.2 Conditions to the Obligations of Parent <strong>and</strong> Newco............................................ 56<br />

6.3 Conditions to the Obligations of the Company <strong>and</strong> Former Shareholders .......... 58<br />

ARTICLE 7 TERMINATION............................................................................................ 59<br />

7.1 Termination.......................................................................................................... 59<br />

7.2 Effect of Termination........................................................................................... 60<br />

7.3 Reverse Termination Fee ..................................................................................... 60<br />

ARTICLE 8 SURVIVAL <strong>OF</strong> REPRESENTATIONS; INDEMNIFICATION................. 61<br />

8.1 Survival of Representations ................................................................................. 61<br />

8.2 General Indemnification ...................................................................................... 62<br />

8.3 Third-Party Claims............................................................................................... 63<br />

8.4 Direct Claims ....................................................................................................... 64<br />

8.5 Limitations on Indemnification Obligations........................................................ 65<br />

8.6 Mitigation............................................................................................................. 66<br />

8.7 Exclusive Remedy ............................................................................................... 66<br />

8.8 Release of Escrow Funds..................................................................................... 67<br />

8.9 Special Procedures for Taxes............................................................................... 68<br />

ARTICLE 9 REPRESENTATIVES <strong>OF</strong> THE FORMER SHAREHOLDERS.................. 68<br />

9.1 Authorization of Representatives......................................................................... 68<br />

ARTICLE 10 MISCELLANEOUS ...................................................................................... 71<br />

10.1 Notices ................................................................................................................. 71<br />

10.2 Disclosure Letter.................................................................................................. 73<br />

10.3 Time of the Essence; Computation of Time ........................................................ 73<br />

10.4 Expenses .............................................................................................................. 73<br />

10.5 Governing Law; Jurisdiction................................................................................ 73<br />

10.6 Assignment; Successors <strong>and</strong> Assigns; No Third-Party Rights ............................ 74<br />

10.7 Counterparts......................................................................................................... 75


TABLE <strong>OF</strong> CONTENTS<br />

(continued)<br />

-iv-<br />

Page<br />

10.8 Titles <strong>and</strong> Headings.............................................................................................. 75<br />

10.9 Entire Agreement................................................................................................. 75<br />

10.10 Severability .......................................................................................................... 75<br />

10.11 No Strict Construction ......................................................................................... 75<br />

10.12 Specific Performance........................................................................................... 75<br />

10.13 WAIVER <strong>OF</strong> JURY TRIAL................................................................................ 76<br />

10.14 Failure or Indulgence not Waiver ........................................................................ 76<br />

10.15 Amendments <strong>and</strong> Waivers ................................................................................... 77<br />

10.16 Legal Representation ........................................................................................... 77<br />

10.17 Certain Underst<strong>and</strong>ings........................................................................................ 77<br />

10.18 Lassonde Industries, Inc. Guaranty...................................................................... 78


Exhibits<br />

Exhibit A Form of Escrow Agreement<br />

Exhibit B Form of Certificate of Merger<br />

Exhibit C Letter of Transmittal<br />

Exhibit D Commitment Letter<br />

Exhibit E [Intentionally Omitted]<br />

Exhibit F Forms of Key Employee Agreement<br />

Exhibit G Form of Non-competition Agreements<br />

Exhibit H P-L Holdings Stockholders’ Agreement<br />

Exhibit I Form of Stock Purchase Agreement<br />

16439551.17.BUSINESS -v-


16439551.17.BUSINESS<br />

<strong>AGREEMENT</strong> <strong>AND</strong> <strong>PLAN</strong> <strong>OF</strong> <strong>MERGER</strong><br />

THIS <strong>AGREEMENT</strong> <strong>AND</strong> <strong>PLAN</strong> <strong>OF</strong> <strong>MERGER</strong>, dated June 17, 2011, <strong>by</strong> <strong>and</strong> <strong>among</strong><br />

Clement Pappas <strong>and</strong> Company, Inc., a New Jersey corporation (the “Company”), Pomona<br />

Holdings, Inc., a Delaware corporation (“Parent”), <strong>and</strong> Pomona Merger Corp., a New Jersey<br />

corporation <strong>and</strong> wholly-owned subsidiary of Parent (“Newco”), <strong>and</strong>, solely for the purposes of<br />

Sections 2.7, 5.10, 8.3, 8.4, 8.8, 8.9 <strong>and</strong> 9.1 <strong>and</strong> Article 10 of this Agreement, Clement David<br />

Pappas <strong>and</strong> Clement Dimitri Pappas, as the Representatives, <strong>and</strong>, solely for the purposes of<br />

Article 10 of this Agreement, Lassonde Industries, Inc., a Canadian corporation (“Lassonde”).<br />

WHEREAS, the respective boards of directors (or similar body) of Parent, Newco <strong>and</strong><br />

the Company have approved this Agreement <strong>and</strong> the merger of Newco with <strong>and</strong> into the<br />

Company on the terms <strong>and</strong> subject to the conditions set forth herein; <strong>and</strong><br />

WHEREAS, the respective boards of directors (or similar body) of Parent, Newco <strong>and</strong><br />

the Company have determined that this Agreement <strong>and</strong> the transactions contemplated <strong>by</strong> this<br />

Agreement, including the Merger (as defined below), are in the best interests of such entity’s<br />

shareholders or members, as the case may be.<br />

NOW, THEREFORE, in consideration of the premises <strong>and</strong> of the mutual representations,<br />

warranties <strong>and</strong> covenants contained herein, <strong>and</strong> intending to be legally bound, the parties hereto<br />

agree as follows:<br />

1.1 Certain Definitions.<br />

ARTICLE 1<br />

CERTAIN DEFINITIONS<br />

As used in this Agreement, the following terms have the respective meanings set forth<br />

below:<br />

“Accounting Firm” has the meaning set forth in Section 2.7(d)(ii).<br />

“Accounting Principles Consistently Applied” means the accounting principles used in<br />

preparing the September 26, 2010 audited consolidated balance sheet included in the Company<br />

Financial Statements (it being understood that the accounting principles used in preparing the<br />

September 26, 2010 audited consolidated balance sheet included in the Company Financial<br />

Statements are in conformity with GAAP, except as otherwise noted therein <strong>and</strong> as noted on<br />

Schedule 3.6(b)(i) of the Disclosure Letter relating to the preparation of the September 26, 2010<br />

audited consolidated balance sheet), using the same accounting methods, policies, practices <strong>and</strong><br />

procedures, with consistent classification, judgments <strong>and</strong> estimation methodology, as were used<br />

in preparing the September 26, 2010 audited consolidated balance sheet included in the<br />

Company Financial Statements, not taking into account or reflecting (x) any changes in<br />

circumstances or events occurring after the opening of business on the Closing Date or (y) any<br />

purchase accounting or other adjustment arising out of the consummation of the transactions<br />

contemplated <strong>by</strong> this Agreement; provided, that inventories for the Company <strong>and</strong> its Subsidiaries<br />

shall be stated at the lower of cost or market using the first-in, first-out (FIFO) method.<br />

- 1 -


“Acquisition Proposal” has the meaning set forth in Section 5.11.<br />

“Actual Adjustment” means (x) the Purchase Price as set forth on the Final Statement of<br />

Purchase Price minus (y) the Estimated Purchase Price.<br />

“Additional Equity Contribution” means the additional equity contribution <strong>by</strong> Lassonde<br />

or its Affiliates, <strong>by</strong> the purchase of additional common shares of P-L Holdings, that would be<br />

required to be made <strong>by</strong> Lassonde or its Affiliates to meet the maximum total leverage ratio<br />

condition precedent contained in paragraph (i)(4) of Exhibit C to the Commitment Letter as in<br />

effect on the date hereof (which purchase of additional common shares shall be required only if<br />

the EBITDA for the RTM Period is equal to or greater than $54,500,000).<br />

“Affiliate” means, with respect to any Person, any other Person directly or indirectly<br />

controlling, controlled <strong>by</strong> or under common control with such Person; provided, that no party to<br />

this Agreement shall be deemed to be an Affiliate of any other party to this Agreement<br />

(including the Company) solely <strong>by</strong> reason of its ownership of Common Stock. For purpose of<br />

this definitions, “control” (including, with correlative meanings, the terms “controlling,”<br />

“controlled <strong>by</strong>” <strong>and</strong> “under common control with”), as used with respect to any Person, shall<br />

mean the possession, directly or indirectly, of the power to direct or cause the direction of the<br />

management or policies of such Person, whether through the ownership of voting securities, <strong>by</strong><br />

agreement or otherwise.<br />

“Aggregate Closing Consideration” means the Estimated Purchase Price, minus the<br />

Escrow Amount.<br />

“Agreement” means this Agreement <strong>and</strong> Plan of Merger.<br />

“Allocation Schedule” has the meaning set forth in Section 5.10(d)(ii).<br />

“Alternate Financing” has the meaning set forth in Section 5.5(a).<br />

“Antitrust Division” means the Antitrust Division of the U.S. Department of Justice.<br />

“Business Day” means a day, other than a Saturday or Sunday, on which commercial<br />

banks in New York, New York, United States of America <strong>and</strong> Montreal, Quebec, Canada are<br />

open for the general transaction of business.<br />

“Certificate of Incorporation” means the Company’s Certificate of Incorporation dated<br />

June 28, 1951, as amended on April 23, 1987, March 31, 1988 <strong>and</strong> February 5, 2001, as reflected<br />

in the records of the Department of Treasury of the State of New Jersey.<br />

“Certificate of Merger” has the meaning set forth in Section 2.3.<br />

“Change in Control Bonus Agreements” means the following agreements: (i) the<br />

employment agreement between the Company <strong>and</strong> John Graham entered into on December 3,<br />

2008, as amended, including the Addendum thereto dated March 9, 2011, (ii) the employment<br />

agreement between the Company <strong>and</strong> Cary Reimer entered into on December 3, 2008, as<br />

- 2 -


amended, including the Addendum thereto dated March 2011, <strong>and</strong> (iii) the employment<br />

agreement between the Company <strong>and</strong> Marc Friedant entered into on March 21, 2011.<br />

“Change in Control Bonus Payments” means the amounts payable to (i) John Graham<br />

<strong>and</strong> Cary Reimer pursuant to the Addendums to their respective Change in Control Bonus<br />

Agreements <strong>and</strong> (ii) Marc Friedant pursuant to Sections 4(a) <strong>and</strong> 4(b) of his Change in Control<br />

Bonus Agreement.<br />

“Claim” has the meaning set forth in Section 9.1(a)(iii).<br />

“Closing” has the meaning set forth in Section 2.2.<br />

“Closing Date” has the meaning set forth in Section 2.2.<br />

“Closing Date Indebtedness” means the Indebtedness of the Company <strong>and</strong> its<br />

Subsidiaries as of immediately prior to the Closing.<br />

“Code” means the Internal Revenue Code of 1986, as amended.<br />

“Commitment Letter” has the meaning set forth in Section 4.6.<br />

“Common Stock” means, collectively, the voting common shares, no par value, <strong>and</strong> the<br />

non-voting common shares, no par value, of the Company.<br />

“Common Stock Ownership Percentage” means, for each holder of shares of Common<br />

Stock, the percentage determined <strong>by</strong> dividing (x) the number of shares of Common Stock held <strong>by</strong><br />

such holder immediately prior to the Effective Time <strong>by</strong> (y) the number of shares of Common<br />

Stock outst<strong>and</strong>ing immediately prior to the Effective Time (other than treasury shares).<br />

“Company” has the meaning set forth in the introductory paragraph hereto.<br />

“Company Expenses” means (i) the out-of-pocket fees <strong>and</strong> expenses incurred on or<br />

before the Closing Date <strong>and</strong> payable <strong>by</strong> the Company to Goldman Sachs & Co. <strong>and</strong> Dechert LLP<br />

or to other legal, accounting or financial advisors in connection with the transactions<br />

contemplated <strong>by</strong> this Agreement (excluding any fees <strong>and</strong> expenses incurred in connection with<br />

any financing of the transactions contemplated here<strong>by</strong>), plus (ii) the aggregate amount of all sale,<br />

retention or change of control bonus payments payable to current directors, officers <strong>and</strong><br />

employees pursuant to any agreement or plan in effect immediately prior to the Closing, <strong>and</strong><br />

payable <strong>by</strong> the Company or its Subsidiaries, either before or after the Closing, as a result of the<br />

consummation of the transactions contemplated here<strong>by</strong>, including any Change in Control Bonus<br />

Payments <strong>and</strong> Retention Bonus Payments (provided, however, that Company Expenses shall (x)<br />

include only 60% of Retention Bonus Payments that are not deductible <strong>by</strong> the Company in a<br />

taxable period ending on or prior to the Closing Date, with it being understood that the remaining<br />

40% portion of such Retention Bonus Payments shall be excluded from Company Expenses, <strong>and</strong><br />

(y) exclude, for the avoidance of doubt, payments to be made under the Company SERP), in all<br />

cases, to the extent unpaid at or immediately prior to the Closing, plus (iii) the Expense Funds<br />

payable to the Representatives pursuant to Section 9.1(b).<br />

- 3 -


“Company Financial Statements” has the meaning set forth in Section 3.6(a).<br />

“Company SERP” means the Clement Pappas <strong>and</strong> Company, Inc. Supplemental<br />

Executive Retirement Plan, amended <strong>and</strong> restated effective January 1, 2008.<br />

“Company Shareholder Approval” has the meaning set forth in Section 5.1.<br />

“Confidentiality Agreement” has the meaning set forth in Section 5.2(b).<br />

“Contracts” has the meaning set forth in Section 3.15.<br />

“Current Representation” has the meaning set forth in Section 10.16(a).<br />

“D&O Indemnified Persons” has the meaning set forth in Section 5.8(a).<br />

“Designated Person” has the meaning set forth in Section 10.16(a).<br />

“Direct Claim” has the meaning set forth in Section 8.4.<br />

“Disclosure Letter” means the letter of the Company to Parent <strong>and</strong> Newco dated the date<br />

of this Agreement <strong>and</strong> delivered pursuant to Section 10.2 hereof.<br />

“Dissenting Shares” has the meaning set forth in Section 2.9.<br />

“EBITDA” means, for any period, (a) the consolidated net income of the Company <strong>and</strong><br />

its Subsidiaries for such period plus (b) the sum of (i) all interest charges <strong>and</strong> charges or<br />

expenses relating to Indebtedness (including imputed interest charges with respect to capital<br />

lease obligations <strong>and</strong> all amortization of debt discount <strong>and</strong> expense), (ii) federal, state <strong>and</strong> local<br />

income tax expense, (iii) depreciation <strong>and</strong> amortization expense, <strong>and</strong> (iv) any charges <strong>and</strong><br />

expenses relating to the Company Expenses, Retention Bonus Payments <strong>and</strong> any other charges<br />

<strong>and</strong> expenses (including those relating to the Company SERP) to the extent resulting from the<br />

transactions contemplated <strong>by</strong> this Agreement, minus (c) to the extent included in the calculation<br />

of net income for such period, $1,547,165 relating to the Company’s reversal of a bonus accrual<br />

in the month ended September 26, 2010, all as calculated in accordance with the accounting<br />

principles used in preparing the September 26, 2010 audited consolidated statement of income<br />

included in the Company Financial Statements, using the same accounting methods, policies,<br />

practices <strong>and</strong> procedures, with consistent classification, judgments <strong>and</strong> estimation methodology,<br />

as were used in preparing the September 26, 2010 audited consolidated statement of income<br />

included in the Company Financial Statements; provided, that inventories for the Company <strong>and</strong><br />

its Subsidiaries shall be stated at the lower of cost or market using the first-in, first-out (FIFO)<br />

method; provided, further, that cranberry <strong>and</strong> cranberry concentrate inventories for the Company<br />

<strong>and</strong> its Subsidiaries shall be stated at the Company’s st<strong>and</strong>ard costs as of the date of this<br />

Agreement, which are set forth on Schedule 1.1(a) of the Disclosure Letter.<br />

“Effective Time” has the meaning set forth in Section 2.3.<br />

“Employee Benefit Plan” means each “employee benefit plan” (as such term is defined in<br />

Section 3(3) of ERISA) <strong>and</strong> all other material plans, agreements (including employment<br />

- 4 -


agreements), policies, programs or arrangements (whether qualified or nonqualified) maintained,<br />

sponsored or contributed to <strong>by</strong> the Company or any of its Subsidiaries providing for fringe<br />

benefits, bonus or incentive compensation, deferred compensation, or profit sharing, severance<br />

pay, retirement benefits, health care, life insurance, disability, sick leave, or other welfare<br />

benefits, stock, stock option, stock purchase, stock appreciation right, performance shares, or<br />

supplemental unemployment, layoff, vacation, holiday, or any other similar benefits for any of<br />

their current or former employees, but excluding any Multiemployer Plan <strong>and</strong> any employee<br />

benefit plan maintained <strong>by</strong> a labor union or similar employee organization.<br />

“Enforcement Costs” has the meaning set forth in Section 7.3.<br />

“Environmental Laws” means all federal, state <strong>and</strong> local statutes, regulations, resolutions,<br />

codes, rules, ordinances or requirements issued, enacted, adopted, promulgated, implemented or<br />

otherwise put into effect <strong>by</strong> or under the authority of any Governmental Authority <strong>and</strong> any<br />

orders, writs, injunctions, awards, judgments <strong>and</strong> decrees applicable to the Company or to any of<br />

its assets, properties or business, concerning or relating to public health <strong>and</strong> safety, worker health<br />

<strong>and</strong> safety, <strong>and</strong> pollution or protection of the environment, including the comprehensive<br />

Environmental Response, Compensation, <strong>and</strong> Liability Act, 42 U.S.C. § 9601 et seq.; the<br />

Resource Conversation <strong>and</strong> Recovery Act, 42 U.S.C. § 6901 et seq.; the Toxic Substances<br />

Control Act, 15 U.S. C. § 2601 et seq.; the Clean Air Act, 42 U.S.C. § 7401 et seq.; the Clean<br />

Water Act, 33 U.S.C. § 1251 et seq.; the Oil Pollution Act, 33 U.S.C. § 2701 et seq.; the<br />

Occupational Safety <strong>and</strong> Health Act, 29 U.S.C. § 651 et seq., <strong>and</strong> state laws <strong>and</strong> regulations<br />

adopted pursuant to such laws, as such requirements are enacted <strong>and</strong> in effect on or prior to the<br />

Closing Date.<br />

“Environmental Permits” has the meaning set forth in Section 3.11(a).<br />

“ERISA” means the Employee Retirement Income Security Act of 1974, as amended,<br />

<strong>and</strong> the rules <strong>and</strong> regulations promulgated thereunder.<br />

“ERISA Affiliate” means any entity that is considered a single employer with the<br />

Company under Section 414 of the Code.<br />

“Escrow Account” means an interest-bearing escrow account established pursuant to the<br />

Escrow Agreement.<br />

“Escrow Agent” means JPMorgan Chase Bank, N.A., as escrow agent under the Escrow<br />

Agreement, or any other substitute escrow agent which if needed shall be mutually agreed upon<br />

between Parent <strong>and</strong> the Representatives.<br />

“Escrow Agreement” means the escrow agreement to be (x) entered into on the Closing<br />

Date <strong>among</strong> Parent, the Surviving Corporation, the Representatives <strong>and</strong> the Escrow Agent <strong>and</strong><br />

(y) substantially in the form of Exhibit A attached hereto (together with any changes reasonably<br />

requested <strong>by</strong> the Escrow Agent).<br />

“Escrow Amount” has the meaning set forth in Section 2.7(c)(iv).<br />

“Escrow Funds” has the meaning set forth in Section 2.7(c)(iv).<br />

- 5 -


“Estimated Purchase Price” has the meaning set forth in Section 2.7(b).<br />

“Excess Expense Funds” has the meaning set forth in Section 9.1(b).<br />

“Executive Life Insurance Policies” means those Variable Life Policies insuring each of<br />

Craig Ablin, Marc Friedant, Mark Gilmour, John Graham, Kenneth Jankowitz, Rick Jochums,<br />

Michael Luciano <strong>and</strong> Cary Reimer, provided <strong>by</strong> New Engl<strong>and</strong> Life Insurance Company <strong>and</strong> held<br />

<strong>by</strong> US Bank, as Trustee of Clement Pappas <strong>and</strong> Company, Inc.<br />

“Expense Funds” has the meaning set forth in Section 9.1(b).<br />

“Final Allocation Schedule” has the meaning set forth in Section 5.10(d)(ii).<br />

“Final Statement of Purchase Price” has the meaning set forth in Section 2.7(d)(ii).<br />

“Financing” has the meaning set forth in Section 4.6.<br />

“Financing Failure” has the meaning set forth in Section 7.3.<br />

“Former Shareholders” means the holders of shares of Common Stock (other than any<br />

Dissenting Shares) immediately prior to the Effective Time.<br />

“FTC” means the U.S. Federal Trade Commission.<br />

“Fundamental Representations” has the meaning set forth in Section 8.1.<br />

“GAAP” means generally accepted accounting principles, consistently applied, as in<br />

effect in the United States on the date of this Agreement.<br />

“Governmental Authority” means any national, federal, state, provincial, county,<br />

municipal or local government, foreign or domestic, or the government of any political<br />

subdivision of any of the foregoing, or any entity, authority, agency, ministry or other similar<br />

body exercising executive, legislative, judicial, regulatory or administrative authority or<br />

functions of or pertaining to government, including any authority or other quasi-governmental<br />

entity established to perform any of such functions.<br />

“Guaranteed Obligations” has the meaning set forth in Section 10.18(a).<br />

“Hazardous Substances” means any substance, material, waste or compound, pollutant or<br />

contaminant that is defined, listed, identified or otherwise subject to regulation, control or<br />

remediation under Environmental Laws or with respect to which liability or st<strong>and</strong>ards of conduct<br />

are imposed under any Environmental Laws, including petroleum or petroleum constituents,<br />

asbestos-containing material or polychlorinated biphenyls.<br />

“HSR Act” means the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as<br />

amended, <strong>and</strong> the rules <strong>and</strong> regulations promulgated thereunder.<br />

“Income Taxes” means all federal, state, local <strong>and</strong> foreign Taxes that are based on or<br />

measured <strong>by</strong> income.<br />

- 6 -


“Indebtedness” means, as of any date, without duplication, the outst<strong>and</strong>ing principal<br />

amount of, accrued <strong>and</strong> unpaid interest on <strong>and</strong> other payment obligations (including any<br />

prepayment premiums or termination penalties payable as a result of the consummation of the<br />

transactions contemplated herein) arising under any obligations of the Company or its<br />

Subsidiaries for (i) indebtedness for borrowed money, (ii) indebtedness evidenced <strong>by</strong> any note,<br />

bond, debenture or other debt security, (iii) reimbursement obligations, contingent or otherwise,<br />

in connection with any letters of credit issued for the account of the Company or its Subsidiaries<br />

but only to the extent drawn, (iv) obligations representing the deferred purchase price of property<br />

or services rendered, including earn-outs <strong>and</strong> other similar forms of contingent purchase prices<br />

(but excluding accounts payable <strong>and</strong> accrued expenses arising in the Ordinary Course of<br />

Business), (v) obligations under any interest rate protection or swap agreements, foreign<br />

currency exchange agreements or other interest rate or exchange rate hedging arrangements<br />

entered into <strong>by</strong> the Company or its Subsidiaries, (vi) obligations under leases required in<br />

accordance with GAAP to be recorded as capital leases (but excluding any obligations under the<br />

capital leases set forth on Schedule 1.1(b)) of the Disclosure Letter), <strong>and</strong> (vii) guarantees of any<br />

of the foregoing, in each case excluding intercompany indebtedness.<br />

“Indemnified Party” has the meaning set forth in Section 8.3(a).<br />

“Intellectual Property Rights” means all rights arising anywhere in the world under (a)<br />

patents <strong>and</strong> patent applications (including provisional applications, divisions, continuations,<br />

continuations in part, reexaminations <strong>and</strong> reissues), inventions, processes, industrial designs <strong>and</strong><br />

techniques; (b) trademarks, service marks, trade names, domain names <strong>and</strong> other indicators of<br />

source, <strong>and</strong> all registrations <strong>and</strong> applications for registration of any of the foregoing; (c)<br />

registered <strong>and</strong> unregistered copyrights in both published works <strong>and</strong> unpublished works <strong>and</strong><br />

copyrightable subject matter; (d) trade secrets <strong>and</strong> confidential <strong>and</strong> proprietary know-how,<br />

formulae, customer lists, technical information, data, process technology, industrial designs,<br />

plans, drawings, blueprints <strong>and</strong> recipes <strong>and</strong> formulations; <strong>and</strong> (e) computer software, including<br />

rights in source code <strong>and</strong> object code.<br />

“IRS” has the meaning set forth in Section 3.13(a).<br />

“Knowledge” means, with respect to any Person, the actual awareness of a fact or other<br />

matter after reasonable inquiry; provided, that in the case of the Company, such knowledge shall<br />

be limited to the Knowledge of Dean C. Pappas, Marc R. Friedant, Clement Dimitri Pappas,<br />

Clement David Pappas, John Graham <strong>and</strong> Cary Reimer. For this purpose, “reasonable inquiry”<br />

means, with respect to each person, (i) review <strong>by</strong> such person of the representations <strong>and</strong><br />

warranties herein qualified <strong>by</strong> Knowledge that relate to the Company or any of its Subsidiaries<br />

<strong>and</strong> (ii) the reasonable review of files <strong>and</strong> other information of the Company or any of its<br />

Subsidiaries in such person’s possession or custody.<br />

“Lassonde” has the meaning set forth in the introductory paragraph hereto.<br />

“Lassonde US Fruit Juice Business” means the sale, manufacture <strong>and</strong> distribution of fruit<br />

juice, beverages containing fruit juice, beverages containing fruit concentrate, beverages<br />

containing tea <strong>and</strong> functional beverages within the United States of America <strong>by</strong> Lassonde <strong>and</strong> its<br />

Affiliates, it being understood that the Lassonde US Fruit Juice Business consists exclusively of<br />

- 7 -


certain agreements, including agreements with customers, distributors <strong>and</strong> brokers, sales<br />

employees exclusively dedicated to the United States, certain customer <strong>and</strong> vendor relationships,<br />

trademarks registered in the United States <strong>and</strong> goodwill <strong>and</strong> does not include any tangible assets<br />

or real property.<br />

“Laws” means (i) all applicable laws, statutes, regulations, rules, ordinances, judgments,<br />

rulings, orders, writs, injunctions, decrees, (ii) any orders, settlements or awards of any<br />

Governmental Authority or (iii) any published policy, st<strong>and</strong>ard or guidance promulgated <strong>by</strong> the<br />

U.S. Food <strong>and</strong> Drug Administration which, although not necessarily having the force of law, is<br />

regarded <strong>by</strong> the U.S. Food <strong>and</strong> Drug Administration as requiring compliance as if it had the force<br />

of law, in each case as in effect on or prior to the Closing Date.<br />

“Leased Property” has the meaning set forth in Section 3.17(b).<br />

“Lenders” means any administrative agents, collateral agents, letter of credit issuers,<br />

arrangers or other agents otherwise titled designated in connection with the syndication of the<br />

Financing, <strong>and</strong> other lenders (or equivalent parties otherwise named) extending or facilitating the<br />

Financing pursuant to the Commitment Letter (or in the case Alternate Financing has been<br />

arranged, such agents, issuers, arrangers other agents or other lenders (or equivalent parties)<br />

extending or facilitating the Alternate Financing), in each case, together with their Affiliates,<br />

officers, directors, employees, agents, advisors <strong>and</strong> representatives <strong>and</strong> their respective<br />

successors <strong>and</strong> assigns.<br />

kind.<br />

“Letter of Transmittal” has the meaning set forth in Section 2.8(a).<br />

“Lien” means any mortgage, pledge, security interest, encumbrance, lien or charge of any<br />

“Loss” has the meaning set forth in Section 8.2(a).<br />

“Material Adverse Effect” means any effect, change, event, occurrence or condition<br />

(whether or not constituting any breach of a representation, warranty, covenant or agreement set<br />

forth in this Agreement) that, individually or in the aggregate with all other effects, changes,<br />

events, occurrences or conditions, has or would reasonably be expected to have a material<br />

adverse effect upon the financial condition, business or results of operations of the Company <strong>and</strong><br />

its Subsidiaries, taken as a whole; provided, however, that any adverse effect, change, event,<br />

occurrence or condition arising from or related to any of the following shall not be taken into<br />

account in determining whether a “Material Adverse Effect” has occurred: (i) conditions<br />

generally affecting the United States economy or generally affecting one or more industries in<br />

which the Company or its Subsidiaries operate, including changes in interest rates or currency<br />

exchange rates; (ii) changes in the price of commodities or raw materials, including fruit or<br />

concentrate, used in the business of the Company <strong>and</strong> its Subsidiaries; (iii) national or<br />

international political conditions, including terrorism or the engagement <strong>by</strong> the United States in<br />

hostilities or acts of war; (iv) financial, banking or securities markets (including any disruption<br />

thereof <strong>and</strong> any decline in the price of any security or any market index); (v) changes in GAAP<br />

or other accounting requirements; (vi) changes in any Laws or other binding directives issued <strong>by</strong><br />

any Governmental Authority after the date hereof; (vii) any action taken <strong>by</strong> a party hereto<br />

- 8 -


equired <strong>by</strong> or in accordance with this Agreement; (viii) the announcement, pendency or<br />

completion of the transactions contemplated <strong>by</strong> this Agreement; (ix) any failure, in <strong>and</strong> of itself,<br />

<strong>by</strong> the Company or its Subsidiaries to meet any internal or disseminated projections, forecasts or<br />

revenue or earnings predictions for any period (it being understood that the facts <strong>and</strong><br />

circumstances giving rise or contributing to such failure may be taken into account in<br />

determining whether there has been a Material Adverse Effect); or (x) any effect, change, event,<br />

occurrence or condition to the extent described on Schedule 3.7, Schedule 3.8, Schedule 3.11 or<br />

Schedule 5.3 of the Disclosure Letter; provided, however, that any effect, change, event,<br />

occurrence or condition referred to in clause (i), (iii), (iv), (v) or (vi) may be taken into account<br />

in determining whether there has been a Material Adverse Effect to the extent that such effect,<br />

change, event or occurrence has a disproportionate adverse effect on the Company <strong>and</strong> its<br />

Subsidiaries, taken as a whole, as compared to other participants in the industry in which the<br />

Company <strong>and</strong> its Subsidiaries operate (in which case only the incremental disproportionate<br />

impact or impacts may be taken into account in determining whether a Material Adverse Effect<br />

has occurred). References in this Agreement to dollar amount thresholds shall not be deemed to<br />

be evidence of a Material Adverse Effect or materiality or the lack thereof.<br />

“Material Lease” has the meaning set forth in Section 3.17(b).<br />

“Merger” has the meaning set forth in Section 2.1.<br />

“Merger Consideration” means an amount equal to the sum of (a) the Purchase Price <strong>and</strong><br />

(b) the Closing Date Indebtedness.<br />

“Merger Documents” means, collectively, this Agreement, the Certificate of Merger <strong>and</strong><br />

all other agreements <strong>and</strong> certificates executed in connection with the Merger <strong>and</strong> the other<br />

transactions contemplated here<strong>by</strong>.<br />

“Multiemployer Plan” has the meaning set forth in Section 3(37) of ERISA.<br />

“Net Working Capital” means, as of the open of business on the Closing Date, (a) the<br />

“current assets” of the Company <strong>and</strong> its Subsidiaries less (b) the “current liabilities” of the<br />

Company <strong>and</strong> its Subsidiaries on a consolidated basis (including obligations to employees for<br />

accrued <strong>and</strong> unpaid vacation <strong>and</strong> pro rata employee bonus accruals), with each item thereof,<br />

including reserves, as determined in accordance with the Accounting Principles Consistently<br />

Applied; provided, however, that there shall be (x) included in “current assets” the aggregate<br />

cash surrender value of the Executive Life Insurance Policies (provided that (A) for purposes of<br />

determining the estimated Net Working Capital Adjustment pursuant to Section 2.7(a), the<br />

Company shall use an aggregate estimated cash surrender value of the Executive Life Insurance<br />

Policies as set forth in the then most recently available estimate from New Engl<strong>and</strong> Life<br />

Insurance <strong>and</strong> (B) for purposes of determining the Final Statement of Purchase Price pursuant to<br />

Section 2.7(d)(ii) to be used in calculating the Actual Adjustment pursuant to Section 2.7(e), the<br />

parties hereto shall use the aggregate cash proceeds received <strong>by</strong> the Surviving Corporation in<br />

respect of the cancellation <strong>and</strong> liquidation of the Executive Life Insurance Policies pursuant to<br />

Section 5.7(f)), (y) excluded from “current assets” (including any contra asset accounts) <strong>and</strong><br />

“current liabilities” (i) any Indebtedness of the Company, (ii) any deferred tax or income tax<br />

assets, (iii) any deferred tax or income tax liabilities, (iv) any fees, expenses or liabilities related<br />

- 9 -


to any financing <strong>by</strong> Parent <strong>and</strong> its respective Affiliates of the transactions contemplated here<strong>by</strong>,<br />

(v) any note or account receivable from, or cash advance to, any Former Shareholder or Affiliate<br />

thereof, (vi) any intercompany accounts <strong>and</strong> transactions between the Company <strong>and</strong>/or any<br />

Subsidiary, on the one h<strong>and</strong>, <strong>and</strong> another Subsidiary, on the other h<strong>and</strong>, (vii) any obligations<br />

under or accruals relating to the Company SERP or the Retention Bonus Agreements <strong>and</strong> (viii)<br />

any Company Expenses <strong>and</strong> (z) for the avoidance of doubt, included as a “current liability” the<br />

remaining payable to Upper Deerfield Township Sewer Company in respect of past audits<br />

relating to the calendar years 2004 through 2009 of sewer usage calculations.<br />

“Net Working Capital Adjustment” means (i) the amount <strong>by</strong> which Net Working Capital<br />

exceeds the Reference Amount or (ii) the amount <strong>by</strong> which Net Working Capital is less than the<br />

Reference Amount; provided, that any amount which is calculated pursuant to clause (ii) above<br />

shall be deemed to be a negative number.<br />

“New Jersey Corporation Act” has the meaning set forth in Section 2.1.<br />

“Newco” has the meaning set forth in the introductory paragraph hereto.<br />

“Ordinary Course of Business” means the ordinary course of business of the Company<br />

<strong>and</strong> its Subsidiaries consistent with past practice.<br />

“Owned Real Property” has the meaning set forth in Section 3.17(a).<br />

“Pappas Group” has the meaning set forth in the P-L Holdings Stockholders’ Agreement.<br />

“Pappas Shareholders’ Agreement” means that certain Shareholders Agreement, dated as<br />

of November 19, 2001, <strong>by</strong> <strong>and</strong> <strong>among</strong> Peter C. Pappas <strong>and</strong> Dean C. Pappas, as the same may be<br />

amended from time to time.<br />

“Parent” has the meaning set forth in the introductory paragraph hereto.<br />

“Parent Indemnitee” <strong>and</strong> “Parent Indemnitees” have the meanings set forth in Section<br />

8.2(a).<br />

“Parent Plans” has the meaning set forth in Section 5.7(a).<br />

“Pass-Through Tax” means any liability for Tax of a Former Shareholder, whether paid<br />

<strong>by</strong> a Former Shareholder or <strong>by</strong> the Company or any Subsidiary on behalf of (<strong>and</strong> treated as a<br />

distribution to) a Former Shareholder, that is calculated <strong>by</strong> reference to or otherwise directly<br />

affected <strong>by</strong> the amount of taxable income or gain (or deduction, credit or loss) or similar item of<br />

the Company, the Surviving Corporation or any Subsidiary under Subchapter S of the Code or<br />

any corresponding or similar provision under foreign, state or local law.<br />

“Per Share Adjustment Amount” means, if the Actual Adjustment is a positive number,<br />

the amount obtained <strong>by</strong> dividing the Actual Adjustment <strong>by</strong> the number of shares of Common<br />

Stock outst<strong>and</strong>ing immediately prior to the Effective Time (other than treasury shares).<br />

- 10 -


“Per Share Closing Consideration” means the amount obtained <strong>by</strong> dividing the Aggregate<br />

Closing Consideration <strong>by</strong> the number of shares of Common Stock outst<strong>and</strong>ing immediately prior<br />

to the Effective Time (other than treasury shares).<br />

“Per Share Holdback Amount” means the amount obtained <strong>by</strong> dividing (i) the sum of (A)<br />

any amounts released from the Escrow Account pursuant to this Agreement <strong>and</strong> the Escrow<br />

Agreement for payment to Former Shareholders, when, as <strong>and</strong> if so released, <strong>and</strong> (B) any Excess<br />

Expense Funds, <strong>by</strong> (ii) the number of shares of Common Stock outst<strong>and</strong>ing immediately prior to<br />

the Effective Time (other than treasury shares).<br />

“Per Share Merger Consideration” has the meaning set forth in Section 2.6(a).<br />

“Permit” means all licenses, permits, certificates, approvals, consents <strong>and</strong> other<br />

authorizations of any Governmental Authority.<br />

“Permitted Liens” means (i) mechanics’, materialmens’, carriers’, workmens’,<br />

repairmens’, contractors’ or other similar Liens arising or incurred in the Ordinary Course of<br />

Business <strong>and</strong> for amounts which are not yet due <strong>and</strong> payable <strong>and</strong> which would not constitute a<br />

Material Adverse Effect, (ii) zoning, building, entitlement, conservation restriction <strong>and</strong> other<br />

l<strong>and</strong> use <strong>and</strong> environmental regulations <strong>by</strong> Governmental Authority, <strong>and</strong> exceptions, restrictions,<br />

easements, imperfections of title, charges, rights-of-way <strong>and</strong> other similar encumbrances that do<br />

not materially interfere with the present use of or the marketability of title to the Real Property,<br />

(iii) Liens for Taxes not yet due <strong>and</strong> payable or for Taxes that the taxpayer is contesting in good<br />

faith, (iv) purchase money Liens securing rental payments under capital lease arrangements, (v)<br />

real estate taxes, assessments <strong>and</strong> other governmental levies, fees or charges imposed which are<br />

not yet due <strong>and</strong> payable or are being contested in good faith, (vi) Liens imposed <strong>by</strong> law, (vii) as<br />

to any Leased Property, Liens created, permitted or suffered <strong>by</strong> the fee owners thereof, (viii)<br />

matters disclosed of public record or matters that would be disclosed on a correct survey, (ix)<br />

Liens securing the Closing Date Indebtedness (which liens shall be terminated on the Closing<br />

Date upon payment in full of the Closing Date Indebtedness in accordance with the terms hereof)<br />

<strong>and</strong> (x) other Liens arising in the Ordinary Course of Business <strong>and</strong> not incurred in connection<br />

with the borrowing of money.<br />

“Person” means an individual, partnership, corporation, limited liability company, joint<br />

stock company, unincorporated organization or association, trust, joint venture, association or<br />

other organization, whether or not a legal entity, or a Governmental Authority.<br />

“P-L Holdings” means Pappas Lassonde Holdings, Inc., a Delaware corporation <strong>and</strong> the<br />

holder of all of the outst<strong>and</strong>ing capital stock of Parent.<br />

“P-L Holdings Stockholders’ Agreement” means that certain stockholders’ agreement to<br />

be entered into on the Closing Date <strong>by</strong> P-L Holdings, the Surviving Corporation, 3346625<br />

CANADA INC., Lassonde (U.S.A.) Inc. <strong>and</strong> the stockholders listed on the signature page<br />

thereto.<br />

“Post-Closing Representation” has the meaning set forth in Section 10.16(a).<br />

“Post-Closing Tax Period” has the meaning set forth in Section 5.10(c)(i).<br />

- 11 -


“Pre-Closing Period Return” has the meaning set forth in Section 5.10(a).<br />

“Principal Customers” has the meaning set forth in Section 3.21.<br />

“Principal Suppliers” has the meaning set forth in Section 3.21.<br />

“Proposed Closing Date Balance Sheet” has the meaning set forth in Section 2.7(d)(i).<br />

“Proposed Closing Date Calculations” has the meaning set forth in Section 2.7(d)(i).<br />

“Proposed Closing Date Statement of Net Working Capital” has the meaning set forth in<br />

Section 2.7(d)(i).<br />

“Proposed Purchase Price Calculation” has the meaning set forth in Section 2.7(d)(i).<br />

“Purchase Price” has the meaning set forth in Section 2.7(a).<br />

“Purchase Price Dispute Notice” has the meaning set forth in Section 2.7(d)(ii).<br />

“Recall” means (a) the removal from sale or use <strong>by</strong> the Company or any of its<br />

Subsidiaries of at least 35,000 units of a product because (i) such product violates, or the<br />

Company or any Subsidiary reasonably believed it violates, any Laws, including the Laws<br />

promulgated <strong>by</strong> the U.S. Food <strong>and</strong> Drug Administration or (ii) the Company or any of its<br />

Subsidiaries determined that such product did not comply with customer specifications, or did<br />

not meet minimum quality st<strong>and</strong>ards followed <strong>by</strong> the Company, any of its Subsidiaries or similar<br />

food processing <strong>and</strong> manufacturing companies in the same industry or (b) either a Class I recall<br />

or Class II recall, as defined in Chapter 7 of the Investigations Operations Manual maintained <strong>by</strong><br />

the U.S. Food <strong>and</strong> Drug Administration as of the date hereof.<br />

“Reference Amount” means $50,300,000.<br />

“Representatives” has the meaning set forth in Section 9.1(a).<br />

“Responsible Party” has the meaning set forth in Section 8.3(a).<br />

“Retention Bonus Agreements” means (i) the Letter Agreement between the Company<br />

<strong>and</strong> Craig Ablin dated March 29, 2011, (ii) the Letter Agreement between the Company <strong>and</strong><br />

Robert Crawford dated March 29, 2011, (iii) the Letter Agreement between the Company <strong>and</strong><br />

Rick Jochums dated March 29, 2011, (iv) the Letter Agreement between the Company <strong>and</strong><br />

Michael Luciano dated April 4, 2011, (v) the Letter Agreement between the Company <strong>and</strong><br />

Patricia Nicolino dated April 4, 2011, (vi) the Letter Agreement between the Company <strong>and</strong><br />

Glenn McKellar dated February 22, 2011, (vii) the Letter Agreement between the Company <strong>and</strong><br />

Sue McGrath dated February 21, 2011, <strong>and</strong> (viii) the Letter Agreement between the Company<br />

<strong>and</strong> Seth French dated February 22, 2011.<br />

“Retention Bonus Payments” means the amounts payable to (i) Craig Ablin pursuant to<br />

Article II(i) of his Retention Bonus Agreement <strong>and</strong> (ii) Robert Crawford pursuant to Article II of<br />

his Retention Bonus Agreement <strong>and</strong> (iii) Rick Jochums, Michael Luciano, Patricia Nicolino,<br />

- 12 -


Glenn McKellar, Sue McGrath <strong>and</strong> Seth French pursuant to their respective Retention Bonus<br />

Agreements.<br />

“Reverse Termination Fee” has the meaning set forth in Section 7.3.<br />

“Reverse Termination Fee Events” has the meaning set forth in Section 7.3.<br />

“RTM Period” has the meaning set forth in Section 6.2(o).<br />

“Section 338 Election” has the meaning set forth in Section 5.10(d)(i).<br />

“Shareholder Indemnitee” has the meaning set forth in Section 8.2(b).<br />

“Stock Certificates” means the outst<strong>and</strong>ing certificates which immediately prior to the<br />

Effective Time represent shares of Common Stock.<br />

“Straddle Period” or “Straddle Periods” have the meanings set forth in Section 5.10(b).<br />

“Straddle Period Returns” has the meaning set forth in Section 5.10(b).<br />

“Subsidiary” or “Subsidiaries” means, with respect to any Person, any corporation,<br />

partnership, association or other business entity of which (i) if a corporation, a majority of the<br />

total voting power of shares of capital stock entitled (without regard to the occurrence of any<br />

contingency) to vote in the election of directors, managers or trustees thereof is at the time<br />

owned or controlled, directly or indirectly, <strong>by</strong> that Person or one or more of the other<br />

Subsidiaries of that Person or a combination thereof, or (ii) if a partnership, association or other<br />

business entity, a majority of the partnership or other similar ownership interests thereof is at the<br />

time owned or controlled, directly or indirectly, <strong>by</strong> any Person or one or more Subsidiaries of<br />

that Person or a combination thereof. For purposes hereof, a Person or Persons shall be deemed<br />

to have a majority ownership interest in a partnership, association or other business entity if such<br />

Person or Persons shall be allocated a majority of partnership, association or other business<br />

entity gains or losses or shall be or control the managing director, managing member, general<br />

partner or other managing Person of such partnership, association or other business entity.<br />

Unless the context requires otherwise, each reference to a Subsidiary shall be deemed to be a<br />

reference to a Subsidiary of the Company.<br />

“Surviving Corporation” has the meaning set forth in Section 2.1.<br />

“Tax” means any federal, state, local or foreign income, gross receipts, franchise,<br />

estimated, alternative minimum, add on minimum, sales, use, transfer, real property gains,<br />

registration, value added, excise, stamp, occupation, windfall profits, real property, personal<br />

property, capital stock, social security (or similar), unemployment, disability, payroll, license,<br />

employee or other withholding, or other tax, of any kind whatsoever, including any interest,<br />

penalties or additions to tax or similar items in respect of the foregoing.<br />

“Tax Return” means any return, report, declaration, claim for refund, information return<br />

or other document (including any related or supporting schedule, statement or information) filed<br />

or required to be filed in connection with the determination, assessment or collection of any Tax<br />

- 13 -


of any party or the administration of any laws, regulations or administrative requirements<br />

relating to any Tax (including any amendment thereof).<br />

“Termination Date” has the meaning set forth in Section 7.1(b).<br />

“Third-Party Claim” has the meaning set forth in Section 8.3(a).<br />

“Third-Party Intellectual Property” has the meaning set forth in Section 3.14(b)(i).<br />

“Threshold” has the meaning set forth in Section 8.5(b)(iii).<br />

“Treasury Regulations” means the income Tax regulations, including temporary<br />

regulations, promulgated under the Code, as such regulations may be amended from time to<br />

time.<br />

1.2 Interpretation.<br />

Unless otherwise indicated to the contrary herein <strong>by</strong> the context or use thereof: (i) the<br />

words, “herein,” “hereto,” “hereof,” “hereunder” <strong>and</strong> words of similar import refer to this<br />

Agreement as a whole <strong>and</strong> not to any particular Section or paragraph hereof; (ii) the word<br />

“including” means “including, but not limited to”; (iii) masculine gender shall also include the<br />

feminine <strong>and</strong> neutral genders, <strong>and</strong> vice versa; (iv) words importing the singular shall also include<br />

the plural, <strong>and</strong> vice versa; <strong>and</strong> (v) accounting terms which are not otherwise defined in this<br />

Agreement shall have the meanings given to them under GAAP.<br />

ARTICLE 2<br />

THE <strong>MERGER</strong><br />

2.1 The Merger; Effects of the Merger.<br />

Upon the terms <strong>and</strong> subject to the conditions of this Agreement, at the Effective Time,<br />

Newco shall, pursuant to the provisions of the New Jersey Business Corporation Act, Title 14A<br />

of the New Jersey Statutes (as amended from time to time, the “New Jersey Corporation Act”),<br />

be merged with <strong>and</strong> into the Company (the “Merger”), <strong>and</strong> the separate corporate existence of<br />

Newco shall thereupon cease in accordance with the provisions of the New Jersey Corporation<br />

Act. The Company shall be the surviving corporation in the Merger <strong>and</strong> shall continue to exist as<br />

said surviving corporation under its present name pursuant to the provisions of the New Jersey<br />

Corporation Act. The separate corporate existence of the Company with all its rights, privileges,<br />

powers <strong>and</strong> franchises shall continue unaffected <strong>by</strong> the Merger. The Merger shall have the<br />

effects specified in the New Jersey Corporation Act. From <strong>and</strong> after the Effective Time, the<br />

Company is sometimes referred to herein as the “Surviving Corporation.”<br />

- 14 -


2.2 Closing.<br />

The closing of the Merger (the “Closing”) shall take place at the offices of Dechert LLP,<br />

Cira Centre, 2929 Arch Street, Philadelphia, Pennsylvania 19104, at 10:00 a.m., New York City<br />

time, on the third Business Day following the satisfaction or waiver of the conditions set forth in<br />

Article 6 (other than those conditions that <strong>by</strong> their terms must be satisfied on the Closing Date,<br />

but subject to the satisfaction or waiver of such conditions at the Closing), or at such place <strong>and</strong><br />

on such date <strong>and</strong> time as the Company <strong>and</strong> Parent shall mutually agree. The time <strong>and</strong> date of the<br />

Closing is herein called the “Closing Date.”<br />

2.3 Certificate of Merger.<br />

As part of the Closing, the parties hereto shall cause a certificate of merger substantially<br />

in the form attached hereto as Exhibit B (the “Certificate of Merger”) to be properly executed<br />

<strong>and</strong> filed in accordance with the relevant provisions of the New Jersey Corporation Act <strong>and</strong> shall<br />

make all other filings or recordings required under the New Jersey Corporation Act to effectuate<br />

the Merger. The Merger shall be effective at the time <strong>and</strong> on the date of the filing of the<br />

Certificate of Merger in accordance with the New Jersey Corporation Act (the date <strong>and</strong> time the<br />

Merger becomes effective being the “Effective Time”), which filing shall occur on the Closing<br />

Date, or at such other time as the Company <strong>and</strong> Newco shall agree shall be specified in the<br />

Certificate of Merger.<br />

2.4 Organizational Documents.<br />

The certificate of incorporation <strong>and</strong> <strong>by</strong>-laws of Newco immediately prior to the Effective<br />

Time shall be the certificate of incorporation <strong>and</strong> <strong>by</strong>-laws of the Surviving Corporation <strong>and</strong> shall<br />

continue in full force <strong>and</strong> effect until further amended in the manner prescribed <strong>by</strong> the provisions<br />

of the New Jersey Corporation Act.<br />

2.5 Directors; Officers.<br />

The directors <strong>and</strong> officers identified in the P-L Holdings Stockholders’ Agreement shall<br />

be the directors <strong>and</strong> officers, respectively, of the Surviving Corporation <strong>and</strong> will serve until their<br />

successors are duly elected or appointed <strong>and</strong> qualify in the manner provided in the certificate of<br />

incorporation or <strong>by</strong>-laws of the Surviving Corporation or as otherwise provided <strong>by</strong> law, or until<br />

their earlier death, resignation or removal.<br />

2.6 Conversion of Common Stock.<br />

(a) Conversion of Common Stock Held <strong>by</strong> Shareholders. As of the Effective<br />

Time, <strong>by</strong> virtue of the Merger <strong>and</strong> without any action on the part of any holder thereof or<br />

any party hereto, each share of Common Stock issued <strong>and</strong> outst<strong>and</strong>ing immediately prior<br />

to the Effective Time <strong>and</strong> held <strong>by</strong> any shareholder (other than (i) shares held in the<br />

Company’s treasury <strong>and</strong> (ii) Dissenting Shares) shall be converted into the right to<br />

receive (A) the Per Share Closing Consideration, (B) the Per Share Holdback Amount<br />

<strong>and</strong> (C) the Per Share Adjustment Amount (the sum of clauses (A), (B) <strong>and</strong> (C), the “Per<br />

Share Merger Consideration”), payable in cash to the holder thereof, without interest<br />

- 15 -


thereon, upon surrender of the Stock Certificate formerly representing such share, all in<br />

accordance with Sections 2.7 <strong>and</strong> 2.8 hereof <strong>and</strong> the Escrow Agreement.<br />

(b) Treasury Shares. Each share of Common Stock held in the treasury of the<br />

Company immediately prior to the Effective Time shall, <strong>by</strong> virtue of the Merger <strong>and</strong><br />

without any action on the part of the holders thereof, be canceled, retired <strong>and</strong> cease to<br />

exist as of the Effective Time <strong>and</strong> no payment shall be made with respect thereto.<br />

(c) Newco Shares. As of the Effective Time, each share of capital stock of<br />

Newco issued <strong>and</strong> outst<strong>and</strong>ing immediately prior to the Effective Time shall, without any<br />

action on the part of Newco, be converted on a one-for-one basis into shares of the<br />

corresponding class of capital stock of the Surviving Corporation.<br />

(d) Holders of Stock Certificates. From <strong>and</strong> after the Effective Time, the<br />

holders of the Stock Certificates (other than Stock Certificates representing Dissenting<br />

Shares) which immediately prior to the Effective Time represented any shares of<br />

Common Stock shall cease to have any rights with respect to such shares of Common<br />

Stock, except the right to receive the Per Share Closing Consideration, the Per Share<br />

Holdback Amount <strong>and</strong> the Per Share Adjustment Amount, as applicable.<br />

2.7 Purchase Price; Calculation of Estimated Purchase Price; Closing Date<br />

Payments; Adjustment to Estimated Purchase Price.<br />

(a) Purchase Price. For purposes of this Agreement, “Purchase Price” shall<br />

mean a dollar amount equal to (i) $390,000,000 plus (ii) the Net Working Capital<br />

Adjustment (which may be a negative number), minus (iii) the amount of Closing Date<br />

Indebtedness, minus (iv) the amount of any Company Expenses not paid <strong>by</strong> the Company<br />

or its Subsidiaries prior to the Closing.<br />

(b) Estimated Purchase Price. No later than three Business Days prior to the<br />

Closing, the Company shall deliver to Parent a reasonably detailed calculation of the<br />

Estimated Purchase Price, together with a certificate signed <strong>by</strong> the chief financial officer<br />

of the Company to the effect that the Estimated Purchase Price was determined in good<br />

faith in accordance with this Section 2.7(b) <strong>and</strong> including a reasonably detailed<br />

calculation of each component described in Section 2.7(a)(i)-(iv) above. The “Estimated<br />

Purchase Price” shall be a good faith estimate of the Purchase Price, as determined <strong>by</strong> the<br />

Company based upon the Company’s most recent financial statements as of the date of<br />

such estimate while taking into account to the extent reasonably possible changes in the<br />

Company’s financial position since the date of such financial statements, <strong>and</strong> prepared in<br />

accordance with the Accounting Principles Consistently Applied <strong>and</strong> the applicable<br />

definitions set forth in this Agreement.<br />

(c) Closing Date Payments. On the Closing Date, contemporaneously with<br />

the filing of the Certificate of Merger, Parent shall, or shall cause Newco or the Surviving<br />

Corporation to, make the following payments:<br />

- 16 -


(i) to each holder of a Stock Certificate (other than Stock Certificates<br />

representing Dissenting Shares) properly surrendered, together with a duly<br />

executed Letter of Transmittal, on or prior to the Closing Date in accordance with<br />

Section 2.8, the Per Share Closing Consideration in exchange for each share of<br />

Common Stock formerly evidenced there<strong>by</strong>;<br />

(ii) to the holders of the Closing Date Indebtedness, the amount of<br />

such Closing Date Indebtedness on behalf of the Company <strong>and</strong> its Subsidiaries <strong>by</strong><br />

wire transfer of immediately available funds as directed <strong>by</strong> the Representatives;<br />

(iii) to each payee of Company Expenses not paid <strong>by</strong> the Company or<br />

its Subsidiaries prior to the Closing, the amount of such Company Expenses, on<br />

behalf of the Company <strong>and</strong> its Subsidiaries as directed <strong>by</strong> the Representatives;<br />

<strong>and</strong><br />

(iv) to the Escrow Agent, an amount of cash equal to $30,000,000<br />

(such amount the “Escrow Amount” <strong>and</strong> such cash the “Escrow Funds”), to be<br />

held <strong>and</strong> disbursed <strong>by</strong> the Escrow Agent in accordance with the Escrow<br />

Agreement.<br />

The Estimated Purchase Price less any amounts paid under the preceding clauses (i) <strong>and</strong> (ii) shall<br />

be held in trust <strong>by</strong> the Surviving Corporation, in a segregated account, for the benefit of the<br />

Former Shareholders <strong>and</strong> holders of Dissenting Shares.<br />

(d) Preparation of the Final Statement of Purchase Price.<br />

(i) As soon as practicable, but no later than 60 days after the Closing<br />

Date, the Surviving Corporation shall prepare <strong>and</strong> deliver to the Representatives<br />

(A) a consolidated balance sheet of the Company as of the opening of business on<br />

the Closing Date, in the same form <strong>and</strong> including the same line items as the<br />

Company’s September 26, 2010 audited consolidated balance sheet (the<br />

“Proposed Closing Date Balance Sheet”), (B) a proposed calculation of Net<br />

Working Capital derived from the Proposed Closing Date Balance Sheet as of the<br />

opening of business on the Closing Date (the “Proposed Closing Date Statement<br />

of Net Working Capital”) <strong>and</strong> (C) a proposed calculation of the Purchase Price<br />

derived from the Proposed Closing Date Balance Sheet (the “Proposed Purchase<br />

Price Calculation” <strong>and</strong> together with the Proposed Closing Date Statement of Net<br />

Working Capital, the “Proposed Closing Date Calculations”) <strong>and</strong> the components<br />

thereof, in each case prepared in good faith, in accordance with the Accounting<br />

Principles Consistently Applied <strong>and</strong> the applicable definitions set forth in this<br />

Agreement, together with a certificate signed <strong>by</strong> the chief financial officer of the<br />

Surviving Corporation to the effect that the Proposed Closing Date Calculations<br />

were determined in good faith in accordance with the Accounting Principles<br />

Consistently Applied <strong>and</strong> the applicable definitions set forth in this Agreement.<br />

(ii) Upon receipt of the Proposed Closing Date Calculations, the<br />

Representatives shall have 30 days to review such calculations, together with any<br />

- 17 -


supporting schedules, analyses, working papers <strong>and</strong> other supporting<br />

documentation of the Company that the Representatives may request. If the<br />

Representatives do not give written notice of dispute (a “Purchase Price Dispute<br />

Notice”) to Parent prior to 5:00 p.m., New York City time, on the 30 th day<br />

following receipt of the Proposed Closing Date Calculations, the Representatives<br />

<strong>and</strong> the other parties hereto agree that, absent fraud, the Proposed Closing Date<br />

Calculations shall be deemed to set forth (A) the Net Working Capital as of the<br />

opening of business on the Closing Date <strong>and</strong> (B) the Purchase Price. Any<br />

Purchase Price Dispute Notice shall state each item to which the Representatives<br />

take exception <strong>and</strong> specify in reasonable detail the nature <strong>and</strong>, if known, the<br />

amount of any disagreement so asserted. If the Representatives give a Purchase<br />

Price Dispute Notice to Parent within such 30-day period, the Representatives <strong>and</strong><br />

Parent will use reasonable efforts to resolve the dispute during an additional 30day<br />

period commencing on the date Parent receives the applicable Purchase Price<br />

Dispute Notice from the Representatives. Any resolution <strong>by</strong> the Representatives<br />

during such 30-day period shall be set forth in writing <strong>and</strong>, absent fraud, shall be<br />

conclusive <strong>and</strong> binding upon the Representatives, Parent <strong>and</strong> the other parties<br />

hereto. If the Representatives <strong>and</strong> Parent do not obtain a final resolution within<br />

such additional 30-day period (or such longer period as they may mutually agree<br />

in writing), then the items in dispute shall be submitted immediately to the New<br />

York, New York office of PricewaterhouseCoopers LLP, or if such firm has a<br />

conflict or is otherwise unable to serve in such capacity, another independent<br />

registered public accounting firm mutually acceptable to the Representatives <strong>and</strong><br />

Parent (the “Accounting Firm”). The Accounting Firm shall be instructed to<br />

render a determination of the applicable dispute within 30 days after referral of<br />

the matter to the Accounting Firm, which determination must be in writing <strong>and</strong><br />

must set forth, in reasonable detail, the basis therefor. The determination of the<br />

Accounting Firm shall be conclusive <strong>and</strong> binding upon the Representatives,<br />

Parent <strong>and</strong> the other parties hereto, absent fraud, <strong>and</strong> judgment may be entered<br />

upon the determination of the Accounting Firm in any court having jurisdiction<br />

over the party against which such determination is to be enforced.<br />

The Accounting Firm shall determine, based solely on written submissions <strong>and</strong><br />

presentations <strong>by</strong> the Surviving Corporation, Parent <strong>and</strong> the Representatives <strong>and</strong> their respective<br />

representatives, <strong>and</strong> not <strong>by</strong> independent review, the disputed items set forth in the Purchase Price<br />

Dispute Notice (as the same may be supplemented prior to the submission of the matter to the<br />

Accounting Firm). In resolving any disputed item, the Accounting Firm shall be bound <strong>by</strong> the<br />

principles set forth in this Section 2.7 <strong>and</strong> shall not assign a value to any item greater than the<br />

greatest value for such item claimed <strong>by</strong> either party or less than the smallest value for such item<br />

claimed <strong>by</strong> either party. Each party shall use its reasonable best efforts to furnish to the<br />

Accounting Firm such work papers <strong>and</strong> other documents <strong>and</strong> information pertaining to the<br />

matters in dispute as the Accounting Firm may reasonably request. If any party fails to submit a<br />

statement regarding any items in dispute submitted to the Accounting Firm within the time<br />

determined <strong>by</strong> the Accounting Firm or otherwise fails to give the Accounting Firm access as<br />

reasonably requested, then the Accounting Firm shall render a decision based solely on the<br />

evidence timely submitted <strong>and</strong> the access afforded to the Accounting Firm <strong>by</strong> the other party.<br />

- 18 -


The Surviving Corporation will revise the Proposed Closing Date Calculations as<br />

appropriate to reflect the resolution of any objections thereto pursuant to this Section 2.7(d)(ii).<br />

The “Final Statement of Purchase Price” shall mean the Proposed Purchase Price Calculation<br />

together with any revisions thereto pursuant to this Section 2.7(d)(ii).<br />

(iii) In the event the Representatives <strong>and</strong> Parent submit any unresolved<br />

objections to the Accounting Firm for resolution as provided in Section<br />

2.7(d)(ii) above, the fees, costs <strong>and</strong> expenses of the Accounting Firm (i) shall be<br />

paid <strong>by</strong> Parent in the proportion that the aggregate dollar amount of such disputed<br />

items so submitted that are successfully disputed <strong>by</strong> the Representatives (as<br />

finally determined <strong>by</strong> the Accounting Firm) bears to the aggregate dollar amount<br />

of such items so submitted <strong>and</strong> (ii) shall be paid from the Escrow Funds in the<br />

proportion that the aggregate dollar amount of such disputed items so submitted<br />

that are unsuccessfully disputed <strong>by</strong> the Representatives (as finally determined <strong>by</strong><br />

the Accounting Firm) bears to the aggregate dollar amount of such items so<br />

submitted. The Accounting Firm shall include in its determination of any disputed<br />

items a determination, which shall be final <strong>and</strong> binding on the Representatives,<br />

Parent <strong>and</strong> the other parties hereto, of the aggregate portion of the Accounting<br />

Firm’s fees, costs <strong>and</strong> expenses that shall be borne <strong>by</strong> Parent or paid from the<br />

Escrow Funds in accordance with the provisions of this Section 2.7(d)(iii).<br />

(iv) Parent <strong>and</strong> the Surviving Corporation will cooperate with, make its<br />

financial records available to <strong>and</strong> otherwise assist the Representatives <strong>and</strong> their<br />

management, staff, accountants <strong>and</strong> other representatives at reasonable times<br />

during the review <strong>by</strong> the Representatives of, <strong>and</strong> the resolution of any objections<br />

with respect to, the Proposed Closing Date Calculations.<br />

(e) Adjustment to Estimated Purchase Price.<br />

(i) If the Actual Adjustment is a positive amount, the Surviving<br />

Corporation will pay to each Former Shareholder an amount equal to (x) the<br />

number of shares of Common Stock held <strong>by</strong> such former holder immediately prior<br />

to the Effective Time multiplied <strong>by</strong> (y) the Per Share Adjustment Amount, <strong>by</strong><br />

wire transfer or delivery of other immediately available funds, within three<br />

Business Days after the date on which the Purchase Price is finally determined<br />

pursuant to Section 2.7(d) above.<br />

(ii) If the Actual Adjustment is a negative amount, then within three<br />

Business Days after the date on which the Purchase Price is finally determined<br />

pursuant to Section 2.7(d) above, Parent <strong>and</strong> the Representatives shall deliver<br />

joint written instructions to the Escrow Agent instructing the Escrow Agent to<br />

deliver to the Surviving Corporation from the Escrow Account an amount equal to<br />

the absolute value of such negative amount.<br />

(iii) All payments under this Section 2.7(e) shall be treated as<br />

adjustments to the Merger Consideration for all Tax purposes except as otherwise<br />

required <strong>by</strong> applicable law.<br />

- 19 -


2.8 Letters of Transmittal <strong>and</strong> Stock Certificates.<br />

(a) Promptly after the date hereof, the Company shall mail or otherwise<br />

deliver a letter of transmittal substantially in the form attached as Exhibit C hereto (a<br />

“Letter of Transmittal”) to each record holder of Stock Certificates (other than Stock<br />

Certificates representing Dissenting Shares or for which a Letter of Transmittal has<br />

already been received) for return to the Company <strong>and</strong> instructions for use in effecting the<br />

surrender of the Stock Certificates <strong>and</strong> payment therefor.<br />

(b) Upon surrender of any Stock Certificates (other than Stock Certificates<br />

representing Dissenting Shares), together with a duly executed Letter of Transmittal, on<br />

or prior to the Closing Date, to Parent, Newco or the Surviving Corporation, the holder of<br />

each Stock Certificate shall receive from the Surviving Corporation on the Closing Date<br />

in exchange for each share of Common Stock formerly evidenced there<strong>by</strong>, the Per Share<br />

Closing Consideration.<br />

(c) Upon surrender of any Stock Certificates (other than Stock Certificates<br />

representing Dissenting Shares), together with a duly executed Letter of Transmittal, after<br />

the Closing Date, to Parent or the Surviving Corporation, the holder of each Stock<br />

Certificate shall receive from the Surviving Corporation as promptly as practicable<br />

following such surrender in exchange for each share of Common Stock formerly<br />

evidenced there<strong>by</strong>, the Per Share Closing Consideration.<br />

(d) Each share of Common Stock evidenced <strong>by</strong> such Stock Certificate so<br />

surrendered shall be canceled; provided, that notwithst<strong>and</strong>ing the cancellation of such<br />

share of Common Stock, the former holder thereof shall remain entitled to receive, for<br />

each share of Common Stock so canceled, the Per Share Holdback Amount <strong>and</strong> the Per<br />

Share Adjustment Amount. Following the Effective Time, until surrendered in<br />

accordance with the provisions of this Section 2.8, each share of Common Stock<br />

evidenced <strong>by</strong> such Stock Certificate so surrendered (other than Stock Certificates<br />

canceled pursuant to Section 2.6(b) <strong>and</strong> Stock Certificates representing Dissenting<br />

Shares) shall represent for all purposes only the right to receive the Per Share Closing<br />

Consideration, the Per Share Holdback Amount <strong>and</strong> the Per Share Adjustment Amount.<br />

(e) If payment or delivery is to be made to a Person other than the Person in<br />

whose name a Stock Certificate so surrendered is registered, it shall be a condition of<br />

payment that the Stock Certificate so surrendered shall be properly endorsed or otherwise<br />

in proper form for transfer, that the signatures on the Stock Certificate or any related<br />

stock power shall be properly guaranteed <strong>and</strong> that the Person requesting such payment<br />

either pay any transfer or other Taxes required <strong>by</strong> reason of the payment to a Person other<br />

than the registered holder of the Stock Certificate so surrendered or establish to the<br />

satisfaction of the Surviving Corporation that such Tax has been paid or is not applicable.<br />

(f) Any Person entitled to a portion of the Purchase Price who has provided<br />

wire transfer instructions to Parent prior to the Closing Date shall be entitled to payment<br />

<strong>by</strong> wire transfer on the Closing Date in accordance with the instructions specified in such<br />

Person’s Letter of Transmittal. No interest will be paid or will accrue for the benefit of<br />

- 20 -


the holders of Common Stock on the consideration payable upon the surrender of the<br />

Letters of Transmittal <strong>and</strong> the Stock Certificates.<br />

(g) In the event that any Stock Certificate (other than any Stock Certificate<br />

representing Dissenting Shares) shall have been lost, stolen or destroyed, upon the<br />

making of an affidavit of that fact <strong>by</strong> the registered holder of such lost, stolen or<br />

destroyed Stock Certificate in form <strong>and</strong> substance reasonably acceptable to Parent<br />

(if such affidavit is accepted before the Effective Time) or the Surviving Corporation (if<br />

such affidavit is accepted after the Effective Time), the Surviving Corporation will issue<br />

in exchange for such lost, stolen or destroyed Stock Certificate the applicable form of<br />

consideration in respect thereof in the manner set forth in Sections 2.7 <strong>and</strong> 2.8.<br />

(h) After the Effective Time, there shall be no transfers on the stock transfer<br />

books of the Surviving Corporation of the shares of Common Stock that were outst<strong>and</strong>ing<br />

immediately prior to the Effective Time. If, after the Effective Time, Stock Certificates<br />

(other than Stock Certificates representing Dissenting Shares) are presented to the<br />

Surviving Corporation for transfer, they shall be canceled <strong>and</strong> exchanged for the<br />

applicable consideration as provided for, <strong>and</strong> in accordance with, the provisions, of this<br />

Agreement.<br />

2.9 Dissenting Shares.<br />

Each share of Common Stock issued <strong>and</strong> outst<strong>and</strong>ing immediately prior to the Effective<br />

Time held <strong>by</strong> shareholders who shall have properly exercised their right to dissent to the Merger<br />

under Section 14A:11-1 et seq. of the New Jersey Corporation Act (“Dissenting Shares”) shall<br />

not be converted into the right to receive the applicable form of consideration pursuant to the<br />

Merger, but shall be entitled to receive payment of the fair value of such shares in accordance<br />

with the provisions of Section 14A:11-1 et seq. of the New Jersey Corporation Act, except that<br />

each Dissenting Share held <strong>by</strong> a shareholder who shall thereafter withdraw his or her dem<strong>and</strong> for<br />

appraisal or shall fail to perfect or shall otherwise waive or lose his or her right to such payment<br />

as provided in such Section 14A:11-1 et seq. shall be deemed to be converted, as of the Effective<br />

Time, into the right to receive the applicable form of consideration in the form such holder<br />

otherwise would have been entitled to receive as a result of the Merger.<br />

- 21 -


ARTICLE 3<br />

REPRESENTATIONS <strong>AND</strong> WARRANTIES <strong>OF</strong> THE COMPANY<br />

The Company here<strong>by</strong> represents <strong>and</strong> warrants to Parent <strong>and</strong> Newco as follows:<br />

3.1 Organization <strong>and</strong> Qualification.<br />

Each of the Company <strong>and</strong> its Subsidiaries is a corporation or limited liability company, as<br />

applicable, duly organized, validly existing <strong>and</strong> in good st<strong>and</strong>ing under the laws of its<br />

jurisdiction of organization specified on Schedule 3.1 of the Disclosure Letter <strong>and</strong> has the power<br />

<strong>and</strong> authority necessary to own or lease its property <strong>and</strong> assets <strong>and</strong> to carry on its business as<br />

presently conducted, <strong>and</strong> is duly qualified to do business as a foreign corporation or limited<br />

liability company, as applicable, <strong>and</strong> is in good st<strong>and</strong>ing in each jurisdiction wherein the nature<br />

of its business or the ownership of its assets makes such qualification necessary, except where<br />

the failure to be so qualified <strong>and</strong> in good st<strong>and</strong>ing would not, individually or in the aggregate,<br />

constitute a Material Adverse Effect. The Company has previously provided or made available<br />

to Parent <strong>and</strong> Newco true <strong>and</strong> complete copies of (i) its Certificate of Incorporation <strong>and</strong> its <strong>by</strong>laws<br />

as currently in effect <strong>and</strong> (ii) the certificate or articles of incorporation <strong>and</strong> <strong>by</strong>laws (or<br />

comparable organizational documents) as currently in effect of each of its Subsidiaries.<br />

3.2 Authorization.<br />

The Company has the corporate power <strong>and</strong> authority to execute <strong>and</strong> deliver this<br />

Agreement <strong>and</strong> each other Merger Document to be executed <strong>by</strong> the Company in connection<br />

herewith <strong>and</strong> to perform its obligations hereunder <strong>and</strong> thereunder, all of which have been duly<br />

authorized <strong>by</strong> all requisite corporate action, subject only to the adoption of this Agreement <strong>by</strong> the<br />

shareholders of the Company <strong>and</strong> the filing of the Certificate of Merger. This Agreement has<br />

been duly authorized, executed <strong>and</strong> delivered <strong>by</strong> the Company <strong>and</strong>, assuming that this<br />

Agreement has been duly <strong>and</strong> validly authorized, executed <strong>and</strong> delivered <strong>by</strong> the other parties<br />

hereto, constitutes a valid <strong>and</strong> binding agreement of the Company, enforceable against the<br />

Company in accordance with its terms, except to the extent that the enforceability thereof may be<br />

limited <strong>by</strong> applicable bankruptcy, insolvency, reorganization, moratorium, fraudulent<br />

conveyance or other laws from time to time in effect relating to creditors’ rights <strong>and</strong> remedies<br />

generally <strong>and</strong> general principles of equity.<br />

3.3 Non-contravention.<br />

Except as set forth on Schedule 3.3 of the Disclosure Letter, neither the execution <strong>and</strong><br />

delivery of this Agreement nor any other Merger Document, the consummation of the Merger<br />

<strong>and</strong> the other transactions contemplated here<strong>by</strong> nor the fulfillment of <strong>and</strong> the performance <strong>by</strong> the<br />

Company of its obligations hereunder will (i) contravene any provision contained in the<br />

Company’s Certificate of Incorporation or <strong>by</strong>-laws, (ii) conflict with, violate or result in a breach<br />

(with or without the lapse of time, the giving of notice or both) of, or constitute a default (with or<br />

without the lapse of time, the giving of notice or both) under, or require the consent or approval<br />

of any third party under, (A) any Contract required to be scheduled on Schedule 3.15 of the<br />

Disclosure Letter or Permit required to be scheduled on Schedule 3.8 of the Disclosure Letter or<br />

- 22 -


(B) assuming satisfaction of the requirements set forth in Section 3.4 below, any material<br />

judgment, order, decree, statute, law, rule or regulation or other restriction of any Governmental<br />

Authority, in each case to which the Company or any of its Subsidiaries is a party or <strong>by</strong> which<br />

the Company or any of its Subsidiaries is bound or to which any of their respective assets or<br />

properties are subject, or (iii) result in the acceleration of, or permit any Person to terminate,<br />

modify, cancel, accelerate or declare due <strong>and</strong> payable prior to its stated maturity, any material<br />

obligation of the Company or any of its Subsidiaries.<br />

3.4 Governmental Consents.<br />

No consent, approval, order, permit or authorization of, or registration, declaration, notice<br />

or filing with, any Governmental Authority is required <strong>by</strong> or with respect to the Company in<br />

connection with the execution <strong>and</strong> delivery of this Agreement <strong>by</strong> the Company or the<br />

consummation <strong>by</strong> the Company or its Subsidiaries of the Merger <strong>and</strong> the other transactions<br />

contemplated here<strong>by</strong>, except for those required under or in relation to the HSR Act or the New<br />

Jersey Corporation Act with respect to the filing of the Certificate of Merger, except for any<br />

consents, approvals, orders, permits, authorizations, registrations, declarations, notices <strong>and</strong><br />

filings for which no material consequences will arise from the failure to make or obtain them.<br />

3.5 Capitalization; Subsidiaries.<br />

(a) The Company’s authorized capital stock consists of (i) 2,500 authorized<br />

shares of voting common stock, no par value, 1,130 shares of which are issued <strong>and</strong><br />

outst<strong>and</strong>ing as of the date hereof, <strong>and</strong> (ii) 1,000,000 authorized shares of non-voting<br />

common stock, no par value, 403,608 shares of which are issued <strong>and</strong> outst<strong>and</strong>ing. As of<br />

the date hereof, the outst<strong>and</strong>ing shares of Common Stock are held of record <strong>by</strong> the<br />

Persons set forth on Schedule 3.5(a) of the Disclosure Letter in the amounts set forth<br />

opposite such Person’s name.<br />

(b) The Company does not have any outst<strong>and</strong>ing options or warrants relating<br />

to its capital stock or any outst<strong>and</strong>ing securities or obligations convertible into or<br />

exchangeable for, or giving any Person any right to subscribe for or acquire from it, any<br />

shares of its capital stock nor have any dividends been accrued or declared that are<br />

unpaid on the Company’s or the Subsidiaries’ capital stock. Except as set forth in this<br />

Agreement or in the Pappas Shareholders’ Agreement, there are no (i) outst<strong>and</strong>ing<br />

obligations of the Company to repurchase, redeem or otherwise acquire any capital stock<br />

of the Company or (ii) voting trusts, proxies or other agreements <strong>among</strong> the Company’s<br />

shareholders with respect to the voting or transfer of the Company’s capital stock. All of<br />

the issued <strong>and</strong> outst<strong>and</strong>ing shares of capital stock of the Company have been duly<br />

authorized, validly issued, are fully paid <strong>and</strong> are nonassessable.<br />

(c) Schedule 3.5(c) of the Disclosure Letter lists all Subsidiaries of the<br />

Company, including each Subsidiary’s authorized stock, outst<strong>and</strong>ing stock <strong>and</strong> record<br />

owner thereof. Except as set forth on Schedule 3.5(c) of the Disclosure Letter, all of the<br />

issued <strong>and</strong> outst<strong>and</strong>ing shares of capital stock of each Subsidiary of the Company are<br />

directly or indirectly owned <strong>by</strong> the Company free <strong>and</strong> clear of all Liens. No Subsidiary of<br />

the Company has any outst<strong>and</strong>ing options or warrants relating to its capital stock or any<br />

- 23 -


outst<strong>and</strong>ing securities or obligations convertible into or exchangeable for, or giving any<br />

Person any right to subscribe for or acquire from it, any shares of its capital stock. There<br />

are no (i) outst<strong>and</strong>ing obligations of any Subsidiary of the Company to repurchase,<br />

redeem or otherwise acquire any of its capital stock or (ii) voting trusts, proxies or other<br />

agreements <strong>among</strong> its shareholders with respect to the voting or transfer of the capital<br />

stock of such Subsidiary. All of the issued <strong>and</strong> outst<strong>and</strong>ing shares of capital stock of each<br />

Subsidiary of the Company have been duly authorized, validly issued, are fully paid <strong>and</strong><br />

are nonassessable.<br />

3.6 Financial Statements; Absence of Undisclosed Liabilities.<br />

(a) On or prior to the date hereof, the Company has made available to Parent<br />

true <strong>and</strong> correct copies of (i) the audited consolidated balance sheets of the Company<br />

(including the related notes) as of September 26, 2010, September 27, 2009 <strong>and</strong><br />

September 28, 2008 <strong>and</strong> the related consolidated statements of income <strong>and</strong><br />

comprehensive income, consolidated statements of retained earnings <strong>and</strong> consolidated<br />

statements of cash flows (including the related notes) for the years ended September 26,<br />

2010, September 27, 2009 <strong>and</strong> September 28, 2008 <strong>and</strong> (ii) the unaudited consolidated<br />

balance sheet of the Company (including the related notes) as of March 27, 2011 <strong>and</strong> the<br />

related consolidated statements of operations <strong>and</strong> consolidated statements of cash flows<br />

(including the related notes) for the twenty-six weeks ended March 27, 2011<br />

(collectively, the “Company Financial Statements”).<br />

(b) The Company Financial Statements were derived from <strong>and</strong> are consistent,<br />

in all material respects, with the books <strong>and</strong> records of the Company <strong>and</strong> present fairly, in<br />

all material respects, the consolidated financial position <strong>and</strong> consolidated results of<br />

operations <strong>and</strong> cash flows of the Company <strong>and</strong> its consolidated Subsidiaries as of the<br />

respective dates or for the respective periods set forth therein, all in conformity in all<br />

material respects with GAAP, except as otherwise noted therein or on Schedule 3.6(b)(i)<br />

<strong>and</strong> (ii) of the Disclosure Letter hereto, <strong>and</strong> subject, in the case of the unaudited interim<br />

financial statements, to the absence of certain notes <strong>and</strong> to normal year-end adjustments.<br />

(c) Neither the Company nor any of its Subsidiaries have any material<br />

liabilities or obligations of the nature required to be disclosed in a balance sheet prepared<br />

in accordance with GAAP other than (i) as reflected in the Company Financial<br />

Statements (including the related notes thereto), (ii) liabilities incurred after March 27,<br />

2011 in the Ordinary Course of Business, (iii) Liabilities otherwise disclosed on Schedule<br />

3.6(c) of the Disclosure Letter or the other Schedules to this Agreement, (iv) Liabilities<br />

incurred in connection with this Agreement <strong>and</strong> the transactions contemplated here<strong>by</strong> <strong>and</strong><br />

(v) executory liabilities under any contract or agreement to which the Company or any of<br />

its Subsidiaries is a party.<br />

- 24 -


3.7 Absence of Certain Developments.<br />

Except as set forth on Schedule 3.7 of the Disclosure Letter or as expressly permitted <strong>by</strong><br />

this Agreement, since March 27, 2011 to the date of this Agreement (i) there has not been any<br />

Material Adverse Effect, (ii) the Company <strong>and</strong> its Subsidiaries have conducted their business in<br />

the ordinary <strong>and</strong> usual course consistent with past practices, <strong>and</strong> (iii) there has not occurred any<br />

action or event that, had it occurred after the date of this Agreement, would have required the<br />

consent of Parent under Section 5.3. Since March 27, 2011 to the date of this Agreement, the<br />

Company <strong>and</strong> its Subsidiaries have not experienced any uninsured physical damage or<br />

destruction causing losses in excess of $75,000 to their tangible properties or assets.<br />

3.8 Compliance with Laws; Governmental Authorizations; Licenses; Etc.<br />

(a) Schedule 3.8 of the Disclosure Letter sets forth all material Permits issued<br />

or granted to the Company or any Subsidiary <strong>and</strong> in effect as of the date hereof. Except as<br />

set forth on Schedule 3.8 of the Disclosure Letter, (i) during the past three years, the<br />

Company or the applicable Subsidiary has not received written notice of any proceeding<br />

relating to the material noncompliance with, revocation or material modification of any<br />

such material Permits, (ii) the Company <strong>and</strong> its Subsidiaries have all material Permits,<br />

<strong>and</strong> have made all material notifications, registrations, certifications <strong>and</strong> filings with all<br />

Governmental Authorities, necessary or advisable for the operation of their business as<br />

currently conducted, <strong>and</strong> (iii) the Company <strong>and</strong> its Subsidiaries are in compliance in all<br />

material respects with all Laws (including the Food, Drug <strong>and</strong> Cosmetics Act). Neither<br />

the Company nor any of its Subsidiaries nor, to the Knowledge of the Company, any of<br />

their officers, directors or employees, has taken any action which would cause the<br />

Company to be in violation of the Foreign Corrupt Practices Act during the three years<br />

prior to the date of this Agreement. Except as set forth on Schedule 3.8, no proceeding<br />

has been filed, or to the Knowledge of the Company, threatened, against the Company or<br />

any Subsidiary alleging any failure <strong>by</strong> the Company or any Subsidiary to so comply in all<br />

material respects with applicable Laws.<br />

(b) To the Knowledge of the Company, since June 1, 2008 to the date of this<br />

Agreement, (i) no product produced <strong>by</strong> the Company has been the subject of a Recall or<br />

has been published on any list of Recalls <strong>by</strong> a Governmental Authority <strong>and</strong> (ii) to the<br />

Knowledge of the Company, no product produced <strong>by</strong> the Company is subject to a Recall<br />

that has been threatened <strong>by</strong> a Governmental Authority.<br />

(c) Notwithst<strong>and</strong>ing the foregoing, no representation or warranty is made<br />

under this Section 3.8 in respect of any (i) matters relating to Taxes, which are addressed<br />

in Section 3.10 (as to which no representation or warranty is made except as set forth in<br />

Section 3.10), (ii) matters relating to Environmental Laws, which are addressed in<br />

Section 3.11 (as to which no representation or warranty is made except as set forth in<br />

Section 3.11), <strong>and</strong> (iii) employee <strong>and</strong> employee benefit matters, which are addressed in<br />

Sections 3.12 <strong>and</strong> 3.13 (as to which no representation or warranty is made except as set<br />

forth in Sections 3.12 <strong>and</strong> 3.13).<br />

- 25 -


3.9 Litigation.<br />

Except as set forth on Schedule 3.9 of the Disclosure Letter, there are no lawsuits,<br />

actions, proceedings, claims or complaints <strong>by</strong> or before any Governmental Authority, pending or,<br />

to the Company’s Knowledge, threatened in writing against the Company or its Subsidiaries<br />

(i) relating to the Company, its Subsidiaries or their business or properties or (ii) seeking to<br />

enjoin the transactions contemplated here<strong>by</strong>. Except as set forth on Schedule 3.9 of the<br />

Disclosure Letter, neither the Company nor any of its Subsidiaries are subject to any order, writ,<br />

judgment, investigation or decree of any court or Governmental Authority.<br />

3.10 Taxes.<br />

Except as set forth on Schedule 3.10 of the Disclosure Letter:<br />

(a) (i) each of the Company <strong>and</strong> its Subsidiaries has duly <strong>and</strong> timely filed all<br />

Tax Returns with respect to any Income Taxes <strong>and</strong> all other material Tax Returns<br />

required to be filed (taking into account valid extensions) <strong>by</strong> it, <strong>and</strong> all such Tax Returns<br />

have been prepared in compliance with all applicable laws <strong>and</strong> regulations <strong>and</strong> are true,<br />

correct <strong>and</strong> complete, in all material respects <strong>and</strong> (ii) all Taxes owed <strong>by</strong> each of the<br />

Company <strong>and</strong> its Subsidiaries have been timely paid;<br />

(b) neither the Company nor any Subsidiary is currently the subject of a Tax<br />

audit or examination, <strong>and</strong> neither the Company nor any Subsidiary has received from any<br />

taxing authority any (i) written notice, or, to the Knowledge of the Company, any other<br />

notice indicating an intent to open a Tax audit or review of any Tax Return, (ii) written<br />

request for additional information related to Tax matters, or (iii) written notice of<br />

deficiency or proposed adjustment for any amount of Tax proposed, asserted, or assessed<br />

<strong>by</strong> any taxing authority against the Company or any Subsidiary;<br />

(c) neither the Company nor any Subsidiary is currently the beneficiary of any<br />

extension of time within which to file any Tax return <strong>and</strong> neither the Company nor any<br />

Subsidiary has consented to extend the time, or is the beneficiary of any extension of<br />

time, in which any Tax may be assessed or collected <strong>by</strong> any Governmental Authority;<br />

(d) no Governmental Authority with which the Company or a Subsidiary does<br />

not file Tax Returns has asserted in writing that the Company or any Subsidiary is or may<br />

be required to pay Taxes to or file Tax Returns with that Governmental Authority, nor, to<br />

the Knowledge of the Company, is there a reasonable factual basis for such an assertion<br />

for Tax periods ending on or before the Closing Date;<br />

(e) neither the Company nor any of its Subsidiaries (A) is a party to any<br />

“closing agreements” described in Code § 7121 (or any comparable provision of state,<br />

local or foreign Tax law) or (B) has requested or received any Tax ruling, in either case<br />

that would have continuing effect after the Closing Date;<br />

(f) the Company is <strong>and</strong> has been since March 27, 2000 a validly electing S<br />

corporation within the meaning of Section 1361 of the Code, <strong>and</strong> each of the Subsidiaries<br />

listed on Schedule 3.10(f) of the Disclosure Letter is <strong>and</strong> has been since the applicable<br />

- 26 -


date listed on Schedule 3.10(f) of the Disclosure Letter a “qualified subchapter S<br />

subsidiary” within the meaning of Code § 1361(b)(3)(B) of the Code;<br />

(g) (i) the Company <strong>and</strong> its Subsidiaries shall not be liable for any Tax under<br />

Code § 1374 (or any corresponding or similar provision of state, local, or non-U.S.<br />

income Tax law) in connection with the deemed sale of the Company <strong>and</strong> its<br />

Subsidiaries’ assets caused <strong>by</strong> the Section 338 Election contemplated in Section 5.10(d)<br />

of this Agreement; (ii) the Company has not, in the past ten years, (A) acquired assets<br />

from another corporation in a transaction in which the Company’s Tax basis was<br />

determined, in whole or in part, <strong>by</strong> reference to the Tax basis of the acquired assets (or<br />

any other property) in the h<strong>and</strong>s of the transferor or (B) acquired the stock of any<br />

corporation that is a “qualified subchapter S subsidiary” within the meaning of<br />

Code § 1361(b)(3)(B); <strong>and</strong> (iii) no Subsidiary is classified as a corporation for U.S.<br />

federal income tax purposes;<br />

(h) each of the Company <strong>and</strong> its Subsidiaries has withheld <strong>and</strong> paid to the<br />

appropriate taxing authority all Taxes required to have been withheld <strong>and</strong> paid;<br />

(i) neither the Company nor any Subsidiary has been included in an affiliated<br />

group filing a consolidated Tax return <strong>and</strong> neither the Company nor any Subsidiary has<br />

any liability for the Taxes of any Person under Treasury Regulations § 1.1502-6 (or any<br />

similar provision of state, local, or foreign law) as a transferee or successor, <strong>by</strong> contract<br />

or otherwise;<br />

(j) neither the Company nor any Subsidiary is a party to or bound <strong>by</strong> any Tax<br />

allocation or sharing agreement, or similar agreement (whether express or implied), with<br />

any third party, including any terminated agreement as to which the Company or any<br />

Subsidiary could have any continuing liabilities on or after the Closing Date;<br />

(k) there are no liens for Taxes (other than Taxes not yet due <strong>and</strong> payable or<br />

for Taxes that the taxpayer is contesting in good faith) upon any of the assets of the<br />

Company or any of its Subsidiaries;<br />

(l) neither the Company nor any Subsidiary will be required to include any<br />

item of income in, or exclude any item of deduction from, taxable income for any taxable<br />

period (or portion thereof) ending after the Closing Date as a result of any (i) change in<br />

method of accounting for any taxable period ending on or prior to the Closing Date, (ii)<br />

intercompany transaction or excess loss account described in Treasury Regulations under<br />

Code § 1502 (or any corresponding or similar provision of state, local or non-U.S.<br />

income Tax law), (iii) any installment or open transaction disposition made on or prior to<br />

the Closing Date, or (iv) prepaid amount received on or prior to the Closing Date;<br />

(m) neither the Company nor any Subsidiary has made or become obligated to<br />

make, nor will the Company or any Subsidiary, as a result of any event connected with<br />

the transactions contemplated here<strong>by</strong> <strong>and</strong>/or any termination of employment related to<br />

such transaction, make or become obligated to make any “excess parachute payment,” as<br />

defined in Code § 280G (without regard to (b)(4) thereof);<br />

- 27 -


(n) there are no joint ventures, partnerships or limited liability companies, or<br />

other arrangements or contracts to which the Company or any Subsidiary is a party <strong>and</strong><br />

that could be treated as a partnership for U.S. federal income Tax purposes; <strong>and</strong><br />

(o) no Tax Return filed on behalf of the Company or any Subsidiary for a<br />

taxable year after 2006 contains a disclosure statement with respect to the Company or<br />

any Subsidiary under Code § 6662 (or any predecessor statute) or any similar provision<br />

of law <strong>and</strong> neither the Company nor any Subsidiary has, directly or indirectly, entered<br />

into either a “reportable transaction” as defined <strong>by</strong> Code § 6707A(c)(i) or a “listed<br />

transaction” as defined in Treasury Regulations § 1.6011-4(b)(2).<br />

The representations <strong>and</strong> warranties in this Section 3.10 are the sole <strong>and</strong> exclusive<br />

representations <strong>and</strong> warranties of the Company concerning Tax matters.<br />

3.11 Environmental Matters.<br />

(a) Except as set forth on Schedule 3.11(a) of the Disclosure Letter, the<br />

Company <strong>and</strong> its Subsidiaries are in material compliance, <strong>and</strong> for the past three years<br />

have materially complied, with all applicable Environmental Laws <strong>and</strong> possess <strong>and</strong> are in<br />

material compliance with all material environmental Permits necessary or advisable for<br />

the operation of their business, assets, Owned Real Property <strong>and</strong> Leased Property as<br />

currently conducted (“Environmental Permits”). A list of all such Environmental Permits<br />

is set forth in Schedule 3.11(a) of the Disclosure Letter.<br />

(b) Except as set forth on Schedule 3.11(b) of the Disclosure Letter, during<br />

the past three years, the Company <strong>and</strong> its Subsidiaries have not received any written<br />

notice, written inquiry or written claim from any Governmental Authority or other Person<br />

regarding (i) any actual or alleged material violation of Environmental Laws, (ii) any<br />

material failure to have or comply with any Environmental Permit, or (iii) any material<br />

liabilities or material potential liabilities for personal injury, property damage or<br />

investigation or remediation obligations arising under Environmental Laws.<br />

(c) Except as set forth on Schedule 3.11(c) of the Disclosure Letter, the<br />

Company <strong>and</strong> its Subsidiaries have not received any written request for information,<br />

notice of claim, dem<strong>and</strong> or notification in the past three years or that remains unresolved<br />

that any of them is or may be potentially responsible with respect to any material<br />

investigation or remediation of any threatened or actual release of any Hazardous<br />

Substance.<br />

(d) Except as set forth on Schedule 3.11(d) of the Disclosure Letter, the<br />

Company <strong>and</strong> its Subsidiaries have not treated, used, stored, processed, disposed of,<br />

arranged for the disposal of, transported, h<strong>and</strong>led, produced, distributed, exposed any<br />

person to, released, spilled, discharged or emitted any Hazardous Substances in violation<br />

of Environmental Laws in a manner that has given or would reasonably be expected to<br />

give rise to material Losses pursuant to Environmental Laws.<br />

(e) Except as set forth on Schedule 3.11(e) of the Disclosure Letter, the<br />

Company <strong>and</strong> its Subsidiaries have not, either expressly or <strong>by</strong> operation of law assumed<br />

- 28 -


or undertaken any material liabilities, including any obligation for corrective or remedial<br />

action, of any other Person, relating to Environmental Laws.<br />

(f) Except as set forth on Schedule 3.11(f) of the Disclosure Letter, the<br />

Company has delivered to or otherwise made available for review <strong>by</strong> Parent correct <strong>and</strong><br />

complete copies of (i) all material Environmental Permits in effect as of the date of this<br />

Agreement <strong>and</strong> (ii) any material reports, studies, analyses, <strong>and</strong> reports of tests, or<br />

monitoring, in the possession or control of the Company pertaining to Hazardous<br />

Substances in, on, or under the Owned Real Property or Leased Property, or concerning<br />

non-compliance <strong>by</strong> the Company with Environmental Laws.<br />

(g) To the Company’s Knowledge, neither this Agreement nor the<br />

consummation of the transactions contemplated <strong>by</strong> this Agreement will result in any<br />

obligations of the Company or any Subsidiary for site investigation or cleanup, or consent<br />

of a Governmental Authority or other third parties under Environmental Laws.<br />

(h) The representations <strong>and</strong> warranties in this Section 3.11 are the sole <strong>and</strong><br />

exclusive representations <strong>and</strong> warranties of the Company concerning environmental<br />

matters, including matters arising under Environmental Laws.<br />

3.12 Employee Matters.<br />

(a) Except as set forth on Schedule 3.12(a) of the Disclosure Letter, (i) the<br />

Company <strong>and</strong> its Subsidiaries are not bound <strong>by</strong> any collective bargaining agreements<br />

with respect to their employees, (ii) there is no labor strike, work stoppage or lockout<br />

pending or, to the Company’s Knowledge, threatened in writing against the Company or<br />

any of its Subsidiaries, (iii) to the Company’s Knowledge, no union organization<br />

campaign is in progress with respect to any of the employees of the Company or its<br />

Subsidiaries, <strong>and</strong> (iv) there is no unfair labor practice, charge or complaint pending<br />

against the Company or any of its Subsidiaries, except, in the case of clauses (ii), (iii) or<br />

(iv), as would not, individually or in the aggregate, constitute a Material Adverse Effect.<br />

(b) Except as set forth on Schedule 3.12(b), the Company <strong>and</strong> its Subsidiaries<br />

are in compliance in all material respects with all applicable Laws respecting labor,<br />

employment, fair employment practices, terms <strong>and</strong> conditions of employment, plant<br />

closing laws, health <strong>and</strong> safety, workers’ compensation, employee classification <strong>and</strong><br />

wages <strong>and</strong> hours, <strong>and</strong> there are no charges or claims pending against the Company or its<br />

Subsidiaries before the Equal Employment Opportunity Commission, Department of<br />

Labor or any other federal, state or local agency which deals with unlawful employment<br />

practices.<br />

(c) Schedule 3.12(c) sets forth all written employment agreements between<br />

the Company or its Subsidiaries <strong>and</strong> any of their respective employees, in each case<br />

which is not terminable at-will. Except as set forth on Schedule 3.12(c) of the Disclosure<br />

Letter or for those temporary employees utilized <strong>by</strong> the Company <strong>and</strong> its Subsidiaries in<br />

the Ordinary Course of Business, neither the Company nor its Subsidiaries utilize any<br />

regular independent contractors or leased employees to perform services that would<br />

- 29 -


ordinarily be performed <strong>by</strong> employees of the Company or its Subsidiaries in connection<br />

with the business of the Company <strong>and</strong> its Subsidiaries.<br />

(d) To the Knowledge of the Company, no employee of the Company or its<br />

Subsidiaries is subject to any noncompetition or restrictive covenant agreements with any<br />

Person that would restrict such employee from providing to the Company or its<br />

Subsidiaries such services that such employee provides to the Company or its<br />

Subsidiaries as of the date of this Agreement.<br />

(e) The representations <strong>and</strong> warranties in this Section 3.12 <strong>and</strong> in Section 3.13<br />

are the sole <strong>and</strong> exclusive representations <strong>and</strong> warranties of the Company concerning<br />

employee <strong>and</strong> employee benefit plan matters.<br />

3.13 Employee Benefit Plans<br />

(a) Schedule 3.13(a) of the Disclosure Letter lists each Employee Benefit<br />

Plan. As applicable with respect to each Employee Benefit Plan, the Company has made<br />

available to Parent copies of (i) each Employee Benefit Plan, including all amendments<br />

thereto, (ii) all trust documents <strong>and</strong> insurance contracts relating thereto, (iii) the current<br />

summary plan description <strong>and</strong> each summary of material modifications thereto, (iv) the<br />

most recently filed annual report (Form 5500 <strong>and</strong> all schedules thereto) <strong>and</strong> (v) the most<br />

recent Internal Revenue Service (“IRS”) determination or opinion letter.<br />

(b) Except as set forth on Schedule 3.13(b) of the Disclosure Letter:<br />

(i) all Employee Benefit Plans have been maintained, funded <strong>and</strong><br />

administered in compliance with the terms of such plans, the terms of any<br />

applicable collective bargaining agreements, <strong>and</strong> all applicable laws, including<br />

ERISA <strong>and</strong> the Code, except where such noncompliance would not constitute a<br />

Material Adverse Effect;<br />

(ii) no Employee Benefit Plan, or any trustee or administrator thereof<br />

nor any “fiduciary” has engaged in any breach of fiduciary responsibility or any<br />

“prohibited transaction” (as such term is defined in Section 406 of ERISA or<br />

Section 4975 of the Code) for which an exemption does not apply <strong>and</strong> which<br />

would subject any such Employee Benefit Plan or trustee or administrator thereof,<br />

or the Company, Parent or any of their respective Subsidiaries, to a tax or penalty<br />

under Section 409 or Section 502 of ERISA, or Section 4975 of the Code, that<br />

would, individually or in the aggregate, constitute a Material Adverse Effect;<br />

(iii) each Employee Benefit Plan intended to qualify under Section<br />

401(a) of the Code has received a favorable determination, opinion or advisory<br />

letter from the IRS that such Employee Benefit Plan is a “qualified plan” under<br />

Section 401(a) of the Code <strong>and</strong> the related trusts are exempt from tax under<br />

Section 501(a) of the Code, <strong>and</strong>, to the Knowledge of the Company, no facts or<br />

circumstances exist that would be reasonably likely to jeopardize the qualification<br />

of such Employee Benefit Plan;<br />

- 30 -


(iv) except for the Retention Bonus Payments, the Change in Control<br />

Payments <strong>and</strong> the Company SERP or as otherwise disclosed on Schedule<br />

3.13(b)(iv) of the Disclosure Letter, the Company’s execution of, <strong>and</strong><br />

performance of the transactions contemplated <strong>by</strong>, this Agreement will not<br />

constitute an event under any Employee Benefit Plan that will result (without the<br />

occurrence of any other event) in any material payment, acceleration, vesting or<br />

increase in benefits with respect to any employee of the Company or any of its<br />

Subsidiaries; <strong>and</strong><br />

(v) neither the Company nor any of its Subsidiaries has any liability<br />

under any Employee Benefit Plan, or otherwise, to provide medical or death<br />

benefits with respect to current or former employees of the Company or any of its<br />

Subsidiaries beyond their termination of employment (other than coverage<br />

m<strong>and</strong>ated <strong>by</strong> Law).<br />

(c) Neither the Company nor any ERISA Affiliate (i) maintains, contributes<br />

to, is required to contribute to, or has any liability (contingent or otherwise) relating to<br />

any defined benefit pension plan that is subject to Part 3, Subtitle B of Title I of ERISA<br />

or Title IV of ERISA, (ii) contributes to or is required to contribute to, any<br />

Multiemployer Plan or (iii) has any liability (contingent or otherwise) relating to the<br />

withdrawal or partial withdrawal from a Multiemployer Plan.<br />

(d) The representations <strong>and</strong> warranties in this Section 3.13 <strong>and</strong> in Section 3.12<br />

are the sole <strong>and</strong> exclusive representations <strong>and</strong> warranties of the Company concerning<br />

employee <strong>and</strong> employee benefit plan matters.<br />

3.14 Intellectual Property Rights.<br />

(a)<br />

(i) Schedule 3.14(a)(i) of the Disclosure Letter sets forth a list of (A)<br />

all material registered Intellectual Property Rights owned <strong>by</strong> the Company or any<br />

of its Subsidiaries; <strong>and</strong> (B) all applications for the registration of Intellectual<br />

Property Rights owned <strong>by</strong> the Company or any of its Subsidiaries.<br />

(ii) Except as set forth on Schedule 3.14(a)(ii) of the Disclosure Letter,<br />

the Company or a Subsidiary owns all right, title <strong>and</strong> interest in <strong>and</strong> to the<br />

Intellectual Property Rights set forth on Schedule 3.14(a)(i) of the Disclosure<br />

Letter, <strong>and</strong> there is, to the Knowledge of the Company, no pending claim before<br />

any Governmental Authority against the Company or any of its Subsidiaries <strong>by</strong><br />

any third party contesting the validity, enforceability, or ownership of any<br />

Intellectual Property Right owned <strong>by</strong> the Company or any of its Subsidiaries.<br />

Except as set forth on Schedule 3.14(a)(ii) of the Disclosure Letter, (A) to the<br />

Knowledge of the Company, the conduct of the business of the Company <strong>and</strong> its<br />

Subsidiaries does not infringe, misappropriate or dilute the Intellectual Property<br />

Rights of others, <strong>and</strong> (B) the Company <strong>and</strong> its Subsidiaries have not received,<br />

within the two years prior to the date hereof, any written notice from a third party<br />

- 31 -


that any of them have infringed any Intellectual Property Rights of any third<br />

party.<br />

(iii) Except as set forth on Schedule 3.14(a) of the Disclosure Letter, to<br />

the Company’s Knowledge no third party is infringing or misappropriating any of<br />

the material Intellectual Property Rights owned <strong>by</strong> the Company or any of its<br />

Subsidiaries.<br />

(iv) Schedule 3.14(a) of the Disclosure Letter contains a complete <strong>and</strong><br />

correct list of all licenses of any kind relating to the material Intellectual Property<br />

Rights owned <strong>by</strong> the Company that have been granted <strong>by</strong> the Company or any<br />

Subsidiary to third parties.<br />

(b)<br />

(i) Schedule 3.14(b) of the Disclosure Letter contains a complete <strong>and</strong><br />

correct list of all written license agreements pursuant to which intellectual<br />

property of any third party used <strong>by</strong> the Company or any Subsidiary in the<br />

operation of its business as currently conducted is licensed to the Company or<br />

Subsidiary, except for off-the-shelf <strong>and</strong> click-through software available to the<br />

general public <strong>and</strong> other software that is generally available on nondiscriminatory<br />

terms (“Third-Party Intellectual Property”).<br />

(ii) The Company <strong>and</strong>, as applicable, its Subsidiaries have obtained<br />

licenses or other legal rights to use that are sufficient to permit the Company <strong>and</strong><br />

its Subsidiaries to operate <strong>and</strong> use all computer software used in the conduct of<br />

their respective businesses other than off-the-shelf <strong>and</strong> click-through software<br />

available to the general public <strong>and</strong> other software that is generally available on<br />

non-discriminatory terms, <strong>and</strong> all license fees, royalties, <strong>and</strong> other amounts (if<br />

any) due <strong>and</strong> payable under such licenses or agreements have been paid. The<br />

consummation of the transactions contemplated here<strong>by</strong> will not, pursuant to the<br />

terms of any written license agreement set forth on Schedule 3.14(b) of the<br />

Disclosure Letter, result in the loss or impairment of any rights of the Company or<br />

Subsidiary to use such Third-Party Intellectual Property.<br />

3.15 Contracts.<br />

Schedule 3.15 of the Disclosure Letter sets forth all written contracts (except for purchase<br />

or service orders executed in the normal course of business or real estate leases), agreements,<br />

leases, permits or licenses, to which, as of the date hereof, the Company or any Subsidiary is a<br />

party or is otherwise bound, of the type described below (the “Contracts”):<br />

(a) all agreements or commitments for the purchase or lease <strong>by</strong> the Company<br />

or any Subsidiary of delivery vehicles, machinery, equipment or other personal property<br />

other than those that are for amounts not in excess of $500,000 per annum;<br />

(b) all employment, consulting or other agreements with any individual<br />

director, officer, employee or independent contractor in each case to the extent providing<br />

- 32 -


annual compensation in excess of $100,000 <strong>and</strong> not terminable at-will, <strong>and</strong> all severance<br />

or other agreements with continuing obligations to any former individual director, officer,<br />

employee or independent contractor;<br />

(c) the license agreements set forth on Schedules 3.14(a) <strong>and</strong> (b) of the<br />

Disclosure Letter;<br />

(d) all agreements that materially restrict the Company or any Subsidiary from<br />

freely engaging in any business, except for use restrictions under licenses to Intellectual<br />

Property Rights entered into in the Ordinary Course of Business;<br />

(e) all mortgages, indentures, notes, bonds or other agreements relating to<br />

Indebtedness of the Company <strong>and</strong> its Subsidiaries;<br />

(f) any power of attorney that is currently effective <strong>and</strong> outst<strong>and</strong>ing with<br />

respect to any material business or asset of the Company <strong>and</strong> its Subsidiaries;<br />

(g) any written warranty or guaranty with respect to contractual performance<br />

extended <strong>by</strong> the Company or any Subsidiary other than in the Ordinary Course of<br />

Business;<br />

(h) any st<strong>and</strong><strong>by</strong> letters of credit, bank guarantees <strong>and</strong> surety bonds issued for<br />

the account of the Company or any Subsidiary <strong>by</strong> any bank, financial institution or surety<br />

company with respect to obligations of the Company or any Subsidiary;<br />

(i) any sales, marketing, distributorship, agency representative <strong>and</strong> valueadded<br />

reseller agreement involving amounts in excess of $1,000,000 per annum;<br />

(j) any agreement between the Company or any Subsidiary, on the one h<strong>and</strong>,<br />

<strong>and</strong> any Former Shareholder or an Affiliate (other than the Company or any Subsidiary)<br />

of any Former Shareholder, on the other h<strong>and</strong>;<br />

(k) all partnership agreements <strong>and</strong> joint venture agreements relating to the<br />

Company <strong>and</strong> its Subsidiaries;<br />

(l) any material agreement concerning confidentiality, except for such<br />

agreements entered into in connection with transactions or communications with third<br />

parties in the Ordinary Course of Business <strong>and</strong> such agreements entered into in<br />

contemplation of a possible acquisition transaction involving the Company or any<br />

Subsidiary;<br />

(m) all contracts with customers of the Company or its Subsidiaries involving<br />

amounts in excess of $2,000,000 per annum;<br />

(n) all contracts to supply goods or services to the Company or its<br />

Subsidiaries involving amounts in excess of $1,000,000 per annum;<br />

- 33 -


(o) all agreements <strong>by</strong> the Company, any of its Subsidiaries or any predecessor<br />

of the Company or any of its Subsidiaries to (i) acquire any capital stock or other equity<br />

interests, or any substantial portion of the assets of, any Person or (ii) sell or otherwise<br />

transfer any of their capital stock or other equity interests, or any substantial portion of<br />

their assets (including any acquisition, sale or transfer structured as a merger,<br />

consolidation, recapitalization or equity exchange), in each case that (x) were entered into<br />

<strong>by</strong> the Company, any of its Subsidiaries or any predecessor of the Company or any of its<br />

Subsidiaries within the past five years or (y) include material indemnification or payment<br />

obligations of the Company or any of its Subsidiaries continuing as of the date of this<br />

Agreement; <strong>and</strong><br />

(p) any commitment to do any of the foregoing described in clauses (a)<br />

through (o).<br />

Each Contract set forth on Schedule 3.15 of the Disclosure Letter is a valid <strong>and</strong> binding<br />

agreement of the Company or a Subsidiary, as applicable, enforceable in accordance with its<br />

terms (subject to applicable bankruptcy, insolvency, reorganization, moratorium or other laws<br />

affecting generally the enforcement of creditors’ rights <strong>and</strong> subject to general principles of<br />

equity). Except as set forth on Schedule 3.15 of the Disclosure Letter, the Company or a<br />

Subsidiary <strong>and</strong>, to the Knowledge of the Company, each of the other parties thereto, have<br />

performed all obligations required to be performed <strong>by</strong> them under, <strong>and</strong> are not in default under,<br />

any of such Contracts. No event has occurred which, with notice or lapse of time, or both, would<br />

constitute a default under any Contract, except for any such non-performance or defaults which<br />

would not, individually or in the aggregate, constitute a Material Adverse Effect. The Company<br />

has made available to Parent <strong>and</strong> Newco true <strong>and</strong> complete copies of all Contracts, including all<br />

amendments thereto. Neither the Company nor any Subsidiary is a party to a legally binding<br />

unwritten contract enforceable against the Company or any of its Subsidiaries that, if such<br />

contract were in writing, would constitute a “Contract” under this Agreement.<br />

3.16 Insurance.<br />

The Company has made available to Parent true <strong>and</strong> complete copies of all policies listed<br />

on Schedule 3.16 of the Disclosure Letter, which contains an accurate <strong>and</strong> complete list of all<br />

current (i.e., policies whose policy period includes the date hereof) policies of fire, liability,<br />

workers’ compensation, property, casualty <strong>and</strong> other forms of insurance owned or held <strong>by</strong> the<br />

Company <strong>and</strong> its Subsidiaries as of the date hereof. All such policies are (a) legal, valid <strong>and</strong><br />

binding obligations of the Company or a Subsidiary of the Company <strong>and</strong>, to the Knowledge of<br />

the Company, the other parties thereto <strong>and</strong> (b) in full force <strong>and</strong> effect as of the date hereof <strong>and</strong><br />

will continue in effect until Closing (or if such policies are canceled or lapse prior to Closing,<br />

renewals or reasonably equivalent replacements thereof will be entered into in the Ordinary<br />

Course of Business without any gaps in coverage occurring to the extent such renewals or<br />

replacements are available on commercially reasonable terms), <strong>and</strong> neither the Company nor any<br />

of its Subsidiaries nor, to the Knowledge of the Company, the insurers thereunder are in breach<br />

or default in any material respect under such policies. As of the date hereof, no notice of<br />

cancellation or termination has been received with respect to any such policy. The<br />

representations <strong>and</strong> warranties set forth in this Section 3.16 do not apply to insurance maintained<br />

- 34 -


or provided in connection with any Employee Benefit Plan, including the Executive Life<br />

Insurance Policies.<br />

3.17 Real Property.<br />

(a) Schedule 3.17(a) of the Disclosure Letter sets forth the address of each<br />

parcel of real property owned <strong>by</strong> the Company or its Subsidiaries (collectively, together<br />

with all appurtenant rights, easements <strong>and</strong> privileges <strong>and</strong> all improvements located on<br />

such real property, the “Owned Real Property”), <strong>and</strong> for each parcel of Owned Real<br />

Property, contains the correct (i) street address (if any) <strong>and</strong> (ii) record owner of such<br />

Owned Real Property. With respect to each parcel of Owned Real Property: (i) the<br />

Company or one of its Subsidiaries has good <strong>and</strong> marketable fee simple title, free <strong>and</strong><br />

clear of all Liens, except Permitted Liens or as set forth on Schedule 3.17(a) of the<br />

Disclosure Letter; (ii) except for Permitted Liens or as set forth on Schedule 3.17(a) of<br />

the Disclosure Letter, neither the Company nor any of the Subsidiaries has leased or<br />

otherwise granted to any Person the right to use or occupy such Owned Real Property or<br />

any portion thereof; <strong>and</strong> (iii) there are no outst<strong>and</strong>ing options, rights of first offer or rights<br />

of first refusal to purchase such Owned Real Property or any portion thereof or interest<br />

therein.<br />

(b) Schedule 3.17(b) of the Disclosure Letter sets forth (whether as lessee or<br />

lessor) a list of all leases of material real property (such real property, the “Leased<br />

Property”) to which the Company or any Subsidiary is a party or <strong>by</strong> which it is bound, in<br />

each case as of the date hereof (each a “Material Lease”). Except as set forth on<br />

Schedule 3.17(b) of the Disclosure Letter, each Material Lease is valid <strong>and</strong> binding on the<br />

Company or a Subsidiary <strong>and</strong>, to the Company’s Knowledge, on the other parties thereto<br />

<strong>and</strong> is in full force <strong>and</strong> effect. Except as set forth on Schedule 3.17 of the Disclosure<br />

Letter, the Company or a Subsidiary <strong>and</strong>, to the Company’s Knowledge, each of the other<br />

parties thereto has performed in all material respects all obligations required to be<br />

performed <strong>by</strong> it under each Material Lease <strong>and</strong> to the Knowledge of the Company, no<br />

event has occurred that with notice or lapse of time, or both, would constitute a default <strong>by</strong><br />

the Company or Subsidiary as the case may be.<br />

(c) All buildings, material fixtures <strong>and</strong> material improvements on the Owned<br />

Real Property <strong>and</strong>, to the Knowledge of the Company, real property leased <strong>by</strong> the<br />

Company or any Subsidiary pursuant to the Material Leases, are in good operating<br />

condition <strong>and</strong> repair, subject to normal wear <strong>and</strong> tear <strong>and</strong> except for deviations from such<br />

good operating condition <strong>and</strong> repair that are not individually or in the aggregate material<br />

in nature or cost to the business of the Company <strong>and</strong> its Subsidiaries taken as a whole,<br />

<strong>and</strong> are adequate for the uses to which they are currently being put, <strong>and</strong> shall be adequate<br />

for the conduct of the business of the Company <strong>and</strong> its Subsidiaries immediately<br />

following the Closing in substantially the same manner as conducted prior to the Closing.<br />

The use of the Owned Real Property <strong>and</strong> the real property leased to the Company or its<br />

Subsidiaries under the Material Leases does not violate in any material respect any<br />

applicable Law or any covenant, restriction or easement with respect to the Owned Real<br />

Property or, to the Knowledge of the Company, the Leased Property. Except as set forth<br />

on Schedule 3.17(c) of the Disclosure Letter, no buildings, material fixtures or material<br />

- 35 -


improvements on the Owned Real Property <strong>and</strong>, to the Knowledge of the Company, real<br />

property leased pursuant to the Material Leases are in need of maintenance or repairs<br />

except for maintenance <strong>and</strong> repairs that are not individually or in the aggregate material<br />

in nature or cost to the business of the Company <strong>and</strong> its Subsidiaries taken as a whole.<br />

The Owned Real Property <strong>and</strong>, to the Company’s Knowledge, the Leased Property<br />

complies in all material respects with all applicable Laws <strong>and</strong> is benefited <strong>by</strong> those<br />

licenses or permits required to be maintained <strong>by</strong> the Company <strong>and</strong> its Subsidiaries for the<br />

development, or use or occupancy of any portion of the Owned Real Property or Leased<br />

Property.<br />

3.18 Title to Assets.<br />

The Company <strong>and</strong> its Subsidiaries have good title to all of their respective tangible assets<br />

<strong>and</strong> properties (including those reflected on the Company’s balance sheet as of September 26,<br />

2010, but excluding any such tangible assets <strong>and</strong> properties sold, consumed, or otherwise<br />

disposed of in the Ordinary Course of Business since September 26, 2010) as is necessary to<br />

permit the use <strong>and</strong> enjoyment of such tangible assets <strong>and</strong> properties taken as a whole<br />

substantially in the manner such tangible assets <strong>and</strong> properties are now utilized <strong>by</strong> the Company<br />

<strong>and</strong> its Subsidiaries, free <strong>and</strong> clear of all Liens except for Permitted Liens <strong>and</strong> except as set forth<br />

on Schedule 3.18 of the Disclosure Letter. Except for reasonable wear <strong>and</strong> tear or as set forth on<br />

Schedule 3.18 of the Disclosure Letter, all material machinery, equipment, vehicles <strong>and</strong> tools<br />

used or held for use <strong>by</strong> the Company <strong>and</strong> its Subsidiaries are in good operating condition, except<br />

where the failure of such assets to be in good operating condition would not limit the Company<br />

<strong>and</strong> its Subsidiaries from operating immediately following the Closing (as the Surviving<br />

Corporation <strong>and</strong> its Subsidiaries) substantially in the same manner as the Company <strong>and</strong> its<br />

Subsidiaries operate as of the date of this Agreement.<br />

3.19 Related-Party Transactions.<br />

Except as set forth on Schedule 3.19 of the Disclosure Letter, none of the Company’s or<br />

its Subsidiaries’ directors, executive officers or shareholders (or any spouse, parent, child, sibling<br />

or corresponding relative <strong>by</strong> marriage of any such Person) is involved in any business<br />

arrangement or relationship with the Company or any Subsidiary other than employment<br />

arrangements entered into in the Ordinary Course of Business, <strong>and</strong> none of the Company’s or its<br />

Subsidiaries’ directors, executive officers or 5% holders of Common Stock owns any material<br />

property or right, tangible or intangible, which is used <strong>by</strong> the Company or its Subsidiaries.<br />

3.20 Brokers.<br />

Except for Goldman Sachs & Co., no Person engaged <strong>by</strong> the Company, its Affiliates or<br />

shareholders is or will be entitled to a broker’s, finder’s, investment banker’s, financial adviser’s<br />

or similar fee from the Company or its Subsidiaries in connection with this Agreement or any of<br />

the transactions contemplated here<strong>by</strong>.<br />

- 36 -


3.21 Customers <strong>and</strong> Suppliers.<br />

Schedule 3.21 of the Disclosure Letter lists each customer that individually or with its<br />

Affiliates was, based on revenues in the fiscal year ended September 26, 2010, one of the twenty<br />

largest customers of the Company <strong>and</strong> its Subsidiaries during such fiscal year (the “Principal<br />

Customers”). Schedule 3.21 of the Disclosure Letter also lists the twenty largest suppliers or<br />

service providers to the Company <strong>and</strong> its Subsidiaries based on the amount paid <strong>by</strong> the Company<br />

<strong>and</strong> its Subsidiaries to such suppliers or service providers in the fiscal year ended September 26,<br />

2010 (the “Principal Suppliers”). Except as disclosed on Schedule 3.21 of the Disclosure Letter,<br />

since September 26, 2010 through the date hereof: (a) no Principal Customer or Principal<br />

Supplier has delivered written notice to the Company or any of its Subsidiaries, or, to the<br />

Knowledge of the Company, otherwise advised the Company or any of its Subsidiaries, that such<br />

Principal Customer or Principal Supplier has canceled or otherwise terminated, or intends to<br />

cancel or terminate after the Closing, its relationship with the Company or any Subsidiary, <strong>and</strong><br />

(b) no Principal Customer has delivered written notice to the Company or any of its Subsidiaries<br />

or, to the Knowledge of the Company, otherwise advised the Company or any of its Subsidiaries,<br />

that such Principal Customer will reduce such Principal Customer’s total purchases from the<br />

Company <strong>and</strong> its Subsidiaries <strong>by</strong> more than $2,000,000 in any future annual period.<br />

3.22 Bank Accounts.<br />

Schedule 3.22 of the Disclosure Letter sets forth a correct <strong>and</strong> complete list as of the date<br />

hereof of each deposit account maintained <strong>by</strong> the Company <strong>and</strong> its Subsidiaries at any bank or<br />

other financial institution, including the following information for each such account: (a) the<br />

name <strong>and</strong> location of the institution at which such account is maintained, (b) the name in which<br />

such account is maintained <strong>and</strong> the account number of such account, <strong>and</strong> (c) the names of all<br />

individuals authorized to draw on or make withdrawals from such account.<br />

3.23 NO ADDITIONAL REPRESENTATIONS.<br />

EXCEPT AS OTHERWISE EXPRESSLY SET FORTH IN ARTICLE 3 <strong>OF</strong> THIS<br />

<strong>AGREEMENT</strong>, THE COMPANY EXPRESSLY DISCLAIMS ANY REPRESENTATIONS OR<br />

WARRANTIES <strong>OF</strong> ANY KIND OR NATURE, EXPRESS OR IMPLIED, INCLUDING AS<br />

TO THE CONDITION, VALUE OR QUALITY <strong>OF</strong> THE BUSINESS OR THE ASSETS <strong>OF</strong><br />

THE COMPANY, <strong>AND</strong> THE COMPANY SPECIFICALLY DISCLAIMS ANY<br />

REPRESENTATION OR WARRANTY <strong>OF</strong> MERCHANTABILITY, USAGE, SUITABILITY<br />

OR FITNESS FOR ANY PARTICULAR PURPOSE WITH RESPECT TO THE ASSETS <strong>OF</strong><br />

THE COMPANY, OR ANY PART THERE<strong>OF</strong>, OR AS TO THE WORKMANSHIP<br />

THERE<strong>OF</strong>, OR THE ABSENCE <strong>OF</strong> ANY DEFECTS THEREIN, WHETHER LATENT OR<br />

PATENT, IT BEING UNDERSTOOD THAT SUCH ASSETS ARE BEING ACQUIRED “AS<br />

IS, WHERE IS” ON THE CLOSING DATE, <strong>AND</strong> IN THEIR PRESENT CONDITION, <strong>AND</strong><br />

PARENT <strong>AND</strong> NEWCO SHALL RELY ON THEIR OWN EXAMINATION <strong>AND</strong><br />

INVESTIGATION THERE<strong>OF</strong>.<br />

- 37 -


ARTICLE 4<br />

REPRESENTATIONS <strong>AND</strong> WARRANTIES <strong>OF</strong> PARENT <strong>AND</strong> NEWCO<br />

Parent <strong>and</strong> Newco jointly <strong>and</strong> severally represent <strong>and</strong> warrant to the Company:<br />

4.1 Organization.<br />

Each of Parent <strong>and</strong> Newco is a corporation duly organized, validly existing <strong>and</strong> in good<br />

st<strong>and</strong>ing under the laws of its jurisdiction of organization <strong>and</strong> has all requisite power <strong>and</strong><br />

authority to own, lease <strong>and</strong> operate its property <strong>and</strong> assets <strong>and</strong> to carry on its business as<br />

presently conducted. Each of Parent <strong>and</strong> Newco has delivered or made available to the Company<br />

true <strong>and</strong> complete copies of its certificate of incorporation <strong>and</strong> <strong>by</strong>-laws (or comparable<br />

organizational documents) as currently in effect.<br />

4.2 Authorization.<br />

Each of Parent <strong>and</strong> Newco has the power <strong>and</strong> authority to execute <strong>and</strong> deliver this<br />

Agreement <strong>and</strong> each other agreement or instrument to be executed in connection herewith <strong>and</strong> to<br />

perform its obligations hereunder <strong>and</strong> thereunder, all of which have been duly authorized <strong>by</strong> all<br />

requisite action (including any required shareholder or member approvals). This Agreement <strong>and</strong><br />

each other agreement or instrument to be executed in connection herewith has been duly<br />

authorized, executed <strong>and</strong> delivered <strong>by</strong> Parent <strong>and</strong> Newco <strong>and</strong> constitutes a valid <strong>and</strong> binding<br />

agreement of Parent <strong>and</strong> Newco, enforceable against Parent <strong>and</strong> Newco in accordance with its<br />

terms.<br />

4.3 Non-contravention.<br />

The execution, delivery <strong>and</strong> performance <strong>by</strong> Parent <strong>and</strong> Newco of this Agreement <strong>and</strong><br />

any other Merger Document, the consummation of the Merger <strong>and</strong> the other transactions<br />

contemplated here<strong>by</strong> do not <strong>and</strong> will not (i) contravene any provision contained in such entity’s<br />

certificate of incorporation or <strong>by</strong>-laws (or comparable organizational documents), (ii) conflict<br />

with, violate or result in a material breach (with or without the lapse of time, the giving of notice<br />

or both) of or constitute a material default (with or without the lapse of time, the giving of notice<br />

or both) under, or require the consent or approval of any third party under (A) any contract,<br />

agreement, commitment, indenture, mortgage, lease, pledge, note, bond, license, permit or other<br />

instrument or obligation or (B) assuming satisfaction of the requirements set forth in Section 4.4<br />

below, any material judgment, order, decree, statute, law, rule or regulation or other restriction of<br />

any Governmental Authority, in each case to which such entity is a party or <strong>by</strong> which it is bound<br />

or to which any of its assets or properties are subject, or (iii) result in the acceleration of, or<br />

permit any Person to terminate, modify, cancel, accelerate or declare due <strong>and</strong> payable prior to its<br />

stated maturity, any material obligation of such entity.<br />

- 38 -


4.4 No Consents.<br />

Except for (i) filing <strong>and</strong> recordation of appropriate merger documents as required <strong>by</strong> the<br />

New Jersey Corporation Act <strong>and</strong> (ii) filings, permits, authorizations, consents <strong>and</strong> approvals<br />

required under, <strong>and</strong> other applicable requirements of, the HSR Act, no notice to, filing with, or<br />

authorization, registration, consent or approval of any Governmental Authority is necessary for<br />

the execution, delivery or performance of this Agreement or the consummation of the<br />

transactions contemplated here<strong>by</strong> <strong>by</strong> Parent <strong>and</strong> Newco, except for any consents, approvals,<br />

orders, permits, authorizations, registrations, declarations, notices <strong>and</strong> filings for which no<br />

material consequences will arise from the failure to make or obtain them.<br />

4.5 Litigation.<br />

Neither Parent nor Newco is party to any litigation or, to the Knowledge of Parent or<br />

Newco, threatened litigation which would reasonably be expected to affect or prohibit the<br />

consummation of the transactions contemplated here<strong>by</strong>.<br />

4.6 Financial Ability.<br />

(a) Exhibit D attached hereto sets forth a correct <strong>and</strong> complete copy of an<br />

executed commitment letter (with attached Summary of Terms <strong>and</strong> Conditions) (together<br />

with the related fee letter (containing “flex” provisions therein), collectively, including<br />

such “flex” provisions, the “Commitment Letter”), which has been provided in the form<br />

executed to the Company, except that monetary amounts, percentages <strong>and</strong> provisions that<br />

identify matters that are subject to such “flex” provisions in the fee letter have been<br />

redacted therefrom, from Jefferies Finance LLC <strong>and</strong> Bank of Montreal to provide<br />

financing, subject only to the terms <strong>and</strong> conditions set forth therein, in an aggregate<br />

amount set forth therein for the purposes of financing the transactions contemplated <strong>by</strong><br />

this Agreement, the other purposes set forth therein <strong>and</strong> any related fees <strong>and</strong> expenses<br />

(the “Financing”). The Commitment Letter is in full force <strong>and</strong> effect <strong>and</strong> has not been<br />

withdrawn or terminated, or otherwise amended or modified, in any material respect<br />

except in accordance with the provisions of Section 5.5 hereof; <strong>and</strong> no withdrawal,<br />

termination, amendment or modification is contemplated <strong>by</strong> Parent or Lassonde or, to<br />

Parent’s Knowledge, the Lenders. The Commitment Letter is a legal, valid, binding <strong>and</strong><br />

enforceable obligation of Parent <strong>and</strong>, to Parent’s Knowledge, the Lenders. There are no<br />

other agreements, side letters or arrangements relating to the Commitment Letter to<br />

which Parent or any of its Affiliates is a party that could affect the availability of the<br />

Financing. As of the date of this Agreement, subject to the satisfaction of the conditions<br />

set forth in Sections 6.1 <strong>and</strong> 6.2 hereof, Parent has no Knowledge of any facts or<br />

circumstances that may be expected to result in either Parent’s or Newco’s inability to<br />

satisfy any of the conditions to closing set forth in the Commitment Letter to be satisfied<br />

<strong>by</strong> Parent or Newco on or before the date of the Closing. No event has occurred which,<br />

with or without notice, lapse of time or both, would constitute a default or breach on the<br />

part of Parent or Newco under any term or condition of the Commitment Letter, <strong>and</strong><br />

neither Parent nor Newco has any reason to believe that it will be unable to satisfy on a<br />

timely basis any term or condition to be satisfied <strong>by</strong> it contained in the Commitment<br />

Letter. Parent has fully paid any <strong>and</strong> all commitment fees or other fees required to be paid<br />

- 39 -


y it under the Commitment Letter. The Commitment Letter contains all of the conditions<br />

precedent to the obligations of the Lenders to make the Financing available to Parent <strong>and</strong><br />

Newco on the terms therein. The redacted portions of the Commitment Letter do not<br />

contain any conditions precedent to the obligations of the Lenders to make the Financing<br />

available to Parent <strong>and</strong> Newco. The amount of funds contemplated to be provided<br />

pursuant to the Commitment Letter, together with Parent’s available access to funds, will<br />

be sufficient to enable Parent <strong>and</strong> Newco to pay <strong>and</strong> satisfy all of their obligations under<br />

this Agreement, to consummate the Merger <strong>and</strong> the transactions contemplated <strong>by</strong> this<br />

Agreement <strong>and</strong> to pay all related fees <strong>and</strong> expenses that are the obligation of Parent or<br />

Newco to pay; <strong>and</strong> such funds <strong>and</strong> available access to funds are not subject to any<br />

conditions regarding Parent’s, its Affiliates’ or any other Person’s ability to obtain<br />

financing for the consummation of the transactions contemplated <strong>by</strong> this Agreement<br />

except as provided in the Commitment Letter.<br />

4.7 Acknowledgement <strong>by</strong> Parent <strong>and</strong> Newco.<br />

Each of Parent <strong>and</strong> Newco acknowledges <strong>and</strong> agrees that:<br />

(a) except for the matters that are expressly covered <strong>by</strong> the provisions of this<br />

Agreement, it is relying solely on its own investigation <strong>and</strong> analysis in entering into the<br />

transactions contemplated here<strong>by</strong>. It is knowledgeable about the industries in which the<br />

Company <strong>and</strong> its Subsidiaries operate <strong>and</strong> is capable of evaluating the merits <strong>and</strong> risks of<br />

the transactions contemplated <strong>by</strong> this Agreement <strong>and</strong> is able to bear the substantial<br />

economic risk of such investment for an indefinite period of time. It has been afforded<br />

access to the books, records, facilities <strong>and</strong> personnel of the Company <strong>and</strong> its Subsidiaries<br />

as requested <strong>by</strong> it for purposes of conducting a due diligence investigation <strong>and</strong> has<br />

conducted a full due diligence investigation of the Company <strong>and</strong> its Subsidiaries;<br />

(b) in connection with its investigation of the Company <strong>and</strong> its Subsidiaries<br />

<strong>and</strong> their business, it has received from the Company <strong>and</strong> their Affiliates <strong>and</strong> agents<br />

certain projections <strong>and</strong> other forecasts, including projected financial statements, cash<br />

flow items, certain business plan information <strong>and</strong> other data of the business of the<br />

Company <strong>and</strong> its Subsidiaries. It acknowledges that (i) there are uncertainties inherent in<br />

attempting to make such projections, forecasts <strong>and</strong> plans <strong>and</strong>, accordingly, is not relying<br />

on them, (ii) it is familiar with such uncertainties <strong>and</strong> is taking full responsibility for<br />

making its own evaluation of the adequacy <strong>and</strong> accuracy of all projections, forecasts <strong>and</strong><br />

plans so furnished to it <strong>and</strong> (iii) it shall have no claim against anyone with respect to any<br />

of the foregoing. Accordingly, it acknowledges that, without limiting the representations<br />

<strong>and</strong> warranties set forth in Article 3, neither the Company nor any of its Subsidiaries has<br />

made any representation or warranty with respect to such projections <strong>and</strong> other forecasts<br />

<strong>and</strong> plans; <strong>and</strong><br />

(c) (i) the Company does not make, <strong>and</strong> has not made (<strong>and</strong> Parent <strong>and</strong> Newco<br />

are not relying on), any representations or warranties relating to the Company, the<br />

Company’s Subsidiaries, the business of the Company or any of its Subsidiaries or<br />

otherwise in connection with the transactions contemplated here<strong>by</strong> other than those<br />

expressly set forth in Article 3, (ii) no Person has been authorized <strong>by</strong> the Company to<br />

- 40 -


make any representation or warranty relating to the Company, the Company’s<br />

Subsidiaries, the business of the Company or its Subsidiaries or otherwise in connection<br />

with the transactions contemplated here<strong>by</strong> except as set forth in Article 3 <strong>and</strong>, if made,<br />

such representation or warranty must not be relied upon as having been authorized <strong>by</strong> the<br />

Company, <strong>and</strong> (iii) any estimates, projections, predictions, data, financial information,<br />

memor<strong>and</strong>a, presentations or any other materials or information provided or addressed to<br />

it are not <strong>and</strong> shall not be deemed to be or to include representations or warranties of the<br />

Company or any of their respective Affiliates.<br />

4.8 Brokers.<br />

Except for Jefferies & Company, Inc., no Person engaged <strong>by</strong> Parent or its Affiliates or<br />

stockholders is or will be entitled to a broker’s, finder’s, investment banker’s, financial adviser’s<br />

or similar fee from Parent or Newco in connection with this Agreement or any of the transactions<br />

contemplated here<strong>by</strong>.<br />

5.1 Shareholder Matters.<br />

ARTICLE 5<br />

COVENANTS <strong>AND</strong> <strong>AGREEMENT</strong>S<br />

The Company shall, in accordance with the New Jersey Corporation Act <strong>and</strong> its<br />

Certificate of Incorporation <strong>and</strong> <strong>by</strong>-laws, seek to obtain the requisite approval <strong>and</strong> adoption of<br />

this Agreement <strong>and</strong> the Merger <strong>by</strong> the shareholders of the Company pursuant to the New Jersey<br />

Corporation Act (the “Company Shareholder Approval”).<br />

5.2 Access <strong>and</strong> Information.<br />

(a) From the date hereof until the Closing Date or earlier termination of this<br />

Agreement, <strong>and</strong> except to the extent Parent <strong>and</strong> Newco are in breach of this Agreement,<br />

Parent <strong>and</strong> Newco shall be entitled to access to the Company <strong>and</strong> its Subsidiaries as<br />

Parent <strong>and</strong> Newco deem reasonably necessary or advisable during normal business hours<br />

<strong>and</strong> upon advance notice, <strong>and</strong> the Company shall cooperate with any such reasonable<br />

access to the extent such access does not unreasonably interfere with the operations,<br />

activities <strong>and</strong> employees of the Company <strong>and</strong> its Subsidiaries. All requests for<br />

information pursuant to this Section 5.2 shall be directed to the executive officer(s) or<br />

other Person(s) designated <strong>by</strong> the Company. The foregoing access rights shall not include<br />

the right to (i) take any samples or conduct any environmental reviews or investigations<br />

unless approved in advance <strong>by</strong> the Company in its sole discretion, (ii) have access to any<br />

information the disclosure of which is restricted <strong>by</strong> contract or applicable law (including<br />

competition or antitrust law) or which would result in the waiver of any privileges, or (iii)<br />

have access to any customer or supplier lists, know-how or other proprietary knowledge<br />

of the Company or its Subsidiaries. Parent <strong>and</strong> Newco <strong>and</strong> their representatives <strong>and</strong><br />

agents shall not contract or hold discussions with suppliers or customers of the Company<br />

or its Subsidiaries without the prior written consent of the Company <strong>and</strong> in any event<br />

only with the participation of representatives of the Company. Parent <strong>and</strong> Newco agree to<br />

- 41 -


conduct any such discussions with reasonable discretion <strong>and</strong> sensitivity to the Company’s<br />

<strong>and</strong> its Subsidiaries’ relationships with its suppliers, customers <strong>and</strong> employees.<br />

(b) All information disclosed, whether before or after the date hereof,<br />

pursuant to this Agreement or in connection with the transactions contemplated <strong>by</strong>, or the<br />

discussions <strong>and</strong> negotiations preceding, this Agreement to Parent <strong>and</strong> Newco (or their<br />

representatives or Affiliates) shall be kept confidential <strong>by</strong> such Persons in accordance<br />

with the confidentiality agreement dated January 31, 2011 <strong>by</strong> <strong>and</strong> between Goldman<br />

Sachs & Co., as agent for the Company, <strong>and</strong> Parent (the “Confidentiality Agreement”)<br />

<strong>and</strong> shall not be used <strong>by</strong> any Person, other than in connection with the transactions<br />

contemplated <strong>by</strong> this Agreement.<br />

(c) After the Closing Date, Parent shall make available <strong>and</strong> shall cause the<br />

Surviving Corporation to make available to the Representatives <strong>and</strong> their accountants,<br />

agents <strong>and</strong> representatives any <strong>and</strong> all books, records, contracts <strong>and</strong> other information of<br />

the Company <strong>and</strong> its Subsidiaries existing on the Closing Date to the extent requested <strong>by</strong><br />

the Representatives in connection with any purposes contemplated <strong>by</strong> this Agreement.<br />

Parent will cause the Surviving Corporation to hold all of the books <strong>and</strong> records of the<br />

Company <strong>and</strong> its Subsidiaries existing on the Closing Date <strong>and</strong> not destroy or dispose of<br />

any thereof for a period of seven years from the Closing Date or such longer time as may<br />

be required <strong>by</strong> law, <strong>and</strong> thereafter, if it desires to destroy or dispose of such books <strong>and</strong><br />

records, will offer first in writing at least 60 days prior to such destruction or disposition<br />

to surrender them to the Representatives.<br />

5.3 Conduct of Business <strong>by</strong> the Company.<br />

From the date hereof to the Effective Time, the Company will <strong>and</strong> will cause each of its<br />

Subsidiaries to, except as otherwise contemplated or provided herein or consented to in writing<br />

<strong>by</strong> Parent (which consent shall not be unreasonably delayed or withheld), conduct its business<br />

only in the ordinary course consistent with past practice. Without limiting the foregoing, from<br />

the date hereof until the earlier of the Closing Date or the termination of this Agreement, except<br />

(i) as set forth on Schedule 5.3 of the Disclosure Letter, (ii) otherwise contemplated or provided<br />

herein, (iii) required <strong>by</strong> applicable Law or (iv) otherwise consented to in writing <strong>by</strong> Parent<br />

(which consent shall not be unreasonably delayed or withheld), the Company <strong>and</strong> its Subsidiaries<br />

shall:<br />

(a) not amend its Certificate of Incorporation or <strong>by</strong>-laws, or similar<br />

organizational documents;<br />

(b) except for transactions in the Ordinary Course of Business, not sell, lease,<br />

transfer, assign, pledge, mortgage or otherwise dispose of or encumber or incur or suffer<br />

to exist any material Lien (other than Permitted Liens) on any of their respective<br />

properties or assets;<br />

(c) perform all of their respective obligations under the Contracts in all<br />

material respects;<br />

- 42 -


(d) other than in the Ordinary Course of Business (i) enter into any<br />

agreements, contracts, leases, or licenses for which the Company or any of its<br />

Subsidiaries would reasonably be likely to incur liability in excess of $500,000 per<br />

annum individually or $1,500,000 per annum in the aggregate, (ii) accelerate, modify,<br />

terminate, cancel or change any Contract, (iii) cancel, compromise, waive or release any<br />

right, claim or debts involving amounts in excess of $100,000, (iv) issue any note, bond<br />

or other debt security or create, incur, assume, or guarantee or otherwise become subject<br />

to any reimbursement obligations (contingent or otherwise) with respect to any letter of<br />

credit or any Indebtedness, except for borrowings under the Company’s existing<br />

revolving credit facility, or (v) make any loan to, or enter into any business transaction,<br />

agreement, arrangement or underst<strong>and</strong>ing of any other nature with, any Former<br />

Shareholder, director or other employee of the Company, or any Affiliate or associate of<br />

any Former Shareholder (other than any Subsidiary of the Company), director or other<br />

employee of the Company other than advances to employees for business expenses in the<br />

Ordinary Course of Business that do not individually exceed $5,000;<br />

(e) not make, change, or revoke any material election in respect of Taxes,<br />

change an annual accounting period, adopt or change any material accounting method or<br />

principles (other than as required <strong>by</strong> GAAP), make any material agreement or settlement<br />

with respect to Taxes, file any amended Tax Return that is material (other than a Tax<br />

Return with respect to a Pass-Through Tax), surrender any right to claim a material<br />

refund of Taxes (other than with respect to Pass-Through Taxes), or consent to any<br />

extension or waiver of the limitation period applicable to any Tax claim or assessment;<br />

(f) not merge or consolidate with, or purchase all or substantially all of the<br />

assets of, or otherwise acquire the business of, any Person;<br />

(g) not sell, transfer, lease or otherwise dispose of any material assets other<br />

than in the Ordinary Course of Business;<br />

(h) maintain its books of account <strong>and</strong> records consistent with its past practice<br />

in all material respects;<br />

(i) not issue any capital stock or issue or become a party to any subscriptions,<br />

warrants, rights, options, convertible securities or other agreements or commitments of<br />

any character relating to its issued or unissued capital stock, or its other equity securities,<br />

if any, or grant any stock appreciation or similar rights;<br />

(j) not make any material change in any method of accounting or accounting<br />

practice or policy other than those required <strong>by</strong> GAAP;<br />

(k) except as set forth in the Company’s fiscal year 2011 budget for capital<br />

expenditures attached to the Disclosure Letter as Schedule 5.3(k), not make any capital<br />

expenditures in excess of $250,000 individually or $750,000 in the aggregate;<br />

(l) not (i) materially increase the compensation or benefits payable to any<br />

individual officers, directors or employees of the Company or its Subsidiaries except for<br />

normal increases in the Ordinary Course of Business or as required <strong>by</strong> any Employee<br />

- 43 -


Benefit Plan or other agreement in effect on the date hereof, (ii) pay or agree to pay any<br />

pension, retirement allowance or other material employee benefit not required <strong>by</strong> any<br />

Employee Benefit Plan or made in the Ordinary Course of Business to any current or<br />

former employee, or (iii) adopt, materially modify or terminate (or commit to do the<br />

same) any Employee Benefit Plan or any other pension, profit-sharing, bonus, incentive,<br />

deferred compensation, group insurance, severance, retirement or other benefit plan,<br />

contract, agreement or arrangement with respect to its directors, officers, <strong>and</strong> employees,<br />

except as required <strong>by</strong> Law or required to maintain the tax qualified status of any<br />

Employee Benefit Plan. Except in the Ordinary Course of Business, neither the Company<br />

nor any of its Subsidiaries shall enter into, modify or amend any material consulting<br />

agreements;<br />

(m) use commercially reasonable efforts to maintain their present relationships<br />

with the Principal Customers <strong>and</strong> Principal Suppliers <strong>and</strong> shall not (i) grant any discounts<br />

to a customer for early payment of accounts receivable or (ii) defer payment of accounts<br />

payable or (iii) make any grant of credit to any customer or supplier, in each case except<br />

in the Ordinary Course of Business;<br />

(n) maintain their insurance policies <strong>and</strong> programs (other than the Executive<br />

Life Insurance Policies) in their current amounts on a basis consistent with past practice<br />

(or if such policies are canceled or lapse prior to Closing, renewals or replacements<br />

thereof, enter into <strong>and</strong> maintain renewals or reasonably equivalent replacements thereof<br />

in the Ordinary Course of Business without any gaps in coverage occurring to the extent<br />

such renewals or replacements are available on commercially reasonable terms);<br />

(o) not revoke the Company’s S election to be treated as a S corporation or the<br />

election of any Subsidiary to be treated as a qualified subchapter S subsidiary within the<br />

meaning of Code § 1361 or § 1362 <strong>and</strong> shall not take or allow any action that would<br />

result in the termination of the Company’s status as a validly electing S corporation or of<br />

a Subsidiary’s status as either a qualified subchapter S subsidiary within the meaning of<br />

Code § 1361 or §1362 or a disregarded entity within the meaning of Treasury<br />

Regulations § 301.7701-3; <strong>and</strong><br />

(p) not agree to or commit to do any of the foregoing referred to in clauses<br />

(a) - (o) of this Section 5.3.<br />

5.4 Reasonable Best Efforts; Further Assurances<br />

(a) Subject to the terms <strong>and</strong> conditions herein provided, each of the parties<br />

hereto shall use its commercially reasonable best efforts to take, or cause to be taken, all<br />

action, <strong>and</strong> to do, or cause to be done, all things reasonably necessary, proper or<br />

advisable under applicable laws <strong>and</strong> regulations to consummate <strong>and</strong> make effective the<br />

transactions contemplated <strong>by</strong> this Agreement. Without limiting the generality of the<br />

foregoing, the Company shall, <strong>and</strong> shall cause its Subsidiaries to, use their commercially<br />

reasonable best efforts to cooperate with Parent, at its request, to obtain all consents<br />

under any Contracts that are required as a result of the Merger; provided, however, that<br />

such effort shall not require the Company or its Subsidiaries to incur any actual out of<br />

- 44 -


pocket costs payable to any third-party. Each of the Company, on one h<strong>and</strong>, <strong>and</strong> Parent<br />

<strong>and</strong> Newco, on the other h<strong>and</strong>, will use their respective commercially reasonable best<br />

efforts to obtain consents of all Governmental Authorities <strong>and</strong> third parties necessary to<br />

the consummation of the transactions contemplated <strong>by</strong> this Agreement. Each party shall<br />

bear its own costs incurred in connection with obtaining such consents; provided, that,<br />

the HSR Act filing fee shall be borne <strong>by</strong> Parent. Each party hereto shall make an<br />

appropriate filing pursuant to the HSR Act within 10 Business Days of the date hereof<br />

<strong>and</strong> shall supply as promptly as practicable to the appropriate Governmental Authorities<br />

any additional information <strong>and</strong> documentary material that may be requested pursuant to<br />

the HSR Act. If requested <strong>by</strong> the Company, Parent <strong>and</strong> Newco here<strong>by</strong> agree that they<br />

shall request early termination of the waiting period under the HSR Act. Without<br />

limitation of the foregoing, the Company, on one h<strong>and</strong>, <strong>and</strong> Parent <strong>and</strong> Newco, on the<br />

other h<strong>and</strong>, <strong>and</strong> their respective Affiliates shall not extend any waiting period or<br />

comparable period under the HSR Act or enter into any agreement with any<br />

Governmental Authority not to consummate the transactions contemplated here<strong>by</strong>, except<br />

with the prior written consent of the other parties hereto. Parent <strong>and</strong> Newco shall (<strong>and</strong><br />

shall cause their affiliates to) offer to take (<strong>and</strong> if such offer is accepted, commit to take)<br />

all steps which they are capable of taking to avoid or eliminate impediments under any<br />

antitrust, competition, or trade regulation law that may be asserted <strong>by</strong> the FTC, the<br />

Antitrust Division or any other Governmental Authority or Person with respect to the<br />

Merger so as to enable the Closing to occur as expeditiously as possible. Without limiting<br />

the foregoing, Parent <strong>and</strong> Newco shall (<strong>and</strong> shall cause their affiliates to) propose,<br />

negotiate, offer to commit <strong>and</strong> effect (<strong>and</strong> if such offer is accepted, commit to <strong>and</strong> effect),<br />

<strong>by</strong> consent decree, or hold separate order, or otherwise offer to take (<strong>and</strong> take if the offer<br />

is accepted) any action which it is capable of taking in order to avoid the entry of, or to<br />

effect the dissolution of, any injunction, temporary restraining order or other order in any<br />

suit or proceeding, which would otherwise have the effect of preventing the Closing.<br />

Notwithst<strong>and</strong>ing anything else contained in this Agreement, Parent shall not be required<br />

to divest any assets or business that Parent or its Affiliates own prior to the date of this<br />

Agreement or any assets or business of the Surviving Corporation or its Subsidiaries,<br />

except if <strong>and</strong> to the extent required to avoid the entry of, or to effect the dissolution of,<br />

any injunction, temporary restraining order or other order in any suit or proceeding<br />

brought <strong>by</strong> or on behalf of the FTC or Antitrust Division, which would otherwise have<br />

the effect of preventing the Closing, Parent shall cause the Lassonde US Fruit Juice<br />

Business (but no other assets or business of Parent, its Affiliates, the Surviving<br />

Corporation or its Subsidiaries) to be divested <strong>by</strong> Lassonde <strong>and</strong> its Affiliates. Each party<br />

shall (i) promptly notify the other party of any written communication to that party from<br />

the FTC, the Antitrust Division or any other Governmental Authority <strong>and</strong>, subject to<br />

applicable law, permit the other party to review in advance any proposed written<br />

communication to any of the foregoing <strong>and</strong> (ii) furnish the other party with copies of all<br />

correspondence, filings, <strong>and</strong> communications (<strong>and</strong> memor<strong>and</strong>a setting forth the substance<br />

thereof) between them <strong>and</strong> their respective affiliates on the one h<strong>and</strong>, <strong>and</strong> any<br />

Governmental Authority, on the other h<strong>and</strong>, with respect to this Agreement <strong>and</strong> the<br />

Merger.<br />

(b) In the event any claim, action, suit, investigation or other proceeding <strong>by</strong><br />

any Governmental Authority or other Person is commenced which questions the validity<br />

- 45 -


or legality of the Merger or any of the other transactions contemplated here<strong>by</strong> or seeks<br />

damages in connection therewith, the parties agree to cooperate <strong>and</strong> use reasonable best<br />

efforts to defend against such claim, action, suit, investigation or other proceeding <strong>and</strong>, if<br />

an injunction or other order is issued in any such action, suit or other proceeding, to use<br />

reasonable best efforts to have such injunction or other order lifted, <strong>and</strong> to cooperate<br />

reasonably regarding any other impediment to the consummation of the transactions<br />

contemplated here<strong>by</strong>.<br />

(c) The Company shall reasonably cooperate with Parent with respect to any<br />

transfer of, application for, or notices related to Environmental Permits required under<br />

Environmental Laws as a result of the transactions contemplated <strong>by</strong> this Agreement.<br />

5.5 Financing.<br />

(a) Parent <strong>and</strong> Newco shall use their respective commercially reasonable best<br />

efforts to arrange <strong>and</strong> obtain the Financing on the terms <strong>and</strong> conditions described in the<br />

Commitment Letter, including using their commercially reasonable best efforts to (i)<br />

maintain in effect the Commitment Letter until the transactions contemplated <strong>by</strong> this<br />

Agreement are consummated, (ii) satisfy (or obtain a waiver for) on a timely basis all<br />

conditions <strong>and</strong> covenants in the Commitment Letter to be satisfied <strong>by</strong> Parent or Newco,<br />

(iii) on or before the date of the Closing enter into definitive agreements with respect<br />

thereto on substantially the same terms <strong>and</strong> conditions contemplated <strong>by</strong> the Commitment<br />

Letter, (iv) cause the funding of <strong>and</strong> consummate the Financing at or prior to Closing<br />

upon <strong>and</strong> subject to the terms <strong>and</strong> conditions of the Commitment Letter (as it may be<br />

amended without violating this Section 5.5) <strong>and</strong> on such other terms as Parent, Newco<br />

<strong>and</strong> the Lenders may agree, so long as such amended or other terms do not (x) exp<strong>and</strong><br />

upon the conditions precedent to the Financing as set forth in the Commitment Letter or<br />

(y) prevent, impair or delay the availability of the Financing <strong>and</strong> the consummation of the<br />

transactions contemplated <strong>by</strong> this Agreement, <strong>and</strong> (v) enforce their respective rights<br />

under the Commitment Letter. Without the prior written approval of the Company, Parent<br />

shall not amend, alter or waive, or agree to amend, alter or waive, the Commitment Letter<br />

in any manner that would reasonably be expected to impair, delay or prevent the funding<br />

of the Financing or the occurrence of the transactions contemplated <strong>by</strong> this Agreement. If<br />

any portion of the Financing becomes unavailable on the terms <strong>and</strong> conditions<br />

contemplated in the Commitment Letter, Parent <strong>and</strong> Newco shall use their respective<br />

commercially reasonable best efforts to arrange <strong>and</strong> obtain alternative financing from<br />

alternative sources in an amount sufficient to consummate the transactions contemplated<br />

<strong>by</strong> this Agreement as promptly as practicable following the occurrence of such event <strong>and</strong><br />

on terms <strong>and</strong> conditions, taken as a whole, no less favorable to Parent <strong>and</strong> Newco in the<br />

Commitment Letter (if any, the “Alternate Financing”). Notwithst<strong>and</strong>ing the foregoing,<br />

subject to Sections 7.3 <strong>and</strong> 10.12(b), Parent <strong>and</strong> Newco acknowledge <strong>and</strong> agree that<br />

obtaining the Financing, or any Alternate Financing, is not a condition to Closing <strong>and</strong><br />

reaffirm their obligations under this Agreement irrespective <strong>and</strong> independently of the<br />

availability of the Financing or any Alternate Financing. Parent shall give the Company<br />

prompt written notice of any material breach <strong>by</strong> any party to the Commitment Letter of<br />

which Parent becomes aware or any termination of the Commitment Letter. Parent shall<br />

keep the Company informed on a reasonably current basis in reasonable detail of the<br />

- 46 -


status of Parent’s <strong>and</strong> Newco’s efforts to arrange or obtain the Financing.<br />

Notwithst<strong>and</strong>ing the foregoing, subject to Sections 7.3 <strong>and</strong> 10.12(b), compliance <strong>by</strong><br />

Parent <strong>and</strong> Newco with this Section 5.5 shall not relieve Parent <strong>and</strong> Newco of their<br />

obligations to consummate the transactions contemplated here<strong>by</strong>, whether or not the<br />

Financing (or any Alternate Financing) is available.<br />

(b) Prior to the Closing, the Company shall, <strong>and</strong> shall cause its Subsidiaries<br />

to, use commercially reasonable best efforts to provide <strong>and</strong> cause its <strong>and</strong> their officers<br />

<strong>and</strong> employees to provide, on a timely basis, all cooperation reasonably requested <strong>by</strong><br />

Parent <strong>and</strong> that is customary in connection with the arrangement of the Financing or any<br />

Alternate Financing (provided, that such requested cooperation does not (x) unreasonably<br />

interfere with the ongoing operations of the Company <strong>and</strong> the Subsidiaries, (y) cause any<br />

representation, warranty or covenant in this Agreement to be inaccurate or breached or<br />

(z) cause any closing condition set forth in Article 6 to fail to be satisfied), including<br />

using its commercially reasonable best efforts to (i) provide financial <strong>and</strong> other pertinent<br />

information regarding the Company <strong>and</strong> the Subsidiaries as may be reasonably requested<br />

in writing <strong>by</strong> Parent in order to consummate the Financing or any Alternate Financing or<br />

to satisfy the conditions set forth in the Commitment Letter, (ii) assist Parent <strong>and</strong> Newco<br />

in obtaining copies of the most recent appraisals, environmental reports, evidence of title<br />

(including copies of deeds, lease documentation, title insurance policies <strong>and</strong>/or<br />

commitments for title insurance, title opinions, surveys, <strong>and</strong> similar information) <strong>and</strong><br />

similar information with respect to the properties <strong>and</strong> assets (including the Owned Real<br />

Property <strong>and</strong>, with respect to environmental reports <strong>and</strong> other items <strong>and</strong> information<br />

reasonably requested <strong>by</strong> the Lenders, the Leased Property) of the Company <strong>and</strong> the<br />

Subsidiaries as may be reasonably requested <strong>by</strong> Parent <strong>and</strong> are in the possession or<br />

reasonable control of the Company, (iii) provide other reasonably requested customary<br />

certificates or documents, including a customary certificate of the principal financial<br />

officer (in his capacity as such), (iv) participate in a reasonable number of informational<br />

meetings <strong>and</strong> road show meetings in connection with the Financing, (v) provide<br />

reasonable assistance to Parent <strong>and</strong> its financing sources in the preparation of credit or<br />

loan agreements, instruments <strong>and</strong> other agreements (including review of schedules for<br />

completeness) <strong>and</strong> information memor<strong>and</strong>a <strong>and</strong> other marketing <strong>and</strong> rating agency<br />

materials for the Financing or any such Alternate Financing, it being understood <strong>and</strong><br />

agreed that information <strong>and</strong> documents provided <strong>by</strong> the Company <strong>and</strong> the Subsidiaries<br />

may be delivered to agents <strong>and</strong> Lenders under the Commitment Letter <strong>and</strong> their<br />

representatives (subject to customary arrangements for confidentiality that are<br />

substantially similar to the provisions in the Confidentiality Agreement or reasonably<br />

acceptable to the Company), (vi) providing documentation <strong>and</strong> information required <strong>by</strong><br />

regulatory authorities under applicable “know your customer” <strong>and</strong> anti-money laundering<br />

rules <strong>and</strong> regulations <strong>and</strong> (vii) using commercially reasonable best efforts to arrange for<br />

customary documents <strong>and</strong> instruments for the repayment <strong>and</strong> termination of existing<br />

Indebtedness <strong>and</strong> release of related Liens; provided, that (x) no certificate, document or<br />

instrument referred to above shall be effective until the Effective Time, (y) none of the<br />

Company or any of the Subsidiaries shall be required to pay any commitment or other<br />

similar fee or incur any other liability or obligation in connection with the Financing or<br />

any Alternate Financing prior to the effectiveness of the Closing <strong>and</strong> (z) all obligations in<br />

this Section 5.5 shall be subject to applicable Laws relating to exchange of information<br />

- 47 -


<strong>and</strong> attorney-client communication <strong>and</strong> privileges. Parent shall promptly, upon request <strong>by</strong><br />

the Company, reimburse Company for all out-of-pocket costs (including attorneys’ fees)<br />

incurred <strong>by</strong> the Company or any of the Subsidiaries in connection with the cooperation of<br />

the Company <strong>and</strong> the Subsidiaries contemplated <strong>by</strong> this Section 5.5(b) <strong>and</strong> shall<br />

indemnify <strong>and</strong> hold harmless the Company, the Subsidiaries <strong>and</strong> their respective<br />

directors, officers, employees <strong>and</strong> representatives from <strong>and</strong> against any <strong>and</strong> all losses,<br />

damages, claims, costs or expenses suffered or incurred <strong>by</strong> any of them in connection<br />

with the arrangement of the Financing or any Alternate Financing <strong>and</strong> any information<br />

used in connection therewith, except (i) with respect to any written information provided<br />

<strong>by</strong> the Company or any of its Subsidiaries expressly for use in connection with the<br />

Financing or any Alternate Financing <strong>and</strong> (ii) to the extent such losses, damages, claims,<br />

costs or expenses are proximately caused <strong>by</strong> the gross negligence or willful misconduct<br />

of the Company, the Subsidiaries or any of their respective directors, officers, employees<br />

<strong>and</strong> representatives.<br />

5.6 Public Announcements.<br />

The timing <strong>and</strong> content of all announcements regarding any aspect of this Agreement or<br />

the Merger to the financial community, Governmental Authorities, employees or the general<br />

public shall be mutually agreed upon in advance <strong>by</strong> the Representatives, the Company <strong>and</strong><br />

Parent <strong>and</strong> shall not, subject to the terms of this Section 5.6, disclose the Purchase Price;<br />

provided, that each party hereto may make any such announcement which it in good faith<br />

believes, based on advice of counsel, is required <strong>by</strong> law; provided, further, that if a party<br />

believes, based on advice of counsel, in good faith that any such announcement is required <strong>by</strong><br />

law, such party shall use its reasonable best efforts to consult with the other parties prior to any<br />

such announcement to the extent practicable, <strong>and</strong> shall in any event promptly provide the other<br />

parties hereto with copies of any such announcement.<br />

5.7 Employee Benefits.<br />

(a) Parent shall cause each employee benefit plan of Parent or its Affiliates<br />

(the “Parent Plans”) that covers the employees of the Company <strong>and</strong> its Subsidiaries to<br />

grant such employees credit for any service with the Company or its Subsidiaries (i) for<br />

eligibility, vesting <strong>and</strong> benefit accrual purposes (other than benefit accruals under a<br />

defined benefit pension plan) <strong>and</strong> (ii) for purposes of vacation <strong>and</strong> paid time off accrual.<br />

In addition, with respect to each employee of the Company or its Subsidiaries <strong>and</strong> his or<br />

her covered dependents who becomes eligible, on or after the Closing Date, to participate<br />

in a Parent Plan that is an “employee welfare benefit plan” within the meaning of Section<br />

3(1) of ERISA, Parent shall cause each such Parent Plan to (i) waive all pre-existing<br />

condition exclusion <strong>and</strong> actively-at-work requirements <strong>and</strong> similar limitations, eligibility<br />

waiting periods <strong>and</strong> evidence of insurability requirements to the extent waived or<br />

satisfied under a comparable Employee Benefit Plan, <strong>and</strong> (ii) recognize any covered<br />

expenses incurred under a comparable Employee Benefit Plan during the plan year in<br />

which such employee (or dependent thereof) becomes eligible to participate in such<br />

Parent Plan for purposes of satisfying applicable deductible, coinsurance <strong>and</strong> maximum<br />

out-of-pocket provisions.<br />

- 48 -


(b) For the period beginning immediately after the Effective Time <strong>and</strong> ending<br />

on December 31, 2011, Parent shall, or shall cause its Affiliates (including, after the<br />

Effective Time, the Surviving Corporation <strong>and</strong> its Subsidiaries) to, provide all employees<br />

of the Company <strong>and</strong> its Subsidiaries who were so employed immediately prior to the<br />

Effective Time <strong>and</strong> who continue to be so employed immediately after the Effective<br />

Time with (i) employee retirement plan <strong>and</strong> welfare plan benefits that are not less<br />

favorable in the aggregate than the employee benefits provided to such employees as of<br />

immediately prior to the Effective Time <strong>and</strong> (ii) a level of compensation (including base<br />

salary or wages, paid time-off <strong>and</strong> bonuses or other variable pay opportunities) that is not<br />

less favorable in the aggregate than the compensation provided to such employees as of<br />

immediately prior to the Effective Time.<br />

(c) Parent shall cause the Surviving Corporation <strong>and</strong> its Subsidiaries from <strong>and</strong><br />

after the Effective Time to continue to be bound <strong>by</strong> <strong>and</strong> comply with the terms of all<br />

written employment agreements, Retention Bonus Agreements <strong>and</strong> severance agreements<br />

of the Company <strong>and</strong> its Subsidiaries as set forth on Schedule 3.13(a) of the Disclosure<br />

Letter <strong>and</strong> in effect immediately prior to the Effective Time.<br />

(d) Parent shall cause the Surviving Corporation <strong>and</strong> its Subsidiaries from <strong>and</strong><br />

after the Effective Time to continue to be bound <strong>by</strong> <strong>and</strong> comply with the terms of all<br />

collective bargaining agreements to which the Company or its Subsidiaries is a party as<br />

of immediately prior to the Effective Time.<br />

(e) The Company SERP shall be terminated effective immediately prior to the<br />

earlier of the Effective Time or the Closing. As of immediately prior to the Closing, all<br />

amounts owed thereunder shall become fully vested <strong>and</strong> payable to the Company SERP<br />

participants. On or before the Closing Date (but no later than immediately prior to the<br />

Closing), the Company shall take all actions necessary to cause to be distributed to each<br />

participant in the Company SERP his or her full account balance therein <strong>and</strong> to fully<br />

extinguish all liabilities of the Company under the Company SERP. Parent shall cause the<br />

Surviving Corporation <strong>and</strong> its Subsidiaries from <strong>and</strong> after the Effective Time to take any<br />

additional action needed to complete the termination <strong>and</strong> liquidation of the Company<br />

SERP.<br />

(f) The Company shall instruct New Engl<strong>and</strong> Life Insurance to cancel <strong>and</strong><br />

liquidate the Executive Life Insurance Policies immediately prior to the earlier of the<br />

Effective Time or the Closing, <strong>and</strong> shall cause the trustee of the Company SERP to direct<br />

the New Engl<strong>and</strong> Life Insurance Company to promptly pay the aggregate cash surrender<br />

value of the Executive Life Insurance Policies to the Surviving Corporation. Parent shall<br />

cause the Surviving Corporation <strong>and</strong> its Subsidiaries from <strong>and</strong> after the Effective Time to<br />

take any additional action the Representatives determine reasonably necessary to<br />

complete the cancellation <strong>and</strong> liquidation of the Executive Life Insurance Policies;<br />

provided, however, that Parent, the Surviving Corporation <strong>and</strong> its Subsidiaries shall not<br />

be required to incur any actual out of pocket costs payable to any third-party in<br />

connection therewith.<br />

- 49 -


(g) Subject to Section 5.7(c) <strong>and</strong> Section 5.7(d), nothing contained in this<br />

Agreement shall confer upon any employee of the Company or its Subsidiaries any right<br />

with respect to employment <strong>by</strong> the Surviving Corporation or its Subsidiaries, nor shall<br />

anything herein interfere with the right of the Surviving Corporation or its Subsidiaries<br />

following the Effective Time to terminate the employment of any such employee at any<br />

time, with or without cause.<br />

(h) Subject to Section 5.7(c), no provision of this Section 5.7 or any other<br />

provision of this Agreement shall (i) create any rights in any employee or former<br />

employee of the Company or its Subsidiaries in respect of any benefits that may be<br />

provided under any employee benefit plan, (ii) be construed to establish, amend, or<br />

modify any employee benefit plan, (iii) require Parent, the Surviving Corporation or its<br />

Subsidiaries to continue or amend any particular employee benefit plan, (iv) restrict<br />

Parent, the Surviving Corporation or its Subsidiaries from amending or terminating any<br />

employee benefit plan in accordance with its terms <strong>and</strong> applicable law, or (v) except as<br />

set forth in Sections 5.7(c), 5.8, 8.2 <strong>and</strong> 9.1(a), make any employee or former employee<br />

of the Company or its Subsidiaries a third party beneficiary of this Agreement.<br />

5.8 Indemnification of Directors <strong>and</strong> Officers.<br />

(a) After the Closing Date through the sixth anniversary of the Closing Date,<br />

Parent <strong>and</strong> the Surviving Corporation shall, jointly <strong>and</strong> severally, indemnify <strong>and</strong> hold<br />

harmless <strong>and</strong> provide advancement of expenses to, each present (as of the Closing Date)<br />

or former officer or director of the Company <strong>and</strong> its Subsidiaries (the “D&O Indemnified<br />

Persons”), against any <strong>and</strong> all claims, losses, liabilities, damages, judgments, fines <strong>and</strong><br />

reasonable fees, costs <strong>and</strong> expenses (including attorneys’ fees <strong>and</strong> expenses <strong>and</strong> any <strong>and</strong><br />

all other out-of-pocket expenses incurred in investigating, preparing to defend or<br />

defending against any action or proceeding, commenced or threatened <strong>by</strong> any third party,<br />

whether or not such officer or director is a formal party thereto) incurred in connection<br />

with any claim, action, proceeding or investigation, whether civil, criminal,<br />

administrative or investigative, arising out of or pertaining to the fact that the D&O<br />

Indemnified Person is or was an officer or director of the Company or any of the<br />

Subsidiaries, whether asserted or claimed prior to, at or after the Closing Date, to the<br />

same extent such persons are indemnified or have the right to advancement of expenses<br />

as of the date of this Agreement <strong>by</strong> the Company pursuant to the Company’s Certificate<br />

of Incorporation <strong>and</strong> <strong>by</strong>-laws, in existence on the date hereof; provided, however, that<br />

such period of indemnification shall be extended for the duration of any <strong>and</strong> all actions or<br />

proceedings with respect to any claim for indemnification made prior to the expiration of<br />

such six-year period.<br />

(b) Parent shall cause the Surviving Corporation to maintain in effect (i) in its<br />

certificate of incorporation <strong>and</strong> <strong>by</strong>-laws (or similar governing documents) for a period of<br />

six years after the Closing Date, the current provisions regarding elimination of liability<br />

of directors <strong>and</strong> indemnification of, <strong>and</strong> advancement of expenses to, officers, directors<br />

<strong>and</strong> employees contained in the Certificate of Incorporation <strong>and</strong> <strong>by</strong>-laws the Company<br />

<strong>and</strong> (ii) for a period of six years after the Closing Date, the current policies of directors’<br />

<strong>and</strong> officers’ liability insurance <strong>and</strong> fiduciary liability insurance maintained for the<br />

- 50 -


enefit of the directors <strong>and</strong> officers of the Company (provided, that the Surviving<br />

Corporation may substitute therefor policies of at least the same coverage <strong>and</strong> amounts<br />

containing terms <strong>and</strong> conditions which are, in the aggregate, no less advantageous to the<br />

insured) with respect to claims arising from facts or events that occurred on or before the<br />

Closing Date; provided, however, that in no event shall the Surviving Corporation be<br />

required to expend in any one year an amount in excess of two hundred percent of the<br />

annual premiums currently paid <strong>by</strong> the Company for such insurance; <strong>and</strong> provided,<br />

further, that if the annual premiums of such insurance coverage exceed such amount, the<br />

Surviving Corporation, as the case may be, shall be obligated to obtain a policy with the<br />

greatest coverage available for a cost not exceeding such amount.<br />

(c) Notwithst<strong>and</strong>ing any time limit herein to the contrary, if any claim, action,<br />

proceeding or investigation (whether arising before, at or after the Closing Date) is made<br />

against any D&O Indemnified Person on or prior to the sixth anniversary of the Closing<br />

Date, the provisions of this Section 5.8 (without regard to any such time limit) shall<br />

continue in effect until the final disposition of such claim, action, proceeding or<br />

investigation.<br />

(d) In the event that Parent or the Surviving Corporation or any of their<br />

respective successors or assigns (i) consolidates with or merges into any other Person <strong>and</strong><br />

shall not be the continuing or surviving corporation or entity of such consolidation or<br />

merger or (ii) transfers or conveys all or substantially all of its properties <strong>and</strong> assets to<br />

any Person, then, <strong>and</strong> in each such case, proper provision shall be made so that the<br />

successors or assigns of Parent or the Surviving Corporation, as the case may be, shall<br />

succeed to the obligations set forth in this Section 5.8.<br />

(e) This Section 5.8 shall survive the consummation of the Merger, is<br />

intended to benefit the Company, the Surviving Corporation <strong>and</strong> the D&O Indemnified<br />

Persons, shall be binding on all successors <strong>and</strong> assigns of the Surviving Corporation <strong>and</strong><br />

shall be enforceable <strong>by</strong> the D&O Indemnified Persons.<br />

5.9 Obligations of Parent.<br />

Parent will take all action reasonably necessary (a) to cause Newco to perform its<br />

obligations under this Agreement <strong>and</strong> to consummate the Merger on the terms <strong>and</strong> conditions set<br />

forth in this Agreement <strong>and</strong> (b) to ensure that, prior to the Effective Time, Newco shall not<br />

conduct any business or make any investments other than as specifically contemplated <strong>by</strong> this<br />

Agreement. Whenever this Agreement requires Newco or the Surviving Corporation to take any<br />

action, such requirement shall be deemed to include an undertaking on the part of Parent to cause<br />

Newco or the Surviving Corporation to take such action.<br />

5.10 Tax Filings.<br />

(a) The Representatives shall be responsible for preparing, <strong>and</strong> the Surviving<br />

Corporation shall be responsible for timely filing, all Tax Returns with respect to any<br />

Pass-Through Tax as prepared <strong>by</strong> the Representatives <strong>and</strong> that are required to be filed <strong>by</strong><br />

or with respect to the Company after the Closing Date <strong>and</strong> that relate to taxable years or<br />

- 51 -


periods ending on or before the Closing Date (“Pre-Closing Period Return”); provided,<br />

however, that the Surviving Corporation shall not be required to file any such Pre-<br />

Closing Period Return if Parent obtains an opinion of counsel that a position taken on<br />

such Pre-Closing Period Return fails to meet an exception to the application of penalties<br />

even if disclosed on IRS Form 8275 or any similar form. The Representatives shall<br />

permit Parent to review <strong>and</strong> comment on each such Pre-Closing Period Return <strong>and</strong> shall<br />

consider in good faith comments of Parent to each such Pre-Closing Period Return prior<br />

to filing. Parent shall make available <strong>and</strong> shall cause the Surviving Corporation to make<br />

available to the Representatives <strong>and</strong> their accountants, advisors, agents <strong>and</strong><br />

representatives any <strong>and</strong> all books, records, contracts <strong>and</strong> employees of Parent <strong>and</strong> the<br />

Surviving Corporation <strong>and</strong> such other information of the Company <strong>and</strong> its Subsidiaries,<br />

<strong>and</strong> otherwise assist <strong>and</strong> cooperate (<strong>and</strong> cause their respective employees to assist <strong>and</strong><br />

cooperate) with the Representatives <strong>and</strong> their accountants, advisors, agents <strong>and</strong><br />

representatives, to the extent reasonably requested <strong>by</strong> the Representatives in connection<br />

with the preparation of the Pre-Closing Period Returns. The out-of-pocket expense of<br />

preparing any Pre-Closing Period Return shall be borne <strong>by</strong> the Former Shareholders.<br />

(b) Parent shall be responsible for preparing <strong>and</strong> timely filing all other Tax<br />

Returns that are required to be filed <strong>by</strong> or with respect to the Company <strong>and</strong> the Surviving<br />

Corporation after the Closing Date <strong>and</strong> that relate to taxable years or periods ending on or<br />

before the Closing Date, including Tax Returns (other than any Pre-Closing Period<br />

Return) of the Company <strong>and</strong> the Surviving Corporation for any Tax periods that begin<br />

before the Closing Date <strong>and</strong> end after the Closing Date (collectively, the “Straddle<br />

Periods” <strong>and</strong> each a “Straddle Period” <strong>and</strong> such Tax Returns, the “Straddle Period<br />

Returns”). Parent shall provide to the Representatives, no later than 15 Business Days<br />

prior to the due date thereof, a copy of each Tax Return described in the preceding<br />

sentence <strong>and</strong> permit the Representatives to review, <strong>and</strong> Parent shall consider in good faith<br />

any comments of the Representatives to each such Tax Return prior to filing.<br />

(c) For purposes of this Agreement:<br />

(i) In the case of any gross receipts tax, Income Tax, or similar Taxes<br />

that is payable with respect to a Straddle Period, the portion of such Taxes<br />

allocable to (a) the portion of the Straddle Period that ends on the Closing Date<br />

<strong>and</strong> (b) the portion of the Straddle Period beginning on the day after the Closing<br />

Date (the “Post-Closing Tax Period”) shall be determined on the basis of a<br />

deemed closing at the end of the Closing Date of the books <strong>and</strong> records of the<br />

Company (but exemptions, allowances, or deductions that are calculated on an<br />

annual basis (including depreciation <strong>and</strong> amortization deductions), other than<br />

exemptions, allowances or deductions to the extent attributable solely to a Section<br />

338 Election (as defined below), shall be deemed to be the amount of such<br />

exemptions, allowances or deductions for the entire period multiplied <strong>by</strong> a<br />

fraction, the numerator of which is the number of days in the Straddle Period from<br />

the commencement of the Straddle Period through <strong>and</strong> including the Closing Date<br />

<strong>and</strong> the denominator of which is the number of days in the entire Straddle Period).<br />

- 52 -


(ii) In the case of any Taxes (other than gross receipt taxes, Income<br />

Taxes or similar Taxes) that are payable with respect to a Straddle Period, the<br />

portion of such Taxes allocable to the portion of the Straddle Period ending on the<br />

Closing Date shall be equal to the product of all such Taxes multiplied <strong>by</strong> a<br />

fraction the numerator of which is the number of days in the Straddle Period from<br />

the commencement of the Straddle Period through <strong>and</strong> including the Closing Date<br />

<strong>and</strong> the denominator of which is the number of days in the entire Straddle Period;<br />

provided, however, that appropriate adjustments shall be made to reflect specific<br />

events that can be identified <strong>and</strong> specifically allocated as occurring on or prior to<br />

the Closing Date (in which case the Former Shareholders shall be jointly <strong>and</strong><br />

severally responsible for any Taxes related thereto) or occurring after the Closing<br />

Date (in which case, the Surviving Corporation shall be responsible for any Taxes<br />

related thereto).<br />

(iii) The Surviving Corporation shall be responsible for any Taxes with<br />

respect to the Post-Closing Tax Period of the Straddle Periods.<br />

(d) Section 338(h)(10) Election.<br />

(i) Parent <strong>and</strong> the Former Shareholders shall join in timely making an<br />

election under (x) Section 338(h)(10) of the Code <strong>and</strong>/or (y) any similar provision<br />

of state or local tax law, with respect to the Merger under this Agreement (the<br />

“Section 338 Election”) <strong>and</strong> shall join in any filings that may be necessary in<br />

order to effect the Section 338 Election, including IRS Forms 8023 <strong>and</strong> 8883,<br />

<strong>and</strong>/or any comparable state or local Tax forms, provided there are no holders of<br />

Dissenting Shares. Except as otherwise specifically provided in this Section<br />

5.10(d), Parent shall be responsible for the preparation <strong>and</strong> timely filing of all<br />

forms necessary to effectuate the Section 338 Election <strong>and</strong> Parent <strong>and</strong> the Former<br />

Shareholders shall execute such forms or documents as are required <strong>by</strong> any Tax<br />

laws to effect the Section 338 Election, including IRS Forms 8023 <strong>and</strong> 8833,<br />

<strong>and</strong>/or any other comparable state or local tax forms. To the extent permitted or<br />

required <strong>by</strong> Law, any income, gain, loss or deduction, or other tax item resulting<br />

from the deemed sale pursuant to the Section 338 Election shall be included in the<br />

Tax Returns of the Company <strong>and</strong> the Subsidiaries for the taxable period ending on<br />

or prior to the Closing Date. The Representatives will provide to Parent an IRS<br />

Form 8023 (<strong>and</strong> comparable state or local Tax forms requested <strong>by</strong> Parent)<br />

properly signed <strong>and</strong> executed <strong>by</strong> the Former Shareholders on or before the<br />

Closing Date.<br />

(ii) Within 90 days after the Closing Date, Parent shall deliver to the<br />

Representatives a completed IRS Form 8883, setting forth the allocation of the<br />

adjusted grossed-up basis (as defined in Treasury Regulation section 1.338-5)<br />

<strong>among</strong> the assets of the Company <strong>and</strong> its Subsidiaries (the “Allocation Schedule”)<br />

which schedule shall be prepared in a manner consistent with Sections 338 <strong>and</strong><br />

1060 of the Code <strong>and</strong> in a manner consistent with the principles set forth on<br />

Schedule 5.10(d)(ii) of the Disclosure Letter. The Representatives shall have the<br />

right to review the IRS Form 8883. If there is any dispute concerning the<br />

- 53 -


Allocation Schedule, the Representatives shall notify Parent within 30 calendar<br />

days after receiving the Allocation Schedule <strong>and</strong> Parent <strong>and</strong> the Representatives<br />

shall negotiate in good faith to resolve such dispute. If within 15 calendar days of<br />

such notification, Parent <strong>and</strong> the Representatives shall have been unable to resolve<br />

their dispute, all unresolved items shall be submitted to the Accounting Firm to be<br />

resolved in accordance with the terms of Section 2.7(d). The Allocation<br />

Schedule, as finalized in accordance with the foregoing, shall be adjusted in a<br />

manner consistent with the methodology of the Allocation Schedule if <strong>and</strong> to the<br />

extent of any adjustment to the Merger Consideration pursuant to this Agreement<br />

(the “Final Allocation Schedule”). Parent, Newco <strong>and</strong> the Company shall file all<br />

Tax Returns <strong>and</strong> information reports in a manner consistent with such Final<br />

Allocation Schedule <strong>and</strong> the Section 338 Election, <strong>and</strong> shall not, unless otherwise<br />

required <strong>by</strong> applicable law or a final determination under Section 1313 of the<br />

Code or similar provision under foreign, state or local law, take (<strong>and</strong> Parent shall<br />

not permit its Affiliates to take) any action that would be inconsistent with or<br />

would prejudice the Section 338 Election.<br />

(iii) Notwithst<strong>and</strong>ing anything to the contrary in this Agreement, any<br />

increase in liability for Tax of the Company or any Subsidiary (for the avoidance<br />

of doubt, other than an increase in any Pass-Through Tax) for any taxable years or<br />

periods ending on or before the Closing Date resulting solely from the Section<br />

338 Election (other than any such increase in Tax attributable to any Tax under<br />

Code § 1374) shall be borne solely <strong>by</strong> the Surviving Corporation, <strong>and</strong> shall be<br />

treated for all purposes of this Agreement as a liability of the Surviving<br />

Corporation with respect to the period beginning after the Closing Date.<br />

(e) None of the Company, Parent, Newco, or any Affiliate of the Company,<br />

Parent or Newco shall (or shall cause or permit the Surviving Corporation to) amend,<br />

refile or otherwise modify (or grant an extension of any statute of limitation with respect<br />

to) any Pre-Closing Period Return or Straddle Period Return, without the prior written<br />

consent of the Representatives.<br />

(f) Parent, the Company <strong>and</strong> the Representatives shall cooperate fully, as <strong>and</strong><br />

to the extent reasonably requested <strong>by</strong> any party, in connection with the filing of Tax<br />

Returns pursuant to this Section 5.10 <strong>and</strong> any proceeding with respect to Taxes. Such<br />

cooperation shall include the retention <strong>and</strong> (upon the other party’s request) the provision<br />

of records <strong>and</strong> information reasonably relevant to any such proceeding. Parent <strong>and</strong><br />

Representatives agree (i) to retain all books <strong>and</strong> records with respect to Tax matters<br />

pertinent to the Company relating to any taxable period beginning before the Closing<br />

Date until the expiration of the statute of limitations (<strong>and</strong>, to the extent notified <strong>by</strong> Parent<br />

or Representatives, any extensions thereof) of the respective taxable periods, <strong>and</strong> to abide<br />

<strong>by</strong> all record retention agreements entered into with any taxing authority, <strong>and</strong> (ii) to give<br />

the other party reasonable written notice prior to transferring, destroying or discarding<br />

any such books <strong>and</strong> records <strong>and</strong>, if the other so requests, Parent or the Representatives, as<br />

the case may be, shall allow the other to take possession of such books <strong>and</strong> records.<br />

- 54 -


(g) Parent <strong>and</strong> the Representatives further agree, upon reasonable request, to<br />

provide the other party with all information that either party may be required to report<br />

pursuant to Code § 6043 or § 6043A <strong>and</strong> all Treasury Department Regulations<br />

promulgated thereunder.<br />

5.11 Exclusive Dealing.<br />

During the period from the date hereof through the Closing Date or the termination of<br />

this Agreement pursuant to Article 7, (i) the Company shall not, <strong>and</strong> shall cause its Affiliates <strong>and</strong><br />

the directors, officers, employees <strong>and</strong> agents of Company <strong>and</strong> its Affiliates to not, take any<br />

action to (A) solicit, initiate or encourage the submission of any proposal or offer from any<br />

Person other than Lassonde, Parent, Newco or their Affiliates relating to the acquisition of any<br />

capital stock, or any substantial portion of the assets (other than sales of inventory in the<br />

Ordinary Course of Business), of the Company or any of its Subsidiaries (including any<br />

acquisition structured as a merger, consolidation, recapitalization or equity exchange) (each, an<br />

“Acquisition Proposal”) or (B) participate in any discussions or negotiations regarding, furnish<br />

any information with respect to, assist or participate in, or facilitate in any other manner any<br />

effort or attempt <strong>by</strong> any such Person to do or seek any of the foregoing, (ii) the Company shall<br />

promptly (<strong>and</strong> in any event within twenty-four hours) notify Parent after any such Person makes<br />

any proposal, offer, inquiry, or contact with respect to any of the foregoing, <strong>and</strong> (iii) the<br />

Company shall not enter into any agreement in respect of an Acquisition Proposal.<br />

5.12 Transactions with Former Shareholders.<br />

Prior to the Closing, the Company shall cancel <strong>and</strong> terminate, without any payment<br />

therefor, any note or account receivable from, or cash advance to, any Former Shareholder or<br />

Affiliate thereof.<br />

5.13 Matters relating to the Additional Equity Contribution.<br />

If Lassonde or any of its Affiliates need to make the Additional Equity Contribution<br />

under the Commitment Letter so as to satisfy the maximum total leverage ratio condition<br />

precedent contained in paragraph (i)(4) of Exhibit C to the Commitment Letter as in effect on the<br />

date hereof, (i) Parent shall deliver written notice of such event to the Company at least five<br />

Business Days prior to Closing <strong>and</strong> (ii) each member of the Pappas Group shall have the right,<br />

but not the obligation, to elect to purchase from P-L Holdings additional common shares of P-L<br />

Holdings in an amount up to an amount that would allow such member of the Pappas Group to<br />

continue to maintain the same proportionate ownership interest in P-L Holdings as it would have<br />

held absent the issuance of the additional common shares to Lassonde <strong>by</strong> delivering written<br />

notice to Lassonde not less than three Business Days prior to Closing. If such member of the<br />

Pappas Group provides such notice, then such member of the Pappas Group holding common<br />

shares in P-L Holdings shall purchase the number of additional common shares set forth in such<br />

notice. In addition, if any member or members of the Pappas Group declines to exercise its right<br />

under this Section 5.13 in full (or fails to deliver timely written notice of its exercise of such<br />

right), the other members of the Pappas Group shall have the right, but not the obligation, to elect<br />

to purchase from P-L Holdings any such additional common shares of P-L Holdings as the<br />

declining member was entitled to purchase under this Section 5.13, in such amounts <strong>and</strong><br />

- 55 -


proportions as such other members of the Pappas Group shall agree, <strong>by</strong> delivering written notice<br />

to Lassonde not less than two Business Days prior to Closing. The purchase <strong>and</strong> sale of any such<br />

additional common shares to the members of the Pappas Group shall be made pursuant to the<br />

Stock Purchase Agreement substantially in the form of Exhibit I attached hereto <strong>and</strong> for the same<br />

price <strong>and</strong> on the same terms as the sale of the additional common shares to Lassonde or its<br />

Affiliates.<br />

6.1 Mutual Conditions.<br />

ARTICLE 6<br />

CONDITIONS TO CLOSING<br />

The respective obligations of each party to consummate the transactions contemplated <strong>by</strong><br />

this Agreement shall be subject to the fulfillment at or prior to Closing of each of the following<br />

conditions:<br />

(a) No Injunction. At the Closing there shall be no effective injunction, writ<br />

or preliminary restraining order or any order of any nature issued <strong>by</strong> a court or<br />

Governmental Authority of competent jurisdiction to the effect that the Merger may not<br />

be consummated as herein provided.<br />

(b) Antitrust Clearance. The waiting period (<strong>and</strong> any extension thereof) under<br />

the HSR Act applicable to the transactions contemplated here<strong>by</strong> shall have expired or<br />

shall have been terminated.<br />

(c) Company Shareholder Approval. The Company Shareholder Approval<br />

shall have been obtained in accordance with the applicable provisions of the New Jersey<br />

Corporation Act.<br />

6.2 Conditions to the Obligations of Parent <strong>and</strong> Newco.<br />

The obligations of Parent <strong>and</strong> Newco to consummate the transactions contemplated <strong>by</strong><br />

this Agreement shall be subject to the fulfillment prior to or at Closing of each of the following<br />

conditions, any <strong>and</strong> all of which may be waived, in whole or in part, <strong>by</strong> Parent <strong>and</strong> Newco to the<br />

extent permitted <strong>by</strong> applicable law:<br />

(a) Representations <strong>and</strong> Warranties. (i) The Fundamental Representations (as<br />

defined in Section 8.1) of the Company shall be true <strong>and</strong> correct in all material respects<br />

as of the Closing Date as if made on the Closing Date, <strong>and</strong> (ii) the representations <strong>and</strong><br />

warranties of the Company set forth in Article 3, other than the Fundamental<br />

Representations, without giving effect to any materiality or “Material Adverse Effect”<br />

qualifications therein, shall be true <strong>and</strong> correct as of the date of this Agreement <strong>and</strong> as of<br />

the Closing Date as though made on <strong>and</strong> as of the Closing Date, except (x) in the case of<br />

clauses (i) <strong>and</strong> (ii), (A) that the representations <strong>and</strong> warranties that are made as of a<br />

specific date shall be true <strong>and</strong> correct only as of such date, <strong>and</strong> (B) as permitted <strong>by</strong> this<br />

Agreement to change between the date of this Agreement <strong>and</strong> the Closing Date; (y) in the<br />

- 56 -


case of clause (ii), for breaches of representations <strong>and</strong> warranties the effect of which,<br />

individually or in the aggregate, does not constitute a Material Adverse Effect.<br />

(b) Covenants. The Company shall have duly performed or complied with, in<br />

all material respects, all of the covenants, obligations <strong>and</strong> conditions to be performed or<br />

complied with <strong>by</strong> them on or prior to or at Closing under this Agreement.<br />

(c) Closing Certificate. The Company shall have delivered to Parent a<br />

certificate of the Company signed <strong>by</strong> the President or a Vice President of the Company,<br />

dated the Closing Date, to the effect that the conditions specified in Sections 6.2(a) <strong>and</strong><br />

6.2(b) have been satisfied.<br />

(d) [Intentionally omitted].<br />

(e) Certified Documents. The Company shall have delivered to Parent each<br />

of the following:<br />

(i) a certified copy of the resolutions duly adopted <strong>by</strong> the board of<br />

directors of the Company authorizing the execution, delivery <strong>and</strong> performance of<br />

this Agreement <strong>and</strong> the consummation of all transactions contemplated here<strong>by</strong>;<br />

(ii) a true <strong>and</strong> correct copy of the Company’s Certificate of<br />

Incorporation; <strong>and</strong><br />

(iii) a true <strong>and</strong> correct copy of the Company’s <strong>by</strong>-laws, together with<br />

all amendments in effect as of Closing.<br />

(f) Material Adverse Effect. Since the date of this Agreement, there shall not<br />

have been any Material Adverse Effect.<br />

(g) Company Shareholder Approval. No later than the day following the date<br />

of this Agreement, the Company shall have delivered to Parent a unanimous written<br />

consent action signed <strong>by</strong> the holders of all of the outst<strong>and</strong>ing shares of Common Stock of<br />

the Company adopting <strong>and</strong> approving this Agreement, the Merger <strong>and</strong> the transactions<br />

contemplated <strong>by</strong> this Agreement, <strong>and</strong> there shall otherwise be no outst<strong>and</strong>ing shares of<br />

Common Stock of the Company that remain eligible to become Dissenting Shares under<br />

the New Jersey Corporation Act.<br />

(h) Escrow Agreement. The Company, the Representatives <strong>and</strong> the Escrow<br />

Agent shall have executed <strong>and</strong> delivered the Escrow Agreement.<br />

(i) Pappas Shareholders’ Agreement. The Company shall provide evidence<br />

of the termination of the Pappas Shareholders’ Agreement, dated November 19, 2001<br />

between Peter C. Pappas <strong>and</strong> Dean C. Pappas.<br />

(j) FIRPTA Certificate. The Former Shareholders shall have delivered, as<br />

part of the Letter of Transmittal, to Parent a certificate confirming to the requirements of<br />

Treasury Regulations § 1.1445-2(b)(2).<br />

- 57 -


(k) Employment Agreements. The Company shall have entered into<br />

employment agreements with Clement David Pappas <strong>and</strong> Clement Dimitri Pappas<br />

substantially in the forms attached as Exhibit F hereto.<br />

(l) Payoff Letters. The Company shall have delivered payoff letters with<br />

respect to any outst<strong>and</strong>ing loans from, <strong>and</strong> the security interests granted to secure such<br />

loans to, Bank of Montreal.<br />

(m) Section 338(h)(10) Documentation. If requested <strong>by</strong> Parent, the<br />

Representatives shall deliver to Parent an IRS Form 8023 (<strong>and</strong> any comparable state or<br />

local tax form) executed <strong>and</strong> signed <strong>by</strong> each of the Former Shareholders.<br />

(n) Non-competition Agreements. Aleni M. Pappas, Clement Dimitri Pappas,<br />

Dean C. Pappas, Edward L.B. Pappas <strong>and</strong> Zachary P. Pappas shall have entered into noncompetition<br />

agreements substantially in the form of Exhibit G hereto.<br />

(o) Minimum EBITDA. EBITDA for the Company <strong>and</strong> its Subsidiaries on a<br />

consolidated basis for the rolling 12 month period ending on the last Sunday of the month<br />

immediately preceding the month in which the Closing occurs (unless such last Sunday<br />

occurs less than 30 days prior to the Closing, in which case such rolling 12 month period<br />

shall be the rolling 12 month period ending on the last Sunday of the second month<br />

immediately preceding the month in which the Closing occurs) (such applicable rolling<br />

12 month period, the “RTM Period”) shall not be less than $54,500,000, <strong>and</strong> the<br />

Company shall have delivered to Parent a certificate of the Company signed <strong>by</strong> the chief<br />

financial officer of Company, dated as of the Closing Date, to that effect. By way of<br />

example only, if the Closing were to occur between July 27, 2011 <strong>and</strong> August 29, 2011,<br />

the RTM Period would be June 28, 2010 through June 26, 2011.<br />

(p) P-L Holdings Stockholders’ Agreement. The parties identified in the P-L<br />

Holdings Stockholders’ Agreement (other than P-L Holdings, the Surviving Corporation<br />

<strong>and</strong> the Lassonde Group (as defined therein)) shall have executed <strong>and</strong> delivered the P-L<br />

Holdings Stockholders’ Agreement substantially in the form of Exhibit H attached hereto.<br />

(q) Stock Purchase Agreement. The parties identified therein (other than<br />

Parent) shall have executed <strong>and</strong> delivered the Stock Purchase Agreement substantially in<br />

the form of Exhibit I attached hereto.<br />

6.3 Conditions to the Obligations of the Company <strong>and</strong> Former Shareholders.<br />

The obligations of the Company <strong>and</strong> Former Shareholders to consummate the<br />

transactions contemplated <strong>by</strong> this Agreement shall be subject to the fulfillment at or prior to the<br />

Closing of each of the following conditions, any <strong>and</strong> all of which may be waived in whole or in<br />

part <strong>by</strong> the Company to the extent permitted <strong>by</strong> applicable law:<br />

(a) Representations <strong>and</strong> Warranties. (i) The Fundamental Representations of<br />

Parent <strong>and</strong> Newco shall be true <strong>and</strong> correct in all material respects as of the Closing Date<br />

as if made on the Closing Date <strong>and</strong> (ii) the representations <strong>and</strong> warranties of Parent <strong>and</strong><br />

Newco set forth in Article 4, other than the Fundamental Representations, without giving<br />

- 58 -


effect to any materiality or “Material Adverse Effect” qualifications therein, shall be true<br />

<strong>and</strong> correct as of the date of this Agreement <strong>and</strong> as of the Closing Date as though made<br />

on <strong>and</strong> as of the Closing Date, except (x) in the case of clauses (i) <strong>and</strong> (ii), (A) that the<br />

representations <strong>and</strong> warranties that are made as of a specific date shall be true <strong>and</strong> correct<br />

only as of such date, <strong>and</strong> (B) as permitted <strong>by</strong> this Agreement to change between the date<br />

of this Agreement <strong>and</strong> the Closing Date; <strong>and</strong> (y) in the case of clause (ii), for breaches of<br />

representations <strong>and</strong> warranties the effect of which, individually or in the aggregate, has<br />

not had <strong>and</strong> would not reasonably be expected to have a material adverse effect on the<br />

ability of Parent <strong>and</strong> Newco to perform their obligations hereunder.<br />

(b) Covenants. Parent <strong>and</strong> Newco shall have duly performed or complied<br />

with, in all material respects, all of the covenants, obligations <strong>and</strong> conditions to be<br />

performed or complied with <strong>by</strong> each of them under the terms of this Agreement on or<br />

prior to or at the Closing.<br />

(c) Closing Certificate. Parent <strong>and</strong> Newco shall have delivered to the<br />

Company a certificate, signed <strong>by</strong> the President or a Vice President of Parent, dated the<br />

Closing Date, to the effect that the conditions specified in Sections 6.3(a) <strong>and</strong> 6.3(b) have<br />

been satisfied.<br />

(d) Escrow Agreement. Parent <strong>and</strong> the Escrow Agent shall have executed <strong>and</strong><br />

delivered the Escrow Agreement.<br />

(e) P-L Holdings Stockholders’ Agreement. The parties identified in the P-L<br />

Holdings Stockholders’ Agreement (other than the Pappas Group) shall have executed<br />

<strong>and</strong> delivered the P-L Holdings Stockholders’ Agreement substantially in the form of<br />

Exhibit H attached hereto.<br />

(f) Stock Purchase Agreement. Parent shall have executed <strong>and</strong> delivered the<br />

Stock Purchase Agreement substantially in the form of Exhibit I attached hereto.<br />

7.1 Termination.<br />

ARTICLE 7<br />

TERMINATION<br />

This Agreement may be terminated <strong>and</strong> the Merger may be ab<strong>and</strong>oned at any time,<br />

notwithst<strong>and</strong>ing the approval thereof <strong>by</strong> the shareholders of the Company at any time prior to<br />

Closing:<br />

(a) <strong>by</strong> mutual written consent of the Company <strong>and</strong> Parent;<br />

(b) <strong>by</strong> either the Company or Parent, if the Merger shall not have been<br />

consummated on or before August 15, 2011 (the “Termination Date”), unless extended<br />

<strong>by</strong> written agreement of the parties hereto; provided, however, that the right to terminate<br />

this Agreement <strong>and</strong> ab<strong>and</strong>on the Merger under this paragraph shall not be available to<br />

any party whose failure to fulfill any obligation under this Agreement has been the cause<br />

- 59 -


of, or resulted in, the failure of the Merger to occur on or prior to such date; provided,<br />

further, that if any condition set forth in Sections 6.1(a) or 6.1(b) shall not have been<br />

satisfied as of the Termination Date, the Company may extend the Termination Date on<br />

one or more occasions for an aggregate number of 90 additional calendar days upon<br />

notice given to Parent at any time prior to a termination pursuant to this clause (b);<br />

(c) <strong>by</strong> the Company, if (i) all of the conditions set forth in Sections 6.1 <strong>and</strong><br />

6.2 have been satisfied or waived (other than those conditions that <strong>by</strong> their terms are to be<br />

satisfied at the Closing), (ii) Parent <strong>and</strong> Newco fail to consummate or complete the<br />

Closing within two Business Days following the date on which the Closing should have<br />

occurred pursuant to Section 2.2 <strong>and</strong> (iii) the Company gives written notice to Parent that<br />

the Company is prepared to consummate or complete the Closing; provided that any<br />

termination of this Agreement under Section 7.1(b) shall be deemed to be a termination<br />

under this Section 7.1(c) if the Company was entitled to terminate this Agreement under<br />

this Section 7.1(c) at the time of such termination; or<br />

(d) <strong>by</strong> either the Company or Parent, if any Governmental Authority shall<br />

have issued an order, decree or ruling or taken any other action restraining, enjoining or<br />

otherwise prohibiting the Merger <strong>and</strong> such order, decree, ruling or other action shall have<br />

become final <strong>and</strong> nonappealable.<br />

7.2 Effect of Termination.<br />

If this Agreement is terminated pursuant to Section 7.1 hereof, (a) all rights <strong>and</strong><br />

obligations of the parties hereunder shall terminate <strong>and</strong> no party shall have any liability to the<br />

other party, except for obligations of the parties hereto in Sections 5.2(b), 5.6, 7.3, 9.1 <strong>and</strong><br />

Article 10 (<strong>and</strong> any related definitional provisions set forth in Article 1), which shall survive the<br />

termination of this Agreement, <strong>and</strong> (b) such termination shall not preclude either party from<br />

suing the other party for any willful breaches of this Agreement.<br />

7.3 Reverse Termination Fee.<br />

In the event that (i) this Agreement is terminated or deemed terminated pursuant to<br />

Section 7.1(c) <strong>and</strong> (ii) (A) the proceeds of the Financing or the Alternate Financing are not<br />

available to Lassonde, Parent or Newco <strong>and</strong> would not be available if Lassonde, Parent <strong>and</strong><br />

Newco complied with all of their obligations hereunder <strong>and</strong> under the Commitment Letter (or the<br />

similar documentation related to the Alternate Financing) <strong>and</strong> made the “Equity Contribution”<br />

(as defined in the Commitment Letter) <strong>and</strong> the “Additional Equity Contribution” (as defined in<br />

this Agreement) (a “Financing Failure”) or (B) the Company otherwise so elects, in writing, in<br />

its sole discretion (the “Reverse Termination Fee Events”), then in such event Parent shall pay or<br />

cause to be paid to the Company $11,700,000 (the “Reverse Termination Fee”) <strong>by</strong> wire transfer<br />

of immediately available funds within three Business Days following such termination. In the<br />

event that Parent shall fail to pay the Reverse Termination Fee when due, Parent shall also<br />

reimburse the Company for all reasonable costs <strong>and</strong> expenses incurred <strong>by</strong> the Company<br />

(including attorneys’ fees) after the date such Reverse Termination Fee becomes due in<br />

connection with the collection under <strong>and</strong> enforcement of this Section 7.3 (the “Enforcement<br />

Costs”). In the event a Reverse Termination Fee Event occurs <strong>and</strong> the Reverse Termination Fee<br />

- 60 -


<strong>and</strong> the Enforcement Costs (if any) are paid to the Company, (i) the payment of the Reverse<br />

Termination Fee <strong>and</strong> the Enforcement Costs (if any) shall be deemed to be liquidated damages<br />

for any <strong>and</strong> all claims, actions, causes of action, judgments, awards, losses, damages, liabilities,<br />

fines, penalties, expenses or costs (including reasonable attorney’s fees <strong>and</strong> other out-of-pocket<br />

costs incurred in investigating, preparing <strong>and</strong> defending the foregoing) suffered or incurred <strong>by</strong><br />

the Company or any of its Affiliates or any other Person in connection with or related to or<br />

arising out of this Agreement, the Financing, any Alternate Financing, the Commitment Letter,<br />

the transactions contemplated here<strong>by</strong> <strong>and</strong> there<strong>by</strong> (<strong>and</strong> the ab<strong>and</strong>onment or termination thereof),<br />

any oral representation made or alleged to have been made in connection herewith or therewith<br />

or any matter forming the basis for such termination, <strong>and</strong> (ii) none of the Company, any of its<br />

respective Affiliates or any other Person shall thereafter be entitled to bring or maintain any<br />

other claim, action or proceeding against Parent, the parties to the Commitment Letter (including<br />

the Lenders), or any of their respective former, current or future general or limited partners,<br />

shareholders, managers, members, directors, officers, affiliates, employees, agents or other<br />

representatives arising out of this Agreement, the Financing, any Alternate Financing, the<br />

Commitment Letter (or the ab<strong>and</strong>onment or the termination thereof), the transactions<br />

contemplated here<strong>by</strong> <strong>and</strong> there<strong>by</strong> (or the ab<strong>and</strong>onment thereof), any oral representation made or<br />

alleged to have been made in connection herewith or therewith or any matter forming the basis<br />

for such termination. Notwithst<strong>and</strong>ing anything to the contrary in this Agreement, in the event a<br />

Reverse Termination Fee Event occurs <strong>and</strong> the Reverse Termination Fee <strong>and</strong> the Enforcement<br />

Costs (if any) are paid to the Company, (i) under no circumstances will the Company or its<br />

Affiliates be entitled to monetary damages or other monetary remedies for any Losses suffered as<br />

a result of the failure of the transactions contemplated herein to be consummated or for a breach<br />

or failure to perform hereunder or any oral representation made or alleged to have been made in<br />

connection herewith in excess of the amount of the Reverse Termination Fee <strong>and</strong> the<br />

Enforcement Costs (if any), once paid to the Company, regardless of whether such monetary<br />

damages or other remedies are based on a claim in law or equity, <strong>and</strong> (ii) under no circumstances<br />

shall the Company or its Affiliates be permitted or entitled to receive a grant of specific<br />

performance or any additional damages or other monetary remedies.<br />

ARTICLE 8<br />

SURVIVAL <strong>OF</strong> REPRESENTATIONS; INDEMNIFICATION<br />

8.1 Survival of Representations.<br />

The representations <strong>and</strong> warranties under this Agreement shall survive for the period<br />

ending on the eighteen month anniversary of the Closing Date, except that representations <strong>and</strong><br />

warranties of the Company set forth in Section 3.2 (Company Authorization), Section 3.5<br />

(Company Capitalization; Subsidiaries), Section 3.20 (Brokers), Section 4.2 (Parent <strong>and</strong> Newco<br />

Authorization) <strong>and</strong> Section 4.8 (Brokers) (the “Fundamental Representations”) shall survive for<br />

the period ending on the five year anniversary of the Closing Date <strong>and</strong> the representations <strong>and</strong><br />

warranties of the Company set forth in Sections 3.10(f) <strong>and</strong> 3.10(g) (Taxes) shall survive the<br />

Closing until the date that is 60 days after the expiration of the applicable statute of limitations.<br />

The covenants <strong>and</strong> agreements of the parties that require performance prior to the Closing shall<br />

expire at <strong>and</strong> shall not survive the Closing, <strong>and</strong> those covenants <strong>and</strong> agreements that require or<br />

contemplate performance after the Closing shall survive in accordance with their respective<br />

- 61 -


terms. No action or claim for Losses (as hereinafter defined) shall be brought or made after the<br />

expiration of the survival period applicable to the representation, warranty or claim on which the<br />

claim is based, except for any claims which have been asserted <strong>and</strong> which are the subject of a<br />

written notice from the Representatives to Parent or from Parent to the Representatives, as may<br />

be applicable, prior to the expiration of such periods, which notice specifies in reasonable detail<br />

the nature, amount <strong>and</strong> basis of the claim.<br />

8.2 General Indemnification.<br />

(a) Subject to all of the limitations in this Article 8, after the Closing, Parent,<br />

the Surviving Corporation <strong>and</strong>/or each of its officers, directors, employees, Affiliates<br />

<strong>and</strong>/or agents (each a “Parent Indemnitee” <strong>and</strong> together the “Parent Indemnitees”) shall<br />

be entitled to be indemnified <strong>and</strong> held harmless from any damages, losses, liabilities,<br />

obligations, claims, interest or expenses (including reasonable attorneys’ <strong>and</strong> consultants’<br />

fees <strong>and</strong> expenses but excluding (except to the extent actually awarded to a third party)<br />

punitive or consequential damages or any damages measured <strong>by</strong> lost profits or any type<br />

of multiple or diminution of value) (“Losses”) resulting from (i) the breach of any<br />

representation or warranty made <strong>by</strong> the Company <strong>and</strong> contained in the Agreement,<br />

(ii) any breach <strong>by</strong> the Company of any of its covenants or agreements contained herein to<br />

be performed at or prior to the Closing, (iii) any breach <strong>by</strong> the Representatives (in their<br />

respective capacities as Representatives) after the Closing of any of their covenants or<br />

agreements contained herein to be performed after the Closing, or (iv) any Income Taxes<br />

or withholding or payroll Taxes of the Company or its Subsidiaries with respect to<br />

taxable periods ending on or prior to the Closing Date <strong>and</strong> all Income Taxes or<br />

withholding or payroll Taxes of the Company or its Subsidiaries with respect to the<br />

Straddle Periods to the extent that any such Income Taxes or withholding or payroll<br />

Taxes are allocable in accordance with Section 5.10(c) to the period prior to Closing<br />

Date, all Income Taxes of any member of an affiliated, consolidated, combined, or<br />

unitary group of which the Company or any Subsidiary (or any predecessor of the<br />

Company or any Subsidiary) is or was a member on or prior to the Closing Date,<br />

including pursuant to Treasury Regulation § 1.1502-6 or any analogous or similar state,<br />

local, or foreign law or regulation, <strong>and</strong> all Taxes of any Person allocable to a period prior<br />

to the Closing Date imposed on the Company or any Subsidiary as a transferee, successor<br />

or <strong>by</strong> contract or pursuant to any law, rule or regulation (such obligations shall be without<br />

regard to whether there was any breach of any representation or warranty under Article 3<br />

with respect to such Tax or any disclosures that may have been made with respect to<br />

Article 3 or otherwise). The indemnification obligations under Section 8.2(a)(iv) shall<br />

apply even if the additional tax liability results from the filing of a return or amended<br />

return with respect to a pre-Closing Date transaction or period (or portion of a period) <strong>by</strong><br />

Parent that is prepared <strong>and</strong> filed in a manner consistent with the requirements <strong>and</strong><br />

procedures contained in this Agreement.<br />

(b) Subject to all of the limitations in this Article 8, after the Closing, each of<br />

Parent <strong>and</strong> the Surviving Corporation agrees to indemnify, defend <strong>and</strong> hold each Former<br />

Shareholder <strong>and</strong> their respective officers, directors, employees, Affiliates <strong>and</strong>/or agents<br />

(each a “Shareholder Indemnitee” <strong>and</strong> together the “Shareholder Indemnitees”) harmless<br />

from any Losses resulting from (i) the breach of any representation or warranty made <strong>by</strong><br />

- 62 -


Parent <strong>and</strong> Newco <strong>and</strong> contained in the Agreement, (ii) any breach <strong>by</strong> Parent or Newco of<br />

any of their covenants or agreements contained herein to be performed prior to, at or after<br />

the Closing, or (iii) any breach <strong>by</strong> the Surviving Corporation (including <strong>by</strong> way of being<br />

the successor of Newco but excluding, for purposes of breaches <strong>by</strong> the Company of any<br />

of its covenants or agreements contained herein to be performed at or prior to the<br />

Closing, <strong>by</strong> way of being the successor to the Company) of any of its covenants or<br />

agreements contained herein to be performed after the Closing.<br />

(c) The obligations to indemnify <strong>and</strong> hold harmless pursuant to Section 8.2(a)<br />

<strong>and</strong> pursuant to Section 8.2(b) shall survive the consummation of the transactions<br />

contemplated here<strong>by</strong> until the end of the survival period applicable to the representation,<br />

warranty or covenant on which the claim is based (or in the case of claims under<br />

Section 8.2(a)(iv), until the date that is 60 days after the expiration of the applicable<br />

statute of limitations), except for claims for indemnification pursuant to such clauses<br />

asserted prior to the end of the applicable survival period in accordance with Section 8.1<br />

or this Section 8.2(c), which claims shall survive until final resolution thereof; provided<br />

that any such claim shall be deemed to have been withdrawn <strong>and</strong> waived two years after<br />

being made unless (x) claim proceedings shall have been commenced with respect to<br />

such claim within such two year period or (y) the claimant is actively continuing in good<br />

faith discussions with the potentially indemnifying parties to pursue <strong>and</strong> finalize such<br />

claim as soon as practicable.<br />

(d) All indemnification payments under this Article 8 shall be treated as<br />

adjustments to the Merger Consideration for all Tax purposes except as otherwise<br />

required <strong>by</strong> applicable law.<br />

(e) If any Parent Indemnitee becomes entitled to indemnification for Losses<br />

pursuant to this Article 8, (i) such indemnification payment will be made first out of the<br />

Escrow Account <strong>and</strong> (ii) in the event that the Escrow Funds then in the Escrow Account<br />

are insufficient to satisfy such indemnification obligation in full, such Parent Indemnitee<br />

shall, subject to all of the applicable limitations set forth in this Article 8, including<br />

Sections 8.5(b)(iv) <strong>and</strong> 8.5(c), be permitted to proceed against each Former Shareholder<br />

for an amount up to (x) such Former Shareholder’s Common Stock Ownership<br />

Percentage multiplied <strong>by</strong> (y) the indemnifiable Losses for which payment was not made<br />

out of the Escrow Account.<br />

(f) If any Parent Indemnitee becomes entitled to indemnification for Losses<br />

pursuant to this Article 8, such indemnification payment shall be made directly to the<br />

Surviving Corporation.<br />

8.3 Third-Party Claims.<br />

(a) If a claim, action, suit or proceeding <strong>by</strong> a third party (a “Third-Party<br />

Claim”) is made against any Person or entity entitled to indemnification pursuant to<br />

Section 8.2 hereof (an “Indemnified Party”), <strong>and</strong> if such Indemnified Party intends to<br />

seek indemnity with respect thereto under this Article 8, such Indemnified Party shall<br />

promptly, but no later than 20 days following such Indemnified Party’s receipt of the<br />

- 63 -


Third-Party Claim, notify the party obligated to indemnify such Indemnified Party (such<br />

party obligated to provide indemnification, the “Responsible Party”) (or, in the case of a<br />

Parent Indemnitee seeking indemnification, such Parent Indemnitee shall promptly notify<br />

the Representatives, who shall act on behalf of each Former Shareholder in such former<br />

holder’s capacity as a Responsible Party in accordance with Article 9) of such claims;<br />

provided, that the failure to so notify shall not relieve the Responsible Party of its<br />

obligations hereunder, except to the extent the Responsible Party is prejudiced there<strong>by</strong>.<br />

The Responsible Party shall have the right to assume the conduct <strong>and</strong> control, through<br />

counsel reasonably acceptable to the Indemnified Party at the expense of the Responsible<br />

Party, of the settlement or defense thereof, <strong>and</strong> the Indemnified Party shall cooperate with<br />

it in connection therewith. If the Responsible Party assumes the defense of a Third-Party<br />

Claim, the Indemnified Party shall have the right to participate in but not control such<br />

defense, including through counsel chosen <strong>by</strong> such Indemnified Party; provided, that the<br />

fees <strong>and</strong> expenses of such counsel shall be borne <strong>by</strong> such Indemnified Party. The<br />

Indemnified Party shall not pay or settle any claim without the prior written consent of<br />

the Responsible Party unless, in connection with such payment or settlement, the<br />

Indemnified Party waives any right to indemnity for such claim. The Indemnified Party<br />

shall have the right to undertake the defense of a Third-Party Claim the defense of which<br />

is not undertaken <strong>by</strong> the Responsible Party; provided, that the Indemnified Party shall not<br />

settle or compromise any such Third-Party Claim without the prior written consent of the<br />

Responsible Party, such consent not to be unreasonably withheld, conditioned or delayed.<br />

The Responsible Party shall not, except with the prior written consent of the Indemnified<br />

Party, such consent not to be unreasonably withheld, conditioned or delayed, enter into<br />

any settlement or consent to entry of judgment of a Third-Party Claim that does not<br />

include as an unconditional term thereof the giving <strong>by</strong> the Person or Persons asserting<br />

such claim to all Indemnified Parties of an unconditional release from all liability with<br />

respect to such claim.<br />

(b) Any Indemnified Party shall cooperate in all reasonable respects with the<br />

Responsible Party <strong>and</strong> its attorneys in the investigation, trial <strong>and</strong> defense of any Third-<br />

Party Claim <strong>and</strong> any appeal arising therefrom <strong>and</strong> shall furnish such records, information<br />

<strong>and</strong> testimony, <strong>and</strong> attend such conferences, discovery proceedings, hearings, trials <strong>and</strong><br />

appeals as may be reasonably requested in connection therewith. Such cooperation shall<br />

include access during normal business hours afforded to the Responsible Party <strong>and</strong> its<br />

agents <strong>and</strong> representatives to, <strong>and</strong> reasonable retention <strong>by</strong> the Indemnified Party of,<br />

records <strong>and</strong> information which have been identified <strong>by</strong> the Responsible Party as being<br />

reasonably relevant to such Third-Party Claim, <strong>and</strong> making employees available on a<br />

mutually convenient basis to provide additional information <strong>and</strong> explanation of any<br />

material provided hereunder. The parties shall cooperate with each other in any<br />

notifications to insurers.<br />

8.4 Direct Claims.<br />

Each Indemnified Party shall assert any claim on account of any Losses which do not<br />

result from a Third-Party Claim (a “Direct Claim”) <strong>by</strong> giving the Responsible Party (or, in the<br />

case of a Parent Indemnitee seeking indemnification, such Parent Indemnitee shall promptly<br />

notify the Representatives, who shall act on behalf of each Former Shareholder in such former<br />

- 64 -


holder’s capacity as a Responsible Party in accordance with Article 9) written notice thereof<br />

reasonably promptly (<strong>and</strong>, in any event, no later than 30 days following the Indemnified Party’s<br />

discovery of the applicable Losses reasonably likely to give rise to a claim under this Article 8).<br />

Such notice <strong>by</strong> the Indemnified Party shall describe the Direct Claim in reasonable detail,<br />

include copies of all available material written evidence thereof <strong>and</strong> indicate the estimated<br />

amount, if reasonably practicable, of Losses that have been or may be sustained <strong>by</strong> the<br />

Indemnified Party; provided, that the failure to timely give such notice shall not affect the rights<br />

of an Indemnified Party hereunder except to the extent such failure has a prejudicial effect on the<br />

defenses or other rights available to the Responsible Party with respect to, or ability to mitigate,<br />

such Direct Claim.<br />

8.5 Limitations on Indemnification Obligations.<br />

(a) Nothing provided in this Section 8.5 shall limit any duty of an Indemnified<br />

Party to mitigate Losses under applicable law or Section 8.6.<br />

(b) The rights of the Parent Indemnitees to indemnification pursuant to the<br />

provisions of Section 8.2(a) are subject to the following limitations:<br />

(i) The amount of any <strong>and</strong> all Losses will be determined net of (x) any<br />

accruals or reserves that are included in the Company Financial Statements or the<br />

Final Statement of Purchase Price or included in the calculation of Net Working<br />

Capital, in each case, to address the matters to which such Losses relate, (y) any<br />

amounts actually recovered <strong>by</strong> the Parent Indemnitees under indemnification<br />

agreements or arrangements with third parties or under insurance policies with<br />

respect to such Losses <strong>and</strong> (z) an amount equal to the Tax savings or benefits that<br />

are actually realized <strong>by</strong> the Surviving Corporation or its Subsidiaries, during the<br />

period between the Closing Date <strong>and</strong> the end of the first taxable year following<br />

the year of the date of the Loss, attributable to any deduction, loss, credit or other<br />

Tax benefit resulting from or arising out of such Losses. If the amount to be<br />

netted hereunder from any payment required under Section 8.2(a) is determined<br />

after payment of any amount otherwise required to be paid to an Indemnified<br />

Party under this Article 8, the Indemnified Party shall repay to the Responsible<br />

Parties, promptly after such determination, any amount that the Responsible<br />

Parties would not have had to pay pursuant to this Article 8 had such<br />

determination been made at the time of such payment;<br />

(ii) The Parent Indemnitees shall not be entitled to recover for any<br />

Losses or series of Losses under Section 8.2(a)(i) resulting from a breach of the<br />

representations <strong>and</strong> warranties of the Company set forth in Section 3.6 with<br />

respect to amounts that were compromised in determining the Final Statement of<br />

Purchase Price.<br />

(iii) The Parent Indemnitees shall not be entitled to recover Losses<br />

pursuant to Section 8.2(a)(i) until the total amount of Losses which the Parent<br />

Indemnitees would have been entitled to recover under Section 8.2(a)(i) (as<br />

limited <strong>by</strong> the other sections of this Section 8.5) but for this Section 8.5(b)(iii)<br />

- 65 -


exceeds $2,500,000 (the “Threshold”) <strong>and</strong> then only for the Losses in excess of<br />

the Threshold; provided, that claims asserted under Section 8.2(a)(i) for Losses<br />

resulting from a breach of a Fundamental Representation or the representations<br />

<strong>and</strong> warranties of the Company set forth in Sections 3.10(f) or 3.10(g) shall not be<br />

subject to the Threshold; <strong>and</strong><br />

(iv) In no event shall the Parent Indemnitees be entitled to be<br />

indemnified hereunder for Losses in excess of the Escrow Amount; provided, that<br />

this clause (iv) shall not apply to (x) any breach of a Fundamental Representation<br />

or the representations <strong>and</strong> warranties of the Company set forth in Sections 3.10(f)<br />

or 3.10(g) or (y) any indemnification of the Parent Indemnitees under Section<br />

8.2(a)(iv), which shall remain subject to all of the other applicable limitations set<br />

forth in this Article 8, including Section 8.5(c).<br />

(c) Notwithst<strong>and</strong>ing anything contained herein to the contrary, in no event<br />

shall any Former Shareholder be liable for indemnification pursuant to this Article 8 for<br />

any Losses, together with the aggregate amount of all Losses for which such Former<br />

Shareholder has indemnified any Parent Indemnitee pursuant to this Article 8 (whether<br />

directly or through disbursements from the Escrow Account), in excess of the portion of<br />

the Purchase Price received <strong>by</strong> such Former Shareholder.<br />

(d) Following the Closing, in no event shall Parent be required to indemnify<br />

any Shareholder Indemnitee, <strong>and</strong> Parent shall have no liability, for any Losses under this<br />

Article 8 to the extent such Losses, together with the aggregate amount of all Losses for<br />

which Parent has indemnified any Shareholder Indemnitee pursuant to this Article 8,<br />

exceed $30,000,000; provided that this Section 8.5(d) shall not apply to (x) any breach of<br />

a Fundamental Representation or (y) any claims under Section 8.2(b) for breaches of<br />

Article 2, Section 5.7, Section 5.8, Section 5.10, Section 8.8 <strong>and</strong> Section 8.9.<br />

(e) An Indemnified Party shall not be entitled to recover from a Responsible<br />

Party pursuant to this Article 8 more than once in respect of the same Losses suffered.<br />

8.6 Mitigation.<br />

Each Indemnified Party shall use its commercially reasonable efforts to mitigate any<br />

indemnifiable Loss. In the event that an Indemnified Party fails to mitigate an indemnifiable<br />

Loss, the Responsible Party shall have no liability for any portion of such Loss that would likely<br />

have been avoided had the Indemnified Party made such efforts.<br />

8.7 Exclusive Remedy.<br />

Notwithst<strong>and</strong>ing anything else contained in this Agreement to the contrary, except in the<br />

case of actual fraud <strong>and</strong> equitable relief pursuant to Section 10.12, after the Closing<br />

indemnification pursuant to, <strong>and</strong> subject to the conditions <strong>and</strong> limitations of, the provisions of<br />

this Article 8 shall be the sole <strong>and</strong> exclusive remedy with respect to any <strong>and</strong> all claims <strong>by</strong> Parent<br />

Indemnitees relating to this Agreement, the Company, the events giving rise to or subject matter<br />

of this Agreement <strong>and</strong> the transactions contemplated here<strong>by</strong>. Without limiting the generality or<br />

effect of the foregoing, Parent, Newco <strong>and</strong> the Surviving Corporation here<strong>by</strong> waive, from <strong>and</strong><br />

- 66 -


after the Closing, any claim or cause of action, known <strong>and</strong> unknown, foreseen <strong>and</strong> unforeseen,<br />

which it or any of its Affiliates may have against the other parties hereto or their directors,<br />

officers or shareholders, including under the common law or federal or state securities laws,<br />

trade regulation laws or other Laws (including any relating to tax, environmental or employee<br />

matters), <strong>by</strong> reason of this Agreement, the events giving rise to or subject matter of this<br />

Agreement <strong>and</strong> the transactions contemplated here<strong>by</strong>, except for claims of actual fraud or claims<br />

or causes of action brought under <strong>and</strong> subject to the terms, conditions <strong>and</strong> limitations of the<br />

provisions contained in this Article 8.<br />

8.8 Release of Escrow Funds.<br />

(a) On the Business Day immediately succeeding the eighteen month<br />

anniversary of the Closing Date, the Escrow Agent shall release (<strong>and</strong> Parent <strong>and</strong> the<br />

Representatives shall instruct the Escrow Agent through joint written instructions to so<br />

release) from the Escrow Account all remaining Escrow Funds to the Former<br />

Shareholders as directed <strong>by</strong> the Representatives (or, to the extent directed <strong>by</strong> the<br />

Representatives, to the Representatives on behalf of the Former Shareholders); provided,<br />

that if, on such day, any bona fide claim for indemnification <strong>by</strong> any Parent Indemnitee<br />

under this Article 8 is pending, then the amount that would otherwise be paid <strong>by</strong> the<br />

Escrow Agent to the Former Shareholders (or, to the extent directed <strong>by</strong> the<br />

Representatives, to the Representatives on behalf of the Former Shareholders) pursuant to<br />

this sentence shall be reduced <strong>by</strong> the amount of each such bona fide claim. Parent <strong>and</strong> the<br />

Representatives shall instruct the Escrow Agent not to release such amount equal to each<br />

such claim amount from the Escrow Account. Upon resolution with respect to each such<br />

claim, Parent <strong>and</strong> the Representatives shall promptly deliver joint written instructions to<br />

the Escrow Agent instructing the Escrow Agent to, within two Business Days, reimburse<br />

the Surviving Corporation for the amount of the related Loss, if any, specified in such<br />

joint written instruction from the Escrow Account <strong>and</strong> release the remaining amounts<br />

retained in connection with such claim to the Former Shareholders as directed <strong>by</strong> the<br />

Representatives (or, to the extent directed <strong>by</strong> the Representatives, to the Representatives<br />

on behalf of the Former Shareholders); provided, further, that the disbursement to the<br />

Surviving Corporation of any sums to which a Parent Indemnitee may be entitled to<br />

receive pursuant to the terms <strong>and</strong> conditions hereof may be subject to such additional<br />

requirements as the Lenders may require pursuant to the documentation governing the<br />

Financing.<br />

(b) In the event that any funds are released <strong>by</strong> the Escrow Agent to the Former<br />

Shareholders (or to the Representatives on behalf of the Former Shareholders) from the<br />

Escrow Account pursuant to this Section 8.8, the Representatives shall direct the Escrow<br />

Agent to pay any such funds (or, if the Representatives receive any such funds on behalf<br />

of the Former Shareholders, the Representatives shall hold any such funds in trust for the<br />

benefit of the applicable Former Shareholders <strong>and</strong> shall promptly disburse such funds,<br />

without interest) to each Former Shareholder in an amount equal to such Former<br />

Shareholder’s Common Stock Ownership Percentage of the aggregate amount of cash<br />

released <strong>by</strong> the Escrow Agent pursuant to this Section 8.8.<br />

- 67 -


8.9 Special Procedures for Taxes.<br />

(a) Notwithst<strong>and</strong>ing anything to the contrary contained in this Agreement,<br />

Parent shall have the sole right to control <strong>and</strong> make all decisions regarding interests in<br />

any Tax audit or proceeding relating to Taxes, including selection of counsel <strong>and</strong><br />

selection of a forum for such contest, provided, however, that in the event such audit or<br />

proceeding relates to Taxes for which the Former Shareholders are responsible <strong>and</strong> have<br />

agreed to indemnify Parent, (i) Parent, the Company, <strong>and</strong> the Representatives (on behalf<br />

of the Former Shareholders) shall cooperate in the conduct of any audit or proceeding<br />

relating to such period, (ii) the Representatives (on behalf of the Former Shareholders)<br />

shall have the right (but not the obligation) to control such audit or proceedings at the<br />

Representatives’ expense (in their capacity as Representatives), <strong>and</strong> in such event Parent<br />

shall have the right (but not the obligation) to participate in such audit or proceeding at<br />

Parent’s expense, <strong>and</strong> (iii) the Representatives shall not enter into any agreement or<br />

settlement with the relevant taxing authority pertaining to such Taxes that could affect the<br />

Company, the Surviving Corporation or any of its Subsidiaries in a post-Closing Date<br />

taxable period without the prior written consent of Parent, which consent shall not be<br />

unreasonably withheld. In the event of any conflict between this Section 8.9(a) <strong>and</strong> any<br />

other section hereof, the provisions of this Section 8.9(a) shall prevail.<br />

(b) The parties will keep each other informed as to matters related to any<br />

proceeding involving Taxes for which indemnification may be sought hereunder,<br />

including any settlement negotiations.<br />

ARTICLE 9<br />

REPRESENTATIVES <strong>OF</strong> THE FORMER SHAREHOLDERS<br />

9.1 Authorization of Representatives.<br />

(a) Clement David Pappas <strong>and</strong> Clement Dimitri Pappas are here<strong>by</strong> appointed,<br />

authorized <strong>and</strong> empowered to act together, but not individually, as joint representatives<br />

(the “Representatives”), for the benefit of the Former Shareholders, as the exclusive<br />

agents <strong>and</strong> attorneys-in-fact to act on behalf of each Former Shareholder, in connection<br />

with this Agreement <strong>and</strong> the transactions contemplated here<strong>by</strong>, including pursuant to the<br />

Escrow Agreement, which shall include the power <strong>and</strong> authority:<br />

(i) to execute <strong>and</strong> deliver the Escrow Agreement (with such<br />

modifications or changes therein as to which the Representatives, in their sole<br />

discretion, shall have consented) <strong>and</strong> to agree to such amendments or<br />

modifications thereto as the Representatives, in their sole discretion, determine to<br />

be desirable;<br />

(ii) to execute <strong>and</strong> deliver following the Closing such waivers, releases<br />

<strong>and</strong> consents in connection with this Agreement <strong>and</strong> the Escrow Agreement <strong>and</strong><br />

the consummation of the transactions contemplated here<strong>by</strong> <strong>and</strong> there<strong>by</strong> as the<br />

Representatives, in their sole discretion, may deem necessary or desirable;<br />

- 68 -


(iii) as Representatives, to enforce <strong>and</strong> protect the rights <strong>and</strong> interests<br />

of the Former Shareholders <strong>and</strong> to enforce <strong>and</strong> protect the rights <strong>and</strong> interests of<br />

the Representatives arising out of or under or in any manner relating to this<br />

Agreement <strong>and</strong> the Escrow Agreement, <strong>and</strong> each other agreement, document,<br />

instrument or certificate referred to herein or therein or the transactions provided<br />

for herein or therein (including in connection with any <strong>and</strong> all claims for<br />

indemnification brought under Article 8 hereof), <strong>and</strong> to take any <strong>and</strong> all actions<br />

which the Representatives believe are necessary or appropriate under the Escrow<br />

Agreement <strong>and</strong>/or this Agreement for <strong>and</strong> on behalf of the Former Shareholders,<br />

including asserting or pursuing any claim, action, proceeding or investigation (a<br />

“Claim”) against Parent, Newco <strong>and</strong>/or the Surviving Corporation, defending any<br />

Third-Party Claims or Direct Claims <strong>by</strong> the Parent Indemnitees, consenting to,<br />

compromising or settling any such Third-Party Claims or Direct Claims,<br />

conducting negotiations with Parent, the Surviving Corporation <strong>and</strong> their<br />

respective representatives regarding such Claims, <strong>and</strong>, in connection therewith, to<br />

(A) assert any claim or institute any action, proceeding or investigation;<br />

(B) investigate, defend, contest or litigate any claim, action, proceeding or<br />

investigation initiated <strong>by</strong> Parent, the Surviving Corporation or any other Person,<br />

or <strong>by</strong> any federal, state or local Governmental Authority against the<br />

Representatives, any of the Former Shareholders <strong>and</strong>/or the Escrow Funds, <strong>and</strong><br />

receive process on behalf of any or all of the Former Shareholders in any such<br />

claim, action, proceeding or investigation <strong>and</strong> compromise or settle on such terms<br />

as the Representatives shall determine to be appropriate, <strong>and</strong> give receipts,<br />

releases <strong>and</strong> discharges with respect to, any such claim, action, proceeding or<br />

investigation; (C) file any proofs of debt, claims <strong>and</strong> petitions as the<br />

Representatives may deem advisable or necessary; (D) settle or compromise any<br />

claims asserted under the Escrow Agreement; <strong>and</strong> (E) file <strong>and</strong> prosecute appeals<br />

from any decision, judgment or award rendered in any such action, proceeding or<br />

investigation, it being understood that the Representatives shall not have any<br />

obligation to take any such actions, <strong>and</strong> shall not have any liability for any failure<br />

to take any such actions;<br />

(iv) to refrain from enforcing any right of the Former Shareholders or<br />

any of them <strong>and</strong>/or the Representatives arising out of or under or in any manner<br />

relating to this Agreement, the Escrow Agreement or any other agreement,<br />

instrument or document in connection with the foregoing; <strong>and</strong><br />

(v) to make, execute, acknowledge <strong>and</strong> deliver all such other<br />

agreements, guarantees, orders, receipts, endorsements, notices, requests,<br />

instructions, certificates, stock powers, letters <strong>and</strong> other writings, <strong>and</strong>, in general,<br />

to do any <strong>and</strong> all things <strong>and</strong> to take any <strong>and</strong> all action that the Representatives, in<br />

their sole <strong>and</strong> absolute discretion, may consider necessary or proper or convenient<br />

in connection with or to carry out the transactions contemplated <strong>by</strong> this<br />

Agreement, the Escrow Agreement <strong>and</strong> all other agreements, documents or<br />

instruments referred to herein or therein or executed in connection herewith <strong>and</strong><br />

therewith.<br />

- 69 -


In the event that the Representatives are unable to reach agreement as to any matter arising in<br />

their respective capacities as Representatives hereunder, the Representatives shall promptly<br />

submit such dispute for the consideration of the Former Shareholders. The affirmative vote of the<br />

Former Shareholders, whether at a meeting held in person or telephonically or <strong>by</strong> writing,<br />

holding a greater percentage, in the aggregate, of Common Stock Ownership Percentage shall<br />

decide any such dispute <strong>and</strong> shall be conclusive <strong>and</strong> binding upon the Representatives.<br />

(b) The Representatives shall not be entitled to any fee, commission or other<br />

compensation for the performance of their services hereunder, but shall be entitled to<br />

payment from the Former Shareholders of all their expenses incurred as the<br />

Representatives. In connection with the foregoing, at the Closing, the Company shall<br />

transfer $500,000 (the “Expense Funds”) to account(s) designated <strong>by</strong> the Representatives,<br />

to be used <strong>by</strong> the Representatives to pay expenses incurred <strong>by</strong> the Representatives in their<br />

capacity as Representatives. Once the Representatives determine, in their sole discretion,<br />

that such Representatives will not incur any additional expenses in their capacity as<br />

Representatives, then the Representatives will distribute the remaining unused Expense<br />

Funds pro rata to the Former Shareholders in accordance with their respective Common<br />

Stock Ownership Percentages of the remaining unused Expense Funds (the “Excess<br />

Expense Funds”). In connection with this Agreement, the Escrow Agreement <strong>and</strong> any<br />

instrument, agreement or document relating hereto or thereto, <strong>and</strong> in exercising or failing<br />

to exercise all or any of the powers conferred upon the Representatives hereunder, (i) the<br />

Representatives shall incur no responsibility whatsoever to any Former Shareholder <strong>by</strong><br />

reason of any error in judgment or other act or omission performed or omitted hereunder<br />

or in connection with the Escrow Agreement or any such other agreement, instrument or<br />

document, excepting only responsibility for any act or failure to act which represents bad<br />

faith or willful misconduct, <strong>and</strong> (ii) the Representatives shall be entitled to rely in good<br />

faith on the advice of counsel, public accountants or other experts experienced in the<br />

matter at issue, <strong>and</strong> any error in judgment or other act or omission of the Representatives<br />

pursuant to such advice shall in no event subject the Representatives to liability to any<br />

Former Shareholders. The powers conferred upon the Representatives hereunder may not<br />

be exercised <strong>by</strong> either Clement David Pappas or Clement Dimitri Pappas individually but<br />

instead may be exercised only <strong>by</strong> Clement David Pappas <strong>and</strong> Clement Dimitri Pappas<br />

acting jointly. Notwithst<strong>and</strong>ing the previous sentence, if either Clement David Pappas or<br />

Clement Dimitri Pappas dies or otherwise becomes incapacitated <strong>and</strong> unable to serve as a<br />

Representative, the other party shall become the sole Representative <strong>and</strong> individually<br />

shall have full power <strong>and</strong> authority granted to the Representatives in this Agreement <strong>and</strong><br />

the Merger Documents. The death or incapacity of any Representative shall not terminate<br />

the agency <strong>and</strong> powers of attorney granted here<strong>by</strong> <strong>and</strong> under any Merger Document to the<br />

Representatives. In the event that both Representatives hereunder have died or otherwise<br />

become incapacitated <strong>and</strong> unable to serve as a Representative, a successor Representative<br />

shall be designated <strong>by</strong> the Former Shareholders holding a majority of the Common Stock<br />

Ownership Percentage.<br />

(c) All of the indemnities, immunities <strong>and</strong> powers granted to the<br />

Representatives under this Agreement shall survive the Closing Date <strong>and</strong>/or any<br />

termination of this Agreement <strong>and</strong>/or the Escrow Agreement.<br />

- 70 -


(d) Parent <strong>and</strong> the Surviving Corporation shall have the right to rely upon all<br />

actions taken or omitted to be taken <strong>by</strong> the Representatives pursuant to this Agreement<br />

<strong>and</strong> the Escrow Agreement, all of which actions or omissions shall be legally binding<br />

upon the Former Shareholders.<br />

(e) The grant of authority provided for herein (i) is coupled with an interest<br />

<strong>and</strong> shall be irrevocable <strong>and</strong> survive the death, incompetency, bankruptcy or liquidation<br />

of any Former Shareholder <strong>and</strong> (ii) shall survive the consummation of the Merger.<br />

10.1 Notices.<br />

ARTICLE 10<br />

MISCELLANEOUS<br />

All notices or other communications required or permitted hereunder shall be in writing<br />

<strong>and</strong> shall be delivered personally, <strong>by</strong> facsimile or sent <strong>by</strong> certified, registered or express air mail,<br />

postage prepaid, <strong>and</strong> shall be deemed given when so delivered personally, or <strong>by</strong> facsimile upon<br />

electronic confirmation of receipt, or if mailed <strong>by</strong> overnight courier service guaranteeing next<br />

day delivery, one day after mailing, or if mailed in any other way, then upon receipt, as follows:<br />

If to Parent or Newco:<br />

Lassonde Industries, Inc.<br />

755 Principale<br />

Rougemont, Quebec J0L 1M0<br />

Attention: Jean Gattuso<br />

with a copy to (which shall not constitute notice):<br />

Squire, S<strong>and</strong>ers & Dempsey (US) LLP<br />

4900 Key Tower<br />

127 Public Square<br />

Clevel<strong>and</strong>, OH 44114<br />

Attention: Laura D. Nemeth, Esq.<br />

- 71 -


If to the Company:<br />

Clement Pappas <strong>and</strong> Company, Inc.<br />

1 Collins Drive<br />

Suite 200<br />

Carneys Point, NJ 08069<br />

Facsimile: (856) 455-8746<br />

Attention: Clement Dimitri Pappas<br />

with a copy to (which shall not constitute notice):<br />

Dechert LLP<br />

Cira Centre<br />

2929 Arch Street<br />

Philadelphia, PA 19104-2808<br />

Facsimile: (215) 994-2222<br />

Attention: Carmen J. Romano, Esq.<br />

R. Jeffrey Legath, Esq.<br />

If to the Representatives:<br />

Clement David Pappas<br />

c/o Clement Pappas <strong>and</strong> Company, Inc.<br />

1 Collins Drive<br />

Suite 200<br />

Carneys Point, NJ 08069<br />

Facsimile: (856) 455-8746<br />

Attention: Clement David Pappas<br />

Clement Dimitri Pappas<br />

c/o Clement Pappas <strong>and</strong> Company, Inc.<br />

1 Collins Drive<br />

Suite 200<br />

Carneys Point, NJ 08069<br />

Facsimile: (856) 455-8746<br />

Attention: Clement Dimitri Pappas<br />

with a copy to (which shall not constitute notice):<br />

Dechert LLP<br />

Cira Centre, 2929 Arch Street<br />

Philadelphia, PA 19104-2808<br />

Facsimile: (215) 994-2222<br />

Attention: Carmen J. Romano, Esq.<br />

R. Jeffrey Legath, Esq.<br />

- 72 -


or to such other address as any party hereto shall notify the other parties hereto (as provided<br />

above) from time to time.<br />

10.2 Disclosure Letter.<br />

On the date hereof, the Company shall deliver the Disclosure Letter, including all<br />

Schedules to this Agreement, to Parent <strong>and</strong> Newco. For the purposes of this Agreement, any<br />

matter that is disclosed in a particular Schedule to this Agreement shall be deemed to have been<br />

included in the other Schedules, notwithst<strong>and</strong>ing the omission of a cross reference thereto, so<br />

long as the relevance of such matter to such other Schedules is reasonably apparent on the face<br />

of such disclosure. The Schedules are qualified in their entirety <strong>by</strong> reference to the specific<br />

provisions of this Agreement <strong>and</strong> do not constitute representations, warranties or covenants of<br />

any party to this Agreement. Disclosure of any fact or item in any Schedule shall not necessarily<br />

mean that such fact or item is material to the Company or its Subsidiaries individually or taken<br />

as a whole. Certain facts <strong>and</strong> items disclosed in the Schedules are not believed to be material <strong>and</strong><br />

are not required to be disclosed pursuant to the terms of the representations <strong>and</strong> warranties in the<br />

Agreement. Such facts <strong>and</strong> items are being disclosed for informational purposes only. No<br />

disclosure on any Schedule relating to a possible breach or violation of any contract or law shall<br />

be construed as an admission or indication that a breach or violation exists or has actually<br />

occurred.<br />

10.3 Time of the Essence; Computation of Time.<br />

Time is of the essence for each <strong>and</strong> every provision of this Agreement. Whenever the last<br />

day for the exercise of any privilege or the discharge or any duty hereunder shall fall upon a<br />

Saturday, Sunday, or any date on which banks in New York, New York <strong>and</strong> Montreal, Canada<br />

are authorized to be closed, the party having such privilege or duty may exercise such privilege<br />

or discharge such duty on the next succeeding day which is a regular Business Day.<br />

10.4 Expenses.<br />

Regardless of whether the transactions provided for in this Agreement are consummated,<br />

except as otherwise provided herein, each party hereto shall pay its own expenses incident to this<br />

Agreement <strong>and</strong> the transactions contemplated herein. Parent <strong>and</strong> Newco underst<strong>and</strong> <strong>and</strong><br />

acknowledge that, except as otherwise provided in this Agreement, all out-of-pocket fees <strong>and</strong><br />

expenses incurred or to be incurred <strong>by</strong> the Company in connection with the transactions<br />

contemplated here<strong>by</strong> (including the Company Expenses) shall be paid <strong>by</strong> the Company <strong>and</strong>/or<br />

the Surviving Corporation. Any transfer, documentary, sales, use, stamp, registration <strong>and</strong> other<br />

such Taxes, <strong>and</strong> all conveyance fees, recording charges <strong>and</strong> other fees <strong>and</strong> charges (including<br />

any penalties <strong>and</strong> interest) incurred in connection with consummation of the transactions<br />

contemplated <strong>by</strong> this Agreement shall be paid, or caused to be paid, <strong>by</strong> Parent when due, <strong>and</strong><br />

Parent shall, at its own expense, file all necessary Tax Returns <strong>and</strong> other documentation with<br />

respect to all such Taxes, fees <strong>and</strong> charges.<br />

10.5 Governing Law; Jurisdiction.<br />

This Agreement shall be construed in accordance with <strong>and</strong> governed <strong>by</strong> the laws of the<br />

State of New York applicable to agreements made <strong>and</strong> to be performed wholly within that<br />

- 73 -


jurisdiction; provided, that the Merger shall be effected in accordance with the laws of the State<br />

of New Jersey. In connection with any suit, action or other proceeding arising out of or relating<br />

to this Agreement, the events giving rise to this Agreement or any transaction contemplated<br />

here<strong>by</strong>, including the proposed Financing or the Commitment Letter or any termination thereof<br />

or failure to fund thereunder, the parties hereto here<strong>by</strong> agree <strong>and</strong> consent to be subject to the<br />

exclusive jurisdiction of the United States District Court for the Southern District of New York,<br />

<strong>and</strong> in the absence of such Federal jurisdiction, the parties consent to be subject to the exclusive<br />

jurisdiction of the state courts located in New York, New York, <strong>and</strong> here<strong>by</strong> waive the right to<br />

assert the lack of personal or subject matter jurisdiction or improper venue in connection with<br />

any such suit, action or other proceeding. In furtherance of the foregoing, each of the parties (i)<br />

waives the defense of inconvenient forum, (ii) agrees not to commence, <strong>and</strong> agrees not to permit<br />

any Affiliate to commence, any suit, action or other proceeding arising out of or relating to this<br />

Agreement, the proposed Financing, any Alternate Financing, the Commitment Letter, the events<br />

giving rise to this Agreement, the proposed Financing, any Alternate Financing, the Commitment<br />

Letter, or any other transaction contemplated here<strong>by</strong> or there<strong>by</strong> other than in any such court <strong>and</strong><br />

(iii) agrees that the Lenders are beneficiaries of any liability cap or limitation on damages or<br />

remedies in this Agreement with respect to events or circumstances that occur prior to the<br />

Closing, <strong>and</strong> (iv) agrees that a final judgment in any such suit, action or other proceeding shall be<br />

conclusive <strong>and</strong> may be enforced in other jurisdictions <strong>by</strong> suit or judgment or in any other manner<br />

provided <strong>by</strong> law. Each party hereto further agrees that service of any process, summons, notice<br />

or document <strong>by</strong> U.S. registered mail to such party’s address set forth in Section 10.1 above shall<br />

be effective service of process for any claim, action or proceeding with respect to any matters to<br />

which it has submitted to jurisdiction in this Section 10.5 or otherwise.<br />

10.6 Assignment; Successors <strong>and</strong> Assigns; No Third-Party Rights.<br />

Except as otherwise provided herein, this Agreement may not, without the prior written<br />

consent of the other parties hereto, be assigned <strong>by</strong> operation of law or otherwise, <strong>and</strong> any<br />

attempted assignment shall be null <strong>and</strong> void; provided, that the Company, the Representatives<br />

<strong>and</strong> the Former Shareholders acknowledge <strong>and</strong> agree that the rights <strong>and</strong> remedies of Parent <strong>and</strong><br />

Newco hereunder <strong>and</strong> under the other documents contemplated here<strong>by</strong>, including the Escrow<br />

Agreement, may be assigned at or following the Closing as collateral to the Lenders in<br />

connection with the Financing; provided, further, that the foregoing shall not relieve Parent,<br />

Newco or the Surviving Corporation of their obligations hereunder. Subject to the foregoing, this<br />

Agreement shall be binding upon <strong>and</strong> inure to the benefit of the parties hereto <strong>and</strong> their<br />

respective heirs, successors, permitted assigns <strong>and</strong> legal representatives. Except as set forth in<br />

Sections 5.7(c), 5.8, 8.2 <strong>and</strong> 9.1(a) hereof, <strong>and</strong> except as expressly set forth herein with respect to<br />

the Lenders, the Commitment Letter <strong>and</strong> the proposed Financing, this Agreement shall be for the<br />

sole benefit of the parties to this Agreement <strong>and</strong> their respective heirs, successors, permitted<br />

assigns <strong>and</strong> legal representatives <strong>and</strong> is not intended, nor shall be construed, to give any Person,<br />

other than the parties hereto <strong>and</strong> their respective heirs, successors, assigns <strong>and</strong> legal<br />

representatives, any legal or equitable right, remedy or claim hereunder; provided that each of<br />

the parties agrees that the Lenders are express third party beneficiaries of, <strong>and</strong> may enforce, the<br />

provisions set forth in this Section 10.6 <strong>and</strong> Sections 7.3, 10.5, 10.12(c), 10.13 <strong>and</strong> 10.15;<br />

provided, further, that each of the parties agrees that the members of the Pappas Group are<br />

express third party beneficiaries of, <strong>and</strong> may enforce, the provisions set forth in this Section 10.6<br />

<strong>and</strong> Section 5.13.<br />

- 74 -


10.7 Counterparts.<br />

This Agreement may be executed in two or more counterparts for the convenience of the<br />

parties hereto, each of which shall be deemed an original <strong>and</strong> all of which together will constitute<br />

one <strong>and</strong> the same instrument. Delivery of an executed counterpart of a signature page to this<br />

Agreement <strong>by</strong> facsimile or portable document format shall be effective as delivery of a manually<br />

executed counterpart to this Agreement.<br />

10.8 Titles <strong>and</strong> Headings.<br />

The titles, captions <strong>and</strong> table of contents in this Agreement are for reference purposes<br />

only, <strong>and</strong> shall not in any way define, limit, extend or describe the scope of this Agreement or<br />

otherwise affect the meaning or interpretation of this Agreement.<br />

10.9 Entire Agreement.<br />

This Agreement, including the Exhibits attached hereto, the Disclosure Letter <strong>and</strong> the<br />

Confidentiality Agreement constitute the entire agreement <strong>among</strong> the parties with respect to the<br />

matters covered here<strong>by</strong> <strong>and</strong> supersede all previous written, oral or implied underst<strong>and</strong>ings <strong>among</strong><br />

them with respect to such matters.<br />

10.10 Severability.<br />

The invalidity of any portion hereof shall not affect the validity, force or effect of the<br />

remaining portions hereof.<br />

10.11 No Strict Construction.<br />

Each of the parties hereto acknowledges that this Agreement has been prepared jointly <strong>by</strong><br />

the parties hereto <strong>and</strong> shall not be strictly construed against either party. As a consequence, the<br />

parties do not intend that the presumptions of any laws or rules relating to the interpretation of<br />

contracts against the drafter of any particular clause should be applied to this Agreement <strong>and</strong><br />

therefore waive their effects.<br />

10.12 Specific Performance.<br />

(a) Each of the Company, on one h<strong>and</strong>, <strong>and</strong> Lassonde, Parent <strong>and</strong> Newco, on<br />

the other h<strong>and</strong>, acknowledges that the rights of each party to consummate the transactions<br />

contemplated here<strong>by</strong> are unique <strong>and</strong> recognizes <strong>and</strong> affirms that in the event of a breach<br />

of this Agreement <strong>by</strong> any party, money damages would be inadequate <strong>and</strong> the nonbreaching<br />

party would have no adequate remedy at law. Accordingly, the parties agree,<br />

subject to Sections 7.3 <strong>and</strong> 10.12(b), that such non-breaching party shall have the right to<br />

specific performance, injunctive <strong>and</strong>/or other equitable relief (without the necessity of<br />

proving the inadequacy as a remedy of money damages or the posting of bond or other<br />

security), in addition to any other rights <strong>and</strong> remedies existing in their favor at law or in<br />

equity, to enforce their rights <strong>and</strong> the other parties’ obligations hereunder. Parent, Newco<br />

<strong>and</strong> Lassonde agree that they will not oppose the granting of an injunction, specific<br />

performance <strong>and</strong> other equitable relief on the basis that the Company has an adequate<br />

- 75 -


emedy at law or an award of specific performance is not an appropriate remedy for any<br />

reason at law or equity.<br />

(b) Notwithst<strong>and</strong>ing the foregoing, it is explicitly agreed that the Company<br />

shall be entitled to specific performance of Parent’s <strong>and</strong> Newco’s obligations to fund the<br />

transactions contemplated <strong>by</strong> this Agreement <strong>and</strong> to consummate the transactions<br />

contemplated <strong>by</strong> this Agreement (<strong>and</strong> of Lassonde’s guarantee of such obligations<br />

pursuant to Section 10.18) only in the event that (i) all of the conditions set forth in<br />

Sections 6.1 <strong>and</strong> 6.2 have been satisfied or waived (other than those conditions that <strong>by</strong><br />

their terms are to be satisfied at the Closing), (ii) the proceeds of the Financing or the<br />

Alternate Financing are available to Lassonde, Parent or Newco or would be available if<br />

Lassonde, Parent <strong>and</strong> Newco had complied with all of their obligations hereunder <strong>and</strong><br />

made the “Equity Contribution” (as defined in the Commitment Letter) <strong>and</strong> the<br />

Additional Equity Contribution <strong>and</strong> (iii) notwithst<strong>and</strong>ing the occurrence of the events<br />

specified in clauses (i) <strong>and</strong> (ii) of this Section 10.12(b), the Company has not elected<br />

pursuant to Section 7.3(i)(B) to receive (<strong>and</strong> has not in fact so received), the Reverse<br />

Termination Fee <strong>and</strong> Enforcement Costs (if any).<br />

(c) Notwithst<strong>and</strong>ing anything to the contrary in this Agreement, each of<br />

Parent, the Company <strong>and</strong> the Former Shareholders acknowledge <strong>and</strong> agree that they have<br />

no right of recovery against, <strong>and</strong> no personal liability shall attach to, in each case with<br />

respect to damages of Parent, the Company, the Former Shareholders <strong>and</strong> their respective<br />

affiliates, officers, directors, employees <strong>and</strong>/or agents, <strong>and</strong> none of the foregoing shall be<br />

entitled under this Agreement to bring or maintain any action, cause of action, claim,<br />

cross-claim or third-party claim of any kind or description, whether in law or in equity,<br />

whether in contract or in tort or otherwise, against, any Lender or source of Alternate<br />

Financing whether <strong>by</strong> or through a claim <strong>by</strong> or on behalf of Parent against any Lender or<br />

source of Alternate Financing, <strong>by</strong> the enforcement of any assessment or <strong>by</strong> any legal or<br />

equitable proceeding, <strong>by</strong> virtue of any statute, regulation or applicable law, or otherwise,<br />

in each case with respect to this Agreement or the failure of the Financing or the<br />

Alternate Financing to occur. Recourse against the parties hereto to the extent permitted<br />

or set forth in this Agreement shall be the sole <strong>and</strong> exclusive remedy of the Company <strong>and</strong><br />

its Affiliates against the Lenders or sources of Alternate Financing in respect of any<br />

liabilities arising under, or in connection with, this Agreement or the failure of the<br />

Financing or the Alternate Financing to occur. For the avoidance of doubt, the foregoing<br />

shall in no way limit the ability of the parties to the Commitment Letter or the Definitive<br />

Debt Documents (as defined in the Commitment Letter) to enforce the rights <strong>and</strong><br />

obligations set forth therein.<br />

10.13 WAIVER <strong>OF</strong> JURY TRIAL.<br />

EACH <strong>OF</strong> THE PARTIES HERETO WAIVES ANY RIGHT IT MAY HAVE TO<br />

TRIAL BY JURY IN RESPECT <strong>OF</strong> ANY LITIGATION BASED ON, ARISING OUT <strong>OF</strong>,<br />

UNDER OR IN CONNECTION WITH THIS <strong>AGREEMENT</strong>, THE PROPOSED FINANCING,<br />

THE COMMITMENT LETTER OR ANY COURSE <strong>OF</strong> CONDUCT, COURSE <strong>OF</strong> DEALING,<br />

VERBAL OR WRITTEN STATEMENT OR ACTION <strong>OF</strong> ANY PARTY HERETO OR<br />

THERETO WHETHER OR NOT ANY LENDER IS A PARTY THERETO.<br />

- 76 -


10.14 Failure or Indulgence not Waiver.<br />

No failure or delay on the part of any party hereto in the exercise of any right hereunder<br />

shall impair such right or be construed to be waiver of, or acquiescence in, any breach of any<br />

representation, warranty or agreement herein, nor shall any single or partial exercise of any such<br />

right preclude any other or further exercise thereof or any other right. All rights <strong>and</strong> remedies<br />

existing under this Agreement are cumulative to, <strong>and</strong> not exclusive of, any rights or remedies<br />

otherwise available.<br />

10.15 Amendments <strong>and</strong> Waivers.<br />

This Agreement may be amended, modified, waived <strong>and</strong> supplemented <strong>by</strong> a written<br />

instrument authorized <strong>and</strong> executed (a) on behalf of Parent <strong>and</strong> the Company at any time prior to<br />

the Effective Time with respect to any of the terms contained herein <strong>and</strong> (b) on behalf of Parent<br />

<strong>and</strong> the Representatives at any time after the Effective Time with respect to any of the terms<br />

contained herein; provided that no amendment, modification, waiver or supplementation of this<br />

Agreement that has the substantive effect of amending, modifying or waiving this proviso or<br />

Section 10.5 (as it relates to the Lenders), the penultimate proviso of Section 10.6, Section<br />

10.12(c) or Section 10.13 (as it relates to the Lenders) that is, individually or in the aggregate,<br />

materially adverse to any Lender shall be effective unless Jefferies Finance LLC <strong>and</strong> Bank of<br />

Montreal have consented thereto in writing.<br />

10.16 Legal Representation.<br />

(a) Parent here<strong>by</strong> waives <strong>and</strong> will not assert, <strong>and</strong> agrees to cause the<br />

Surviving Corporation <strong>and</strong> each of its Subsidiaries to waive <strong>and</strong> to not assert, any conflict<br />

of interest arising out of or relating to the representation, after the Closing (the “Post-<br />

Closing Representation”), of the Company, any Former Shareholder or any other officer,<br />

employee or director of the Company or any of its Subsidiaries (any such Person, a<br />

“Designated Person”) in any matter involving this Agreement or any other Merger<br />

Document or transactions contemplated here<strong>by</strong> or there<strong>by</strong> (including any litigation,<br />

arbitration, mediation or other proceeding), <strong>by</strong> any legal counsel currently representing<br />

the Company or any of its Subsidiaries in connection with this Agreement or any other<br />

Merger Document or transactions contemplated here<strong>by</strong> or there<strong>by</strong>, including Dechert<br />

LLP (the “Current Representation”).<br />

(b) Parent here<strong>by</strong> waives <strong>and</strong> will not assert, <strong>and</strong> agrees to cause the<br />

Surviving Corporation <strong>and</strong> each of its Subsidiaries to waive <strong>and</strong> to not assert, any<br />

attorney-client privilege with respect to any communication between any legal counsel<br />

<strong>and</strong> any Designated Person occurring during the Current Representation in connection<br />

with any Post-Closing Representation, including in connection with a dispute with<br />

Parent, <strong>and</strong> following the Closing, with the Surviving Corporation or any of its<br />

Subsidiaries, it being the intention of the parties hereto that all such rights to such<br />

attorney-client privilege <strong>and</strong> to control such attorney-client privilege shall be retained <strong>by</strong><br />

such Designated Person; provided, that the foregoing waiver <strong>and</strong> acknowledgement of<br />

retention shall not extend to any communication not involving the Merger Documents or<br />

- 77 -


any other agreements or transactions contemplated here<strong>by</strong> <strong>and</strong> there<strong>by</strong>, or to<br />

communications with any Person other than the Designated Persons <strong>and</strong> their advisors.<br />

10.17 Certain Underst<strong>and</strong>ings.<br />

Each of the parties is a sophisticated legal entity or person that was advised <strong>by</strong><br />

experienced counsel <strong>and</strong>, to the extent it deemed necessary, other advisors in connection with<br />

this Agreement. Accordingly, each of the parties here<strong>by</strong> acknowledges that (i) no party has relied<br />

or will rely in respect of this Agreement or the transactions contemplated here<strong>by</strong> upon any<br />

document or written or oral information previously furnished to or discovered <strong>by</strong> it or its<br />

representatives, other than as set forth in this Agreement (including the Schedules to the<br />

Disclosure Letter), (ii) there are no representations or warranties <strong>by</strong> or on behalf of any party<br />

hereto or any of its respective Affiliates or representatives other than those expressly set forth in<br />

this Agreement, <strong>and</strong> (iii) the parties’ respective rights <strong>and</strong> obligations with respect to this<br />

Agreement <strong>and</strong> the events giving rise thereto will be solely as set forth in this Agreement.<br />

10.18 Lassonde Industries, Inc. Guaranty.<br />

(a) Lassonde here<strong>by</strong> unconditionally, absolutely <strong>and</strong> irrevocably guarantees<br />

to, <strong>and</strong> for the benefit of the Former Shareholders <strong>and</strong> the Company, (i) the full <strong>and</strong><br />

timely performance <strong>by</strong> Parent <strong>and</strong> Newco of their obligation to comply with any of their<br />

payment obligations pursuant to Section 2.7(c) of this Agreement <strong>and</strong> (ii) until the<br />

Closing has occurred <strong>and</strong> subject to the limitations set forth in Sections 7.3 <strong>and</strong> 10.12<br />

hereof, the full <strong>and</strong> timely performance <strong>by</strong> Parent <strong>and</strong> Newco of their obligations under<br />

this Agreement (together, the “Guaranteed Obligations”). Subject to the limitations set<br />

forth in Sections 7.3 <strong>and</strong> 10.12 hereof, Lassonde agrees to make any such payments <strong>and</strong><br />

cause such performance in accordance with this Agreement as if the Guaranteed<br />

Obligations were the direct contractual obligation of Lassonde, <strong>and</strong> Lassonde here<strong>by</strong><br />

unconditionally waives (i) any defense (A) that may arise <strong>by</strong> reason of the lack of<br />

capacity, power or authority of Parent or Newco <strong>and</strong> (B) that may arise <strong>by</strong> reason of any<br />

failure or lack of dem<strong>and</strong>, presentment, protest or notice of any kind, (ii) any right to<br />

require the Company to proceed against Parent or Newco or pursue any other remedy or<br />

(iii) any defense based on election of remedies <strong>by</strong> the Company. For the avoidance of<br />

doubt, this Section 10.18 is a guarantee of payment <strong>and</strong> performance <strong>and</strong> not of<br />

collection. The Company shall not be required to seek to enforce or resort to any<br />

remedies against Parent or Newco on account of the Guaranteed Obligations. The<br />

obligations of Lassonde under this Section 10.18 shall be automatically reinstated if <strong>and</strong><br />

to the extent that for any reason any payment <strong>by</strong> or on behalf of Parent or any other<br />

Person in respect of the Guaranteed Obligations is rescinded or must be otherwise<br />

restored <strong>by</strong> any holder of the Guaranteed Obligations, whether as a result of any<br />

proceedings in bankruptcy or reorganization or otherwise. Lassonde agrees that until the<br />

indefeasible payment <strong>and</strong> performance <strong>and</strong> satisfaction in full of the Guaranteed<br />

Obligations, it shall not exercise any right or remedy arising <strong>by</strong> reason of any<br />

performance <strong>by</strong> it of its guaranty contained herein, whether <strong>by</strong> subrogation or otherwise,<br />

against Parent or Newco with respect to such Guaranteed Obligations. Lassonde’s<br />

obligations under this Section 10.18 constitute a continuing guaranty <strong>and</strong> shall continue<br />

in full force <strong>and</strong> effect until such time as the Guaranteed Obligations have been fully<br />

- 78 -


performed. By way of clarification <strong>and</strong> not limitation, it is understood <strong>and</strong> agreed that<br />

this Section 10.18 shall not be construed to obligate Lassonde to be a guarantor or other<br />

obligor under the Financing, any Alternate Financing or any of the instruments <strong>and</strong><br />

documents that evidence, secure or otherwise govern the Financing or any Alternate<br />

Financing, it being the intention here<strong>by</strong> that Lassonde’s sole obligations <strong>and</strong> liability to<br />

any Lender in connection with the Financing or any Alternate Financing shall be as<br />

expressly set forth in the Commitment Letter <strong>and</strong> the fee letter related thereto described<br />

in Section 5.5 hereof.<br />

(b) Lassonde is a corporation duly organized, validly existing <strong>and</strong> in good<br />

st<strong>and</strong>ing under the laws of its jurisdiction of organization <strong>and</strong> has all requisite power <strong>and</strong><br />

authority to own, lease <strong>and</strong> operate its property <strong>and</strong> assets <strong>and</strong> to carry on its business as<br />

presently conducted. Lassonde has the power <strong>and</strong> authority to execute <strong>and</strong> deliver this<br />

Agreement <strong>and</strong> each other agreement or instrument to be executed in connection herewith<br />

<strong>and</strong> to perform its obligations hereunder <strong>and</strong> thereunder, all of which have been duly<br />

authorized <strong>by</strong> all requisite action (including any required shareholder or member<br />

approvals). This Agreement <strong>and</strong> each other agreement or instrument to be executed in<br />

connection herewith has been duly authorized, executed <strong>and</strong> delivered <strong>by</strong> Lassonde <strong>and</strong><br />

constitutes a valid <strong>and</strong> binding agreement of Lassonde, enforceable against Lassonde in<br />

accordance with its terms. The execution, delivery <strong>and</strong> performance <strong>by</strong> Lassonde of this<br />

Agreement <strong>and</strong> any other Merger Document, the consummation of the Merger <strong>and</strong> the<br />

other transactions contemplated here<strong>by</strong> do not <strong>and</strong> will not (i) contravene any provision<br />

contained in Lassonde’s certificate of incorporation or <strong>by</strong>-laws (or comparable<br />

organizational documents), (ii) conflict with, violate or result in a material breach (with<br />

or without the lapse of time, the giving of notice or both) of or constitute a material<br />

default (with or without the lapse of time, the giving of notice or both) under, or require<br />

the consent or approval of any third party under (A) any contract, agreement,<br />

commitment, indenture, mortgage, lease, pledge, note, bond, license, permit or other<br />

instrument or obligation, or (B) any judgment, order, decree, statute, law, rule or<br />

regulation or other restriction of any Governmental Authority, in each case to which<br />

Lassonde is a party or <strong>by</strong> which it is bound or to which any of its assets or properties are<br />

subject, or (iii) result in the acceleration of, or permit any Person to terminate, modify,<br />

cancel, accelerate or declare due <strong>and</strong> payable prior to its stated maturity any material<br />

obligation of Lassonde.<br />

* * * * * * *<br />

- 79 -


Exhibit A<br />

Form of Escrow Agreement<br />

16439551.17.BUSINESS A-1


16345690.14.BUSINESS<br />

EXHIBIT A<br />

ESCROW <strong>AGREEMENT</strong><br />

FINAL EXHIBIT FORM<br />

THIS ESCROW <strong>AGREEMENT</strong> is made <strong>and</strong> entered into as of [_____________],<br />

2011 (this “Escrow Agreement”) <strong>by</strong> <strong>and</strong> <strong>among</strong> Pomona Holdings, Inc., a Delaware corporation<br />

(“Parent”), Clement Pappas <strong>and</strong> Company, Inc., a New Jersey corporation (the “Company”),<br />

Clement David Pappas <strong>and</strong> Clement Dimitri Pappas, as the Representatives <strong>and</strong> together with the<br />

Parent <strong>and</strong> Company each a “Party” <strong>and</strong> together, the “Parties”), <strong>and</strong> JPMorgan Chase Bank,<br />

N.A., as escrow agent (the “Escrow Agent”).<br />

Background<br />

A. Pursuant to the Agreement <strong>and</strong> Plan of Merger, dated as of June [__],<br />

2011 (the “Merger Agreement”), <strong>by</strong> <strong>and</strong> <strong>among</strong> the Company, Parent, Pomona Merger Corp., a<br />

New Jersey corporation <strong>and</strong> wholly-owned subsidiary of Parent (“Newco”), <strong>and</strong>, solely for the<br />

purposes of Sections 2.7, 5.10, 8.3, 8.4, 8.8, 8.9 <strong>and</strong> 9.1 <strong>and</strong> Article 10 of the Merger Agreement,<br />

Clement David Pappas <strong>and</strong> Clement Dimitri Pappas, as the Representatives, <strong>and</strong>, solely for the<br />

purposes of Article 10 of the Merger Agreement, Lassonde Industries, Inc., a Canadian<br />

corporation, Newco is being merged with <strong>and</strong> into the Company, with the Company continuing<br />

as the surviving corporation (the “Surviving Corporation”).<br />

B. This Escrow Agreement is entered into pursuant to, <strong>and</strong> as a condition of,<br />

the closing (the “Closing”) of the transactions contemplated <strong>by</strong> the Merger Agreement. Pursuant<br />

to the Merger Agreement, the parties hereto are entering into this Escrow Agreement in order to<br />

provide for the deposit of funds with the Escrow Agent that will be held <strong>and</strong> disbursed as herein<br />

provided.<br />

C. Defined terms used herein, unless otherwise defined herein, shall have the<br />

meanings ascribed to them in the Merger Agreement.<br />

Agreement<br />

THEREFORE, in consideration of the respective agreements <strong>and</strong> covenants<br />

contained herein, <strong>and</strong> intending to be legally bound here<strong>by</strong>, the parties hereto agree as follows:<br />

1.1 Escrow Funds.<br />

ARTICLE I<br />

ESCROW PROCEDURES<br />

(a) Parent here<strong>by</strong> deposits with the Escrow Agent, <strong>and</strong> the Escrow Agent<br />

here<strong>by</strong> acknowledges receipt of, the sum of $30,000,000 in cash (the “Escrow Amount”), which<br />

Escrow Amount Parent has delivered pursuant to the Merger Agreement. The Escrow Amount<br />

has been delivered <strong>by</strong> wire transfer of immediately available funds to an account designated <strong>by</strong><br />

the Escrow Agent in writing to Parent.


(b) The Escrow Amount shall be held <strong>by</strong> the Escrow Agent in a separate <strong>and</strong><br />

segregated account (the “Escrow Account”) in trust for the benefit of Parent <strong>and</strong> the Former<br />

Shareholders as provided in this Escrow Agreement.<br />

(c) The Escrow Amount deposited with the Escrow Agent as provided <strong>by</strong><br />

Section 1.1(a) <strong>and</strong> the income earned on such funds together shall constitute the “Escrow<br />

Funds.” The Escrow Funds shall be held, invested <strong>and</strong> administered in accordance with the<br />

terms <strong>and</strong> provisions of this Escrow Agreement.<br />

1.2 Appointment of Escrow Agent. The Representatives, on behalf of the Former<br />

Shareholders, the Company <strong>and</strong> Parent here<strong>by</strong> appoint the Escrow Agent as Escrow Agent in<br />

accordance with the terms <strong>and</strong> conditions of this Escrow Agreement, <strong>and</strong> the Escrow Agent, <strong>by</strong><br />

signing this Escrow Agreement, accepts the appointment as Escrow Agent <strong>and</strong> agrees to hold,<br />

safeguard <strong>and</strong> distribute all Escrow Funds in accordance with the terms <strong>and</strong> conditions of this<br />

Escrow Agreement.<br />

1.3 Investments; Distributions; Tax Reporting.<br />

(a) Pending disbursement <strong>and</strong> release of the Escrow Funds, the Escrow Agent<br />

shall invest the Escrow Funds in such Permitted Investments (as hereinafter defined) as the<br />

Representatives, from time to time, shall instruct in writing herein or separately in writing from<br />

time to time. For purposes of this Escrow Agreement, “Permitted Investments” shall mean<br />

interest-bearing accounts, a JPMorgan money market account (MMDA), United States<br />

government securities, certificates of deposit or such other instruments or securities as may be<br />

mutually agreed upon <strong>by</strong> Parent <strong>and</strong> the Representatives <strong>and</strong> as shall be acceptable to the Escrow<br />

Agent. In the event that the Escrow Agent shall not have received a separate written direction for<br />

investment for any moneys in the Escrow Funds, the Escrow Agent shall invest the Escrow<br />

Funds in an MMDA account identified on Schedule 4 hereto. Except as otherwise provided in<br />

this Section 1.3, the Escrow Agent shall have no duty, responsibility or obligation to invest any<br />

funds or cash held in the Escrow Funds other than in accordance with this Section 1.3. The<br />

Escrow Agent shall have no liability or responsibility for any investment losses with respect to<br />

Permitted Investments, including, without limitation, any market loss on any Permitted<br />

Investment liquidated (whether at or prior to maturity) in order to make a payment required<br />

under this Escrow Agreement. MMDA have rates of compensation that may vary from time to<br />

time based upon market conditions. Instructions to make any other investment (“Alternative<br />

Investment”) must be in writing <strong>and</strong> shall specify the type <strong>and</strong> identity of the investments to be<br />

purchased <strong>and</strong>/or sold. The Escrow Agent is here<strong>by</strong> authorized to execute purchases <strong>and</strong> sales of<br />

investments through the facilities of its own trading or capital markets operations or those of any<br />

affiliated entity. The Escrow Agent or any of its affiliates may receive compensation with respect<br />

to any Alternative Investment directed hereunder including without limitation charging any<br />

applicable agency fee in connection with each transaction. The Parties recognize <strong>and</strong> agree that<br />

the Escrow Agent will not provide supervision, recommendations or advice relating to either the<br />

investment of moneys held in the Escrow Funds or the purchase, sale, retention or other<br />

disposition of any investment described herein.<br />

In the event that a JPMorgan Money Market Mutual Fund (collectively,<br />

“MMMF”) is selected in writing <strong>by</strong> the Parties <strong>and</strong> acceptable to the Escrow Agent, such<br />

16345690.14.BUSINESS 2


selection will be based upon the Representatives’ independent review of prospectuses previously<br />

delivered to the Parties. The Parties acknowledge that an affiliate of Escrow Agent, JPMorgan<br />

Asset Management, serves as investment manager for the selected MMMF <strong>and</strong> receives fees<br />

from the invested funds for services rendered <strong>by</strong> Escrow Agent as further provided within this<br />

Escrow Agreement.<br />

Market values, exchange rates <strong>and</strong> other valuation information (including without<br />

limitation, market value, current value or notional value) of any Alternative Investment furnished<br />

in any report or statement may be obtained from third party sources <strong>and</strong> is furnished for the<br />

exclusive use of the Parties. Escrow Agent has no responsibility whatsoever to determine the<br />

market or other value of any Alternative Investment <strong>and</strong> makes no representation or warranty,<br />

express or implied, as to the accuracy of any such valuations or that any values necessarily<br />

reflect the proceeds that may be received on the sale of an Alternative Investment.<br />

(b) As <strong>and</strong> when any amount is needed for a payment pursuant to this Escrow<br />

Agreement, the Escrow Agent shall cause a sufficient amount of the Escrow Funds, to the extent<br />

remaining, to be converted into cash.<br />

(c) For purposes of federal <strong>and</strong> other taxes based on income, each of the<br />

Former Shareholders is intended to be, <strong>and</strong> shall be treated as, the owner of the Escrow Funds in<br />

an amount equal to such Former Shareholder's Common Stock Ownership Percentage as outlined<br />

on Schedule 3 hereto multiplied <strong>by</strong> the amount of the Escrow Funds. Any <strong>and</strong> all interest or other<br />

income accrued with respect to the Escrow Account shall be for the account of the Former<br />

Shareholders <strong>and</strong> shall be distributed from the Escrow Account to each of the Former<br />

Shareholders on a quarterly basis in an amount equal to such Former Shareholder's Common<br />

Stock Ownership Percentage as outlined on Schedule 3 hereto multiplied <strong>by</strong> the total amount of<br />

accrued <strong>and</strong> posted interest <strong>and</strong> other income. All interest or other income earned under this<br />

Escrow Agreement shall be reported <strong>by</strong> the Escrow Agent to such Former Shareholders <strong>and</strong>, as<br />

<strong>and</strong> to the extent required <strong>by</strong> law, <strong>by</strong> the Escrow Agent to the Internal Revenue Service (“IRS”),<br />

or any other taxing authority, on IRS Forms 1099 or 1042-S (or other appropriate form) as<br />

income earned from the Escrow Account <strong>by</strong> the Former Shareholders whether or not said income<br />

has been distributed during such year. The Former Shareholders <strong>and</strong> Parent shall file Tax<br />

Returns consistent with such treatment, it being understood that the Escrow Agent shall not be<br />

responsible for any Tax reporting responsibilities of Parent or the Former Shareholders.<br />

Notwithst<strong>and</strong>ing the foregoing, the Escrow Agent shall, for each calendar year (or portion<br />

thereof) that the escrow is in existence, report the income of the escrow to each of the Former<br />

Shareholders in accordance with their respective ownership percentages on IRS Forms 1099-<br />

INT, if applicable, or such other applicable IRS Forms for reporting payments to U.S. persons.<br />

The sole Tax reporting obligation of the Escrow Agent shall be to file appropriate versions of<br />

IRS Forms 1099-INT or other applicable forms with the IRS with respect to income earned on<br />

funds held in the Escrow Account <strong>and</strong> provide copies thereof to the Former Shareholders. The<br />

parties further agree that any distributions made pursuant to Section 1.4 or Section 1.5 shall be<br />

from the Escrow Amount <strong>and</strong> net of distributions <strong>and</strong> payments made pursuant to this Section<br />

1.3(c).<br />

16345690.14.BUSINESS 3


(d) The Parties have provided the Escrow Agent with their respective fully<br />

executed IRS Forms W-8, or W-9 <strong>and</strong>/or other required documentation. In addition, the<br />

Representatives have provided the Escrow Agent with IRS Forms W-9 or W-8 for all of the<br />

Former Shareholders. Escrow Agent shall withhold any taxes required <strong>by</strong> law in the absence of<br />

proper tax documentation, shall issue IRS Forms 1099 or 1042-S disclosing the amount of any<br />

taxes so withheld to the appropriate Former Shareholders, <strong>and</strong> shall remit such taxes to the<br />

appropriate authorities. The Parties here<strong>by</strong> represent <strong>and</strong> warrant to the Escrow Agent that (i)<br />

there is no sale or transfer of an United States real property interest (as defined under Section<br />

897(c)) in the underlying transaction giving rise to this Escrow Agreement that is subject to<br />

withholding under Code Section 1445; <strong>and</strong> (ii) such underlying transaction does not constitute an<br />

installment sale requiring any tax reporting or withholding of imputed interest or original issue<br />

discount to the IRS or other taxing authority.<br />

1.4 Distribution Out of Escrow Account to Surviving Corporation.<br />

(a) Parent Release Dem<strong>and</strong>.<br />

(i) If, prior to the Escrow Release Date (as hereinafter defined), from<br />

time to time there is any amount due to the Surviving Corporation under Section 2.7 of the<br />

Merger Agreement or any of the Parent Indemnitees under Article 8 of the Merger Agreement,<br />

Parent may deliver to the Escrow Agent <strong>and</strong> the Representatives a written notice in the form of<br />

Exhibit A attached hereto executed <strong>by</strong> an officer of Parent (a “Parent Release Dem<strong>and</strong>”) as<br />

indicated on Schedule 1 hereto, which sets forth (A) a statement that the Surviving Corporation<br />

is either (1) due amounts under Section 2.7 of the Merger Agreement or (2) entitled to<br />

indemnification for Losses (as defined in the Merger Agreement) pursuant to Article 8 of the<br />

Merger Agreement, (B) a complete description of the facts giving rise to the claim in regards to<br />

which payment is sought, including the provisions of the Merger Agreement upon which such<br />

claim is based, (C) a specification of the amount due to the Surviving Corporation (the “Release<br />

Dem<strong>and</strong> Amount”), (D) a statement that Parent has simultaneously given a copy of such Parent<br />

Release Dem<strong>and</strong> to the Representatives in accordance with the notice provisions of Section 3.1<br />

<strong>and</strong> (E) a request that the Escrow Agent disburse the Release Dem<strong>and</strong> Amount <strong>by</strong> wire transfer<br />

in immediately available funds in accordance with the instructions set forth therein. If the<br />

Escrow Agent has not received a written notice from the Representatives (an “Objection<br />

Notice”) objecting to the release of the Release Dem<strong>and</strong> Amount on or before 5:00 P.M., New<br />

York time on the twentieth (20 th ) day after (but not including) the date on which such Parent<br />

Release Dem<strong>and</strong> is deemed given to the Escrow Agent <strong>and</strong> the Representatives under Section 3.1<br />

below, then the Escrow Agent shall promptly (<strong>and</strong> in no event later than two (2) Business Days)<br />

thereafter release <strong>and</strong> disburse the Release Dem<strong>and</strong> Amount from the Escrow Account to the<br />

Surviving Corporation in accordance with the Parent Release Dem<strong>and</strong>. The Escrow Agent shall<br />

assume that the Parent Release Dem<strong>and</strong> was delivered to the Representative on the same<br />

Business Day that it has received the Parent Release Dem<strong>and</strong> for purposes of any Objection<br />

Notice deadline.<br />

(ii) If an Objection Notice is delivered to the Escrow Agent prior to the<br />

end of the applicable twenty (20)-day period, then the Escrow Agent shall not release <strong>and</strong><br />

disburse the Release Dem<strong>and</strong> Amount to Parent. The Representatives shall deliver a copy of<br />

16345690.14.BUSINESS 4


such Objection Notice simultaneously to Parent in accordance with the notice provisions of<br />

Section 3.1.<br />

(iii) In the event that the Representatives deliver an Objection Notice,<br />

the Escrow Agent shall within two (2) Business Days after receipt thereof disburse <strong>and</strong> release to<br />

Parent from the Escrow Account the portion of the Release Dem<strong>and</strong> Amount not objected to, if<br />

any, <strong>and</strong> shall continue to hold the remaining portion of the Release Dem<strong>and</strong> Amount unless the<br />

Escrow Agent receives (x) a written notice executed <strong>by</strong> the Representatives <strong>and</strong> Parent (a “Joint<br />

Direction”) directing the Escrow Agent to release <strong>and</strong> deliver the Release Dem<strong>and</strong> Amount or<br />

portion thereof as specified in such Joint Direction or (y) a certificate substantially in the form of<br />

Exhibit B attached hereto (a “Judgment Certificate”) executed <strong>by</strong> Parent or the Representatives<br />

accompanied <strong>by</strong> (1) a non-appealable, final judgment of a court of competent jurisdiction or (2)<br />

with respect to amounts due under Section 2.7 of the Merger Agreement, the final determination<br />

of the Accounting Firm delivered in accordance with Section 2.7 of the Merger Agreement.<br />

(iv) If a Joint Direction or Judgment Certificate is delivered to the<br />

Escrow Agent in accordance with this Escrow Agreement, then the Escrow Agent shall release<br />

<strong>and</strong> disburse the remaining portion of the Release Dem<strong>and</strong> Amount in accordance with such<br />

Joint Direction or Judgment Certificate no later than two (2) Business Days after delivery of such<br />

Joint Direction or Judgment Certificate to the Escrow Agent.<br />

(v) The Parties here<strong>by</strong> acknowledge that any Release Dem<strong>and</strong> Amount<br />

to be disbursed to the Surviving Corporation pursuant to this Section 1.4 may be subject to such<br />

additional requirements as the Lenders may require pursuant to the documentation governing the<br />

Financing (it being understood that no such requirements shall apply to any amounts payable to<br />

the Representatives or Former Shareholders hereunder).<br />

1.5 Escrow Period; Distribution Out of Escrow Account to the Former Shareholders.<br />

(a) The Escrow Account shall be in existence immediately following the<br />

Closing on the date hereof <strong>and</strong> shall continue until 12:01 a.m., Eastern time, on the eighteen<br />

month anniversary of the date hereof (such date, the “Escrow Release Date,” <strong>and</strong> the period from<br />

Closing until the Escrow Release Date, the “Escrow Period”).<br />

(b) On the Business Day immediately succeeding the Escrow Release Date,<br />

the Escrow Agent shall release <strong>and</strong> disburse to the Former Shareholders (or, if directed in writing<br />

<strong>by</strong> the Representatives at least two (2) Business Days prior to the Escrow Release Date, to the<br />

Representatives on behalf of the Former Shareholders) all of the remaining Escrow Funds less<br />

any Release Dem<strong>and</strong> Amounts subject to any pending Parent Release Dem<strong>and</strong>.<br />

(c) Retained Amounts.<br />

(i) In the event that on the Escrow Release Date there is a pending<br />

Parent Release Dem<strong>and</strong> (an “Outst<strong>and</strong>ing Release Dem<strong>and</strong>”) for a Release Dem<strong>and</strong> Amount (the<br />

aggregate of such Release Dem<strong>and</strong> Amounts, the “Retained Amounts”), the Escrow Agent shall<br />

continue to hold the Retained Amounts unless the Escrow Agent receives a Joint Direction or<br />

Judgment Certificate directing the Escrow Agent to release <strong>and</strong> deliver the Retained Amounts or<br />

a portion thereof as specified in such Joint Direction or Judgment Certificate. Upon resolution<br />

16345690.14.BUSINESS 5


with respect to each claim underlying the Outst<strong>and</strong>ing Release Dem<strong>and</strong>s, Parent <strong>and</strong> the<br />

Representatives shall promptly deliver a Joint Direction to the Escrow Agent instructing the<br />

Escrow Agent to reimburse the applicable Parent Indemnitee for the amount of the related Loss,<br />

if any, specified in such Joint Direction from the Escrow Account <strong>and</strong> release the remaining<br />

amounts retained in connection with such Outst<strong>and</strong>ing Release Dem<strong>and</strong> to the Former<br />

Shareholders (or, if directed in writing <strong>by</strong> the Representatives, to the Representatives on behalf<br />

of the Former Shareholders). If the resolution with respect to a claim underlying the Outst<strong>and</strong>ing<br />

Release Dem<strong>and</strong>s is made <strong>by</strong> judgment referred to in a Judgment Certificate, either party may<br />

deliver such Judgment Certificate to the Escrow Agent whereupon the Escrow Agent shall act in<br />

accordance with the provisions of Section 1.5(c)(ii).<br />

(ii) If a Joint Direction or Judgment Certificate is delivered in<br />

accordance with this Escrow Agreement after the Escrow Release Date, the Escrow Agent shall<br />

release <strong>and</strong> disburse the Retained Amounts or a portion thereof in accordance with such Joint<br />

Direction or Judgment Certificate no later than two (2) Business Days after receipt of such Joint<br />

Direction or Judgment Certificate <strong>by</strong> the Escrow Agent.<br />

(iii) If there is an Outst<strong>and</strong>ing Release Dem<strong>and</strong> then, at the end of each<br />

calendar quarter, Parent shall provide the Escrow Agent <strong>and</strong> the Representatives with a written<br />

update in which Parent shall set forth (x) whether the claims underlying any Outst<strong>and</strong>ing Release<br />

Dem<strong>and</strong> have been resolved <strong>and</strong> (y) a description providing in reasonable detail the status of the<br />

claims underlying each Outst<strong>and</strong>ing Release Dem<strong>and</strong> as of such date.<br />

1.6 Joint Direction. Notwithst<strong>and</strong>ing any other provision of this Escrow Agreement,<br />

the Escrow Agent shall deliver all or any part of the Escrow Funds in accordance with the terms<br />

of any Joint Direction except to the extent an order of a court of competent jurisdiction <strong>by</strong> which<br />

the Escrow Agent is bound prohibits the Escrow Agent from complying with the terms hereof.<br />

ARTICLE II<br />

THE ESCROW AGENT<br />

2.1 Rights <strong>and</strong> Responsibilities of the Escrow Agent.<br />

(a) The duties <strong>and</strong> responsibilities of the Escrow Agent shall be limited to<br />

those expressly set forth in this Escrow Agreement, which shall be deemed purely ministerial in<br />

nature, <strong>and</strong> it shall not be subject to, nor obligated to recognize, any other agreement between, or<br />

direction or instruction of, any or all of the parties to this Escrow Agreement.<br />

(b) If (i) any Escrow Funds are at any time attached, garnished or levied upon<br />

under any court order, (ii) the payment of any such Escrow Funds shall be stayed or enjoined <strong>by</strong><br />

any court order, or (iii) any order, judgment or decree shall be made or entered <strong>by</strong> any court<br />

affecting such Escrow Funds or any part thereof, then <strong>and</strong> in any of such events, the Escrow<br />

Agent is authorized, in its sole discretion, to rely upon <strong>and</strong> comply with any such order,<br />

judgment or decree that it is advised <strong>by</strong> legal counsel is binding upon the Escrow Agent whether<br />

with or without jurisdiction. The Escrow Agent shall notify Parent <strong>and</strong> the Representatives of<br />

any such order, judgment or decree that it becomes aware of. If the Escrow Agent complies with<br />

16345690.14.BUSINESS 6


any such order, writ, judgment or decree, it shall not be liable to any of the parties to this Escrow<br />

Agreement <strong>by</strong> reason of such compliance even though such order, writ, judgment or decree may<br />

be subsequently reversed, modified, annulled, set aside or vacated.<br />

(c) The Escrow Agent shall not be liable for any act taken or omitted under<br />

this Escrow Agreement if taken or omitted <strong>by</strong> it in good faith except to the extent that a final<br />

adjudication of a court of competent jurisdiction determines that the Escrow Agent’s gross<br />

negligence or willful misconduct was the primary cause of any loss to any Party. The Escrow<br />

Agent’s sole responsibility shall be for the safekeeping, investment <strong>and</strong> disbursement of the<br />

Escrow Funds in accordance with the terms of this Escrow Agreement. The Escrow Agent shall<br />

have no implied duties or obligations <strong>and</strong> shall not be charged with knowledge or notice of any<br />

fact or circumstance not specifically set forth herein. The Escrow Agent shall also be fully<br />

protected in relying upon any written notice, dem<strong>and</strong>, certificate or document that it in good faith<br />

believes to be genuine <strong>and</strong> shall have no responsibility for the genuineness or content of any<br />

report specified therein as being what such notice, dem<strong>and</strong>, certificate or document purports it to<br />

be. The Escrow Agent shall not be obligated to take any legal action or commence any<br />

proceeding in connection with the Escrow Funds, any account in which Escrow Funds are<br />

deposited, this Escrow Agreement or the Merger Agreement, or to appear in, prosecute or defend<br />

any such legal action or proceeding. The Escrow Agent may act pursuant to the advice of<br />

counsel with respect to any matter relating to this Escrow Agreement <strong>and</strong> shall not be liable for<br />

any action taken or omitted <strong>by</strong> it in good faith in accordance with such advice. The Escrow<br />

Agent shall not be liable to any Party, any beneficiary or other person for refraining from acting<br />

upon any instruction setting forth, claiming, containing, objecting to, or related to the transfer or<br />

distribution of the Escrow Account, or any portion thereof, unless such instruction shall have<br />

been delivered to the Escrow Agent in accordance with Section 3.2 below <strong>and</strong> the Escrow Agent<br />

has been able to satisfy any applicable security procedures as may be required thereunder. The<br />

Escrow Agent shall be under no duty to inquire into or investigate the validity, accuracy or<br />

content of any such document, notice, instruction or request. The Escrow Agent shall have no<br />

duty to solicit any payments which may be due it or the Escrow Account, including, without<br />

limitation, the Escrow Funds, nor shall the Escrow Agent have any duty or obligation to confirm<br />

or verify the accuracy or correctness of any amounts deposited with it hereunder. The Escrow<br />

Agent may execute any of its powers <strong>and</strong> perform any of its duties hereunder directly or through<br />

affiliates or agents. In the event that the Escrow Agent shall be uncertain or believe there is some<br />

ambiguity as to its duties or rights hereunder or shall receive instructions, claims or dem<strong>and</strong>s<br />

from any Party hereto which, in its reasonable opinion, conflict with any of the provisions of this<br />

Escrow Agreement, it shall be entitled to refrain from taking any action <strong>and</strong> its sole obligation<br />

shall be to keep safely all property held in escrow until it shall be given a direction in writing <strong>by</strong><br />

the Parties which eliminates such ambiguity or uncertainty to the satisfaction of Escrow Agent or<br />

<strong>by</strong> a final <strong>and</strong> non-appealable order or judgment of a court of competent jurisdiction. The Parties<br />

agree to pursue any redress or recourse in connection with any dispute under the Merger<br />

Agreement without making the Escrow Agent a party to the same. Anything in this Escrow<br />

Agreement to the contrary notwithst<strong>and</strong>ing, in no event shall the Escrow Agent be liable for<br />

special, incidental, punitive, indirect or consequential loss or damage of any kind whatsoever<br />

(including but not limited to lost profits), even if the Escrow Agent has been advised of the<br />

likelihood of such loss or damage <strong>and</strong> regardless of the form of action.<br />

16345690.14.BUSINESS 7


(d)<br />

(i) The Escrow Agent, <strong>and</strong> any successor Escrow Agent, may resign<br />

at any time as Escrow Agent hereunder <strong>by</strong> giving at least thirty (30) days written notice to the<br />

Representatives <strong>and</strong> Parent. Any amounts held <strong>by</strong> the Escrow Agent under the terms of this<br />

Escrow Agreement as of the effective date of the resignation shall be delivered to a successor<br />

escrow agent. Upon such resignation <strong>and</strong> the appointment of a successor Escrow Agent, the<br />

resigning Escrow Agent shall be absolved from any <strong>and</strong> all liability in connection with the<br />

exercise of its powers <strong>and</strong> duties as Escrow Agent hereunder except for liability arising in<br />

connection with its bad faith, gross negligence or willful misconduct. Upon their receipt of notice<br />

of resignation from the Escrow Agent, the Representatives <strong>and</strong> Parent shall use reasonable<br />

efforts to designate a successor Escrow Agent. In the event the Representatives <strong>and</strong> Parent do not<br />

agree upon a successor Escrow Agent within thirty (30) days after the receipt of such notice, the<br />

Escrow Agent so resigning may petition any court of competent jurisdiction for the appointment<br />

of a successor Escrow Agent or other appropriate relief <strong>and</strong> any such resulting appointment shall<br />

be binding upon all parties hereto. Escrow Agent’s sole responsibility after such thirty (30) day<br />

notice period expires shall be to hold the Escrow Funds (without any obligation to reinvest the<br />

same) <strong>and</strong> to deliver the same to a designated substitute escrow agent, if any, or in accordance<br />

with the directions of a final order or judgment of a court of competent jurisdiction, at which<br />

time of delivery Escrow Agent’s obligations hereunder shall cease <strong>and</strong> terminate. By mutual<br />

written agreement, the Representatives <strong>and</strong> Parent shall have the right to terminate the<br />

appointment of the Escrow Agent, or successor Escrow Agent, as Escrow Agent.<br />

(ii) Any entity into which the Escrow Agent may be merged or<br />

converted or with which it may be consolidated, or any entity to which all or substantially all the<br />

escrow business may be transferred, shall be the Escrow Agent under this Escrow Agreement<br />

without further act.<br />

2.2 Statements; Notice of Disbursements. The Escrow Agent shall on a monthly basis<br />

mail to the Representatives <strong>and</strong> Parent a written account statement of all transactions relating to<br />

the Escrow Account <strong>and</strong> the balance thereof.<br />

2.3 Compensation <strong>and</strong> Expenses.<br />

(a) The Parties agree jointly <strong>and</strong> severally (i) to pay the Escrow Agent upon<br />

execution of this Escrow Agreement <strong>and</strong> from time to time thereafter reasonable compensation<br />

for the services to be rendered hereunder, along with any fees or charges for accounts, including<br />

those levied <strong>by</strong> any governmental authority which the Escrow Agent may impose, charge or<br />

pass-through, which unless otherwise agreed in writing shall be limited to only those described<br />

in Schedule 2 attached hereto, <strong>and</strong> (ii) to pay or reimburse the Escrow Agent upon request for all<br />

expenses, disbursements <strong>and</strong> advances, including, without limitation reasonable attorney's fees<br />

<strong>and</strong> expenses, incurred or made <strong>by</strong> it in connection with the performance, modification <strong>and</strong><br />

termination of this Escrow Agreement. The obligations set forth in this Section 2.3 shall survive<br />

the resignation, replacement or removal of the Escrow Agent or the termination of this Escrow<br />

Agreement<br />

16345690.14.BUSINESS 8


(b) The Parties agree <strong>among</strong> themselves that the Escrow Agent Fees <strong>and</strong><br />

Expenses shall be divided equally between the Parent, individually, <strong>and</strong> the Representative on<br />

behalf of the Former Shareholders, collectively.<br />

2.4 Indemnification. The Parties hereto here<strong>by</strong> agree, jointly <strong>and</strong> severally, to<br />

indemnify the Escrow Agent <strong>and</strong> its affiliates <strong>and</strong> their respective successors, assigns, agents <strong>and</strong><br />

employees (the “Indemnitees”) <strong>and</strong> hold it harmless from any <strong>and</strong> against all liabilities, losses,<br />

action, suits or proceedings at law or in equity <strong>and</strong> any other expenses, fees, or charges of any<br />

character or nature, including, without limitation, reasonable attorneys’ fees, that the Escrow<br />

Agent may incur <strong>by</strong> reason of its acting as the Escrow Agent under this Escrow Agreement or<br />

arising out of the existence of the Escrow Account or arising out of or in connection with (i) the<br />

Escrow Agent's execution <strong>and</strong> performance of this Escrow Agreement, tax reporting or<br />

withholding, the enforcement of any rights or remedies under or in connection with this Escrow<br />

Agreement, or as may arise <strong>by</strong> reason of any act, omission or error of the Indemnitee, except in<br />

the case of any Indemnitee to the extent that such Losses are finally adjudicated <strong>by</strong> a court of<br />

competent jurisdiction to have been primarily caused <strong>by</strong> the bad faith, gross negligence or willful<br />

misconduct of such Indemnitee, or (ii) its following any instructions or other directions, whether<br />

joint or singular, from the Parties, except to the extent that its following any such instruction or<br />

direction is expressly forbidden <strong>by</strong> the terms hereof. The indemnity obligations set forth in this<br />

Section 2.4 shall survive the resignation, replacement or removal of the Escrow Agent or the<br />

termination of this Escrow Agreement. In so agreeing to indemnify <strong>and</strong> hold harmless <strong>and</strong><br />

reimburse the Escrow Agent, the Parties hereto intend there<strong>by</strong> to cover all losses, claims,<br />

damages, liabilities <strong>and</strong> reasonable expenses, including costs of investigation, counsel fees, <strong>and</strong><br />

disbursements, that may be imposed upon the Escrow Agent or incurred in connection with its<br />

acceptance of appointment as the Escrow Agent hereunder or the performance of its duties<br />

hereunder. Parent, the Company <strong>and</strong> the Representatives agree that any payments made to the<br />

Escrow Agent under this Section 2.4, whether made <strong>by</strong> Parent <strong>and</strong> the Company, on the one<br />

h<strong>and</strong>, or the Representatives, on the other h<strong>and</strong>, or both, are to be borne in equal amounts <strong>by</strong><br />

Parent, on the one h<strong>and</strong>, or the Representatives, on the other h<strong>and</strong>, <strong>and</strong> here<strong>by</strong> grant to each other<br />

a right of contribution to effect the same. The terms of this Section 2.4 shall survive termination<br />

of this Escrow Agreement.<br />

ARTICLE III<br />

MISCELLANEOUS<br />

3.1 Notices. All notices or other communications required or permitted hereunder<br />

shall be in writing <strong>and</strong> except for communications from the Parties setting forth, claiming,<br />

containing, objecting to, or in any way related to the transfer or distribution of funds, including<br />

but not limited to funds transfer instructions (all of which shall be specifically governed <strong>by</strong><br />

Section 3.2 below), shall be deemed to be duly given after it has been received <strong>and</strong> the receiving<br />

party has had a reasonable time to act upon such communication if it is sent or served (i) <strong>by</strong><br />

personal delivery; (ii) <strong>by</strong> facsimile; (iii) <strong>by</strong> overnight courier; or (iv) <strong>by</strong> prepaid registered mail,<br />

return receipt requested, to the appropriate notice address set forth below, or at such other<br />

address as any party hereto may have furnished to the other parties in writing <strong>by</strong> registered mail,<br />

return receipt requested:<br />

16345690.14.BUSINESS 9


(a) If to Parent <strong>and</strong> the Company:<br />

Pomona Holdings, Inc.<br />

c/o Lassonde Industries, Inc.<br />

755 Principale<br />

Rougemont, Quebec J0L 1M0<br />

Attn: Jean Gattuso<br />

Fax No.:<br />

with a copy to (which shall not constitute notice):<br />

Squire, S<strong>and</strong>ers & Dempsey (US) LLP<br />

4900 Key Tower<br />

127 Public Square<br />

Clevel<strong>and</strong>, OH 44114<br />

Attn: Laura D. Nemeth<br />

Fax No.: (216) 479-8780<br />

(b) If to the Representatives:<br />

Clement David Pappas<br />

c/o Clement Pappas <strong>and</strong> Company, Inc.<br />

1 Collins Drive<br />

Suite 200<br />

Carneys Point, NJ 08069<br />

Facsimile: (856) 455-8746<br />

Attention: Clement David Pappas<br />

Clement Dimitri Pappas<br />

c/o Clement Pappas <strong>and</strong> Company, Inc.<br />

1 Collins Drive<br />

Suite 200<br />

Carneys Point, NJ 08069<br />

Facsimile: (856) 455-8746<br />

Attention: Clement Dimitri Pappas<br />

with a copy to (which shall not constitute notice):<br />

Dechert LLP<br />

Cira Centre<br />

2929 Arch Street<br />

Philadelphia, PA 19104<br />

Attention: Carmen J. Romano, Esq.<br />

R. Jeffrey Legath, Esq.<br />

Fax No.: (215) 994-2222<br />

16345690.14.BUSINESS 10


(c) If to the Escrow Agent:<br />

JPMorgan Chase Bank, N.A.<br />

4 New York Plaza, 21 st Floor<br />

New York, NY 10004<br />

Attention: Gregory P. Shea/S<strong>and</strong>ra Frierson<br />

Fax No.: 212-623-6168<br />

Notwithst<strong>and</strong>ing the above, in the case of communications delivered to the Escrow Agent, such<br />

communications shall be deemed to have been given on the date received <strong>by</strong> an officer of the<br />

Escrow Agent or any employee of the Escrow Agent who reports directly to any such officer at<br />

the above-referenced office. In the event that the Escrow Agent, in its sole discretion, shall<br />

determine that an emergency exists, the Escrow Agent may use such other means of<br />

communication as the Escrow Agent deems appropriate. For purposes of this Escrow Agreement,<br />

“Business Day” shall mean any day other than a Saturday, Sunday or any other day on which the<br />

Escrow Agent located at the notice address set forth above is authorized or required <strong>by</strong> law or<br />

executive order to remain closed.<br />

3.2 Security Procedures. Notwithst<strong>and</strong>ing anything to the contrary as set forth in<br />

Section 3.1, any instructions setting forth, claiming, containing, objecting to, or in any way<br />

related to the transfer or distribution of funds, including but not limited to any such funds<br />

transfer instructions that may otherwise be set forth in a written instruction permitted pursuant to<br />

Article I of this Escrow Agreement, may be given to the Escrow Agent only <strong>by</strong> confirmed<br />

facsimile <strong>and</strong> no instruction for or related to the transfer or distribution of the Escrow Funds, or<br />

any portion thereof, shall be deemed delivered <strong>and</strong> effective unless the Escrow Agent actually<br />

shall have received such instruction <strong>by</strong> facsimile at the number provided to the Parties <strong>by</strong> the<br />

Escrow Agent in accordance with Section 3.1 <strong>and</strong> as further evidenced <strong>by</strong> a confirmed<br />

transmittal to that number.<br />

(a) In the event funds transfer instructions are received <strong>by</strong> the Escrow Agent<br />

<strong>by</strong> facsimile, the Escrow Agent is authorized to seek confirmation of such instructions <strong>by</strong><br />

telephone call-back to the person or persons designated on Schedule 1 hereto, <strong>and</strong> the Escrow<br />

Agent may rely upon the confirmation of anyone purporting to be the person or persons so<br />

designated. The persons <strong>and</strong> telephone numbers for call-backs may be changed only in a writing<br />

actually received <strong>and</strong> acknowledged <strong>by</strong> the Escrow Agent. If the Escrow Agent is unable to<br />

contact any of Parent’s authorized representatives identified in Schedule 1, the Escrow Agent is<br />

here<strong>by</strong> authorized both to receive written instructions from <strong>and</strong> seek confirmation of such<br />

instructions <strong>by</strong> telephone call-back to any one or more of Parent’s executive officers,<br />

(“Executive Officers”), which shall include the titles of______________________, as the<br />

Escrow Agent may select. Such “Executive Officer”, as the case may be, shall deliver to the<br />

Escrow Agent a fully executed incumbency certificate, <strong>and</strong> the Escrow Agent may rely upon the<br />

confirmation of anyone purporting to be any such officer. The Escrow Agent <strong>and</strong> the<br />

beneficiary's bank in any funds transfer may rely solely upon any account numbers or similar<br />

identifying numbers provided <strong>by</strong> Parent or Representatives to identify (i) the beneficiary, (ii) the<br />

beneficiary's bank, or (iii) an intermediary bank. The Escrow Agent may apply any of the<br />

Escrow Funds for any payment order it executes using any such identifying number, even when<br />

16345690.14.BUSINESS 11


its use may result in a person other than the beneficiary being paid, or the transfer of funds to a<br />

bank other than the beneficiary's bank or an intermediary bank designated.<br />

(b) The Company acknowledges that the Escrow Agent is authorized to use<br />

the following funds transfer instructions to disburse any funds due to the Surviving Corporation<br />

under this Escrow Agreement without a verifying call-back as set forth in Section 3.2(a) above:<br />

The Surviving Corporation’s Bank account information: Bank name:<br />

Bank Address:<br />

ABA number:<br />

Account name:<br />

Account number:<br />

The Representatives acknowledge that the Escrow Agent is authorized to use the following funds<br />

transfer instructions to disburse any funds due to the Representatives under this Escrow<br />

Agreement:<br />

Representatives’ Bank account information: Bank name:<br />

Bank Address:<br />

ABA number:<br />

Account name:<br />

Account number:<br />

(c) The Parties acknowledge that the security procedures set forth in this<br />

Section 3.2 are commercially reasonable.<br />

3.3 Assignment; Successors <strong>and</strong> Assigns; No Third Party Rights. Except as indicated<br />

in Section 2.1(d)(ii) this Escrow Agreement may not, without the prior written consent of the<br />

other parties hereto, be assigned <strong>by</strong> operation of law or otherwise, <strong>and</strong> any attempted assignment<br />

shall be null <strong>and</strong> void; provided, that this Escrow Agreement may be assigned at or following the<br />

Closing as collateral to the Lenders in connection with the Financing; provided, further, that the<br />

foregoing shall not relieve Parent or the Company or the Representatives of their obligations<br />

hereunder. Subject to the foregoing, this Escrow Agreement shall be binding upon <strong>and</strong> inure to<br />

the benefit of the parties hereto <strong>and</strong> their respective heirs, successors, permitted assigns <strong>and</strong> legal<br />

representatives. This Escrow Agreement shall be for the sole benefit of the parties to this Escrow<br />

Agreement <strong>and</strong> their respective heirs, successors, permitted assigns <strong>and</strong> legal representatives <strong>and</strong><br />

is not intended, nor shall be construed, to give any Person, other than the parties hereto <strong>and</strong> their<br />

respective heirs, successors, assigns , any legal or equitable right, remedy or claim hereunder.<br />

3.2 Amendment. This Escrow Agreement may be amended, modified <strong>and</strong><br />

supplemented <strong>by</strong> a written instrument authorized <strong>and</strong> executed on behalf of the Parties <strong>and</strong> the<br />

Escrow Agent at any time with respect to any of the terms contained herein.<br />

3.3 Failure or Indulgence not Waiver. No failure or delay on the part of any party<br />

hereto in the exercise of any right hereunder shall impair such right or be construed to be waiver<br />

of, or acquiescence in, any breach of any representation, warranty or agreement herein, nor shall<br />

any single or partial exercise of any such right preclude any other or further exercise thereof or<br />

16345690.14.BUSINESS 12


any other right. All rights <strong>and</strong> remedies existing under this Escrow Agreement are cumulative to,<br />

<strong>and</strong> not exclusive of, any rights or remedies otherwise available.<br />

3.4 Governing Law; Consent to Jurisdiction, Etc. This Escrow Agreement shall be<br />

construed in accordance with <strong>and</strong> governed <strong>by</strong> the laws of the State of New York. In connection<br />

with any suit, action or other proceeding arising out of or relating to this Escrow Agreement, the<br />

events giving rise to this Escrow Agreement or any transaction contemplated here<strong>by</strong>, the parties<br />

hereto here<strong>by</strong> agree <strong>and</strong> consent to be subject to the exclusive jurisdiction of the United States<br />

District Court for the Southern District of New York, <strong>and</strong> in the absence of such Federal<br />

jurisdiction, the parties consent to be subject to the exclusive jurisdiction of the state courts<br />

located in New York, New York, <strong>and</strong> here<strong>by</strong> waive the right to assert the lack of personal or<br />

subject matter jurisdiction or improper venue in connection with any such suit, action or other<br />

proceeding. In furtherance of the foregoing, each of the parties (i) waives the defense of<br />

inconvenient forum, (ii) agrees not to commence any suit, action or other proceeding arising out<br />

of or relating to this Escrow Agreement, the events giving rise to this Escrow Agreement or any<br />

transaction contemplated here<strong>by</strong> other than in any such court, <strong>and</strong> (iii) agrees that a final<br />

judgment in any such suit, action or other proceeding shall be conclusive <strong>and</strong> may be enforced in<br />

other jurisdictions <strong>by</strong> suit or judgment or in any other manner provided <strong>by</strong> law. Each party hereto<br />

further agrees that service of any process, summons, notice or document <strong>by</strong> U.S. registered mail<br />

to such party’s address set forth in Section 3.1 above shall be effective service of process for any<br />

claim, action or proceeding with respect to any matters to which it has submitted to jurisdiction<br />

in this Section 3.5 or otherwise. To the extent that in any jurisdiction either Party may now or<br />

hereafter be entitled to claim for itself or its assets, immunity from suit, execution attachment<br />

(before or after judgment), or other legal process, such Party shall not claim, <strong>and</strong> it here<strong>by</strong><br />

irrevocably waives, such immunity. Each Party <strong>and</strong> the Escrow Agent further here<strong>by</strong> waive any<br />

right to a trial <strong>by</strong> jury with respect to any lawsuit or judicial proceeding arising or relating to this<br />

Escrow Agreement. No party to this Escrow Agreement is liable to any other party for losses due<br />

to, or if it is unable to perform its obligations under the terms of this Escrow Agreement because<br />

of, acts of God, fire, war, terrorism, floods, strikes, electrical outages, equipment or transmission<br />

failure, or other causes reasonably beyond its control. A person who is not a party to this Escrow<br />

Agreement shall have no right to enforce any term of this Escrow Agreement. The Parties<br />

represent, warrant <strong>and</strong> covenant that each document, notice, instruction or request provided <strong>by</strong><br />

such Party to Escrow Agent shall comply with applicable laws <strong>and</strong> regulations. Where, however,<br />

the conflicting provisions of any such applicable law may be waived, they are here<strong>by</strong> irrevocably<br />

waived <strong>by</strong> the parties hereto to the fullest extent permitted <strong>by</strong> law, to the end that this Escrow<br />

Agreement shall be enforced as written. Except as expressly provided in Section 2.4 above,<br />

nothing in this Escrow Agreement, whether express or implied, shall be construed to give to any<br />

person or entity other than the Escrow Agent <strong>and</strong> the Parties any legal or equitable right, remedy,<br />

interest or claim under or in respect of this Escrow Agreement or any funds escrowed hereunder.<br />

3.5 Counterparts. This Escrow Agreement may be executed in two or more<br />

counterparts for the convenience of the parties hereto, each of which shall be deemed an original<br />

<strong>and</strong> all of which together will constitute one <strong>and</strong> the same instrument. Delivery of an executed<br />

counterpart of a signature page to this Escrow Agreement <strong>by</strong> facsimile or portable document<br />

format shall be effective as delivery of a manually executed counterpart to this Escrow<br />

Agreement.<br />

16345690.14.BUSINESS 13


3.6 Waiver of Offset Rights. Except as expressly set forth herein, the Escrow Agent<br />

here<strong>by</strong> waives any <strong>and</strong> all rights to offset that it may have against the Escrow Funds including,<br />

without limitation, claims arising as a result of any claims, amounts, liabilities, costs, expenses,<br />

damages or other losses that the Escrow Agent may be otherwise entitled to collect from any<br />

party to this Escrow Agreement (whether in connection with this Escrow Agreement or<br />

otherwise).<br />

3.7 Severability. The invalidity of any portion hereof shall not affect the validity, force<br />

or effect of the remaining portions hereof.<br />

[Signature Page Directly Follows]<br />

16345690.14.BUSINESS 14


IN WITNESS WHERE<strong>OF</strong>, the parties hereto have caused this Escrow Agreement<br />

to be executed <strong>by</strong> their duly authorized officers as of the day <strong>and</strong> year first above written.<br />

16345690.14.BUSINESS<br />

POMONA HOLDINGS, INC.<br />

By:<br />

Name:<br />

Title:<br />

<strong>CLEMENT</strong> PAPPAS <strong>AND</strong> COMPANY, INC.<br />

By:<br />

Name:<br />

Title:<br />

REPRESENTATIVES:<br />

________________________________<br />

Clement David Pappas<br />

________________________________<br />

Clement Dimitri Pappas<br />

JPMORGAN CHASE BANK, N.A.<br />

By: ________________________________<br />

Name:<br />

Title:


16345690.14.BUSINESS<br />

SCHEDULE 1<br />

Telephone Number(s) <strong>and</strong> authorized signature(s) for<br />

Person(s) Designated to give Funds Transfer Instructions<br />

If from Parent:<br />

Name Telephone Number Signature<br />

1. ______________________ _______________________ ___________________<br />

2. ______________________ _______________________ ___________________<br />

3. ______________________ _______________________ ___________________<br />

If from the Representatives:<br />

Name Telephone Number Signature<br />

1. ______________________ _______________________ ___________________<br />

2. ______________________ _______________________ ___________________<br />

3. ______________________ _______________________ ___________________<br />

Telephone Number(s) for Call-Backs <strong>and</strong><br />

Person(s) Designated to Confirm Funds Transfer Instructions<br />

If from Parent:<br />

Name Telephone Number<br />

1. ______________________ _______________________<br />

2. ______________________ _______________________<br />

3. ______________________ _______________________<br />

If from the Representatives:<br />

Name Telephone Number<br />

1. ______________________ _______________________<br />

2. ______________________ _______________________<br />

3. ______________________ _______________________<br />

All funds transfer instructions must include the signature of the person(s) authorizing said funds<br />

transfer.


16345690.14.BUSINESS<br />

SCHEDULE 2<br />

Schedule of of Fees Fees for Escrow Agent Services<br />

Based upon our current underst<strong>and</strong>ing of your proposed transaction, our fee proposal is as follows:<br />

Account Acceptance Fee . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . …...$WAIVED<br />

Encompassing review, negotiation <strong>and</strong> execution of governing documentation, opening of the<br />

account, <strong>and</strong> completion of all due diligence documentation. Payable upon closing.<br />

One Time Administration Fee . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .$2,500.00<br />

The Administration Fee covers our usual <strong>and</strong> customary ministerial duties, including record<br />

keeping, distributions, document compliance <strong>and</strong> such other duties <strong>and</strong> responsibilities expressly set<br />

forth in the governing documents for each transaction. Payable upon closing <strong>and</strong> annually in<br />

advance thereafter, without pro-ration for partial years.<br />

Extraordinary Services <strong>and</strong> Out-of Pocket Expenses<br />

Any additional services beyond our st<strong>and</strong>ard services as specified above, <strong>and</strong> all reasonable out-ofpocket<br />

expenses including attorney’s or accountant’s fees <strong>and</strong> expenses will be considered<br />

extraordinary services for which related costs, transaction charges, <strong>and</strong> additional fees will be billed at<br />

the Bank's then st<strong>and</strong>ard rate. Disbursements, receipts or investments exceeding 25 items per year may<br />

be treated as extraordinary services there<strong>by</strong> incurring additional charges. The Escrow Agent may<br />

impose, charge, pass-through <strong>and</strong> modify fees <strong>and</strong>/or charges for any account established <strong>and</strong> services<br />

provided <strong>by</strong> the Escrow Agent, including but not limited to, transaction, maintenance, balancedeficiency,<br />

<strong>and</strong> service fees <strong>and</strong> other charges, including those levied <strong>by</strong> any governmental authority.<br />

Disclosure & Assumptions<br />

Please note that the fees quoted are based on a review of the transaction documents provided <strong>and</strong><br />

an internal due diligence review. JPMorgan reserves the right to revise, modify, change <strong>and</strong><br />

supplement the fees quoted herein if the assumptions underlying the activity in the account, level<br />

of balances, market volatility or conditions or other factors change from those used to set our<br />

fees.<br />

The escrow deposit shall be continuously invested in a JPMorgan Chase Bank money market<br />

deposit account (“MMDA”) or a JPMorgan Chase Bank Cash Compensation account. MMDA<br />

<strong>and</strong> Cash Compensation Accounts have rates of compensation that may vary from time to time<br />

based upon market conditions. The Annual Administration Fee would include a supplemental<br />

charge up to 25 basis points on the escrow deposit amount if another investment option were to<br />

be chosen.<br />

The Parties acknowledge <strong>and</strong> agree that they are permitted <strong>by</strong> U.S. law to make up to six (6) preauthorized<br />

withdrawals or telephonic transfers from an MMDA per calendar month or statement<br />

cycle or similar period. If the MMDA can be accessed <strong>by</strong> checks, drafts, bills of exchange, notes<br />

<strong>and</strong> other financial instruments (“Items”), then no more than three (3) of these six (6) transfers may<br />

be made <strong>by</strong> an Item. The Escrow Agent is required <strong>by</strong> U.S. law to reserve the right to require at<br />

least seven (7) days notice prior to a withdrawal from a money market deposit account.


Payment of the invoice is due upon receipt.<br />

Compliance<br />

To help the government fight the funding of terrorism <strong>and</strong> money laundering activities, Federal law<br />

requires all financial institutions to obtain, verify, <strong>and</strong> record information that identifies each person<br />

or entity that opens an account. We may ask for information that will enable us to meet the<br />

requirements of the Act.<br />

16345690.14.BUSINESS


16345690.14.BUSINESS<br />

SCHEDULE 3<br />

(Former Shareholders names addresses <strong>and</strong> Ownership Percentages in Excel Format)


16345690.14.BUSINESS<br />

SCHEDULE 4<br />

[JPMORGAN MONEY MARKET ACCOUNT DESCRIPTION]<br />

Pomona Holdings/Clement Pappas & Co/Representatives Escrow A/C # 983617598


[Date]<br />

[Escrow Agent]<br />

[ ]<br />

[ ]<br />

Attention: [•]<br />

16345690.14.BUSINESS<br />

EXHIBIT A<br />

PARENT RELEASE DEM<strong>AND</strong><br />

Re: Dem<strong>and</strong> for Payment under Section 1.4(a)(i) of the Escrow Agreement, dated<br />

_____________________ (“Escrow Agreement”), <strong>among</strong> Pomona Holdings, Inc.<br />

( “Parent”), Clement Pappas <strong>and</strong> Company, Inc. (the “Company”), Clement David<br />

Pappas <strong>and</strong> Clement Dimitri Pappas as the Representatives, <strong>and</strong> JPMorgan Chase<br />

Bank, N.A., as escrow agent (“Escrow Agent”)<br />

Ladies <strong>and</strong> Gentlemen:<br />

Parent here<strong>by</strong> dem<strong>and</strong>s payment of the sum of [$_____________] (“Release Dem<strong>and</strong><br />

Amount”) from the Escrow Account in connection with [amounts due to the Surviving<br />

Corporation under Section 2.7 of the Merger Agreement] OR [a claim for indemnification<br />

pursuant to Article 8 of the Merger Agreement] dated [________________] <strong>among</strong> Clement<br />

Pappas <strong>and</strong> Company, Inc., Parent <strong>and</strong> [Newco, Inc.] (the “Merger Agreement”), <strong>and</strong> here<strong>by</strong><br />

certifies as follows:<br />

1. [The Surviving Corporation is due $[____________] under Section 2.7 of the<br />

Merger Agreement] OR [Parent is entitled to indemnification for Losses (as defined in the<br />

Merger Agreement) pursuant to Article 8 of the Merger Agreement] based upon the following:<br />

[a complete description of the facts that gave rise to the claim, including<br />

the provisions of the Merger Agreement upon which such claim is based]<br />

2. The Release Dem<strong>and</strong> Amount represents not more than the amount [due to the<br />

Surviving Corporation under Section 2.7 of the Merger Agreement] OR [of any known Losses<br />

for which Parent is entitled to indemnification].<br />

3. Parent has requested the Representatives to execute a Joint Direction directing the<br />

Escrow Agent to release <strong>and</strong> disburse the Release Dem<strong>and</strong> Amount to Parent, <strong>and</strong> the<br />

Representatives have either failed or refused to execute such Joint Direction.<br />

4. Parent has simultaneously given a copy of this Parent Release Dem<strong>and</strong> to the<br />

Representatives in accordance with the notice provisions of Section 3.1 of the Escrow<br />

Agreement.


5. By reason of the foregoing, Parent is entitled to be paid the Release Dem<strong>and</strong><br />

Amount from the Escrow Account, provided that the Escrow Agent has not received any<br />

Objection Notice from the Representatives made in accordance with Section 1.4(a)(i) of the<br />

Escrow Agreement.<br />

6. Please disburse the Release Dem<strong>and</strong> Amount in accordance with the following<br />

instructions:<br />

16345690.14.BUSINESS<br />

[Insert Wiring Instructions]<br />

Capitalized terms used but not defined herein shall have the meanings assigned to such<br />

terms in the Escrow Agreement unless the context otherwise requires.<br />

cc: Clement David Pappas<br />

[ ]<br />

[ ]<br />

Attn:<br />

Fax No.:<br />

Clement Dimitri Pappas<br />

[ ]<br />

[ ]<br />

Attn:<br />

Fax No.:<br />

Dechert LLP<br />

Cira Centre<br />

2929 Arch Street<br />

Philadelphia, PA 19104<br />

Attention: Carmen J. Romano, Esq.<br />

R. Jeffrey Legath, Esq.<br />

Fax No.: (215) 994-2222<br />

[PARENT]<br />

By:<br />

Name:<br />

Title:


[Date]<br />

[Escrow Agent]<br />

[ ]<br />

[ ]<br />

Attention: [•]<br />

16345690.14.BUSINESS<br />

EXHIBIT B<br />

JUDGMENT CERTIFICATE<br />

Re: Judgment Certificate under Section 1.4(a)(iii) of the Escrow Agreement, dated<br />

_____________________ (“Escrow Agreement”), <strong>among</strong> Pomona Holdings, Inc.<br />

( “Parent”), Clement Pappas <strong>and</strong> Company, Inc. (the “Company”), Clement David<br />

Pappas <strong>and</strong> Clement Dimitri Pappas as the Representatives, <strong>and</strong> JPMorgan Chase<br />

Bank, N.A., as escrow agent (“Escrow Agent”)<br />

Ladies <strong>and</strong> Gentlemen:<br />

In reference to the Escrow Agreement, the undersigned here<strong>by</strong> certifies to the Escrow<br />

Agent <strong>and</strong> [Parent/the Representatives] that:<br />

1. Attached is [a non-appealable, final judgment of a court of competent<br />

jurisdiction ordering payment to [Parent/the Representatives] of the sum of $[___________] OR<br />

the final determination of the Accounting Firm reflecting payment due to the Surviving<br />

Corporation of the sum of $[___________] pursuant to Section 2.7 of the Merger Agreement]<br />

<strong>and</strong> you are instructed to follow the instructions contained therein.<br />

2. [Parent/The Representatives] [has/have] requested [the<br />

Representatives/Parent] to execute a Joint Direction directing the Escrow Agent to release <strong>and</strong><br />

disburse $[___________] to [Parent/The Representatives], <strong>and</strong> [the Representatives/Parent]<br />

[have/has] either failed or refused to execute such Joint Direction.<br />

3. [Parent/The Representatives] [has/have] simultaneously given a copy of<br />

this Judgment Certificate simultaneously to [Parent/the Representatives] in accordance with the<br />

notice provisions of Section 3.1 of the Escrow Agreement.<br />

4. By reason of the foregoing, [Parent/the Representatives] [is/are] entitled to<br />

be paid $[___________] from the Escrow Account.<br />

instructions:<br />

5. Please disburse $[___________] in accordance with the following<br />

[Insert Wiring Instructions]<br />

Capitalized terms used but not defined herein shall have the meanings assigned to such<br />

terms in the Escrow Agreement unless the context otherwise requires.


cc: Clement David Pappas<br />

[ ]<br />

[ ]<br />

Attn:<br />

Fax No.:<br />

Clement Dimitri Pappas<br />

[ ]<br />

[ ]<br />

Attn:<br />

Fax No.:<br />

Dechert LLP<br />

Cira Centre<br />

2929 Arch Street<br />

Philadelphia, PA 19104<br />

Attention: Carmen J. Romano, Esq.<br />

R. Jeffrey Legath, Esq.<br />

Fax No.: (215) 994-2222<br />

[Parent]<br />

[ ]<br />

[ ]<br />

[ ]<br />

Attn:<br />

Fax No.:<br />

Squire, S<strong>and</strong>ers & Dempsey (US) LLP<br />

4900 Key Tower<br />

127 Public Square<br />

Clevel<strong>and</strong>, OH 44114<br />

Attn: Laura D. Nemeth<br />

Fax No.: (216) 479-8780<br />

16345690.14.BUSINESS<br />

[PARENT/THE REPRESENTATIVES]<br />

By:<br />

Name:<br />

Title:


Exhibit B<br />

Form of Certificate of Merger<br />

16439551.17.BUSINESS B-1


UMC-2 11/03<br />

New Jersey Division of Revenue<br />

Certificate of Merger/Consolidation<br />

(Profit Corporations)<br />

This form may be used to record the merger or consolidation of a corporation with or into another business entity or entities, pursuant<br />

to NJSA 14A. Applicants must insure strict compliance with the requirements of State law <strong>and</strong> insure that all filing requirements are<br />

met. This form is intended to simplify filing with the State Treasurer. Applicants are advised to seek out private legal advice before<br />

submitting filings to the Department of the Treasury, Division of Revenue’s office.<br />

1. Type of Filing (check one): ___Merger ✘<br />

___ Consolidation<br />

2. Name of Surviving Business Entity:<br />

3. Name(s)/Jurisdiction(s) of All Participating Business Entities including Surviving Entity:<br />

Identification # Assigned <strong>by</strong><br />

Name Jurisdiction Treasurer (if applicable)<br />

4. Date Merger/Consolidation adopted:<br />

Clement Pappas <strong>and</strong> Company, Inc.<br />

Clement Pappas <strong>and</strong> Company, Inc. New Jersey 2981701000<br />

Pomona Merger Corp. New Jersey 0101016239<br />

5. Voting: (all corporations involved; attach additional sheets if necessary)<br />

-a Corp. Name Clement Pappas <strong>and</strong> Company, Inc. Outst<strong>and</strong>ing Shares 1,130<br />

If applicable, set forth the number <strong>and</strong> designation of any class or series of shares entitled to vote.<br />

Voting For _______________ Voting Against _________________ ; OR<br />

Merger/consolidation plan was adopted <strong>by</strong> the unanimous written consent of the shareholders without a meeting (check)____ ✘<br />

-b Corp. Name Pomona Merger Corp. Outst<strong>and</strong>ing Shares 100<br />

If applicable, set forth the number <strong>and</strong> designation of any class or series of shares entitled to vote.<br />

Voting For _______________ Voting Against _________________ ; OR<br />

Merger/consolidation plan was adopted <strong>by</strong> the unanimous written consent of the shareholders without a meeting (check)____ ✘<br />

-c Corp. Name Outst<strong>and</strong>ing Shares<br />

If applicable, set forth the number <strong>and</strong> designation of any class or series of shares entitled to vote.<br />

Voting For ________________ Voting Against _________________ ; OR<br />

Merger/consolidation plan was adopted <strong>by</strong> the unanimous written consent of the shareholders without a meeting (check)____<br />

6. Service of Process Address (For use if the surviving business entity is not authorized or registered <strong>by</strong> the State<br />

Treasurer:<br />

The surviving business entity agrees that it may be served with process in this State in any action, suit or proceeding<br />

for the enforcement of any obligation of any domestic or foreign corporation, previously amenable to suit in this<br />

State, which is a party to this merger/consolidation, <strong>and</strong> in any proceeding for the enforcement of the rights of a<br />

dissenting shareholder of such domestic corporation against the surviving corporation.<br />

The Treasurer is here<strong>by</strong> appointed as agent to accept service of process in any such action, suit, or proceeding which<br />

shall be forwarded to the surviving business entity at the Service of Process address stated above.<br />

The Surviving Business Entity also agrees that it will promptly pay to the dissenting shareholders of any such<br />

domestic corporation the amount, if any, to which they may be entitled under the provisions of Title 14A.<br />

NJ076 - 02/15/2006 C T System Online


Certificate of Merger/Consolidation<br />

UMC-2<br />

Page 2<br />

7. Effective Date (see inst.):<br />

Signature Name Title Date<br />

________________________________________ ________________________________ ______________________________ ______________<br />

________________________________________ ________________________________ ______________________________ ______________<br />

________________________________________ ________________________________ ______________________________ ______________<br />

________________________________________ ________________________________ ______________________________ ______________<br />

**Remember to attach: 1) the plan of merger or consolidation; <strong>and</strong> 2) if the surviving or resulting business is not a registered or<br />

authorized domestic or foreign corporation, a Tax Clearance Certificate for each participating corporation.<br />

NJ076 - 02/15/2006 C T System Online<br />

NJ Division of Revenue, PO Box 308, Trenton NJ 08646


Exhibit C<br />

Letter of Transmittal<br />

16439551.17.BUSINESS C-1


16332918.10.BUSINESS<br />

EXHIBIT C<br />

LETTER <strong>OF</strong> TRANSMITTAL<br />

CONSENT, WAIVER <strong>AND</strong> RELEASE<br />

For Shares of Common Stock of<br />

Clement Pappas <strong>and</strong> Company, Inc.<br />

Pursuant to the Agreement <strong>and</strong> Plan of Merger <strong>by</strong> <strong>and</strong> <strong>among</strong><br />

<strong>CLEMENT</strong> PAPPAS <strong>AND</strong> COMPANY, INC.,<br />

POMONA HOLDINGS, INC.,<br />

POMONA <strong>MERGER</strong> CORP.<br />

<strong>and</strong><br />

Clement David Pappas <strong>and</strong> Clement Dimitri Pappas<br />

as Representatives of Former Shareholders<br />

(for purposes of Sections 2.7, 5.10, 8.3, 8.4, 8.8, 8.9 <strong>and</strong> 9.1 <strong>and</strong> Article 10 only),<br />

<strong>and</strong><br />

LASSONDE INDUSTRIES, INC.<br />

(for purposes of Article 10 only)<br />

PLEASE READ <strong>AND</strong> FOLLOW THE ACCOMPANYING INSTRUCTIONS<br />

FINAL EXHIBIT FORM<br />

This letter of transmittal is being delivered <strong>by</strong> the undersigned in connection with the acquisition of<br />

Clement Pappas <strong>and</strong> Company, Inc. (the “Company”) <strong>by</strong> Pomona Holdings, Inc., a Delaware corporation (“Parent”),<br />

through the merger of Pomona Merger Corp., a New Jersey corporation <strong>and</strong> a wholly-owned subsidiary of Parent<br />

(“Newco”), with <strong>and</strong> into the Company (the “Merger”) pursuant to an Agreement <strong>and</strong> Plan of Merger, dated June<br />

[__], 2011 (the “Merger Agreement”), <strong>by</strong> <strong>and</strong> <strong>among</strong> the Company, Parent, Newco, <strong>and</strong>, solely for the purposes of<br />

Sections 2.7, 5.10, 8.3, 8.4, 8.8, 8.9 <strong>and</strong> 9.1 <strong>and</strong> Article 10 of the Merger Agreement, Clement David Pappas <strong>and</strong><br />

Clement Dimitri Pappas, as the Representatives, <strong>and</strong>, solely for the purposes of Article 10 of the Merger Agreement,<br />

Lassonde Industries, Inc., a Canadian corporation. Defined terms used herein, unless otherwise defined herein, shall<br />

have the meanings ascribed to them in the Merger Agreement.<br />

In accordance with the Merger Agreement, the undersigned here<strong>by</strong> surrenders to you the original stock<br />

certificate(s) (“Certificate(s)”) representing the shares of Common Stock of the Company (the “Shares”) that are<br />

described below, each such Share to be exchanged for the Per Share Merger Consideration, as specified in the<br />

Merger Agreement. This letter of transmittal should be promptly (a) completed <strong>and</strong> signed in the space provided<br />

below <strong>and</strong> on the space provided on the IRS Form W-9 included in this letter of transmittal <strong>and</strong> (b) mailed or<br />

delivered with (i) the Certificate(s) representing your Shares <strong>and</strong> (ii) your properly executed affidavit of non-foreign<br />

status that complies with Section 1445 of the Internal Revenue Code (the “FIRPTA Certificate”), included in this<br />

Letter of Transmittal, to, if on or prior to the Closing Date, the Company, or, if following the Closing Date, the<br />

Surviving Corporation at the address below:<br />

Clement Pappas <strong>and</strong> Company, Inc.<br />

1 Collins Drive<br />

Suite 200<br />

Carneys Point, NJ 08069<br />

Instructions regarding the completion of this letter of transmittal are set forth below.


Enclosed are the following Certificates representing shares of Common Stock of the Company:<br />

Print Name <strong>and</strong> Address of Registered<br />

Holder(s) (exactly as name(s) appear(s) on<br />

Certificate(s))<br />

BOX A – DESCRIPTION <strong>OF</strong> CERTIFICATE(S) SURRENDERED<br />

Specify<br />

Voting or Non-Voting<br />

Common Shares<br />

Certificate<br />

Number(s)<br />

Number of<br />

Shares<br />

If the original Certificate(s) is(are) lost, stolen or destroyed, please check this box, review Instruction 1<br />

<strong>and</strong> sign <strong>and</strong> return this letter of transmittal.<br />

REPRESENTATIONS <strong>AND</strong> WARRANTIES<br />

The undersigned represents <strong>and</strong> warrants to Parent <strong>and</strong> to the Company that:<br />

1. the undersigned is the record holder <strong>and</strong> beneficial owner of the Shares <strong>and</strong> has sole power of<br />

disposition in respect of the Shares;<br />

2. the undersigned has all requisite power <strong>and</strong> authority to surrender the Certificate(s) evidencing the<br />

Shares, <strong>and</strong> the surrender of the Certificate(s) evidencing the Shares in accordance with the terms<br />

<strong>and</strong> conditions of this letter of transmittal <strong>and</strong> the Merger Agreement does not violate or conflict<br />

with or result in a breach of any provision of the trust agreement or similar organizational<br />

documents of the undersigned;<br />

3. this letter of transmittal has been duly executed <strong>and</strong> delivered <strong>by</strong> the undersigned <strong>and</strong> constitutes a<br />

valid <strong>and</strong> binding agreement of the undersigned, enforceable in accordance with its terms, except<br />

to the extent such enforceability may be limited <strong>by</strong> applicable bankruptcy, insolvency,<br />

reorganization, moratorium, fraudulent conveyance or other laws from time to time in effect<br />

relating to creditors’ rights <strong>and</strong> remedies generally <strong>and</strong> <strong>by</strong> general principles of equity; <strong>and</strong><br />

4. the undersigned holds good <strong>and</strong> marketable title to the Shares, free <strong>and</strong> clear of all Liens other<br />

than transfer restrictions under applicable securities laws.<br />

ACKNOWLEDGEMENTS, <strong>AGREEMENT</strong>S <strong>AND</strong> RELEASE<br />

The undersigned acknowledges that risk of loss <strong>and</strong> title to the Certificate(s) shall pass only upon or after<br />

the Effective Time following delivery of the Certificate(s) to the Surviving Corporation. If the Merger Agreement is<br />

terminated pursuant to its terms <strong>and</strong> the Merger <strong>and</strong> the other transactions contemplated there<strong>by</strong> have not been<br />

consummated, this letter of transmittal, including without limitation the immediately foregoing paragraph, shall be<br />

deemed void ab initio <strong>and</strong> of no further force <strong>and</strong> effect.<br />

The undersigned acknowledges that the Shareholders Agreement, dated as of November 19, 2001, <strong>by</strong> <strong>and</strong><br />

<strong>among</strong> Peter C. Pappas <strong>and</strong> Dean C. Pappas, as the same may be amended from time to time (the “Shareholders<br />

Agreement”), has been terminated <strong>and</strong> no party to the Shareholders Agreement or beneficiary or assignee thereto has<br />

any further or continuing obligation or responsibility to any other party, beneficiary or assignee pursuant to or any<br />

further or continuing rights under the Shareholders Agreement.


The Merger<br />

The undersigned here<strong>by</strong> acknowledges receipt of the Merger Agreement <strong>and</strong> Escrow Agreement. By<br />

execution of this letter of transmittal, the undersigned agrees that this letter of transmittal <strong>and</strong> all amounts payable to<br />

the undersigned as a Former Shareholder as a result of the Merger are subject to, <strong>and</strong> governed <strong>by</strong>, the terms <strong>and</strong><br />

conditions of the Merger Agreement, the Escrow Agreement <strong>and</strong> the documents related thereto.<br />

The Representatives<br />

The undersigned (on such Former Shareholder’s own behalf <strong>and</strong> on behalf of its successors <strong>and</strong> assigns)<br />

here<strong>by</strong> irrevocably appoints, authorizes <strong>and</strong> empowers Clement David Pappas <strong>and</strong> Clement Dimitri Pappas, acting<br />

together, but not individually, as joint representatives (the “Representatives”), for the benefit of the undersigned <strong>and</strong><br />

the other Former Shareholders, as the exclusive agents <strong>and</strong> attorneys-in-fact to act on behalf of the undersigned <strong>and</strong><br />

each other Former Shareholder, to the extent <strong>and</strong> with respect to the matters described in Article 9 of the Merger<br />

Agreement, <strong>and</strong> agrees to be bound <strong>by</strong> the provisions of the Merger Agreement, the Escrow Agreement <strong>and</strong> the<br />

documents related thereto with respect to such appointment <strong>and</strong> authorization.<br />

The undersigned here<strong>by</strong> agrees to indemnify, pro rata based upon the portion of the Purchase Price to<br />

which such holder is entitled pursuant to the Merger Agreement, the Representatives against all losses, damages,<br />

liabilities, claims, obligations, costs <strong>and</strong> expenses, including reasonable attorneys’, accountants’ <strong>and</strong> other experts’<br />

fees <strong>and</strong> the amount of any judgment against them, of any nature whatsoever (including any <strong>and</strong> all expense<br />

whatsoever reasonably incurred in investigating, preparing or defending against any litigation, commenced or<br />

threatened or any claims whatsoever), arising out of or in connection with any claim, investigation, challenge, action<br />

or proceeding, or in connection with any appeal thereof, relating to the acts or omissions of the Representatives<br />

under or in connection with the Merger Agreement, or the Escrow Agreement or the transactions contemplated<br />

there<strong>by</strong>; provided, however, that the foregoing indemnification shall not apply in the event of any action or<br />

proceeding which finally adjudicates the liability of the Representatives for its bad faith or willful misconduct. Upon<br />

written notice from the Representatives to the Former Shareholder as to the existence of a deficiency toward the<br />

payment of any such indemnification amount or a deficiency in the account used <strong>by</strong> the Representatives to pay<br />

expenses incurred <strong>by</strong> the Representatives in their capacity as Representatives, the undersigned here<strong>by</strong> agrees to<br />

promptly deliver to the Representatives full payment of the undersigned’s ratable share of the amount of such<br />

deficiency (pro rata based upon the portion of the Purchase Price to which the undersigned is entitled pursuant to the<br />

Merger Agreement); provided, that the undersigned shall not be liable for that portion of any claim of<br />

indemnification, individually or in the aggregate, that is in excess of the undersigned’s pro rata portion of the<br />

Purchase Price to which the undersigned is entitled pursuant to the Merger Agreement.<br />

The undersigned here<strong>by</strong> authorizes the Representatives <strong>and</strong> the appropriate officers of the Company to<br />

execute <strong>and</strong> deliver such documents <strong>and</strong> take such other actions as may be required or advisable to carry out the<br />

transactions contemplated <strong>by</strong> the Merger Agreement, the Escrow Agreement <strong>and</strong> the documents related thereto.<br />

Release<br />

Effective as of the Effective Time, the undersigned, for itself <strong>and</strong> all of its affiliates, assigns <strong>and</strong> successors<br />

(the “Releasors”), here<strong>by</strong> completely <strong>and</strong> irrevocably releases <strong>and</strong> forever discharges Parent, Newco, the Company,<br />

the Representatives <strong>and</strong> each of their respective affiliates, <strong>and</strong> their respective directors, officers, managers,<br />

members, stockholders, principals, employees, agents, representatives, predecessors, successors <strong>and</strong> assigns from<br />

any <strong>and</strong> all claims, damages, losses, dem<strong>and</strong>s, actions, causes of action, promises <strong>and</strong>/or liabilities arising out of the<br />

undersigned having been a shareholder of the Company, other than the Former Shareholders’ rights under the<br />

Merger Agreement, the Escrow Agreement, this letter of transmittal <strong>and</strong> the documents related thereto.<br />

All authority conferred herein or agreed to be conferred shall survive the liquidation or dissolution of the<br />

undersigned, <strong>and</strong> any obligation of the undersigned shall be binding upon the successors <strong>and</strong> assigns of the<br />

undersigned.<br />

INSTRUCTIONS TO LETTER <strong>OF</strong> TRANSMITTAL


1. Delivery of Letter of Transmittal <strong>and</strong> Certificates. Certificates surrendered, as well as a<br />

properly completed <strong>and</strong> duly executed letter of transmittal <strong>and</strong> any other documents required <strong>by</strong> this letter of<br />

transmittal, must be delivered to the address set forth on the cover of this letter of transmittal. If any of the<br />

Certificates of the undersigned have been lost, stolen, mutilated or destroyed, then please indicate this on the face of<br />

this letter of transmittal, <strong>and</strong> contact, if on or prior to the Closing Date, the Company (c/o Dimitri Pappas, telephone:<br />

856-455-1000, email: dipappas@clementpappas.com), or, if following the Closing Date, the Surviving Corporation<br />

(c/o [], telephone: [], email: []), <strong>and</strong> the Company or the Surviving Corporation, as the case may be, will<br />

forward you additional documentation that you must complete in order to effectively surrender lost, stolen, mutilated<br />

or destroyed Certificate(s). All questions as to the documents, validity, form, eligibility <strong>and</strong> acceptance for payment<br />

of any Certificate(s) surrendered pursuant to any of the procedures described in this letter of transmittal will be<br />

determined <strong>by</strong> Parent, acting reasonably, <strong>and</strong> such determination will be final <strong>and</strong> binding. Parent also reserves the<br />

absolute right to waive any defect or irregularity in the surrender of any Certificates or delivery of any letter of<br />

transmittal, <strong>and</strong> its reasonable interpretations of other terms <strong>and</strong> conditions of the Merger Agreement <strong>and</strong> this letter<br />

of transmittal (including these instructions) with respect to such irregularities or defects will be final <strong>and</strong> binding.<br />

Delivery of the Certificates will be effected, <strong>and</strong> risk of loss <strong>and</strong> title to the Certificate(s) will pass only upon or after<br />

the Effective Time following delivery of the Certificate(s) to the Surviving Corporation. No alternative, conditional,<br />

irregular or contingent surrender of the Certificate(s) or this letter of transmittal will be accepted. Delivery of<br />

documents to an address other than the address set forth on the cover of this letter of transmittal does not<br />

constitute delivery to the Surviving Corporation. The surrender of the Certificate(s) will be deemed made only<br />

when this letter of transmittal <strong>and</strong> any other documents are actually received <strong>by</strong> the Parent or the Surviving<br />

Corporation.<br />

The method of delivery of the Certificate(s) <strong>and</strong> the other required documents is at the option <strong>and</strong> risk of<br />

the tendering holder. If sent <strong>by</strong> mail, then registered mail with return receipt requested is recommended.<br />

2. Inadequate Space. If there is inadequate space to complete any box or to sign this letter of<br />

transmittal, the information or signatures required to be provided must be set forth on additional sheets substantially<br />

in the form of the corresponding portion of this letter of transmittal <strong>and</strong> attached to this letter of transmittal.<br />

3. Signature on Letter of Transmittal <strong>and</strong> Endorsements.<br />

(a) If this letter of transmittal is signed <strong>by</strong> the registered holder(s) of the Shares evidenced <strong>by</strong><br />

the Certificate(s) surrendered here<strong>by</strong> without any correction or change in the name of the registered<br />

holder(s), the signature(s) must correspond exactly with the name(s) as written on the face of the<br />

Certificate(s) without any change whatsoever. In the event the name of the registered holder(s) needs to be<br />

corrected or has changed (<strong>by</strong> marriage or otherwise), please print such correction or change on the form<br />

itself. If you need additional space, see Instruction 2.<br />

(b) If any Shares evidenced <strong>by</strong> the Certificate(s) surrendered here<strong>by</strong> are registered in<br />

different names on several Certificates, it will be necessary to complete, sign <strong>and</strong> submit as many separate<br />

letters of transmittal as there are different registrations of such Shares.<br />

(c) If this letter of transmittal is signed <strong>by</strong> the registered holder(s) of the Shares listed <strong>and</strong><br />

transmitted here<strong>by</strong>, no endorsements of such Shares are required.<br />

(d) If this letter of transmittal is signed <strong>by</strong> a person(s) other than the registered holder(s) of<br />

the Shares listed, the Certificate(s) evidencing such Shares, as the case may be, must be endorsed or<br />

accompanied <strong>by</strong> appropriate stock powers, in either case signed exactly as the name of the registered<br />

holder(s) appears on the Certificate(s) evidencing such Shares.<br />

(e) If this letter of transmittal or any Share is signed <strong>by</strong> a person(s) other than the registered<br />

holder(s) of the Shares listed <strong>and</strong> the signer(s) is acting in the capacity of trustee, executor, administrator,<br />

guardian, attorney-in-fact, officer of a corporation or any other person(s) acting in a fiduciary or<br />

representative capacity, such person(s) must so indicate when signing <strong>and</strong> must submit proper evidence<br />

satisfactory to the Representatives of authority to act.


4. Payment <strong>and</strong> Delivery Instructions. The undersigned underst<strong>and</strong>s that (a) if the Certificate(s)<br />

surrendered here<strong>by</strong> is(are) properly surrendered on or prior to the Closing Date, the undersigned will receive from<br />

the Surviving Corporation on the Closing Date in exchange for each Share formerly evidenced <strong>by</strong> the Certificate(s)<br />

surrendered here<strong>by</strong>, the Per Share Closing Consideration, <strong>and</strong> (b) if the Certificate(s) surrendered here<strong>by</strong> is(are)<br />

properly surrendered after the Closing Date, the undersigned will receive from the Surviving Corporation as<br />

promptly as practicable following such surrender in exchange for each Share formerly evidenced <strong>by</strong> the<br />

Certificate(s) surrendered here<strong>by</strong>, the Per Share Closing Consideration. Any Person entitled to a portion of the<br />

Purchase Price who has provided wire transfer instructions to Parent prior to the Closing Date shall be entitled to<br />

payment <strong>by</strong> wire transfer on the Closing Date in accordance with the instructions specified in such Person’s Letter<br />

of Transmittal. No interest will be paid or will accrue for the benefit of the holders of Common Stock on the<br />

consideration payable upon the surrender of the letters of transmittal <strong>and</strong> the Certificates.<br />

5. Requests for Assistance <strong>and</strong> Additional Copies. Requests for assistance may be directed to, if<br />

on or prior to the Closing Date, the Company (c/o Dimitri Pappas, telephone: 856-455-1000, email:<br />

dipappas@clementpappas.com), or, if following the Closing Date, the Surviving Corporation (c/o [], telephone:<br />

[], email: []). Additional copies of this letter of transmittal <strong>and</strong> an IRS Form W-9 (“Form W-9”) may be obtained<br />

from, if on or prior to the Closing Date, the Company, or, if following the Closing Date, the Surviving Corporation<br />

at the address <strong>and</strong> telephone number set forth herein.<br />

6. Forms W-9. Each tendering holder is required to provide, if on or prior to the Closing Date, the<br />

Company, or, if following the Closing Date, the Surviving Corporation with a duly executed Form W-9. Those<br />

tendering holders required to provide Form W-9 must cross out item (2) in the certification box on the Form W-9 if<br />

subject to backup withholding. If the tendering holder has not been issued a TIN <strong>and</strong> has applied for a TIN or<br />

intends to apply for a TIN in the near future, write “Applied For” in the space for the TIN on Form W-9. Failure to<br />

provide Form W-9 (or, for those tendering holders who wrote “Applied For” in the space for the TIN on Form W-9,<br />

failure to provide a TIN within sixty (60) days) may subject the tendering holder to federal income tax withholding<br />

at 28% on the payments made to the holder or other payee with respect to the Shares. Instructions to Form W-9 may<br />

be obtained from, if on or prior to the Closing Date, the Company, or, if following the Closing Date, the Surviving<br />

Corporation at the address <strong>and</strong> telephone number set forth on the cover page of this letter of transmittal.<br />

7. FIRPTA Certificate. Each tendering holder is required to submit a FIRPTA Certificate. A<br />

tendering holder who is a business entity should complete <strong>and</strong> sign the FIRPTA Certificate with the heading<br />

“Certification of Nonforeign Status <strong>by</strong> Entity Transferor of U.S. Real Property Interest.” Parent may be required to<br />

withhold tax on the gross proceeds attributable to certain real property with respect to any tendering holder who fails<br />

to provide a FIRPTA Certificate.<br />

8. Indication of Certificate Numbers. This letter of transmittal should indicate the certificate<br />

numbers of the Certificate(s) surrendered here<strong>by</strong> <strong>and</strong> the number of Shares represented <strong>by</strong> each such Certificate(s).<br />

9. Miscellaneous. Parent anticipates that it will provide notification of any defects in the deposit <strong>and</strong><br />

surrender of any Certificate(s), but neither Parent nor the Representatives shall incur any liability for failure to give<br />

such notice.<br />

10. Transfer Taxes. In the event that any transfer or other Taxes are required <strong>by</strong> reason of payment<br />

or delivery to be made to a Person other than the Person in whose name a Certificate so surrendered is registered, it<br />

shall be a condition of payment that the Person requesting such payment either pay any transfer or other Taxes<br />

required <strong>by</strong> reason of the payment to a Person other than the registered holder of the Certificate so surrendered or<br />

establish to the satisfaction of Parent that such Tax has been paid or is not applicable.


16332918.10.BUSINESS<br />

ALL HOLDERS <strong>OF</strong> SHARES MUST SIGN HERE<br />

(Also complete the FIRPTA Certificate <strong>and</strong> Form W-9)<br />

FINAL EXHIBIT FORM<br />

The undersigned acknowledges that the undersigned has thoroughly read this letter of transmittal <strong>and</strong> agrees to be<br />

bound <strong>by</strong> the terms <strong>and</strong> conditions set forth herein <strong>and</strong> in the accompanying materials.<br />

The wire transfer or other payment representing the Former Shareholder’s Per Share Closing Consideration will<br />

be issued only in the name of the person(s) submitting this letter of transmittal or will be mailed to the address<br />

shown in the box on page one entitled “Name <strong>and</strong> Address of Registered Owner”.<br />

Signature(s) of Registered Holder(s) or Agent<br />

Dated: , 2011<br />

(Must be signed <strong>by</strong> registered holder(s) exactly as name(s) on stock certificate(s) or on a security position listing<br />

or <strong>by</strong> person(s) authorized to become registered holder(s) <strong>by</strong> certificates <strong>and</strong> documents transmitted herewith. If<br />

signature is <strong>by</strong> an officer of a corporation, attorney-in-fact, executor, administrator, trustee, guardian or other<br />

person(s) acting in a fiduciary or representative capacity, then please set forth full title <strong>and</strong> see Instruction 3.)<br />

Name(s):<br />

Capacity (Full Title):<br />

(Please print)<br />

Address: (ZIP Code)<br />

Area Code <strong>and</strong> Tel. No.: Dated:<br />

Tax Identification or Social Security No.:<br />

Wire money to:<br />

Account Name:<br />

Account Number:<br />

Bank Name <strong>and</strong> ABA Number:<br />

(Please print)


16332918.10.BUSINESS<br />

IMPORTANT TAX INFORMATION<br />

IRS Circular 230 Disclosure: Any discussion of tax issues set forth in this letter of transmittal was<br />

written in connection with the promotion <strong>and</strong> marketing of the transactions described herein. Such discussion<br />

was not intended or written to be used, <strong>and</strong> cannot be used, <strong>by</strong> any person for the purpose of avoiding<br />

penalties under the Internal Revenue Code. Each holder should seek advice based on its particular<br />

circumstances from an independent tax advisor.<br />

Under federal tax law, a holder who transmits Shares here<strong>by</strong> is required <strong>by</strong> law to provide, if on or prior to<br />

the Closing Date, the Company, or, if following the Closing Date, the Surviving Corporation with such holder’s<br />

correct TIN on Form W-9 below. If such holder is an individual, then the TIN is his or her social security number. If<br />

the Company or the Surviving Corporation, as the case may be, is not provided with the correct TIN, then the holder<br />

or other payee may be subject to penalties imposed <strong>by</strong> the Internal Revenue Service. In addition, payments that are<br />

made to such holder or other payee with respect to Shares may be subject to backup withholding.<br />

If backup withholding applies, then Parent, Newco or the Surviving Corporation, as applicable, is required<br />

to withhold 28% on payments made to the holder or other payee. Backup withholding is not an additional tax.<br />

Rather, the federal income tax liability of persons subject to backup withholding will be reduced <strong>by</strong> the amount of<br />

tax withheld. If withholding results in an overpayment of taxes, then a refund may be obtained from the Internal<br />

Revenue Service.<br />

Purpose of Form W-9<br />

To prevent backup withholding on payments made to a holder or other payee with respect to Shares, the<br />

holder is required to notify, if on or prior to the Closing Date, the Company, or, if following the Closing Date, the<br />

Surviving Corporation of the holder’s correct TIN <strong>by</strong> completing the form below, certifying that the TIN provided<br />

on Form W-9 is correct (or that such holder is awaiting a TIN), that the holder is a U.S. person, <strong>and</strong> that (1) the<br />

holder is exempt from backup withholding, (2) the holder has not been notified <strong>by</strong> the Internal Revenue Service that<br />

the holder is subject to backup withholding as a result of failure to report all interest or dividends, or (3) the Internal<br />

Revenue Service has notified the holder that the holder is no longer subject to backup withholding.<br />

What Number to Give the Company<br />

The holder is required to give, if on or prior to the Closing Date the Company, or, if following the Closing<br />

Date, the Surviving Corporation the TIN (e.g., social security number or employer identification number) of the<br />

record owner of the Shares.<br />

NOTE: Failure to complete <strong>and</strong> return a Form W-9 may result in backup withholding of 28% of any<br />

payments made to you pursuant to the Merger. Please review the guidelines on Form W-9 for additional<br />

details.<br />

FIRPTA Certificate<br />

To prevent potential withholding under sections 897 <strong>and</strong> 1445 of the Code on the gross proceeds<br />

attributable to “United States real property interests” (as defined in section 897(c) of the Code) held <strong>by</strong> the<br />

Company, the tendering holder is required to provide a FIRPTA Certificate to certify its status as a business entity<br />

that is a domestic entity.<br />

NOTE: Failure <strong>by</strong> any tendering holder to complete <strong>and</strong> return the FIRPTA Certificate may result in<br />

withholding <strong>by</strong> Parent with respect to such tendering holder’s Per Share Merger Consideration attributable<br />

to “United States real property interests.”


Form W-9<br />

(Rev. January, 2011)<br />

Department of the Treasury<br />

Internal Revenue Service<br />

Print or type<br />

See Specific Instructions on page 2.<br />

Name (as shown on your income tax return)<br />

Business name, if different from above<br />

Check appropriate box for federal tax<br />

16332918.10.BUSINESS<br />

Request for Taxpayer<br />

Identification Number <strong>and</strong> Certification<br />

classification (required): Individual/Sole proprietor C Corporation S Corporation Partnership Trust/estate<br />

Limited liability company. Enter the tax classification (C=corporation, S=S corporation, P=partnership) _____________________<br />

Other (see instructions) <br />

Address (number, street, <strong>and</strong> apt. or suite no.)<br />

City, state, <strong>and</strong> ZIP code<br />

List account number(s) here (optional)<br />

Part I Taxpayer Identification Number (TIN)<br />

Enter your TIN in the appropriate box. The TIN provided must match the name given the “Name” line<br />

to avoid backup withholding. For individuals, this is your social security number (SSN). However, for a resident<br />

alien, sole proprietor, or disregarded entity, see the Part I instructions on page 3. For other entities, it is your<br />

employer identification number (EIN). If you do not have a number, see How to get a TIN on page 3.<br />

Give Form to the<br />

requester. Do not<br />

send to the IRS.<br />

Requester’s name <strong>and</strong> address (optional)<br />

Social security number<br />

- -<br />

Note. If the account is in more than one name, see the chart on page 4 for guidelines on whose number to enter. Employer identification number<br />

Part Certification<br />

II<br />

Under penalties of perjury, I certify that:<br />

1. The number shown on this form is my correct taxpayer identification number (or I am waiting for a number to be issued to me), <strong>and</strong><br />

-<br />

Exempt Payee<br />

2. I am not subject to backup withholding because: (a) I am exempt from backup withholding, or (b) I have not been notified <strong>by</strong> the Internal Revenue Service (IRS)<br />

that I am subject to backup withholding as a result of a failure to report all interest or dividends, or (c) the IRS has notified me that I am no longer subject to backup<br />

withholding, <strong>and</strong><br />

3. I am a U.S. citizen or other U.S. person (defined below).<br />

Certification instructions. You must cross out item 2 above if you have been notified <strong>by</strong> the IRS that you are currently subject to backup withholding because you<br />

have failed to report all interest <strong>and</strong> dividends on your tax return. For real estate transactions, item 2 does not apply. For mortgage<br />

interest paid, acquisition or ab<strong>and</strong>onment of secured property, cancellation of debt, contributions to an individual retirement arrangement (IRA), <strong>and</strong> generally,<br />

payments other than interest <strong>and</strong> dividends, you are not required to sign the certification, but you must provide your correct TIN. See the instructions on page 4.<br />

Sign<br />

Here<br />

Signature of<br />

U.S. person Date<br />

General Instructions<br />

Section references are to the Internal Revenue Code unless otherwise noted.<br />

Purpose of Form<br />

A person who is required to file an information return with the IRS must obtain<br />

your correct taxpayer identification number (TIN) to report, for example, income<br />

paid to you, real estate transactions, mortgage interest you paid, acquisition or<br />

ab<strong>and</strong>onment of secured property, cancellation of debt, or contributions you<br />

made to an IRA.<br />

Use Form W-9 only if you are a U.S. person (including a resident<br />

alien), to provide your correct TIN to the person requesting it (the requester) <strong>and</strong>,<br />

when applicable, to:<br />

1. Certify that the TIN you are giving is correct (or you are waiting for a<br />

number to be issued),<br />

2. Certify that you are not subject to backup withholding, or<br />

3. Claim exemption from backup withholding if you are a U.S. exempt payee.<br />

If applicable, you are also certifying that as a U.S. person, your allocable share<br />

of any partnership income from a U.S. trade or business is not subject to the<br />

withholding tax on foreign partners’ share of effectively connected income.<br />

Note. If a requester gives you a form other than Form W-9 to request<br />

your TIN, you must use the requester’s form if it is substantially similar<br />

to this Form W-9.<br />

Definition of a U.S. person. For federal tax purposes, you are<br />

considered a U.S. person if you are:<br />

An individual who is a U.S. citizen or U.S. resident alien,<br />

A partnership, corporation, company, or association created or<br />

organized in the United States or under the laws of the United States,<br />

An estate (other than a foreign estate), or<br />

A domestic trust (as defined in Regulations section 301.7701-7).<br />

Special rules for partnerships. Partnerships that conduct a trade or business in<br />

the United States are generally required to pay a withholding tax on any foreign<br />

partners’ share of income from such business.<br />

Further, in certain cases where a Form W-9 has not been received, a partnership is<br />

required to presume that a partner is a foreign person,<br />

<strong>and</strong> pay the withholding tax. Therefore, if you are a U.S. person that is a partner in<br />

a partnership conducting a trade or business in the United States, provide Form W-<br />

9 to the partnership to establish your U.S.<br />

status <strong>and</strong> avoid withholding on your share of partnership income.


Form W-9 (Rev. 1-2011) Page 2<br />

The person who gives Form W-9 to the partnership for purposes of<br />

establishing its U.S. status <strong>and</strong> avoiding withholding on its allocable<br />

share of net income from the partnership conducting a trade or business in the<br />

United States is in the following cases:<br />

The U.S. owner of a disregarded entity <strong>and</strong> not the entity,<br />

The U.S. grantor or other owner of a grantor trust <strong>and</strong> not the trust, <strong>and</strong><br />

The U.S. trust (other than a grantor trust) <strong>and</strong> not the beneficiaries of the trust.<br />

Foreign person. If you are a foreign person, do not use Form W-9. Instead, use<br />

the appropriate Form W-8 (see Publication 515,<br />

Withholding of Tax on Nonresident Aliens <strong>and</strong> Foreign Entities).<br />

Nonresident alien who becomes a resident alien. Generally, only a nonresident alien<br />

individual may use the terms of a tax treaty to reduce or eliminate U.S. tax on certain<br />

types of income. However, most tax treaties contain a provision known as a “saving<br />

clause.” Exceptions specified in the saving clause may permit an exemption from<br />

tax to continue for certain types of income even after the payee has otherwise<br />

become a U.S. resident alien for tax purposes.<br />

If you are a U.S. resident alien who is relying on an exception contained in the<br />

saving clause of a tax treaty to claim an exemption from U.S. tax on certain types<br />

of income, you must attach a statement to Form W-9 that specifies the following<br />

five items:<br />

1. The treaty country. Generally, this must be the same treaty under which you<br />

claimed exemption from tax as a nonresident alien.<br />

2. The treaty article addressing the income.<br />

3. The article number (or location) in the tax treaty that contains the<br />

saving clause <strong>and</strong> its exceptions.<br />

4. The type <strong>and</strong> amount of income that qualifies for the exemption from tax.<br />

5. Sufficient facts to justify the exemption from tax under the terms of the<br />

treaty article.<br />

Example. Article 20 of the U.S.-China income tax treaty allows an exemption<br />

from tax for scholarship income received <strong>by</strong> a Chinese student temporarily present in<br />

the United States. Under U.S. law, this student will become a resident alien for tax<br />

purposes if his or her stay in the United States exceeds 5 calendar years. However,<br />

paragraph 2 of the first Protocol to the U.S.-China treaty (dated April 30, 1984)<br />

allows the provisions of Article 20 to continue to apply even after the Chinese<br />

student becomes a resident alien of the United States. A Chinese student<br />

who qualifies for this exception (under paragraph 2 of the first protocol) <strong>and</strong> is<br />

relying on this exception to claim an exemption from tax on his or her<br />

scholarship or fellowship income would attach to Form W-9 a statement that<br />

includes the information described above to support that exemption.<br />

If you are a nonresident alien or a foreign entity not subject to backup<br />

withholding, give the requester the appropriate completed Form W-8.<br />

What is backup withholding? Persons making certain payments to you must under<br />

certain conditions withhold <strong>and</strong> pay to the IRS 28% of such payments. This is<br />

called “backup withholding.” Payments that may be subject to backup withholding<br />

include interest, tax-exempt interest, dividends, broker <strong>and</strong> barter exchange<br />

transactions, rents, royalties, nonemployee pay, <strong>and</strong> certain payments from fishing<br />

boat operators. Real estate transactions are not subject to backup withholding.<br />

You will not be subject to backup withholding on payments you receive if you<br />

give the requester your correct TIN, make the proper certifications, <strong>and</strong> report all<br />

your taxable interest <strong>and</strong> dividends on your tax return.<br />

Payments you receive will be subject to backup withholding if:<br />

1. You do not furnish your TIN to the requester,<br />

2. You do not certify your TIN when required (see the Part II instructions on<br />

page 3 for details),<br />

3. The IRS tells the requester that you furnished an incorrect TIN,<br />

4. The IRS tells you that you are subject to backup withholding because you<br />

did not report all your interest <strong>and</strong> dividends on your tax return (for reportable<br />

interest <strong>and</strong> dividends only), or<br />

5. You do not certify to the requester that you are not subject to backup<br />

withholding under 4 above (for reportable interest <strong>and</strong> dividend accounts opened<br />

after 1983 only).<br />

Cat. No. 10231X Form W-9 (Rev. 1-2011)<br />

Certain payees <strong>and</strong> payments are exempt from backup withholding. See the<br />

instructions below <strong>and</strong> the separate Instructions for the Requester of Form W-9.<br />

Also see Special rules for partnerships on page 1.<br />

Updating Your Information<br />

You must provide updated information to any person to whom you claimed to<br />

be an exempt payee if you are no longer an exempt payee <strong>and</strong> anticipate<br />

receiving reportable payments in the future from this person. For example,<br />

you may need to provide updated information if you are a C corporation that<br />

elects to be an S corporation, or if you no longer are tax exempt. In addition,<br />

you must furnish a new Form W-9 if the name or TIN changes for the<br />

account, for example, if the grantor of a grantor trust dies.<br />

Penalties<br />

Failure to furnish TIN. If you fail to furnish your correct TIN to a requester, you<br />

are subject to a penalty of $50 for each such failure unless your failure is due to<br />

reasonable cause <strong>and</strong> not to willful neglect.<br />

Civil penalty for false information with respect to<br />

withholding. If you make a false statement with no reasonable basis that results in<br />

no backup withholding, you are subject to a $500 penalty.<br />

Criminal penalty for falsifying information. Willfully falsifying certifications or<br />

affirmations may subject you to criminal penalties including fines <strong>and</strong>/or<br />

imprisonment.<br />

Misuse of TINs. If the requester discloses or uses TINs in violation of federal law,<br />

the requester may be subject to civil <strong>and</strong> criminal penalties.<br />

Specific Instructions<br />

Name<br />

If you are an individual, you must generally enter the name shown on your income<br />

tax return. However, if you have changed your last name, for instance, due to<br />

marriage without informing the Social Security Administration of the name change,<br />

enter your first name, the last name shown on your social security card, <strong>and</strong> your<br />

new last name.<br />

If the account is in joint names, list first, <strong>and</strong> then circle, the name of the person or<br />

entity whose number you entered in Part I of the form.<br />

Sole proprietor. Enter your individual name as shown on your income tax return<br />

on the “Name” line. You may enter your business, trade, or “doing business as<br />

(DBA)” name on the “Business name/disregarded entity name” line.<br />

Partnership, C Corporation, or S Corporation. Enter the entity's name on the<br />

“Name” line <strong>and</strong> any business, trade, or “doing business as (DBA) name” on the<br />

“Business name/disregarded entity name” line.<br />

Disregarded entity. Enter the owner's name on the “Name” line. The name of the<br />

entity entered on the “Name” line should never be a disregarded entity. The name<br />

on the “Name” line must be the name shown on the income tax return on which the<br />

income will be reported. For example, if a foreign LLC that is treated as a<br />

disregarded entity for U.S. federal tax purposes has a domestic owner, the domestic<br />

owner's name is required to be provided on the “Name” line. If the direct owner of<br />

the entity is also a disregarded entity, enter the first owner that is not disregarded<br />

for federal tax purposes. Enter the disregarded entity's name on the “Business<br />

name/disregarded entity name” line. If the owner of the disregarded entity is a<br />

foreign person, you must complete an appropriate Form W-8.<br />

Note. Check the appropriate box for the federal tax classification of the person<br />

whose name is entered on the “Name” line (Individual/sole proprietor, Partnership,<br />

C Corporation, S Corporation, Trust/estate).<br />

Limited Liability Company (LLC). If the person identified on the “Name” line is<br />

an LLC, check the “Limited liability company” box only <strong>and</strong> enter the appropriate<br />

code for the tax classification in the space provided. If you are an LLC that is<br />

treated as a partnership for federal tax purposes, enter “P” for partnership. If you<br />

are an LLC that has filed a Form 8832 or a Form 2553 to be taxed as a corporation,<br />

enter “C” for C corporation or “S” for S corporation. If you are an LLC that is<br />

disregarded as an entity separate from its owner under Regulation section<br />

301.7701-3 (except for employment <strong>and</strong> excise tax), do not check the LLC box<br />

unless the owner of the LLC (required to be identified on the “Name” line) is<br />

another LLC that is not disregarded for federal tax purposes. If the LLC is<br />

disregarded as an entity separate from its owner, enter the appropriate tax<br />

classification of the owner identified on the “Name” line.


Form W-9 (Rev. 1-2011) Page 3<br />

Other entities. Enter your business name as shown on required federal<br />

tax documents on the “Name” line. This name should match the name<br />

shown on the charter or other legal document creating the entity. You<br />

may enter any business, trade, or DBA name on the “Business name/<br />

disregarded entity name” line.<br />

Exempt Payee<br />

If you are exempt from backup withholding, enter your name as<br />

described above <strong>and</strong> check the appropriate box for your status, then<br />

check the “Exempt payee” box in the line following the “Business name/<br />

disregarded entity name,” sign <strong>and</strong> date the form.<br />

Generally, individuals (including sole proprietors) are not exempt from<br />

backup withholding. Corporations are exempt from backup withholding<br />

for certain payments, such as interest <strong>and</strong> dividends.<br />

Note. If you are exempt from backup withholding, you should still<br />

complete this form to avoid possible erroneous backup withholding.<br />

The following payees are exempt from backup withholding:<br />

1. An organization exempt from tax under section 501(a), any IRA, or a<br />

custodial account under section 403(b)(7) if the account satisfies the<br />

requirements of section 401(f)(2),<br />

2. The United States or any of its agencies or instrumentalities,<br />

3. A state, the District of Columbia, a possession of the United States,<br />

or any of their political subdivisions or instrumentalities,<br />

4. A foreign government or any of its political subdivisions, agencies,<br />

or instrumentalities, or<br />

5. An international organization or any of its agencies or<br />

instrumentalities.<br />

Other payees that may be exempt from backup withholding include:<br />

6. A corporation,<br />

7. A foreign central bank of issue,<br />

8. A dealer in securities or commodities required to register in the<br />

United States, the District of Columbia, or a possession of the United<br />

States,<br />

9. A futures commission merchant registered with the Commodity<br />

Futures Trading Commission,<br />

10. A real estate investment trust,<br />

11. An entity registered at all times during the tax year under the<br />

Investment Company Act of 1940,<br />

12. A common trust fund operated <strong>by</strong> a bank under section 584(a),<br />

13. A financial institution,<br />

14. A middleman known in the investment community as a nominee or<br />

custodian, or<br />

15. A trust exempt from tax under section 664 or described in section<br />

4947.<br />

The following chart shows types of payments that may be exempt<br />

from backup withholding. The chart applies to the exempt payees listed<br />

above, 1 through 15.<br />

IF the payment is for . . . THEN the payment is exempt<br />

for . . .<br />

Interest <strong>and</strong> dividend payments All exempt payees except<br />

for 9<br />

Broker transactions Exempt payees 1 through 5 <strong>and</strong> 7<br />

through 13. Also , C corporations.<br />

Barter exchange transactions Exempt payees 1 through 5<br />

<strong>and</strong> patronage dividends<br />

Payments over $600 required Generally, exempt payees<br />

to be reported <strong>and</strong> direct<br />

sales over $5,000 1<br />

1 through 7 2<br />

1 See Form 1099-MISC, Miscellaneous Income, <strong>and</strong> its instructions.<br />

2 However, the following payments made to a corporation <strong>and</strong> reportable on Form<br />

1099-MISC are not exempt from backup withholding: medical <strong>and</strong> health care<br />

payments, attorneys' fees, gross proceeds paid to an attorney, <strong>and</strong> payments for<br />

services paid <strong>by</strong> a federal executive agency.<br />

16332918.10.BUSINESS<br />

Part I. Taxpayer Identification Number (TIN)<br />

Enter your TIN in the appropriate box. If you are a resident alien <strong>and</strong><br />

you do not have <strong>and</strong> are not eligible to get an SSN, your TIN is your IRS<br />

individual taxpayer identification number (ITIN). Enter it in the social<br />

security number box. If you do not have an ITIN, see How to get a TIN<br />

below.<br />

If you are a sole proprietor <strong>and</strong> you have an EIN, you may enter either<br />

your SSN or EIN. However, the IRS prefers that you use your SSN.<br />

If you are a single-member LLC that is disregarded as an entity<br />

separate from its owner (see Limited Liability Company (LLC) on page 2),<br />

enter the owner’s SSN (or EIN, if the owner has one). Do not enter the<br />

disregarded entity’s EIN. If the LLC is classified as a corporation or<br />

partnership, enter the entity’s EIN.<br />

Note. See the chart on page 4 for further clarification of name <strong>and</strong> TIN<br />

combinations.<br />

How to get a TIN. If you do not have a TIN, apply for one immediately.<br />

To apply for an SSN, get Form SS-5, Application for a Social Security<br />

Card, from your local Social Security Administration office or get this<br />

form online at www.ssa.gov. You may also get this form <strong>by</strong> calling<br />

1-800-772-1213. Use Form W-7, Application for IRS Individual Taxpayer<br />

Identification Number, to apply for an ITIN, or Form SS-4, Application for<br />

Employer Identification Number, to apply for an EIN. You can apply for<br />

an EIN online <strong>by</strong> accessing the IRS website at www.irs.gov/businesses<br />

<strong>and</strong> clicking on Employer Identification Number (EIN) under Starting a<br />

Business. You can get Forms W-7 <strong>and</strong> SS-4 from the IRS <strong>by</strong> visiting<br />

IRS.gov or <strong>by</strong> calling 1-800-TAX-FORM (1-800-829-3676).<br />

If you are asked to complete Form W-9 but do not have a TIN, write<br />

“Applied For” in the space for the TIN, sign <strong>and</strong> date the form, <strong>and</strong> give<br />

it to the requester. For interest <strong>and</strong> dividend payments, <strong>and</strong> certain<br />

payments made with respect to readily tradable instruments, generally<br />

you will have 60 days to get a TIN <strong>and</strong> give it to the requester before you<br />

are subject to backup withholding on payments. The 60-day rule does<br />

not apply to other types of payments. You will be subject to backup<br />

withholding on all such payments until you provide your TIN to the<br />

requester.<br />

Note. Entering “Applied For” means that you have already applied for a<br />

TIN or that you intend to apply for one soon.<br />

Caution: A disregarded domestic entity that has a foreign owner must<br />

use the appropriate Form W-8.<br />

Part II. Certification<br />

To establish to the withholding agent that you are a U.S. person, or<br />

resident alien, sign Form W-9. You may be requested to sign <strong>by</strong> the<br />

withholding agent even if item 1, below, <strong>and</strong> items 4 <strong>and</strong> 5 on page 4<br />

indicate otherwise.<br />

For a joint account, only the person whose TIN is shown in Part I<br />

should sign (when required). In the case of a disregarded entity, the<br />

person identified on the “Name” line must sign. Exempt payees, see<br />

Exempt Payee on page 3.<br />

Signature requirements. Complete the certification as indicated in<br />

items 1 through 3, below, <strong>and</strong> items 4 <strong>and</strong> 5 on page 4.<br />

1. Interest, dividend, <strong>and</strong> barter exchange accounts opened<br />

before 1984 <strong>and</strong> broker accounts considered active during 1983.<br />

You must give your correct TIN, but you do not have to sign the<br />

certification.<br />

2. Interest, dividend, broker, <strong>and</strong> barter exchange accounts<br />

opened after 1983 <strong>and</strong> broker accounts considered inactive during<br />

1983. You must sign the certification or backup withholding will apply. If<br />

you are subject to backup withholding <strong>and</strong> you are merely providing<br />

your correct TIN to the requester, you must cross out item 2 in the<br />

certification before signing the form.<br />

3. Real estate transactions. You must sign the certification. You may<br />

cross out item 2 of the certification.


4. Other payments. You must give your correct TIN, but you do not<br />

have to sign the certification unless you have been notified that you<br />

have previously given an incorrect TIN. “Other payments” include<br />

payments made in the course of the requester’s trade or business for<br />

rents, royalties, goods (other than bills for merch<strong>and</strong>ise), medical <strong>and</strong><br />

health care services (including payments to corporations), payments to<br />

a nonemployee for services, payments to certain fishing boat crew<br />

members <strong>and</strong> fishermen, <strong>and</strong> gross proceeds paid to attorneys<br />

(including payments to corporations).<br />

5. Mortgage interest paid <strong>by</strong> you, acquisition or ab<strong>and</strong>onment of<br />

secured property, cancellation of debt, qualified tuition program<br />

payments (under section 529), IRA, Coverdell ESA, Archer MSA or<br />

HSA contributions or distributions, <strong>and</strong> pension distributions. You<br />

must give your correct TIN, but you do not have to sign the certification.<br />

What Name <strong>and</strong> Number To Give the Requester<br />

For this type of account: Give name <strong>and</strong> SSN of:<br />

1. Individual The individual<br />

2. Two or more individuals (joint<br />

account)<br />

3. Custodian account of a minor<br />

(Uniform Gift to Minors Act)<br />

4. a. The usual revocable savings<br />

trust (grantor is also trustee)<br />

b. So-called trust account that is<br />

not a legal or valid trust under<br />

state law<br />

The actual owner of the account or,<br />

if combined funds, the first<br />

individual on the account 1<br />

The minor 2<br />

The grantor-trustee 1<br />

The actual owner 1<br />

5. Sole proprietorship or disregarded The owner<br />

entity owned <strong>by</strong> an individual<br />

3<br />

6. Grantor trust filing under Optional The grantor<br />

Form 1099 Filing Method 1 (see<br />

Regulation section 1.671-4(b)(2)(i)(A))<br />

*<br />

For this type of account: Give name <strong>and</strong> EIN of:<br />

7. Disregarded entity not owned <strong>by</strong> an<br />

individual<br />

The owner<br />

8. A valid trust, estate, or pension trust Legal entity 4<br />

9. Corporate or LLC electing<br />

corporate status on Form 8832 or<br />

Form 2553<br />

10. Association, club, religious,<br />

charitable, educational, or other<br />

tax-exempt organization<br />

The corporation<br />

The organization<br />

11. Partnership or multi-member LLC The partnership<br />

12. A broker or registered nominee The broker or nominee<br />

13. Account with the Department of<br />

Agriculture in the name of a public<br />

entity (such as a state or local<br />

government, school district, or<br />

prison) that receives agricultural<br />

program payments<br />

The public entity<br />

14. Grantor trust filing under the Form The trust<br />

1041 Filing Method or the Optional<br />

Form 1099 Filing Method 2 (see<br />

Regulation section 1.671-4(b)(2)(i)(B))<br />

1<br />

List first <strong>and</strong> circle the name of the person whose number you furnish. If only one person on a<br />

joint account has an SSN, that person’s number must be furnished.<br />

2 Circle the minor’s name <strong>and</strong> furnish the minor’s SSN.<br />

3 You must show your individual name <strong>and</strong> you may also enter your business or “DBA” name on<br />

the “Business name/disregarded entity” name line. You may use either your SSN or EIN (if you<br />

have one), but the IRS encourages you to use your SSN.<br />

4 List first <strong>and</strong> circle the name of the trust, estate, or pension trust. (Do not furnish the TIN of the<br />

personal representative or trustee unless the legal entity itself is not designated in the account<br />

title.) Also see Special rules for partnerships on page 1.<br />

* Note. Grantor also must provide a Form W-9 to trustee of trust.<br />

Privacy Act Notice<br />

Note. If no name is circled when more than one name is listed, the<br />

number will be considered to be that of the first name listed.<br />

Secure Your Tax Records from Identity Theft<br />

Identity theft occurs when someone uses your personal information<br />

such as your name, social security number (SSN), or other identifying<br />

information, without your permission, to commit fraud or other crimes.<br />

An identity thief may use your SSN to get a job or may file a tax return<br />

using your SSN to receive a refund.<br />

To reduce your risk:<br />

• Protect your SSN,<br />

• Ensure your employer is protecting your SSN, <strong>and</strong><br />

• Be careful when choosing a tax preparer.<br />

If your tax records are affected <strong>by</strong> identity theft <strong>and</strong> you receive a<br />

notice from the IRS, respond right away to the name <strong>and</strong> phone number<br />

printed on the IRS notice or letter.<br />

If your tax records are not currently affected <strong>by</strong> identity theft but you<br />

think you are at risk due to a lost or stolen purse or wallet, questionable<br />

credit card activity or credit report, contact the IRS Identity Theft Hotline<br />

at 1-800-908-4490 or submit Form 14039.<br />

For more information, see Publication 4535, Identity Theft Prevention<br />

<strong>and</strong> Victim Assistance.<br />

Victims of identity theft who are experiencing economic harm or a<br />

system problem, or are seeking help in resolving tax problems that have<br />

not been resolved through normal channels, may be eligible for<br />

Taxpayer Advocate Service (TAS) assistance. You can reach TAS <strong>by</strong><br />

calling the TAS toll-free case intake line at 1-877-777-4778 or TTY/TDD<br />

1-800-829-4059.<br />

Protect yourself from suspicious emails or phishing schemes.<br />

Phishing is the creation <strong>and</strong> use of email <strong>and</strong> websites designed to<br />

mimic legitimate business emails <strong>and</strong> websites. The most common act<br />

is sending an email to a user falsely claiming to be an established<br />

legitimate enterprise in an attempt to scam the user into surrendering<br />

private information that will be used for identity theft.<br />

The IRS does not initiate contacts with taxpayers via emails. Also, the<br />

IRS does not request personal detailed information through email or ask<br />

taxpayers for the PIN numbers, passwords, or similar secret access<br />

information for their credit card, bank, or other financial accounts.<br />

If you receive an unsolicited email claiming to be from the IRS,<br />

forward this message to phishing@irs.gov. You may also report misuse<br />

of the IRS name, logo, or other IRS property to the Treasury Inspector<br />

General for Tax Administration at 1-800-366-4484. You can forward<br />

suspicious emails to the Federal Trade Commission at: spam@uce.gov<br />

or contact them at www.ftc.gov/idtheft or 1-877-IDTHEFT<br />

(1-877-438-4338).<br />

Visit IRS.gov to learn more about identity theft <strong>and</strong> how to reduce<br />

your risk.<br />

Section 6109 of the Internal Revenue Code requires you to provide your correct TIN to persons (including federal agencies) who are required to file information returns with<br />

the IRS to report interest, dividends, or certain other income paid to you; mortgage interest you paid; the acquisition or ab<strong>and</strong>onment of secured property; the cancellation<br />

of debt; or contributions you made to an IRA, Archer MSA, or HSA. The person collecting this form uses the information on the form to file information returns with the IRS,<br />

reporting the above information. Routine uses of this information include giving it to the Department of Justice for civil <strong>and</strong> criminal litigation <strong>and</strong> to cities, states, the District<br />

of Columbia, <strong>and</strong> U.S. possessions for use in administering their laws. The information also may be disclosed to other countries under a treaty, to federal <strong>and</strong> state agencies<br />

to enforce civil <strong>and</strong> criminal laws, or to federal law enforcement <strong>and</strong> intelligence agencies to combat terrorism. You must provide your TIN whether or not you are required to<br />

file a tax return. Under section 3406, payers must generally withhold a percentage of taxable interest, dividend, <strong>and</strong> certain other payments to a payee who does not give a<br />

TIN to the payer. Certain penalties may also apply for providing false or fraudulent information.


Certification of Nonforeign Status <strong>by</strong> Entity Transferor of U.S. Real Property Interest<br />

Internal Revenue Code Section 1445 provides that a transferee of a U.S. real property interest<br />

must withhold tax if the transferor is a foreign person. For U.S. tax purposes (including Internal<br />

Revenue Code Section 1445), the owner of a disregarded entity (which has legal title to a U.S.<br />

real property interest under local law) will be the transferor of the property <strong>and</strong> not the<br />

disregarded entity. To inform the transferee that the withholding of tax is not required upon the<br />

disposition of a U.S. real property interest <strong>by</strong> ________________________ (the “Company”),<br />

the undersigned here<strong>by</strong> certifies the following on behalf of the Company:<br />

1. The Company is not a foreign corporation, foreign partnership, foreign trust, or foreign<br />

estate (as those terms are defined in the Internal Revenue Code <strong>and</strong> Treasury<br />

Regulations);<br />

2. The Company is not a disregarded entity as defined in Treasury Regulations Section<br />

1.1445-2(b)(2)(iii);<br />

3. The U.S. employer identification number of the Company is ___________________; <strong>and</strong><br />

4. The office address of the Company is:<br />

___________________________________________<br />

___________________________________________<br />

___________________________________________<br />

The Company underst<strong>and</strong>s that this certification may be disclosed to the Internal Revenue<br />

Service <strong>by</strong> the transferee <strong>and</strong> that any false statement contained herein could be punished <strong>by</strong> fine,<br />

imprisonment, or both.<br />

Under penalties of perjury, I declare that I have examined this certification <strong>and</strong> to the best of my<br />

knowledge <strong>and</strong> belief, it is true, correct, <strong>and</strong> complete <strong>and</strong> I further declare that I have authority<br />

to sign this document on behalf of the Company.<br />

________________________________________ Date: ____________________<br />

Name:<br />

Title:<br />

16332918.10.BUSINESS


Exhibit D<br />

Commitment Letter<br />

16439551.17.BUSINESS D-1


NYI-4378475v10<br />

EXECUTION VERSION<br />

JEFFERIES FINANCE LLC BANK <strong>OF</strong> MONTREAL<br />

520 Madison Avenue 115 South LaSalle Street, 35 th Fl. West<br />

New York, New York 10022 Chicago, Illinois 60603<br />

Lassonde Industries Inc.<br />

755 Principale Street<br />

Rougemont, QC J0L 1M0<br />

CANADA<br />

Attention: Guy Blanchette, Vice-President<br />

<strong>and</strong> Chief Financial Officer<br />

Ladies <strong>and</strong> Gentlemen:<br />

COMMITMENT LETTER<br />

Re: Clement Pappas <strong>and</strong> Company, Inc.<br />

June 17, 2011<br />

You have advised Jefferies Finance LLC (“Jefferies Finance”) <strong>and</strong> Bank of Montreal (“BMO”<br />

<strong>and</strong> together with Jefferies Finance, “we,” “us” or the “Arrangers”) that Lassonde Industries Inc.<br />

(“Lassonde” <strong>and</strong>, together with the Acquiror, “you”) intends to acquire (the “Acquisition”) through<br />

Pomona Merger Corp., a newly-formed New Jersey subsidiary (the “Acquiror”), all of the issued <strong>and</strong><br />

outst<strong>and</strong>ing capital stock of Clement Pappas <strong>and</strong> Company, Inc., a New Jersey corporation (the “Target”<br />

<strong>and</strong>, together with its subsidiaries, the “Acquired Business”), from the “Former Shareholders,” as defined<br />

in the Merger Agreement (the “Sellers”) <strong>and</strong> to refinance (together with any applicable prepayment<br />

premium or fee, with the commitments thereunder being terminated, <strong>and</strong> all guarantees <strong>and</strong> security in<br />

respect thereof being released) substantially all of the existing debt (the “Existing Debt”) of the Acquired<br />

Business (the “Refinancing”). We underst<strong>and</strong> that the Acquisition will be effected <strong>by</strong> means of a merger<br />

(the “Merger”) of the Acquiror with <strong>and</strong> into the Target with the Target being the surviving entity of such<br />

merger pursuant to a merger agreement, dated as of June 17, 2011 (as amended in accordance with the<br />

terms of this Commitment Letter, <strong>and</strong> including all schedules <strong>and</strong> exhibits thereto, the “Merger<br />

Agreement”), <strong>among</strong> you, the Acquired Business <strong>and</strong> the Sellers. Capitalized terms used but not defined<br />

herein <strong>and</strong> defined in any exhibit hereto have the meanings assigned to them in such exhibit.<br />

You have advised us that the total purchase price for the Acquisition (including fees, OID,<br />

commissions <strong>and</strong> expenses <strong>and</strong> the Refinancing) (the “Purchase Price”) will be approximately $403.8<br />

million, <strong>and</strong> that the Purchase Price will be financed with:<br />

(i) no borrowings under a $50.0 million senior secured asset-based<br />

revolving credit facility having the terms set forth in Exhibit B hereto (the “Revolving Credit Facility”)<br />

(other than up to an aggregate principal amount of not more than $25.0 million in addition to (i) any<br />

required “flex” original issue discount <strong>and</strong> upfront fees <strong>and</strong> (ii) to the extent necessary, the cash


collateralization or the issuance of letters of credit to backstop any existing outst<strong>and</strong>ing letters of credit of<br />

the Acquired Business which will remain outst<strong>and</strong>ing on the Closing Date),<br />

(ii) $230.0 million under a senior secured term loan facility having the terms<br />

set forth in Exhibit A hereto (the “Term Loan Facility” <strong>and</strong>, together with the Revolving Credit Facility,<br />

the “Facilities”), <strong>and</strong><br />

(iii) (A) the direct or indirect contribution (the “Equity Contribution”) <strong>by</strong><br />

Lassonde <strong>and</strong> certain affiliates of Lassonde <strong>and</strong>/or Target reasonably satisfactory to us (it being<br />

understood that the shareholders of the Target on the date hereof <strong>and</strong> Lassonde USA, Inc. <strong>and</strong> 3346625<br />

Canada Inc. (the “Lassonde Investor”) are satisfactory to us) as common equity of Pappas Lassonde<br />

Holdings, Inc. (the “Ultimate Parent”), the direct parent company of Pomona Holdings, Inc. (the<br />

“Parent”), together with “reinvested” common equity of the Target contributed <strong>by</strong> certain of the Sellers,<br />

of at least 37% of the pro forma total consolidated capitalization of the Acquired Business on the Closing<br />

Date; provided that not less than 80% of the Equity Contribution shall be contributed, directly or<br />

indirectly, <strong>by</strong> Lassonde <strong>and</strong> the Lassonde Investor as cash common equity, (B) the contribution <strong>by</strong> the<br />

Ultimate Parent of the amount so received as cash common equity to the Parent in exchange for the<br />

issuance to the Parent of all the common stock of the Parent <strong>and</strong> (C) the contribution <strong>by</strong> the Parent of the<br />

amount so received as cash common equity to the Acquiror in exchange for the issuance to the Parent of<br />

all the common stock of the Acquiror.<br />

The transactions described in clauses (i) <strong>and</strong> (ii) above are referred to as the “Debt Financing” <strong>and</strong>,<br />

together with the Acquisition, the Merger, the Refinancing <strong>and</strong> the Equity Contribution <strong>and</strong> the payment<br />

of all related fees, commissions <strong>and</strong> expenses are collectively referred to as the “Transactions.” The<br />

sources <strong>and</strong> uses for the financing of the Transactions are as set forth on Annex A hereto. The Acquiror<br />

(<strong>and</strong> following the Acquisition, the Target <strong>and</strong> its subsidiaries) are referred to herein as the “Company.”<br />

The closing date of the Transactions is referred to herein as the “Closing Date.” As used in this<br />

Commitment Letter <strong>and</strong> the other Debt Financing Letters (as defined below), the words “include,”<br />

“includes” <strong>and</strong> “including” shall be deemed to be followed <strong>by</strong> the phrase “without limitation.”<br />

NYI-4378475v10<br />

1. The Commitments.<br />

Jefferies Finance is pleased to inform you that it here<strong>by</strong> commits, directly or through one or more<br />

of its affiliates, to provide (a) 55% of the Term Loan Facility <strong>and</strong> (b) none of the Revolving Credit<br />

Facility. BMO is pleased to inform you that it here<strong>by</strong> commits, directly or through one or more of its<br />

affiliates, to provide (a) 45% of the Term Loan Facility <strong>and</strong> (b) 100% of the Revolving Credit Facility.<br />

The commitments of Jefferies Finance <strong>and</strong> BMO are several <strong>and</strong> not joint.<br />

The commitments described in this Section 1 are collectively referred to herein as the<br />

“Commitments.” Our Commitments are, in each case, on the terms <strong>and</strong> subject to the conditions set forth<br />

in (i) this letter (including the exhibits, schedules <strong>and</strong> annexes hereto, collectively, this “Commitment<br />

Letter”) <strong>and</strong> (ii) the fee letter, dated as of the date hereof (the “Fee Letter” <strong>and</strong>, together with this<br />

Commitment Letter, the “Debt Financing Letters”), <strong>among</strong> you <strong>and</strong> us. Notwithst<strong>and</strong>ing anything to the<br />

contrary in any Debt Financing Letter, the terms of this Commitment Letter are intended as an outline of<br />

certain of the material provisions of the Facilities, but do not include all of the terms, covenants,<br />

representations, warranties, default clauses <strong>and</strong> other provisions that will be contained in the definitive<br />

documents relating to the Debt Financing, which shall be prepared <strong>by</strong> our respective counsel, except for<br />

the Intercreditor Agreement (as defined in Exhibit A), which shall be prepared <strong>by</strong> Jones Day (collectively,<br />

the “Definitive Debt Documents”); provided that there shall be no closing condition contained in the<br />

Definitive Debt Documents that is not specifically set forth in Section 3 hereof or on Exhibit C to this<br />

Commitment Letter. Those matters that are not covered or made clear in the Debt Financing Letters are<br />

2


subject to mutual agreement of each of the parties hereto. No party hereto has been authorized <strong>by</strong> either<br />

of us to make any oral or written statements or representations that are inconsistent with the Debt<br />

Financing Letters.<br />

2. Titles <strong>and</strong> Roles. As consideration for the Commitments, you here<strong>by</strong> agree that you<br />

here<strong>by</strong> retain <strong>and</strong> will cause your respective affiliates to retain (a) Jefferies Finance or its affiliated<br />

designee to act as the sole administrative agent, sole collateral agent, joint book-runner <strong>and</strong> joint lead<br />

arranger for you <strong>and</strong> your affiliates in connection with the Term Loan Facility <strong>and</strong> as joint book runner,<br />

joint lead arranger <strong>and</strong> sole syndication agent in connection with the Revolving Credit Facility <strong>and</strong> (b)<br />

BMO or its affiliated designee to act as the sole administrative agent, sole collateral agent, joint bookrunner<br />

<strong>and</strong> joint lead arranger for you <strong>and</strong> your affiliates in connection with the Revolving Credit Facility<br />

<strong>and</strong> as joint book runner, joint lead arranger <strong>and</strong> sole syndication agent in connection with the Term Loan<br />

Facility <strong>and</strong>, in each case, no other titles shall be awarded <strong>and</strong> no compensation <strong>and</strong> no other titles shall<br />

be awarded <strong>and</strong> no compensation (other than that expressly contemplated <strong>by</strong> the Debt Financing Letters)<br />

shall be paid in connection with the Facilities, unless mutually agreed. It is further agreed that (x)<br />

Jefferies Finance shall have “left side” designation <strong>and</strong> shall appear on the top left in any marketing<br />

materials or other documentation used in connection with the marketing of the Term Loan Facility <strong>and</strong><br />

shall hold the leading role <strong>and</strong> responsibilities associated with such designation, including maintaining<br />

sole “physical books” <strong>and</strong> syndication rights in respect of the Term Loan Facility <strong>and</strong> (y) BMO shall have<br />

“left side” designation <strong>and</strong> shall appear on the top left in any marketing materials or other documentation<br />

used in connection with the marketing of the Revolving Credit Facility <strong>and</strong> shall hold the leading role <strong>and</strong><br />

responsibilities associated with such designation, including maintaining sole “physical books” <strong>and</strong><br />

syndication rights in respect of the Revolving Credit Facility.<br />

3. Conditions Precedent. The closing of the Facilities, the making of the initial loans <strong>and</strong><br />

other extensions of credit under the Facilities on the Closing Date are conditioned solely upon satisfaction<br />

or waiver <strong>by</strong> each Arranger of each of the following conditions: (i) since March 27, 2011 there shall not<br />

have occurred a Material Adverse Effect (as defined below) <strong>and</strong> (ii) the other conditions expressly set<br />

forth in Exhibit C to this Commitment Letter shall have been satisfied.<br />

For purposes hereof, “Material Adverse Effect” means any effect, change, event, occurrence or<br />

condition (whether or not constituting any breach of a representation, warranty, covenant or agreement set<br />

forth in the Merger Agreement) that, individually or in the aggregate with all other effects, changes,<br />

events, occurrences or conditions, has or would reasonably be expected to have a material adverse effect<br />

upon the financial condition, business or results of operations of the Target <strong>and</strong> its Subsidiaries, taken as a<br />

whole; provided, however, that any adverse effect, change, event, occurrence or condition arising from or<br />

related to any of the following shall not be taken into account in determining whether a “Material Adverse<br />

Effect” has occurred: (i) conditions generally affecting the United States economy or generally affecting<br />

one or more industries in which the Target or its Subsidiaries operate, including changes in interest rates<br />

or currency exchange rates; (ii) changes in the price of commodities or raw materials, including fruit or<br />

concentrate, used in the business of the Target <strong>and</strong> its Subsidiaries; (iii) national or international political<br />

conditions, including terrorism or the engagement <strong>by</strong> the United States in hostilities or acts of war; (iv)<br />

financial, banking or securities markets (including any disruption thereof <strong>and</strong> any decline in the price of<br />

any security or any market index); (v) changes in GAAP or other accounting requirements; (vi) changes<br />

in any Laws or other binding directives issued <strong>by</strong> any Governmental Authority after the date of the<br />

Merger Agreement; (vii) any action taken <strong>by</strong> a party to the Merger Agreement required <strong>by</strong> or in<br />

accordance with the Merger Agreement; (viii) the announcement, pendency or completion of the<br />

transactions contemplated <strong>by</strong> the Merger Agreement; (ix) any failure, in <strong>and</strong> of itself, <strong>by</strong> the Target or its<br />

Subsidiaries to meet any internal or disseminated projections, forecasts or revenue or earnings predictions<br />

for any period (it being understood that the facts <strong>and</strong> circumstances giving rise or contributing to such<br />

failure may be taken into account in determining whether there has been a Material Adverse Effect); or<br />

NYI-4378475v10<br />

3


(x) any effect, change, event, occurrence or condition to the extent described on Schedule 3.7, Schedule<br />

3.8, Schedule 3.11 or Schedule 5.3 of the Disclosure Letter; provided, however, that any effect, change,<br />

event, occurrence or condition referred to in clause (i), (iii), (iv), (v) or (vi) may be taken into account in<br />

determining whether there has been a Material Adverse Effect to the extent that such effect, change, event<br />

or occurrence has a disproportionate adverse effect on the Target <strong>and</strong> its Subsidiaries, taken as a whole, as<br />

compared to other participants in the industry in which the Target <strong>and</strong> its Subsidiaries operate (in which<br />

case only the incremental disproportionate impact or impacts may be taken into account in determining<br />

whether a Material Adverse Effect has occurred). References in the Merger Agreement to dollar amount<br />

thresholds shall not be deemed to be evidence of a Material Adverse Effect or materiality or the lack<br />

thereof).<br />

For the purposes of this definition, “Target” shall have the meaning set forth in this Commitment<br />

Letter. All other defined terms shall have the meaning set forth in the Merger Agreement.<br />

Notwithst<strong>and</strong>ing anything in the Debt Financing Letters (including each of the exhibits hereto or<br />

thereto) to the contrary, (i) the only representations <strong>and</strong> warranties the accuracy of which shall be a<br />

condition to the availability of the Facilities on the Closing Date shall be (A) such of the representations<br />

<strong>and</strong> warranties with respect to the Acquired Business in the Merger Agreement as are material to the<br />

interests of the Lenders or the Arrangers, but only to the extent that you have (or your applicable affiliate<br />

has) the right to terminate your (or its) obligations under the Merger Agreement as a result of a breach of<br />

any such representations or warranties under the Merger Agreement (the “Merger Agreement<br />

Representations”) <strong>and</strong> (B) the Specified Representations (as defined below) <strong>and</strong> (ii) the terms of the<br />

Definitive Debt Documents shall be in a form such that they do not impair availability of the Facilities on<br />

the Closing Date if the conditions expressly set forth herein <strong>and</strong> in Exhibit C are satisfied (it being<br />

understood that, to the extent any Collateral (other than to the extent that a lien on such Collateral may be<br />

perfected (x) <strong>by</strong> the filing of a financing statement under the Uniform Commercial Code, (y) <strong>by</strong> the<br />

delivery of stock certificates of the Borrower <strong>and</strong> its wholly-owned domestic subsidiaries or (z) <strong>by</strong> the<br />

filing of a security agreement on the applicable form with the United States Patent <strong>and</strong> Trademark Office)<br />

is not or cannot be perfected on the Closing Date after your use of commercially reasonable efforts to do<br />

so, the perfection of such Collateral shall not constitute a condition precedent to the availability of the<br />

Facilities on the Closing Date, but shall be required to be perfected within 30 days after the Closing Date<br />

(subject to extensions granted <strong>by</strong> the Administrative Agent under the Term Loan Facility <strong>and</strong> <strong>by</strong> the<br />

Administrative Agent under the Revolving Credit Facility, as applicable). For purposes hereof,<br />

“Specified Representations” means the representations <strong>and</strong> warranties set forth in the Definitive Debt<br />

Documents relating to corporate or other organizational existence, organizational power <strong>and</strong> authority (as<br />

to execution, delivery <strong>and</strong> performance of the applicable Definitive Debt Documents), the due<br />

authorization, execution, delivery <strong>and</strong> enforceability of the applicable Definitive Debt Documents,<br />

solvency of the Borrower <strong>and</strong> its subsidiaries on a consolidated basis on the Closing Date, no conflicts of<br />

the Definitive Debt Documents with charter documents or material laws, absence of material litigation,<br />

Federal Reserve margin regulations, the Patriot Act, the Investment Company Act, status of the Senior<br />

Facilities <strong>and</strong> the related guaranties as senior debt (to the extent applicable), <strong>and</strong>, subject to permitted<br />

liens <strong>and</strong> the limitations set forth in the prior sentence, creation, validity <strong>and</strong> perfection of security<br />

interests. This paragraph shall be referred to herein as the “Certain Funds Provision”.<br />

NYI-4378475v10<br />

4. Syndication.<br />

(a) We reserve the right, at any time prior to or after execution of the definitive<br />

documentation for the Facilities, to syndicate all or part of our Commitments to third parties identified <strong>by</strong><br />

us in consultation with you (collectively, the “Lenders”). Our Commitments shall be reduced dollar-fordollar<br />

as <strong>and</strong> when corresponding commitments are received from any Lenders; provided that, no such<br />

reduction shall relieve us of our obligation to fund on the Closing Date the portion of the Commitments<br />

4


so reduced to the extent any Lender fails, upon satisfaction or waiver of all conditions to such Lender<br />

making its initial extensions of credit on the Closing Date, to fund its Commitment on the Closing Date;<br />

provided, further, that unless you agree in writing, we shall retain exclusive control over the rights <strong>and</strong><br />

obligations with respect to our Commitments in respect of the Facilities, including all rights with respect<br />

to consents, modifications, supplements <strong>and</strong> amendments, until the Closing Date has occurred. We will<br />

exclusively manage all aspects of any syndication in consultation with you, including decisions as to the<br />

selection of prospective Lenders to be approached, when they will be approached, when their<br />

commitments will be accepted, which prospective Lenders will participate, the allocation of the<br />

commitments <strong>among</strong> the Lenders, <strong>and</strong> the amount <strong>and</strong> distribution of fees. To assist us in our syndication<br />

efforts, you agree to prepare <strong>and</strong> provide (<strong>and</strong> to use your commercially reasonable efforts to cause the<br />

Acquired Business to prepare <strong>and</strong> provide) promptly to us all customary information with respect to the<br />

Company, its shareholders <strong>and</strong> affiliates, the Transactions <strong>and</strong> the other transactions contemplated here<strong>by</strong>,<br />

including such Projections (defined below) as we may reasonably request in connection with the<br />

syndication of the Commitments; provided that, following the consummation of the Acquisition, you shall<br />

cause the Acquired Business to prepare <strong>and</strong> provide us with such information.<br />

(b) Each Arranger intends to commence its syndication efforts with respect to the<br />

Facilities promptly upon execution of this Commitment Letter, <strong>and</strong> you agree to assist each Arranger<br />

actively to complete a timely syndication of the Facilities that is reasonably satisfactory to us until the<br />

date that is the earlier of (i) 120 days after the Closing Date <strong>and</strong> (ii) the date on which a Successful<br />

Syndication (as defined in the Fee Letter) is achieved (such earlier date, the “Syndication Date”). Such<br />

assistance shall include:<br />

(i) using commercially reasonable efforts to ensure that each Arranger’s<br />

efforts benefit materially from Lassonde’s <strong>and</strong> the Acquired Business’ existing lending <strong>and</strong> investment<br />

banking relationships,<br />

(ii) direct contact between Lassonde’s senior management, representatives<br />

<strong>and</strong> advisors, on the one h<strong>and</strong>, <strong>and</strong> the senior management representatives <strong>and</strong> advisors of the proposed<br />

Lenders, on the other h<strong>and</strong> (<strong>and</strong> (x) prior to the consummation of the Acquisition, your using<br />

commercially reasonable efforts to cause, <strong>and</strong> (y) thereafter, to cause direct contact between senior<br />

management, representatives <strong>and</strong> advisors of the Acquired Business, on the one h<strong>and</strong>, <strong>and</strong> the senior<br />

management representatives <strong>and</strong> advisors of the proposed Lenders, on the other h<strong>and</strong>),<br />

(iii) Lassonde’s assistance (<strong>and</strong> (x) prior to the consummation of the<br />

Acquisition, your using commercially reasonable efforts to cause, <strong>and</strong> (y) thereafter, to cause the<br />

Acquired Business to assist) in the preparation of one or more confidential information memor<strong>and</strong>a (each,<br />

a “Confidential Information Memor<strong>and</strong>um”), <strong>and</strong> other marketing materials to be used in connection<br />

with the syndication of our Commitments (together with all Confidential Information Memor<strong>and</strong>a, the<br />

“Materials”),<br />

(iv) the provision to each Arranger of copies of any due diligence reports or<br />

memor<strong>and</strong>a prepared at your direction or any of your affiliates <strong>by</strong> legal, accounting, tax or other third<br />

party advisors in connection with the Acquisition, subject to the delivery <strong>by</strong> each Arranger to you of<br />

customary non-disclosure agreements as shall be reasonably requested,<br />

(v) obtaining, not less than 20 consecutive business days prior to the Closing<br />

Date, a monitored public corporate rating <strong>and</strong> a monitored public corporate family rating for the Target<br />

from each of St<strong>and</strong>ard & Poor’s Financial Services LLC, a subsidiary of the McGraw-Hill Companies,<br />

Inc. (“S&P”) <strong>and</strong> Moody’s Investors Service, Inc. (“Moody’s”), respectively, <strong>and</strong> monitored public<br />

facility ratings from each of S&P <strong>and</strong> Moody’s for the Term Loan Facility,<br />

NYI-4378475v10<br />

5


(vi) your causing each Arranger to receive for distribution to the prospective<br />

Lenders, at least five business days prior to the Closing Date, a copies of the definitive credit agreements<br />

with respect to each of the Facilities, each in the form agreed to <strong>by</strong> the Arrangers <strong>and</strong> the Borrower; <strong>and</strong><br />

(vii) the hosting, with each Arranger, of meetings with prospective Lenders at<br />

such times <strong>and</strong> in such places as mutually agreed.<br />

(c) You agree, at the request of an Arranger, to assist in the preparation of a version<br />

of any Materials consisting exclusively of information <strong>and</strong> documentation that is either (i) publicly<br />

available or (ii) not material with respect to the Company or any of its securities for purposes of United<br />

States federal <strong>and</strong> state securities laws (such information <strong>and</strong> Materials, “Public Information”). In<br />

addition, you agree that, unless specifically labeled “Private – Contains Non-Public Information,” no<br />

Materials disseminated to potential Lenders in connection with the syndication of the Facilities, whether<br />

through an Internet website, electronically, in presentations, at meetings or otherwise, will contain any<br />

Material Non-Public Information (as defined below). Any information <strong>and</strong> documentation that is not<br />

Public Information is referred to herein as “Material Non-Public Information.” You acknowledge <strong>and</strong><br />

agree that the following documents contain <strong>and</strong> shall contain solely Public Information (unless you notify<br />

us promptly that any such document contains Material Non-Public Information): (i) drafts <strong>and</strong> final<br />

Definitive Debt Documents with respect to the Facilities, (ii) administrative materials prepared <strong>by</strong> an<br />

Arranger for prospective Lenders (including Lender meeting invitations, Lender allocations, if any, <strong>and</strong><br />

funding <strong>and</strong> closing memor<strong>and</strong>a), <strong>and</strong> (iii) notification of changes in the terms of the Facilities.<br />

(d) You agree that all Materials <strong>and</strong> Information (as defined below) (including draft<br />

<strong>and</strong> execution versions of the Definitive Debt Documents <strong>and</strong> draft or final offering materials relating to<br />

contemporaneous or prior securities issuances <strong>by</strong> the Company) may be disseminated in accordance with<br />

our st<strong>and</strong>ard syndication practices (including through hard copy <strong>and</strong> via one or more internet sites<br />

(including an IntraLinks, SyndTrak or similar workspace), e-mail or other electronic transmissions).<br />

Without limiting the foregoing, you authorize, <strong>and</strong> will obtain contractual undertakings from the Acquired<br />

Business <strong>and</strong> Lassonde to authorize, the use of your <strong>and</strong> its logos in connection with any such<br />

dissemination. You further agree that, at its expense, either Arranger may place advertisements in<br />

financial <strong>and</strong> other newspapers <strong>and</strong> periodicals or on a home page or similar place for dissemination of<br />

information on the Internet or worldwide web as such Arranger may choose, <strong>and</strong> circulate similar<br />

promotional materials, after the closing of the Transactions in the form of a “tombstone” or otherwise,<br />

containing information customarily included in such advertisements <strong>and</strong> materials, including (i) the<br />

names of the Company <strong>and</strong> its affiliates (or any of them), (ii) the Arrangers <strong>and</strong> our affiliates’ titles <strong>and</strong><br />

roles in connection with the Transactions, <strong>and</strong> (iii) the amount, type <strong>and</strong> closing date of such<br />

Transactions.<br />

5. Information. You represent, warrant <strong>and</strong> covenant that (<strong>and</strong>, with respect to the Target<br />

<strong>and</strong> its subsidiaries, to your knowledge that):<br />

(a) all written information <strong>and</strong> data other than the Projections <strong>and</strong> information of a<br />

general economic or industry-specific nature (including the Materials, the “Information”) that has been or<br />

will be made available to us <strong>by</strong> or on behalf of you or the Acquired Business or any of your or its<br />

respective representatives is or will be, when furnished, complete <strong>and</strong> correct in all material respects,<br />

(b) none of the Information shall, when furnished or on the Closing Date <strong>and</strong> when<br />

taken as a whole, contain any untrue statement of a material fact or omit to state a material fact necessary<br />

to make the statements contained therein not misleading in light of the circumstances under which such<br />

statements are made, <strong>and</strong><br />

NYI-4378475v10<br />

6


(c) all projections <strong>and</strong> other forward-looking information that have been or will be<br />

made available to either Arranger <strong>by</strong> or on behalf of you or the Acquired Business or any of your or their<br />

respective representatives (collectively, the “Projections”) have been or will be prepared in good faith<br />

based upon (i) accounting principles consistent with the most recent historical audited financial<br />

statements of the Acquired Business <strong>and</strong> (ii) assumptions that are reasonable at the time made <strong>and</strong> at the<br />

time the related Projections are made available to such Arranger (it being understood that any such<br />

Projections are subject to significant uncertainties <strong>and</strong> contingencies, many of which are beyond your<br />

control, that no assurance can be given that any particular Projections will be realized, that actual results<br />

may differ <strong>and</strong> that such differences may be material).<br />

You agree that, if at any time prior to the later of the Closing Date <strong>and</strong> the Syndication Date, you<br />

become aware that any of the representations <strong>and</strong> warranties in the preceding sentence would be incorrect<br />

in any material respect if the Information or Projections were then being furnished <strong>and</strong> such<br />

representations <strong>and</strong> warranties were then being made, you shall, at such time, supplement promptly such<br />

Information <strong>and</strong>/or Projections, as the case may be, in order that such representations <strong>and</strong> warranties will<br />

be correct under those circumstances.<br />

You shall be solely responsible for Information, including the contents of all Materials. We (i)<br />

will be relying on Information <strong>and</strong> data provided <strong>by</strong> or on behalf of you or the Acquired Business or any<br />

of your or its representatives or otherwise available from generally recognized public sources, without<br />

having independently verified the accuracy or completeness of the same, (ii) do not assume responsibility<br />

for the accuracy or completeness of any such Information <strong>and</strong> data <strong>and</strong> (iii) will not make an appraisal of<br />

your assets or liabilities or the Acquired Business (other than the contemplated inventory appraisals).<br />

You shall (i) furnish each Arranger with all Information <strong>and</strong> data that it may reasonably request in<br />

connection with its activities on behalf of you <strong>and</strong> your affiliates <strong>and</strong> (ii) provide each Arranger full<br />

access, as reasonably requested, to your respective officers, directors, employees <strong>and</strong> professional<br />

advisors <strong>and</strong> use commercially reasonable efforts to provide each Arranger full access, as reasonably<br />

requested, to those of the Acquired Business; provided that, following the consummation of the<br />

Acquisition, you shall cause the Acquired Business to provide each Arranger full access, as reasonably<br />

requested, to such persons or entities.<br />

6. Clear Market. You agree that, from the date hereof until the earlier of (a) the date on<br />

which a Successful Syndication has been achieved, provided such date shall not be earlier than the<br />

Closing Date <strong>and</strong> (b) the date that is 120 days after the Closing Date (the earlier of (a) or (b), the “Clear<br />

Market Period”), you <strong>and</strong> your affiliates will not, <strong>and</strong> prior to the Closing Date, you will include a<br />

covenant <strong>by</strong> the Acquired Business in the Merger Agreement that it will not, <strong>and</strong> after the Closing Date<br />

you will not permit the Acquired Business to, directly or indirectly, (i) syndicate, place, sell or issue, (ii)<br />

attempt or offer to syndicate, place, sell or issue, (iii) announce or authorize the announcement of the<br />

syndication, placement, sale or issuance of, or (iv) engage in discussions concerning the syndication,<br />

placement, offering, sale or issuance of, any debt facility, or debt, equity-linked or equity security of you,<br />

the Acquired Business or any of your or its respective affiliates (other than the financings included in the<br />

Transactions <strong>and</strong> financings for other unrelated portfolio companies of Lassonde or funds affiliated with<br />

Lassonde), including any renewals or refinancings of any existing debt facility, without each Arranger’s<br />

prior written consent, which may be given or withheld in such Arranger’s sole discretion.<br />

7. Fees <strong>and</strong> Expenses. As consideration for the Commitments <strong>and</strong> our other undertakings<br />

hereunder, you here<strong>by</strong> agree to pay or cause to be paid to each Arranger for its own account the fees,<br />

expenses <strong>and</strong> other amounts set forth in the Debt Financing Letters when due <strong>and</strong> payable.<br />

8. Indemnification <strong>and</strong> Waivers. As consideration for the Commitments <strong>and</strong> our other<br />

undertakings hereunder, you agree to the provisions with respect to indemnification, waivers <strong>and</strong> other<br />

NYI-4378475v10<br />

7


matters contained in Annex B hereto, which is here<strong>by</strong> incorporated <strong>by</strong> reference in this Commitment<br />

Letter.<br />

9. Confidentiality. This Commitment Letter is delivered to you on the underst<strong>and</strong>ing that<br />

neither the existence of this Commitment Letter or any other Debt Financing Letter nor any of their terms<br />

or substance will be disclosed, directly or indirectly, to any other person or entity except (a) as required<br />

<strong>by</strong> applicable law or compulsory legal process (in which case you agree to inform each Arranger<br />

promptly thereof <strong>and</strong> to cooperate with us in securing a protective order in respect thereof to the extent<br />

lawfully permitted to do so), (b) to the Acquiror’s <strong>and</strong> Lassonde’s respective officers, directors,<br />

employees, attorneys, accountants <strong>and</strong> advisors on a confidential <strong>and</strong> need-to-know basis <strong>and</strong> only in<br />

connection with the Transactions, (c) the existence of this Commitment Letter may be disclosed (but not<br />

the contents of this Commitment Letter or the Fee Letter) to rating agencies in connection with their<br />

review of the Facilities or the Company, (d) the information contained in this Commitment Letter (but not<br />

that contained in the Fee Letter) may be disclosed in any Confidential Information Memor<strong>and</strong>um or in<br />

connection with the syndication of the Facilities, <strong>and</strong> (e) this Commitment Letter (but not any other Debt<br />

Financing Letter) may be disclosed to the Acquired Business, the Sellers <strong>and</strong> their respective officers,<br />

directors, employees, attorneys, accountants <strong>and</strong> advisors, in each case on a confidential <strong>and</strong> need-toknow<br />

basis <strong>and</strong> only in connection with the Transactions. You may also disclose, on a confidential basis,<br />

the aggregate amount of fees payable under the Fee Letter as part of a generic disclosure regarding<br />

sources <strong>and</strong> uses (but without disclosing any specific fees set forth therein) in connection with the<br />

syndication of the Facilities.<br />

Notwithst<strong>and</strong>ing anything herein to the contrary, you <strong>and</strong> we (<strong>and</strong> any of your <strong>and</strong> each of our<br />

respective employees, representatives or other agents) may disclose to any <strong>and</strong> all persons, without<br />

limitation of any kind, the tax treatment <strong>and</strong> tax structure of the transactions contemplated <strong>by</strong> the Debt<br />

Financing Letters <strong>and</strong> all materials of any kind (including opinions or other tax analyses) that are<br />

provided to you or us relating to such tax treatment <strong>and</strong> tax structure, except that (i) tax treatment <strong>and</strong> tax<br />

structure shall not include the identity of any existing or future party (or any affiliate of such party) to any<br />

Debt Financing Letter, <strong>and</strong> (ii) neither you nor we shall disclose any information relating to such tax<br />

treatment <strong>and</strong> tax structure to the extent nondisclosure is reasonably necessary in order to comply with<br />

applicable securities laws. For this purpose, the tax treatment of the transactions contemplated <strong>by</strong> the<br />

Debt Financing Letters is the purported or claimed U.S. federal income tax treatment of such transactions<br />

<strong>and</strong> the tax structure of such transactions is any fact that may be relevant to underst<strong>and</strong>ing the purported<br />

or claimed U.S. federal income tax treatment of such transactions.<br />

NYI-4378475v10<br />

10. Conflicts of Interest. You acknowledge <strong>and</strong> agree that:<br />

(a) each of us <strong>and</strong>/or each of our respective affiliates <strong>and</strong> subsidiaries (collectively,<br />

the “Arranger Group”), in each of our <strong>and</strong> their respective capacities as principal or agent are involved in<br />

a wide range of commercial banking <strong>and</strong> investment banking activities globally (including investment<br />

advisory, asset management, research, securities issuance, trading, <strong>and</strong> brokerage) from which conflicting<br />

interests or duties may arise <strong>and</strong>, therefore, conflicts may arise between (i) our interests <strong>and</strong> duties<br />

hereunder <strong>and</strong> (ii) the duties or interests or other duties or interests of another member of the Arranger<br />

Group,<br />

(b) each Arranger <strong>and</strong> any other member of the Arranger Group may, at any time,<br />

(i) provide services to any other person, (ii) engage in any transaction (on each of our or its own account<br />

or otherwise) with respect to you or any member of the same group as you or (iii) act in relation to any<br />

matter for any other person whose interests may be adverse to you or any member of your group (a<br />

“Third Party”), <strong>and</strong> may retain for our or its own benefit any related remuneration or profit,<br />

notwithst<strong>and</strong>ing that a conflict of interest exists or may arise <strong>and</strong>/or any member of the Arranger Group is<br />

8


in possession or has come or comes into possession (whether before, during or after the consummation of<br />

the transactions contemplated hereunder) of information confidential to you; provided that such<br />

confidential information shall not be shared with, or used <strong>by</strong>, either of us or any other member of the<br />

Arranger Group in performing services or providing advice to any Third Party; it being understood that no<br />

member of the Arranger Group will act as sell-side advisor to the Acquired Business or the Sellers in<br />

connection with the Transactions. You accept that permanent or ad hoc arrangements/information<br />

barriers may be used between <strong>and</strong> within either of our divisions or divisions of other members of the<br />

Arranger Group for this purpose <strong>and</strong> that locating directors, officers or employees in separate workplaces<br />

is not necessary for such purpose,<br />

(c) information that is held elsewhere within either Arranger or the Arranger Group,<br />

but of which none of the individual directors, officers or employees having primary responsibility for the<br />

consummation of the transactions contemplated <strong>by</strong> this Commitment Letter actually has knowledge (or<br />

can properly obtain knowledge without breach of internal procedures), shall not for any purpose be taken<br />

into account in determining our responsibilities to you hereunder,<br />

(d) neither Arranger nor any other member of the Arranger Group shall have any<br />

duty to disclose to you, or utilize for your benefit, any non-public information acquired in the course of<br />

providing services to any other person, engaging in any transaction (on our or its own account or<br />

otherwise) or otherwise carrying on our or its business,<br />

(e) (i) neither Arranger nor any of its affiliates has assumed any advisory<br />

responsibility or any other obligation in favor of the Company or any of its affiliates except (A) the<br />

obligations expressly provided for under the Debt Financing Letters <strong>and</strong> (B) the advisory services<br />

described in that certain Engagement Letter between Jefferies & Company, Inc. <strong>and</strong> Lassonde dated as of<br />

April 21, 2011, (ii) each Arranger <strong>and</strong> its affiliates, on the one h<strong>and</strong>, <strong>and</strong> the Company <strong>and</strong> its affiliates,<br />

on the other h<strong>and</strong>, have an arm’s-length business relationship that does not directly or indirectly give rise<br />

to, nor does the Company or any of its affiliates rely on, any fiduciary duty on the part of either Arranger<br />

or any of our affiliates <strong>and</strong> (iii) each Arranger is (<strong>and</strong> is affiliated with) full service financial firms <strong>and</strong> as<br />

such may effect from time to time transactions for its own account or the accounts of their customers, <strong>and</strong><br />

hold long or short positions in debt, equity-linked or equity securities or loans of companies that may be<br />

the subject of the transactions contemplated <strong>by</strong> this Commitment Letter (<strong>and</strong>, in particular, each Arranger<br />

<strong>and</strong> any other member of the Arranger Group may at any time hold debt or equity securities for our or its<br />

own account in the Company, Lassonde or their respective affiliates). With respect to any securities<br />

<strong>and</strong>/or financial instruments so held <strong>by</strong> either Arranger, any of its affiliates or any of our respective<br />

customers, all rights in respect of such securities <strong>and</strong> financial instruments, including any voting rights,<br />

will be exercised <strong>by</strong> the holder of such rights, in its sole discretion. You here<strong>by</strong> waive <strong>and</strong> release, to the<br />

fullest extent permitted <strong>by</strong> law, any claims you have, or may have, with respect to (i) any breach or<br />

alleged breach of fiduciary duty or (ii) any conflict of interest arising from such transactions, activities,<br />

investments or holdings, or arising from our failure or the failure of any of our affiliates to bring such<br />

transactions, activities, investments or holdings to your attention, <strong>and</strong><br />

(f) neither Arranger nor any of its affiliates is advising you as to any legal, tax,<br />

investment, accounting or regulatory matters in any jurisdiction. You shall consult with your own<br />

advisors concerning such matters <strong>and</strong> shall be responsible for making your own independent investigation<br />

<strong>and</strong> appraisal of the transactions contemplated <strong>by</strong> the Debt Financing Letters, <strong>and</strong> neither Arranger nor<br />

any of its affiliates shall have responsibility or liability to you with respect thereto. Any review <strong>by</strong> either<br />

Arranger, or on our behalf, of the Company, the Transactions, the other transactions contemplated <strong>by</strong> the<br />

Debt Financing Letters or other matters relating to such transactions will be performed solely for our<br />

benefit <strong>and</strong> shall not be on behalf of you or any of your affiliates.<br />

NYI-4378475v10<br />

9


11. Choice of Law; Jurisdiction; Waivers. The Debt Financing Letters shall be governed <strong>by</strong>,<br />

<strong>and</strong> construed in accordance with, the laws of the State of New York without regard to conflict of law<br />

principles (other than sections 5-1401 <strong>and</strong> 5-1402 of the New York General Obligations Law). To the<br />

fullest extent permitted <strong>by</strong> applicable law, you here<strong>by</strong> irrevocably submit to the exclusive jurisdiction of<br />

any New York State court or federal court sitting in the County of New York <strong>and</strong> the Borough of<br />

Manhattan in respect of any claim, suit, action or proceeding arising out of or relating to the provisions of<br />

any Debt Financing Letter <strong>and</strong> irrevocably agree that all claims in respect of any such claim, suit, action<br />

or proceeding may be heard <strong>and</strong> determined in any such court <strong>and</strong> that service of process therein may be<br />

made <strong>by</strong> certified mail, postage prepaid, to your address set forth above. You <strong>and</strong> each of us here<strong>by</strong><br />

waives, to the fullest extent permitted <strong>by</strong> applicable law, any objection that you or either of us may now<br />

or hereafter have to the laying of venue of any such claim, suit, action or proceeding brought in any such<br />

court, <strong>and</strong> any claim that any such claim, suit, action or proceeding brought in any such court has been<br />

brought in an inconvenient forum. You <strong>and</strong> each of us here<strong>by</strong> waives, to the fullest extent permitted <strong>by</strong><br />

applicable law, any right to trial <strong>by</strong> jury with respect to any claim, suit, action or proceeding (whether<br />

based upon contract, tort or otherwise) arising out of or relating to the Debt Financing Letters, any of the<br />

Transactions or any of the other transactions contemplated here<strong>by</strong> or there<strong>by</strong>. In addition, you here<strong>by</strong><br />

waive, to the fullest extent permitted <strong>by</strong> applicable law, any right to seek specific performance against<br />

either of us or any of our affiliates with respect to any transaction contemplated here<strong>by</strong> or under any other<br />

Debt Financing Letter. The provisions of this Section 11 are intended to be effective upon the execution<br />

of this Commitment Letter without any further action <strong>by</strong> you, <strong>and</strong> the introduction of a true copy of this<br />

Commitment Letter into evidence shall be conclusive <strong>and</strong> final evidence as to such matters.<br />

NYI-4378475v10<br />

12. Miscellaneous.<br />

(a) This Commitment Letter may be executed in one or more counterparts, each of<br />

which will be deemed an original, but all of which taken together will constitute one <strong>and</strong> the same<br />

instrument. Delivery of an executed signature page of this Commitment Letter <strong>by</strong> facsimile, PDF or other<br />

electronic transmission will be effective as delivery of a manually executed counterpart hereof.<br />

(b) You may not assign any of your rights, or be relieved of any of your obligations,<br />

under this Commitment Letter without the prior written consent of each Arranger, which may be given or<br />

withheld in its sole discretion (<strong>and</strong> any purported assignment without such consent, at our sole option,<br />

shall be null <strong>and</strong> void). Each of us may at any time <strong>and</strong> from time to time assign all or any portion of our<br />

respective Commitments hereunder to one or more of our affiliates or to one or more Lenders, whereupon<br />

we shall be released from the portion of such Commitments hereunder so assigned; provided that such<br />

assignment shall not relieve us of our obligation to fund on the Closing Date the portion of such<br />

Commitments so assigned to the extent such assignee fails, upon satisfaction or waiver of all conditions to<br />

such assignee making its initial extensions of credit on the Closing Date, to fund such assigned<br />

Commitments on the Closing Date. Any <strong>and</strong> all obligations of, <strong>and</strong> services to be provided <strong>by</strong>, each of us<br />

hereunder (including the Commitments) may be performed, <strong>and</strong> any <strong>and</strong> all of our rights hereunder may<br />

be exercised, <strong>by</strong> or through any of our affiliates or branches <strong>and</strong> we reserve the right to allocate, in whole<br />

or in part, to our affiliates or branches certain fees payable to us in such manner as we <strong>and</strong> our affiliates<br />

may agree in our <strong>and</strong> their sole discretion. You further acknowledge that we may share with any of our<br />

affiliates, <strong>and</strong> such affiliates may share with us, any information relating to the Transactions, you, the<br />

Acquired Business or Lassonde (<strong>and</strong> your <strong>and</strong> their respective affiliates), or any of the matters<br />

contemplated in the Debt Financing Letters.<br />

(c) This Commitment Letter has been <strong>and</strong> is made solely for the benefit of you, each<br />

of us <strong>and</strong> the indemnified persons (as defined in Annex B hereto) <strong>and</strong> your, each of our <strong>and</strong> their<br />

respective successors <strong>and</strong> assigns, <strong>and</strong> nothing in this Commitment Letter, expressed or implied, is<br />

10


intended to confer or does confer on any other person or entity any rights or remedies under or <strong>by</strong> reason<br />

of this Commitment Letter or your <strong>and</strong> each Arranger’s agreements contained herein.<br />

(d) The Debt Financing Letters set forth the entire underst<strong>and</strong>ing of the parties hereto<br />

as to the scope of the Commitments <strong>and</strong> our obligations hereunder <strong>and</strong> thereunder. The Debt Financing<br />

Letters supersede all prior underst<strong>and</strong>ings <strong>and</strong> proposals with respect to such Commitments <strong>and</strong><br />

obligations, whether written or oral between or <strong>among</strong> either of us <strong>and</strong> you.<br />

(e) You acknowledge that each Arranger <strong>and</strong> its affiliates may be arranging or<br />

providing (or contemplating arranging or providing) a committed form of acquisition financing to other<br />

potential purchasers of the Acquired Business <strong>and</strong> that, in such capacity, we <strong>and</strong> our affiliates may<br />

acquire information about the Acquired Business, the Acquisition, <strong>and</strong> such other potential purchasers<br />

<strong>and</strong> their strategies <strong>and</strong> proposals, but that nonetheless neither we nor our affiliates shall have any<br />

obligation to disclose to you or your affiliates the substance of such information or the fact that we or our<br />

affiliates are in possession thereof.<br />

(f) You agree that each of us or any of our affiliates may disclose information about<br />

the Transactions to market data collectors <strong>and</strong> similar service providers to the financing community.<br />

(g) We here<strong>by</strong> notify you <strong>and</strong>, upon its becoming bound <strong>by</strong> the provisions hereof,<br />

each other Credit Party (as defined in Exhibit A hereto), that pursuant to the requirements of the USA<br />

PATRIOT Act, Pub. L. 107-56 (signed into law October 26, 2001) (as amended from time to time, the<br />

“Patriot Act”), either of us <strong>and</strong> each Lender may be required to obtain, verify <strong>and</strong> record information that<br />

identifies the Credit Parties, which information includes the name, address, tax identification number <strong>and</strong><br />

other information regarding the Credit Parties that will allow the Arrangers or such Lender to identify the<br />

Credit Parties in accordance with the Patriot Act. This notice is given in accordance with the<br />

requirements of the Patriot Act <strong>and</strong> is effective as to each of us <strong>and</strong> each Lender. You agree that we shall<br />

be permitted to share any or all such information with the Lenders.<br />

13. Amendment; Waiver. This Commitment Letter may not be modified or amended except<br />

in a writing duly executed <strong>by</strong> the parties hereto. No waiver <strong>by</strong> any party of any breach of, or any<br />

provision of, this Commitment Letter shall be deemed a waiver of any similar or any other breach or<br />

provision of this Commitment Letter at the same or any prior or subsequent time. To be effective, a<br />

waiver must be set forth in writing signed <strong>by</strong> the waiving party <strong>and</strong> must specifically refer to this<br />

Commitment Letter <strong>and</strong> the breach or provision being waived.<br />

14. Credit Parties to Become Party. On the Closing Date, you shall cause the Borrower <strong>and</strong><br />

the other Credit Parties to assume from you, on a joint <strong>and</strong> several basis, effective upon the closing of the<br />

Acquisition, any <strong>and</strong> all of your duties, responsibilities <strong>and</strong> obligations under Section 8 hereof <strong>and</strong><br />

Annex B hereto with respect to Losses to which any indemnified person, directly or indirectly, may<br />

become subject arising out of, relating to, resulting from or otherwise in connection with the Debt<br />

Financing, the use of the proceeds therefrom, the Transactions, any of the other transactions contemplated<br />

<strong>by</strong> the Debt Financing Letters, or any Claim directly or indirectly arising out of, relating to, resulting from<br />

or otherwise in connection with any of the foregoing (following which you shall only have further rights,<br />

obligations or duties under such Section with respect to Losses to which any indemnified person, directly<br />

or indirectly, may become subject arising out of, relating to, resulting from or otherwise in connection<br />

with the Debt Financing Letters, or any Claim directly or indirectly arising out of, relating to, resulting<br />

from or otherwise in connection the Debt Financing Letters; it being the intention here<strong>by</strong> that<br />

immediately following such assumption you will have no liability or other obligation under the Definitive<br />

Debt Documents). Terms used in this Section 14 <strong>and</strong> defined in Annex B hereto shall have the meanings<br />

referred to therein.<br />

NYI-4378475v10<br />

11


15. Surviving Provisions. Notwithst<strong>and</strong>ing anything to the contrary in this Commitment<br />

Letter: (i) Sections 7 to <strong>and</strong> including 16 hereof shall survive the expiration or termination of this<br />

Commitment Letter, regardless of whether the Definitive Debt Documents have been executed <strong>and</strong><br />

delivered or the Transactions consummated, <strong>and</strong> (ii) Sections 2 <strong>and</strong> 4 to <strong>and</strong> including 14 hereof shall<br />

survive execution <strong>and</strong> delivery of the Definitive Debt Documents <strong>and</strong> the consummation of the<br />

Transactions.<br />

16. Acceptance, Expiration <strong>and</strong> Termination. Please indicate your acceptance of the terms of<br />

the Debt Financing Letters <strong>by</strong> returning to each of us executed counterparts of the Debt Financing Letters<br />

not later than 5:00 p.m., New York City time, on June 20, 2011 (the “Deadline”). The Debt Financing<br />

Letters are conditioned upon your contemporaneous execution <strong>and</strong> delivery to each of us, <strong>and</strong> the<br />

contemporaneous receipt <strong>by</strong> each of us, of executed counterparts of each Debt Financing Letter on or<br />

prior to the Deadline. This Commitment Letter will expire at such time in the event that you have not<br />

returned such executed counterparts to us <strong>by</strong> such time. Thereafter, except with respect to any provision<br />

that expressly survives pursuant to Section 14, this Commitment Letter (but not the other Debt Financing<br />

Letters) will terminate automatically on the earliest of (i) the date of termination of the Merger Agreement<br />

or ab<strong>and</strong>onment of the Acquisition, (ii) the closing of the Acquisition, (iii) the acceptance <strong>by</strong> the Target or<br />

any of its affiliates (or any of their respective equityholders) of an offer for all or any substantial part of<br />

the capital stock or property <strong>and</strong> assets of the Acquired Business (or any parent company thereof) other<br />

than as part of the Transactions <strong>and</strong> (iv) 5:00 p.m., New York City time, on August 15, 2011; provided<br />

that if the term of the Merger Agreement is extended to a date later than August 15, 2011 (the “Extension<br />

Date”) (including <strong>by</strong> mutual consent of the parties thereto, which shall not require consent of the<br />

Arrangers or the Lenders) of the Merger Agreement, this Commitment Letter shall terminate at 5:00 p.m.<br />

on the earlier of (x) the Extension Date <strong>and</strong> (y) September 23, 2011.<br />

NYI-4378475v10<br />

[Remainder of page intentionally blank]<br />

12


NYI-4378475v10<br />

ANNEX A TO COMMITMENT LETTER<br />

SOURCES <strong>AND</strong> USES <strong>OF</strong> FUNDS<br />

($ millions)<br />

SOURCES USES<br />

Term Loan Facility $230.0 Cash purchase price of Acquired<br />

Business<br />

Annex A-1<br />

$390.0<br />

Lassonde Equity Contribution $121.0 Fees <strong>and</strong> Expenses $13.8<br />

Pappas Reinvestment $29.0<br />

Revolving Loan Facility $23.8<br />

Total Sources $403.8 Total Uses $403.8<br />

The $50.0 million Revolving Credit Facility will be undrawn on the Closing Date (other than an<br />

aggregate principal amount of not more than $25.0 million in addition to (i) any required OID (as defined<br />

in the Fee Letter) payable pursuant to the Fee Letter <strong>and</strong> (ii) to the extent necessary, the cash<br />

collateralization or the issuance of letters of credit to backstop any existing outst<strong>and</strong>ing letters of credit of<br />

the Acquired Business which will remain outst<strong>and</strong>ing on the Closing Date). No Incremental Term Loans<br />

(as defined in Exhibit A) will be made on the Closing Date.<br />

* * *


NYI-4378475v10<br />

ANNEX B TO COMMITMENT LETTER<br />

INDEMNIFICATION <strong>AND</strong> WAIVER<br />

Except as otherwise defined in this Annex B, capitalized terms used but not defined herein have<br />

the meanings assigned to them elsewhere in this Commitment Letter.<br />

Lassonde (“you”) here<strong>by</strong> agrees (i) to indemnify <strong>and</strong> hold harmless Jefferies Finance LLC, Bank<br />

of Montreal (collectively, “we,” “us” or the “Arrangers”), the Lenders in the Debt Financing <strong>and</strong> each of<br />

our <strong>and</strong> their respective affiliates <strong>and</strong> subsidiaries (including Jefferies & Company, Inc. (“Jefco”)) <strong>and</strong><br />

each of the respective officers, directors, partners, trustees, employees, affiliates, shareholders, advisors,<br />

agents, representatives, attorneys-in-fact <strong>and</strong> controlling persons of each of the foregoing (each, an<br />

“indemnified person”) from <strong>and</strong> against any <strong>and</strong> all losses, claims, damages <strong>and</strong> liabilities (collectively,<br />

“Losses”) to which any such indemnified person, directly or indirectly, may become subject arising out<br />

of, relating to, resulting from or otherwise in connection with the Debt Financing Letters, the Debt<br />

Financing, the use of the proceeds therefrom, the Transactions, any of the other transactions contemplated<br />

<strong>by</strong> the Debt Financing Letters, or any action, claim, suit, litigation, investigation, inquiry or proceeding<br />

(each, a “Claim”) directly or indirectly arising out of, relating to, resulting from or otherwise in<br />

connection with any of the foregoing (IN ALL CASES, WHETHER OR NOT CAUSED OR<br />

ARISING, IN WHOLE OR IN PART, OUT <strong>OF</strong> THE COMPARATIVE, CONTRIBUTORY OR<br />

SOLE NEGLIGENCE <strong>OF</strong> THE INDEMNIFIED PERSON), regardless of whether any indemnified<br />

person is a named party thereto or whether such Claim is brought <strong>by</strong> you, any of your affiliates or a third<br />

party <strong>and</strong> (ii) to reimburse each indemnified person upon dem<strong>and</strong> at any time <strong>and</strong> from time to time for<br />

all out-of-pocket legal <strong>and</strong> other expenses incurred <strong>by</strong> it in connection with investigating, preparing to<br />

defend or defending, or providing evidence in or preparing to serve or serving as a witness with respect<br />

to, any Claim, directly or indirectly, arising out of, relating to, resulting from or otherwise in connection<br />

with any of the foregoing (including in connection with the enforcement of the indemnification<br />

obligations <strong>and</strong> waivers set forth in this Annex B); provided, however, that no indemnified person will be<br />

entitled to indemnity hereunder in respect of any Loss to the extent that it is found <strong>by</strong> a final, nonappealable<br />

judgment of a court of competent jurisdiction that such Loss resulted solely <strong>and</strong> directly from<br />

the gross negligence or willful misconduct of such indemnified person. In addition, in no event will any<br />

indemnified person be liable for consequential, special, exemplary, punitive or indirect damages<br />

(including any loss of profits, business or anticipated savings), whether, directly or indirectly, as a result<br />

of any failure to fund all or any portion of the Debt Financing or otherwise arising out of, relating to,<br />

resulting from or otherwise in connection with the Debt Financing or arising out of, relating to, resulting<br />

from or otherwise in connection with any Claim or otherwise. In addition, no indemnified person will be<br />

liable for any damages arising from the use <strong>by</strong> unauthorized persons of Information, Projections or other<br />

Materials sent through electronic, telecommunications or other information transmission systems that are<br />

intercepted or otherwise obtained <strong>by</strong> such persons.<br />

You shall not settle or compromise or consent to the entry of any judgment in or otherwise seek<br />

to terminate any pending or threatened Claim in which any indemnified person is or could be a party <strong>and</strong><br />

as to which indemnification or contribution could have been sought <strong>by</strong> such indemnified person<br />

hereunder whether or not such indemnified person is a party to any Debt Financing Letter, unless (i) such<br />

indemnified person <strong>and</strong> each other indemnified person from which such indemnified person could have<br />

sought indemnification or contribution have given their prior written consent, which may be given or<br />

withheld in their sole discretion or (ii) the settlement, compromise, consent or termination includes an<br />

express unconditional release of all indemnified persons <strong>and</strong> their respective affiliates from all Losses,<br />

directly or indirectly, arising out of, relating to, resulting from or otherwise in connection with such<br />

Claim.


If for any reason (other than the gross negligence or willful misconduct of an indemnified person<br />

as provided above) the foregoing indemnity is unavailable to an indemnified person or insufficient to hold<br />

an indemnified person harmless, then you to the fullest extent permitted <strong>by</strong> law, shall contribute to the<br />

amount paid or payable <strong>by</strong> such indemnified person as a result of such Losses in such proportion as is<br />

appropriate to reflect the relative benefits received <strong>by</strong> you, on the one h<strong>and</strong>, <strong>and</strong> <strong>by</strong> the applicable<br />

Arranger, on the other h<strong>and</strong>, from the Transactions or, if allocation on that basis is not permitted under<br />

applicable law, in such proportion as is appropriate to reflect not only the relative benefits received <strong>by</strong><br />

you, on the one h<strong>and</strong>, <strong>and</strong> us, on the other h<strong>and</strong>, but also the relative fault of you, on the one h<strong>and</strong>, <strong>and</strong> us,<br />

on the other h<strong>and</strong>, as well as any relevant equitable considerations. Notwithst<strong>and</strong>ing the provisions<br />

hereof, the aggregate contribution of all indemnified persons to all Losses shall not exceed the portion of<br />

the amount of the Underwriting <strong>and</strong> Arrangement Fees (as defined in the Fee Letter) received or<br />

contemplated to be received <strong>by</strong> such Arranger pursuant to the Fee Letter. For the purposes of this<br />

paragraph, it is here<strong>by</strong> further agreed that (i) the relative benefits to you, on the one h<strong>and</strong>, <strong>and</strong> each<br />

Arranger, on the other h<strong>and</strong>, with respect to the Transactions shall be deemed to be in the same proportion<br />

as (x) the total value paid or received or contemplated to be paid or received <strong>by</strong> you, your equityholders<br />

<strong>and</strong>/or your or their respective affiliates, as the case may be, in the Transactions, whether or not the<br />

Transactions are consummated, bears to (y) the portion of the Underwriting <strong>and</strong> Arrangement Fees paid<br />

or contemplated to be paid to such Arranger under the Fee Letter <strong>and</strong> (ii) the relative fault of you, on the<br />

one h<strong>and</strong>, <strong>and</strong> each of us, on the other h<strong>and</strong>, with respect to the Transactions shall be determined <strong>by</strong><br />

reference to, <strong>among</strong> other things, whether any untrue or alleged untrue statement of a material fact or the<br />

omission or alleged omission to state a material fact relates to information supplied <strong>by</strong> you, any of your<br />

affiliates <strong>and</strong>/or any of your or their respective officers, directors, partners, trustees, employees, affiliates,<br />

shareholders, advisors, agents, representatives, attorneys-in-fact <strong>and</strong> controlling persons (collectively, the<br />

“Lassonde Group”) or <strong>by</strong> either of us, as well as your <strong>and</strong> each of our relative intent, knowledge, access<br />

to information <strong>and</strong> opportunity to correct or prevent such statement or omission.<br />

In addition, you shall reimburse the indemnified persons for all expenses (including fees <strong>and</strong><br />

expenses of internal <strong>and</strong> external counsel), as incurred, in connection with investigating, preparing,<br />

defending or settling any Claim for which indemnification or contribution may be sought <strong>by</strong> the<br />

indemnified person, whether or not any indemnified person is a named party thereto or whether such<br />

Claim is brought <strong>by</strong> you, any of your affiliates or a third party.<br />

The indemnity, contribution <strong>and</strong> expense reimbursement obligations set forth herein (i) shall be in<br />

addition to any liability you may have to any indemnified person at law, in equity or otherwise, (ii) shall<br />

survive the expiration or termination of the Debt Financing Letters (notwithst<strong>and</strong>ing any other provision<br />

of any Debt Financing Letter or the Definitive Debt Documents), (iii) shall apply to any modification,<br />

amendment, waiver or supplement of our <strong>and</strong> any of our affiliates’ commitment <strong>and</strong>/or engagement, (iv)<br />

shall remain operative <strong>and</strong> in full force <strong>and</strong> effect regardless of any investigation made <strong>by</strong> or on behalf of<br />

us or any other indemnified person <strong>and</strong> (v) shall be binding on any successor or assign of you <strong>and</strong> the<br />

successors or assigns to any substantial portion of your business <strong>and</strong> assets.<br />

* * *<br />

NYI-4378475v10 2


NYI-4378475v10 3<br />

EXHIBIT A TO COMMITMENT LETTER<br />

SUMMARY <strong>OF</strong> TERMS <strong>OF</strong> TERM LOAN FACILITY<br />

Set forth below is a summary of certain of the terms of the Term Loan Facility <strong>and</strong> the<br />

documentation related thereto. Capitalized terms used <strong>and</strong> not otherwise defined in this Exhibit A have<br />

the meanings set forth elsewhere in this Commitment Letter.<br />

I. Parties<br />

Borrower...............................................After giving effect to the Acquisition (as defined below),<br />

Clement Pappas <strong>and</strong> Company, Inc., a New Jersey<br />

corporation (the “Borrower”).<br />

Guarantors ...........................................Pomona Holdings, Inc., a Delaware corporation, which is<br />

the direct parent company of the Borrower (the<br />

“Parent”), <strong>and</strong> each of its direct <strong>and</strong> indirect subsidiaries<br />

(other than any subsidiary that is a “controlled foreign<br />

corporation,” within the meaning of section 957 of the<br />

United States Tax Code (a “CFC”) to the extent making<br />

such CFC a guarantor would result in material adverse<br />

tax consequences to the Borrower) (collectively, the<br />

“Guarantors”; the Borrower <strong>and</strong> the Guarantors,<br />

collectively, the “Credit Parties”, with each being a<br />

“Credit Party”).<br />

Joint Lead Arrangers <strong>and</strong> Book Jefferies Finance LLC (“Jefferies Finance”) <strong>and</strong>/or one<br />

Runners .......................................... or more of its designees <strong>and</strong> Bank of Montreal (“BMO”)<br />

<strong>and</strong>/or one or more of its designees (in such capacities,<br />

each an “Arranger” <strong>and</strong>, together, the “Arrangers”). The<br />

Arrangers will perform the duties customarily associated<br />

with such role.<br />

Sole Syndication Agent........................BMO <strong>and</strong>/or one or more of its designees (in such<br />

capacity, the “Syndication Agent”).<br />

Administrative Agent...........................Jefferies Finance <strong>and</strong>/or one or more of its designees (in<br />

such capacity, the “Administrative Agent”). The<br />

Administrative Agent will perform the duties customarily<br />

associated with such role.<br />

Collateral Agent ...................................Jefferies Finance <strong>and</strong>/or one or more of its designees (in<br />

such capacity, the “Collateral Agent”). The Collateral<br />

Agent will perform the duties customarily associated<br />

with such role.<br />

Lenders .................................................A syndicate of banks, financial institutions <strong>and</strong> other<br />

entities (the “Lenders”) arranged <strong>by</strong> Jefferies Finance in<br />

consultation with the Borrower.


Closing Date..........................................The date, on or before the date on which the Term Loan<br />

Commitments are terminated in accordance with Section<br />

15 of the Commitment Letter, on which the Acquisition<br />

is consummated <strong>and</strong> the funding of the Term Loans<br />

occurs (the “Closing Date”).<br />

Term Loan Documents........................The definitive documentation governing or evidencing<br />

the Term Loan Facility (collectively, the “Term Loan<br />

Documents”).<br />

II. Types <strong>and</strong> Amounts of Facilities<br />

Term Loan Facility ..............................A six-year term loan facility (the “Term Loan Facility”)<br />

in an aggregate principal amount equal to $230.0 million<br />

(the loans thereunder, the “Term Loans”). The full<br />

amount of the Term Loan Facility shall be drawn in a<br />

single drawing on the Closing Date (subject to the<br />

Incremental Term Loans set forth below). Amounts<br />

borrowed under the Term Loan Facility that are repaid or<br />

prepaid may not be reborrowed.<br />

NYI-4378475v10 4<br />

The Term Loan Facility will mature on the date that is six<br />

years after the Closing Date <strong>and</strong> will amortize in equal<br />

quarterly installments in aggregate annual amounts equal<br />

to 1.0% of the original principal amount of the Term<br />

Loan Facility, with the balance payable on the sixth<br />

anniversary of the Closing Date.<br />

Use of Proceeds...............................The proceeds of the Term Loans borrowed on the<br />

Closing Date will be used to finance, in part, the<br />

acquisition (the “Acquisition”) of Clement Pappas <strong>and</strong><br />

Company, Inc., a New Jersey corporation (the “Target”),<br />

to finance the refinancing of the existing indebtedness of<br />

the Target <strong>and</strong> pay fees <strong>and</strong> expenses in connection with<br />

the foregoing.<br />

Incremental Term Loans.....................The Borrower shall have the right to increase the size of<br />

the Term Loan Facility in a minimum amount to be<br />

mutually agreed <strong>and</strong> up to a maximum amount to be<br />

mutually agreed, (such new loans, “Incremental Term<br />

Loans”); unless the context otherwise requires,<br />

references in this Term Sheet to the Term Loan Facility<br />

shall be deemed to include a reference to the Incremental<br />

Term Loans), at any time after the Closing Date, from<br />

willing Lenders <strong>and</strong>/or eligible assignees, subject to<br />

certain requirements, including, (i) there shall be no<br />

default or event of default before, or after giving effect<br />

to, any such proposed Incremental Term Loans, (ii) the<br />

Borrower shall be in pro forma compliance with each of<br />

the financial maintenance covenants on the date of<br />

incurrence <strong>and</strong> for the most recent determination period<br />

after giving effect to any such Incremental Term Loans


NYI-4378475v10 5<br />

<strong>and</strong> other customary <strong>and</strong> appropriate adjustment events<br />

(including pro forma compliance with the lesser of (x)<br />

the total leverage ratio on the Closing Date <strong>and</strong> (y) the<br />

then applicable maximum total leverage ratio covenant<br />

(assuming, for purposes of pro forma compliance with<br />

the maximum total leverage financial covenant, that the<br />

maximum total leverage ratio permitted at such time was<br />

0.25 to 1.0 below the ratio actually required to be<br />

maintained at such time)), (v) no Incremental Term Loan<br />

shall have a maturity that is earlier than the Term Loan<br />

Facility or shall have a weighted average life to maturity<br />

that is shorter than the Term Loan Facility, (vi) the initial<br />

yield (to be defined to include all applicable margin,<br />

interest rate floors, upfront fees, original issue discount<br />

<strong>and</strong> similar yield related discounts, deductions or<br />

payments) on each such Incremental Term Loan shall be<br />

no greater than 0.25% per annum higher than the margin<br />

for the Term Loan Facility (or, if such initial yield<br />

exceeds such margin, such margin shall automatically be<br />

increased to equal such initial yield), (vii) the<br />

representations <strong>and</strong> warranties shall be true <strong>and</strong> correct in<br />

all material respects immediately prior to, <strong>and</strong> after<br />

giving effect to, the incurrence of each such Incremental<br />

Term Loan, (viii) the Incremental Term Loans shall share<br />

ratably in any m<strong>and</strong>atory prepayments of the Term Loan<br />

Facility, (ix) the terms of the Incremental Term Loans<br />

shall otherwise be reasonably satisfactory in all respects<br />

to the Administrative Agent <strong>and</strong> (x) the terms of the<br />

Incremental Term Loans shall be otherwise identical to<br />

the terms of the Term Loan Facility.<br />

The Administrative Agent shall be permitted to effect<br />

such amendments to the Term Loan Documents as may<br />

be necessary or appropriate to give effect to the<br />

foregoing, including conforming amendments (which<br />

may be in the form of an amendment <strong>and</strong> restatement).<br />

The Borrower may seek commitments in respect of the<br />

Incremental Term Loans from existing Lenders (each of<br />

which shall be entitled to agree or decline to participate<br />

in its sole discretion) <strong>and</strong> additional banks, financial<br />

institutions <strong>and</strong> other institutional lenders or investors<br />

who will become Lenders in connection therewith<br />

(“Additional Lenders”); provided that the Administrative<br />

Agent shall have consent rights (not to be unreasonably<br />

withheld) with respect to such Additional Lender, if such<br />

consent would be required under the heading<br />

“Assignments <strong>and</strong> Participations” for an assignment of<br />

loans or commitments, as applicable, to such Additional<br />

Lender).


III. Certain Payment Provisions<br />

Fees <strong>and</strong> Interest Rates........................As set forth on Annex A hereto.<br />

Optional Prepayments <strong>and</strong><br />

Commitment Reductions ..............Subject to the terms of the Intercreditor Agreement,<br />

optional prepayments of borrowings under the Term<br />

Loan Facility <strong>and</strong> optional reductions of the unutilized<br />

portion of the commitments under the Term Loan<br />

Facility will be permitted at any time, in minimum<br />

principal amounts to be agreed, without premium or<br />

penalty, subject to (i) payment of any amounts provided<br />

for below in this Exhibit A under the captions “Soft Call<br />

on Term Loans” <strong>and</strong> (ii) reimbursement of the Lenders’<br />

redeployment costs in the case of a prepayment of<br />

Eurodollar Loans other than on the last day of the<br />

relevant interest period (which costs shall be computed<br />

without regard to the Applicable Margin). Voluntary<br />

prepayments of the Term Loan Facility shall be applied<br />

to scheduled amortization payments as directed <strong>by</strong> the<br />

Borrower.<br />

M<strong>and</strong>atory Prepayments <strong>and</strong><br />

Commitment Reductions ..............Subject to the Intercreditor Agreement, the following<br />

amounts will be applied to prepay the Term Loans:<br />

NYI-4378475v10 6<br />

50% of the net proceeds of any sale or issuance of<br />

equity <strong>by</strong>, or capital contribution to, the Parent (with<br />

exceptions to be agreed upon);<br />

100% of the net proceeds of any incurrence of<br />

indebtedness after the Closing Date <strong>by</strong> the Parent or<br />

any of its subsidiaries (other than purchase money<br />

indebtedness <strong>and</strong> other exceptions to be agreed<br />

upon);<br />

100% of the net proceeds of any non-ordinary course<br />

sale or other disposition of assets <strong>by</strong> the Parent or<br />

any of its subsidiaries (including (i) as a result of<br />

casualty or condemnation <strong>and</strong> (ii) any issuance or<br />

sale of equity <strong>by</strong> the Borrower or any of its<br />

subsidiaries) (with certain exceptions <strong>and</strong><br />

reinvestment rights to be agreed upon); <strong>and</strong><br />

75% of excess cash flow (to be defined in a manner<br />

reasonably satisfactory to the Arrangers) for each<br />

fiscal year of the Borrower (commencing with the<br />

fiscal year immediately following the fiscal year in<br />

which the Closing Date occurs), with a step-down to<br />

50% in the event the maximum leverage ratio is<br />

equal to or less than a ratio to be agreed upon.


NYI-4378475v10 7<br />

All such m<strong>and</strong>atory prepayments shall be applied<br />

without premium or penalty (except for breakage costs,<br />

if any) <strong>and</strong> shall be applied to the next four scheduled<br />

installments of principal of the Term Loan Facility in<br />

direct order of maturity <strong>and</strong> thereafter pro rata to the<br />

remaining scheduled installments of principal of the<br />

Term Loan Facility.<br />

Soft Call on Term Loans .....................The Borrower shall pay a “prepayment premium” in<br />

connection with any Repricing Event (as defined below)<br />

with respect to all or any portion of the Term Loans that<br />

occurs on or before the first anniversary of the Closing<br />

Date, in an amount not to exceed 1.0% of the principal<br />

amount of the Term Loans subject to such Repricing<br />

Event. The term “Repricing Event” shall mean (i) any<br />

prepayment or repayment of Term Loans with the<br />

proceeds of, or any conversion of Term Loans into, any<br />

new or replacement tranche of term loans bearing interest<br />

at an “effective” interest rate less than the “effective”<br />

interest rate applicable to the Term Loans (as such<br />

comparative rates are determined <strong>by</strong> the Administrative<br />

Agent) <strong>and</strong> (ii) any amendment to the Term Loan Facility<br />

that, directly or indirectly, reduces the “effective” interest<br />

rate applicable to the Term Loans (in each case, with<br />

original issue discount <strong>and</strong> upfront fees, which shall be<br />

deemed to constitute like amounts of original issue<br />

discount, being equated to interest margins in a manner<br />

consistent with generally accepted financial practice<br />

based on an assumed four-year life to maturity).<br />

IV. Collateral <strong>and</strong> Guarantees.<br />

Collateral ..............................................The obligations of each Credit Party in respect of the<br />

Term Loan Facility will be secured <strong>by</strong> a perfected<br />

security interest in substantially all of its tangible <strong>and</strong><br />

intangible assets, including intellectual property, owned<br />

<strong>and</strong> leased (to the extent permitted <strong>by</strong> the applicable<br />

lease, consented to <strong>by</strong> the l<strong>and</strong>lord or otherwise permitted<br />

after giving effect to the applicable anti-assignment<br />

provisions of the Uniform Commercial Code), real<br />

property (other than immaterial real property), licenses<br />

<strong>and</strong> permits (to the extent permitted <strong>by</strong> any applicable<br />

law or regulation), intercompany indebtedness (which<br />

shall be evidenced <strong>by</strong> a subordinated promissory note)<br />

<strong>and</strong> all of the capital stock of each Credit Party (other<br />

than the Parent) (but limited, in the case of the voting<br />

stock of a CFC, to 66% of all such voting stock to the<br />

extent that the pledge of a greater percentage would<br />

result in material adverse tax consequences to the<br />

Borrower) (collectively, the “Collateral”) provided that<br />

(i) the Term Loan Documents will waive the attachment<br />

or perfection of property if, in the reasonable discretion


NYI-4378475v10 8<br />

of the Administrative Agent, the costs of obtaining such<br />

attachment or perfection in such assets or perfection<br />

thereof are excessive in relation to the benefit to the<br />

Lenders of the security to be afforded there<strong>by</strong>, <strong>and</strong> (ii)<br />

equity interests in any person other than wholly owned<br />

subsidiaries will be pledged only to the extent permitted<br />

<strong>by</strong> the terms of such person’s organizational or joint<br />

venture documents.<br />

The Credit Parties <strong>and</strong> the Collateral Agent would enter<br />

into access agreements that would permit the Collateral<br />

Agent, subject to the Intercreditor Agreement, upon an<br />

Event of Default <strong>and</strong> exercise <strong>by</strong> Collateral Agent of its<br />

remedies under the Term Loan Documents, the right to<br />

use, at no cost, any pledged or unpledged equipment, real<br />

property, <strong>and</strong> intangible assets to process, finish out,<br />

collect or otherwise realize upon the assets so pledged to<br />

Collateral Agent.<br />

Each Credit Party shall cause all proceeds of its<br />

receivables (whether evidenced <strong>by</strong> accounts, instruments,<br />

chattel paper, payment intangibles or otherwise) to be<br />

deposited into a deposit account / lockbox under the sole<br />

control of the Collateral Agent subject to the terms of the<br />

Intercreditor Agreement.<br />

The obligations of each Credit Party in respect of the<br />

Term Loan Facility, <strong>and</strong> the Revolving Credit Facility<br />

will be secured <strong>by</strong> perfected liens having the priority<br />

described below under the caption “Lien Ranking.”<br />

Notwithst<strong>and</strong>ing anything herein to the contrary, the<br />

Collateral securing the Revolving Credit Facility will be<br />

the same as the collateral securing the Term Loan<br />

Facility.<br />

All such security interests will be created pursuant to<br />

documentation reasonably satisfactory in all respects to<br />

the Collateral Agent (including, in the case of real<br />

property, <strong>by</strong> customary items such as reasonably<br />

satisfactory title insurance, including endorsements,<br />

surveys <strong>and</strong> flood certificates) <strong>and</strong>, on the Closing Date,<br />

subject to the Certain Funds Provision, such security<br />

interests shall have become perfected <strong>and</strong> the Collateral<br />

Agent shall have received reasonably satisfactory<br />

evidence as to the enforceability <strong>and</strong> priority thereof.<br />

Guarantees............................................The Guarantors will unconditionally guarantee the<br />

obligations of each Credit Party in respect of the Term<br />

Loan Facility (the “Guarantees”). Such Guarantees will<br />

be in form <strong>and</strong> substance reasonably satisfactory to the<br />

Administrative Agent <strong>and</strong> the Arrangers. All Guarantees<br />

shall be guarantees of payment <strong>and</strong> performance, <strong>and</strong> not


NYI-4378475v10 9<br />

of collection.<br />

Lien Ranking ........................................All indebtedness <strong>and</strong> other obligations under the<br />

Revolving Credit Facility <strong>and</strong> Permitted Secured<br />

Hedging Obligations <strong>and</strong> Permitted Cash Management<br />

Obligations <strong>and</strong> any guarantees of the foregoing<br />

(collectively, the “Revolving Facility Obligations”) will<br />

rank pari passu in right of payment to all of the<br />

indebtedness under the Term Loans <strong>and</strong> any guarantees<br />

thereof (collectively, the “Term Loan Obligations”), in<br />

each case, pursuant to the terms of an intercreditor<br />

agreement reasonably satisfactory to the administrative<br />

agent <strong>and</strong> the lenders under the Revolving Credit Facility<br />

<strong>and</strong> the Administrative Agent <strong>and</strong> the Lenders, in each<br />

case, in their reasonable discretion (the “Intercreditor<br />

Agreement”).<br />

V. Other Provisions<br />

Collateral Consisting of Non-Current Assets. The Term<br />

Loan Obligations will be secured <strong>by</strong> a first priority lien<br />

on the Collateral consisting of “non-current assets” (the<br />

definition of which is to be agreed upon), including a<br />

pledge of all the capital stock directly held <strong>by</strong> any Credit<br />

Party in any subsidiary (including the stock of the<br />

Borrower held <strong>by</strong> the Parent) <strong>and</strong> the Revolving Credit<br />

Obligations will be secured <strong>by</strong> a second priority lien on<br />

such Collateral, in each case, subject to the terms of the<br />

Intercreditor Agreement.<br />

Collateral Consisting of Current Assets. The Revolving<br />

Facility Obligations will be secured <strong>by</strong> a first priority<br />

lien on the Collateral consisting of “current assets” (the<br />

definition of which is to be agreed upon), including cash,<br />

accounts receivable, inventory <strong>and</strong> any proceeds thereof<br />

to the extent such foregoing assets do not constitute the<br />

proceeds of “non-current assets”, <strong>and</strong> the Term Loan<br />

Obligations will be secured <strong>by</strong> a second priority lien on<br />

such Collateral, in each case, subject to the terms of the<br />

Intercreditor Agreement.<br />

Representations <strong>and</strong> Warranties ........Customary for facilities <strong>and</strong> transactions of this type (as<br />

reasonably determined <strong>by</strong> the Arrangers, <strong>and</strong> subject to<br />

customary materiality qualifications) <strong>and</strong> others<br />

reasonably deemed appropriate <strong>by</strong> the Arrangers for this<br />

transaction in particular, including as to: organization<br />

<strong>and</strong> powers; authorization <strong>and</strong> enforceability of Senior<br />

Loan Documents; no conflicts; financial statements,<br />

projections <strong>and</strong> other information; no material adverse<br />

effect; properties; intellectual property; equity interests<br />

<strong>and</strong> subsidiaries; litigation <strong>and</strong> compliance with laws <strong>and</strong><br />

other regulatory matters; organizational documents,


NYI-4378475v10 10<br />

contractual obligations <strong>and</strong> material agreements; federal<br />

reserve regulations; Investment Company Act of 1940, as<br />

amended, <strong>and</strong> other laws restricting incurrence of debt;<br />

use of proceeds; taxes; accuracy <strong>and</strong> completeness of<br />

disclosure; labor matters; solvency; employee benefit<br />

plans <strong>and</strong> ERISA; environmental matters; insurance;<br />

security documents <strong>and</strong> validity, perfection <strong>and</strong> priority<br />

of security interests in the Collateral; acquisition<br />

documents; anti-terrorism laws, money laundering<br />

activities <strong>and</strong> dealing with embargoed persons <strong>and</strong>, if<br />

applicable, status as senior debt <strong>and</strong> as designated senior<br />

debt.<br />

Affirmative Covenants.........................Customary for facilities <strong>and</strong> transactions of this type (as<br />

reasonably determined <strong>by</strong> the Arrangers, <strong>and</strong> subject to<br />

customary materiality qualifications) <strong>and</strong> others<br />

reasonably deemed appropriate <strong>by</strong> the Arrangers for this<br />

transaction in particular, including as to: delivery of<br />

financial statements, reports, accountants’ letters,<br />

projections, officers’ certificates, <strong>and</strong> other information;<br />

notices of litigation <strong>and</strong> other material events; existence;<br />

maintenance of business <strong>and</strong> properties; insurance;<br />

obligations <strong>and</strong> taxes; employee benefits <strong>and</strong> ERISA;<br />

maintaining records; access to properties <strong>and</strong> inspections;<br />

use of proceeds; compliance with environmental laws;<br />

environmental reports; interest rate protection; additional<br />

collateral <strong>and</strong> additional guarantors; security interests;<br />

further assurances; information regarding collateral;<br />

maintenance of corporate separateness, post-closing<br />

matters (if any); regulatory matters; holding an annual<br />

lenders’ meeting; <strong>and</strong> using commercially reasonable<br />

efforts to maintain monitored public ratings for the Term<br />

Loan Facility <strong>and</strong> corporate family/corporate credit<br />

ratings.<br />

Negative Covenants..............................Customary for facilities <strong>and</strong> transactions of this type (as<br />

reasonably determined <strong>by</strong> the Arrangers, <strong>and</strong> subject to<br />

exceptions <strong>and</strong> baskets to be agreed upon) <strong>and</strong> others<br />

reasonably deemed appropriate <strong>by</strong> the Arrangers for this<br />

transaction in particular, including limitations on<br />

indebtedness (including m<strong>and</strong>atorily redeemable equity<br />

interests, guarantees <strong>and</strong> other contingent obligations);<br />

liens; sale <strong>and</strong> leaseback transactions; investments, loans<br />

<strong>and</strong> advances; asset sales; mergers, acquisitions,<br />

consolidations, liquidations <strong>and</strong> dissolutions; dividends<br />

<strong>and</strong> other payments in respect of equity interests <strong>and</strong><br />

other restricted payments; transactions with affiliates;<br />

capital expenditures; prepayments of other indebtedness;<br />

modifications of organizational documents, acquisition<br />

documents <strong>and</strong> certain other documents; limitations on<br />

certain restrictions on subsidiaries; limitations on<br />

issuance of capital stock <strong>and</strong> creation of subsidiaries;


NYI-4378475v10 11<br />

limitations on business activities; limitations on<br />

accounting changes; changes in fiscal year <strong>and</strong> fiscal<br />

quarter; lease obligations; no further negative pledges;<br />

anti-terrorism laws, money laundering activities <strong>and</strong><br />

dealing with embargoed persons; <strong>and</strong> limitations on<br />

holding a material portion of the Collateral in non-US<br />

jurisdictions. Special purpose “holding company”<br />

covenants shall apply at all times to the Parent.<br />

The above limitation on restricted payments will permit<br />

restricted payments to the Parent, which will be permitted<br />

to make such restricted payments to its parent holding<br />

companies <strong>and</strong> ultimate shareholders, (i) in an aggregate<br />

amount not to exceed the “Cumulative Credit” (to be<br />

defined); provided that, both before <strong>and</strong> after giving pro<br />

forma effect to any such payment, (x) no default or event<br />

of default exists, (y) the unused availability under the<br />

Revolving Credit Facility shall be not less than<br />

$30,000,000 <strong>and</strong> (z) the total gross leverage ratio shall be<br />

less than 2.50 to 1.00; provided, further, that not more<br />

than $6,000,000 of such restricted payments may be paid<br />

in any 12-month period ending on or before the third<br />

anniversary of the Closing Date <strong>and</strong> (ii) to pay the<br />

reasonable <strong>and</strong> customary expenses of such parent<br />

holding companies, such as professional fees, taxes <strong>and</strong><br />

directors’ <strong>and</strong> officers’ liability insurance, not to exceed<br />

in any year an aggregate amount to be agreed upon.<br />

Financial Covenants.............................A maximum total leverage ratio <strong>and</strong> minimum interest<br />

coverage ratio, in each case, (i) set at levels to reflect at<br />

least a 25% cushion from Consolidated EBITDA in the<br />

model delivered to Jefferies Finance on May 13, 2011 (to<br />

be adjusted accordingly if market flex provisions are<br />

utilized) <strong>and</strong> (ii) with accounting terms to be interpreted,<br />

<strong>and</strong> all accounting determinations <strong>and</strong> computations to be<br />

made, in accordance with U.S. generally accepted<br />

accounting principles.<br />

Conditions Precedent...........................Conditions precedent to the borrowing of the Term<br />

Loans are set forth in Section 3 of the Commitment<br />

Letter <strong>and</strong> in Exhibit C hereto. Conditions precedent to<br />

each borrowing of Incremental Term Loans will include<br />

(1) the absence of any continuing default or event of<br />

default, (2) the accuracy of all representations <strong>and</strong><br />

warranties, <strong>and</strong> (3) receipt of a customary borrowing<br />

notice.<br />

Interest Rate Management..................An amount equal to 50% of the aggregate principal<br />

amount of the Term Loan Facility shall be hedged for a<br />

period to be agreed <strong>and</strong> on terms reasonably satisfactory<br />

to the Administrative Agent with a Lender or an affiliate<br />

of a Lender or a lender under the Revolving Credit


NYI-4378475v10 12<br />

Facility or an affiliate of such a lender acceptable to the<br />

Administrative Agent.<br />

Events of Default..................................Customary for facilities <strong>and</strong> transactions of this type (as<br />

reasonably determined <strong>by</strong> the Arrangers) <strong>and</strong> others<br />

reasonably deemed appropriate <strong>by</strong> the Arrangers for this<br />

transaction in particular (in certain cases, subject to<br />

customary <strong>and</strong> appropriate grace <strong>and</strong> cure periods <strong>and</strong><br />

materiality thresholds to be agreed) including as to:<br />

nonpayment of principal when due; nonpayment of<br />

interest, fees or other amounts when due; inaccuracy of<br />

representations <strong>and</strong> warranties in any material respect;<br />

violation of covenants; cross-defaults; bankruptcy <strong>and</strong><br />

insolvency events; material judgments; ERISA events;<br />

actual or asserted invalidity or impairment of the<br />

Intercreditor Agreement, guarantees, security documents<br />

or any other Senior Loan Documents (including the<br />

failure of any lien on any portion of the Collateral to<br />

remain perfected with the priority required under the<br />

Term Loan Documents); <strong>and</strong> a change of control or<br />

ownership (to be defined in a manner reasonably<br />

satisfactory to the Arrangers).<br />

Equity Cure Rights ..............................In the event that the Borrower fails to satisfy one or more<br />

financial maintenance covenants, the Senior Loan<br />

Documents will contain certain equity cure rights<br />

pursuant to which, subject to the terms <strong>and</strong> conditions<br />

thereof (which shall be reasonably satisfactory in all<br />

respects to the Administrative Agent), the proceeds of<br />

common equity contributions <strong>by</strong> one or more<br />

shareholders of Pappas Lassonde Holdings, Inc., directly<br />

or indirectly, to Parent that are then contributed as<br />

common equity <strong>by</strong> Parent to the Borrower (“Equity Cure<br />

Contributions”) shall be treated on a dollar-for-dollar<br />

basis as EBITDA of the Borrower for purposes of<br />

retroactively curing the default(s) under such financial<br />

covenant(s); provided that (i) in each four fiscal quarter<br />

period, there shall be a period of at least two consecutive<br />

fiscal quarters in respect of which no Equity Cure<br />

Contributions are made, (ii) in each eight fiscal quarter<br />

period, there shall be a period of at least four consecutive<br />

fiscal quarters in respect of which no Equity Cure<br />

Contributions are made, (iii) no more than four Equity<br />

Cure Contributions may be made during the term of the<br />

Term Loan Facility; (iv) the amount of any Equity Cure<br />

Contributions in any fiscal quarter shall be no greater<br />

than the amount required to cause the Borrower to be in<br />

compliance with the financial covenant as at the end of<br />

such fiscal quarter, <strong>and</strong> (v) all Equity Cure Contributions<br />

shall be disregarded for all purposes other than<br />

retroactively curing defaults under the financial covenant,<br />

including being disregarded for purposes of determining


NYI-4378475v10 13<br />

(x) any baskets with respect to the covenants contained in<br />

the Term Loan Documents <strong>and</strong> (y) compliance with any<br />

performance goals used as the basis for adjustments to<br />

interest rate margins.<br />

Voting....................................................Amendments <strong>and</strong> waivers with respect to the Term Loan<br />

Documents will require the approval of Lenders holding<br />

not less than a majority of the aggregate principal amount<br />

of the Term Loans <strong>and</strong> unused commitments (the<br />

“Required Lenders”), except that (i) the consent of each<br />

Lender directly affected there<strong>by</strong> shall be required with<br />

respect to (a) reductions in the amount or extensions of<br />

the final maturity of any Term Loan held <strong>by</strong> such Lender,<br />

(b) reductions in the rate of interest (other than a waiver<br />

of default interest) or any fee or other amount payable or<br />

extensions of any due date thereof, (c) increases in the<br />

amount or extensions of the expiration date of such<br />

Lender’s commitment or (d) modifications to the<br />

assignment provisions of the Term Loan Documents that<br />

further restrict assignments thereunder, (ii) the consent of<br />

100% of the Lenders shall be required with respect to<br />

(a) reductions of any of the voting percentages or pro rata<br />

provisions, (b) releases of all or substantially all of the<br />

value of the guarantees of the Guarantors or of all or<br />

substantially all of the Collateral (other than in<br />

connection with permitted asset sales), other than<br />

releases of Guarantors (<strong>and</strong> their related Collateral)<br />

expressly permitted under the terms of the Loan<br />

Documents, or (c) assignments <strong>by</strong> any Credit Party of its<br />

rights or obligations under the Term Loan Facility <strong>and</strong><br />

(iii) the consent of Lenders holding not less than 66-2/3%<br />

of the aggregate principal amount of the Term Loans<br />

shall be required to modify the Intercreditor Agreement.<br />

Assignments <strong>and</strong> Participations..........The Lenders shall be permitted to assign <strong>and</strong> sell<br />

participations in their loans <strong>and</strong> commitments subject, in<br />

the case of assignments (other than assignments to<br />

another Lender, an affiliate of a Lender or an approved<br />

fund (to be defined in the Term Loan Documents)), to the<br />

consent of the Administrative Agent; provided further<br />

that, the Term Loan Facility shall not be participated or<br />

assigned to any natural person, Parent, the Borrower or<br />

any of their respective affiliates. In the case of partial<br />

assignments (other than to another Lender, an affiliate of<br />

a Lender or an approved fund), the minimum assignment<br />

amount shall be $1.0 million. Assignments will be <strong>by</strong><br />

novation. The Administrative Agent shall receive an<br />

administrative fee of $3,500 in connection with each<br />

assignment unless otherwise agreed <strong>by</strong> the<br />

Administrative Agent.<br />

Participants shall have the same benefits as the Lenders


NYI-4378475v10 14<br />

with respect to yield protection <strong>and</strong> increased cost<br />

provisions, <strong>and</strong> will be subject to customary limitations<br />

on voting rights (as reasonably determined <strong>by</strong> the<br />

Arrangers). Pledges of Term Loans in accordance with<br />

applicable law shall be permitted without restriction.<br />

Promissory notes shall be issued under the Term Loan<br />

Facility only upon request.<br />

The Term Loan Documents shall contain customary<br />

provisions (as reasonably determined <strong>by</strong> the Arrangers)<br />

for replacing non-consenting Lenders in connection with<br />

amendments <strong>and</strong> waivers requiring the consent of all<br />

Lenders or of all Lenders directly affected there<strong>by</strong> so<br />

long as Lenders holding at least a majority of the<br />

aggregate principal amount of the Term Loans.<br />

The Term Loan Documents shall provide that the Term<br />

Loan Facility may be purchased <strong>by</strong> <strong>and</strong> assigned to<br />

Lassonde Industries Inc. (“Lassonde”), its affiliates<br />

(other than Parent or any of its subsidiaries <strong>and</strong> other<br />

than natural persons) (collectively, the “Affiliated<br />

Lenders”) on a non-pro rata basis through Dutch<br />

auctions open to all Lenders on a pro rata basis in<br />

accordance with customary procedures to be agreed;<br />

provided that (i) Term Loans owned or held <strong>by</strong> Lassonde<br />

or its affiliates shall be excluded in the determination of<br />

any Required Lender votes, (ii) Term Loans owned or<br />

held <strong>by</strong> Lassonde <strong>and</strong> its affiliates shall not at any time,<br />

in the aggregate for all such persons, exceed 20% of the<br />

then aggregate outst<strong>and</strong>ing principal amount of the Term<br />

Loans, (iii) neither Lassonde nor any of its affiliates shall<br />

be permitted to attend any “lender-only” conference calls<br />

or meetings or receive any related “lender-only”<br />

information, (iv) each Affiliated Lender shall<br />

acknowledge <strong>and</strong> agree that the loans owned <strong>by</strong> it shall<br />

be non-voting under sections 1126 <strong>and</strong> 1129 of the<br />

Bankruptcy Code in the event that any proceeding<br />

thereunder shall be instituted <strong>by</strong> or against Borrower or<br />

any other Credit Party, or, alternatively, to the extent that<br />

the foregoing non-voting designation is deemed<br />

unenforceable for any reason, each Affiliated Lender<br />

shall vote in such proceedings in the same proportion as<br />

the allocation of voting with respect to such matter <strong>by</strong><br />

those Lenders who are not Affiliated Lenders, (v) the<br />

Affiliated Lenders may not purchase Term Loans at any<br />

time while they or any of their respective directors or<br />

officers is aware of any non-public information with<br />

respect to the business of Parent, the Borrower or any of<br />

their subsidiaries at the time of such purchase that has<br />

not been disclosed generally to private side lenders that<br />

could reasonably be expected to have a material effect<br />

upon, or otherwise be material to, a Lender’s decision to


NYI-4378475v10 15<br />

assign the Term Loans <strong>and</strong> (vi) other customary<br />

limitations to be agreed.<br />

Cost <strong>and</strong> Yield Protection ...................Each holder of Term Loans will receive cost <strong>and</strong> interest<br />

rate protection customary for facilities <strong>and</strong> transactions of<br />

this type (as reasonably determined <strong>by</strong> the Arrangers),<br />

including compensation in respect of prepayments, taxes<br />

(including gross-up provisions for withholding taxes<br />

imposed <strong>by</strong> any governmental authority <strong>and</strong> income taxes<br />

associated with all gross-up payments), changes in<br />

capital requirements, guidelines or policies or their<br />

interpretation or application, illegality, change in<br />

circumstances, reserves <strong>and</strong> other provisions reasonably<br />

deemed necessary <strong>by</strong> the Arrangers to provide customary<br />

protection for U.S. <strong>and</strong> non-U.S. financial institutions<br />

<strong>and</strong> other lenders.<br />

Expenses................................................The Borrower shall pay (i) all reasonable out-of-pocket<br />

expenses of the Administrative Agent, the Collateral<br />

Agent, the Syndication Agent <strong>and</strong> the Arrangers<br />

associated with the syndication of the Term Loan Facility<br />

<strong>and</strong> the preparation, negotiation, execution, delivery <strong>and</strong><br />

administration of the Term Loan Documents <strong>and</strong> any<br />

amendment or waiver with respect thereto (including the<br />

charges of IntraLinks, SyndTrak or a similar service <strong>and</strong><br />

the reasonable fees, disbursements <strong>and</strong> other charges of<br />

external counsel (but limited, in the case of legal fees <strong>and</strong><br />

expenses, to the reasonable <strong>and</strong> documented fees,<br />

disbursements <strong>and</strong> other charges of (a) one transaction<br />

counsel to the Administrative Agent, the Collateral<br />

Agent, the Syndication Agent <strong>and</strong> the Arrangers, taken as<br />

a whole, <strong>and</strong> (b) if necessary, one local counsel in any<br />

relevant jurisdiction (including Canada <strong>and</strong><br />

Luxembourg), in each case, to the Administrative Agent,<br />

the Collateral Agent, the Syndication Agent <strong>and</strong> the<br />

Arrangers, taken as a whole) <strong>and</strong> (ii) all out-of-pocket<br />

expenses of the Administrative Agent, the Collateral<br />

Agent, the Syndication Agent, the Arrangers, any other<br />

agent appointed in respect of the Term Loan Facility <strong>and</strong><br />

the Lenders (including the fees, disbursements <strong>and</strong> other<br />

charges of external counsel <strong>and</strong> consultants) in<br />

connection with the enforcement of the Term Loan<br />

Documents.<br />

Indemnification ....................................The Term Loan Document will contain customary<br />

indemnities (as reasonably determined <strong>by</strong> the Arrangers)<br />

for (i) the Arrangers, the Collateral Agent, the<br />

Administrative Agent <strong>and</strong> the Lenders, (ii) each affiliate<br />

of any of the foregoing persons <strong>and</strong> (iii) each of the<br />

respective officers, directors, partners, trustees,


NYI-4378475v10 16<br />

employees, affiliates, shareholders, advisors, agents,<br />

attorneys-in-fact <strong>and</strong> controlling persons of each of the<br />

foregoing persons referred to in clauses (i) <strong>and</strong> (ii) above<br />

(other than as a primary result of such entity’s or<br />

person’s gross negligence or willful misconduct as<br />

determined <strong>by</strong> a court of competent jurisdiction in a final<br />

<strong>and</strong> non-appealable ruling).<br />

Governing Law <strong>and</strong> Forum.................The Term Loan Documents will be governed <strong>by</strong> New<br />

York law <strong>and</strong> will provide for the Credit Parties to<br />

submit to the exclusive jurisdiction <strong>and</strong> venue of the<br />

Federal <strong>and</strong> state courts of the State of New York.<br />

Counsel to Jefferies Finance, as an<br />

Arranger, the Collateral Agent<br />

<strong>and</strong> the Administrative Agent ......Jones Day, McCarthy Tétrault (Canada) <strong>and</strong> Arendt &<br />

Medernach (Luxembourg).


NYI-4378475v10<br />

ANNEX A<br />

Interest <strong>and</strong> Certain Fees<br />

Interest Rate Options..............................The Borrower may elect that the Term Loans comprising<br />

each borrowing bear interest at a rate per annum equal to:<br />

(i) the Base Rate plus the Applicable Margin; or<br />

(ii) the Eurodollar Rate plus the Applicable Margin.<br />

As used herein:<br />

“Applicable Margin” means: (i) 2.75%, in the case of<br />

Base Rate Loans (as defined below) <strong>and</strong> (ii) 3.75%, in the<br />

case of Eurodollar Loans (as defined below).<br />

“Base Rate” means the highest of (i) the “U.S. Prime<br />

Lending Rate” as published in The Wall Street Journal<br />

(the “Prime Rate”), (ii) the federal funds effective rate<br />

from time to time, plus 0.50%, (iii) the Eurodollar Rate<br />

for a one-month interest period plus 1.00% <strong>and</strong> (iv)<br />

2.25%.<br />

“Eurodollar Rate” means the higher of (i) the rate per<br />

annum (adjusted for statutory reserve requirements for<br />

Eurocurrency liabilities) at which Eurodollar deposits are<br />

offered in the interbank Eurodollar market for the<br />

applicable interest period, as quoted on Reuters Screen<br />

LIBOR01 Page (or any successor page or service) <strong>and</strong> (ii)<br />

1.25%.<br />

The Borrower may elect interest periods of one, two,<br />

three or six months for Eurodollar Loans.<br />

Interest Payment Dates ..........................With respect to Term Loans bearing interest based upon<br />

the Base Rate (“Base Rate Loans”), quarterly in arrears<br />

on the last day of each calendar quarter <strong>and</strong> on the<br />

applicable maturity date.<br />

With respect to Term Loans bearing interest based upon<br />

the Eurodollar Rate (“Eurodollar Loans”), on the last day<br />

of each relevant interest period <strong>and</strong>, in the case of any<br />

interest period longer than three months, on each<br />

successive date three months after the first day of such<br />

interest period <strong>and</strong> on the applicable maturity date.<br />

Default Rate ...........................................At any time during a default or an event of default under<br />

the Term Loan Facility, outst<strong>and</strong>ing Term Loans <strong>and</strong><br />

other amounts payable under the Term Loan Facility shall<br />

bear interest at 2.00% above the rates otherwise<br />

Annex A-1


NYI-4378475v10<br />

applicable to such Loans (or, in the case of other<br />

amounts, the rates otherwise applicable to Base Rate<br />

Loans) <strong>and</strong> shall be payable on dem<strong>and</strong>.<br />

Rate <strong>and</strong> Fee Basis.................................All per annum rates shall be calculated on the basis of a<br />

year of 360 days (or 365/366 days, in the case of Base<br />

Rate Loans the interest rate payable on which is then<br />

based on the Prime Rate) for the actual number of days<br />

elapsed (including the first day but excluding the last<br />

day).<br />

* * *<br />

Annex A-2


NYI-4378475v10<br />

EXHIBIT B TO COMMITMENT LETTER<br />

SUMMARY <strong>OF</strong> TERMS <strong>OF</strong> THE REVOLVING CREDIT FACILITY<br />

Set forth below is a summary of certain of the terms of the Revolving Credit Facility <strong>and</strong> the<br />

documentation related thereto. Capitalized terms used <strong>and</strong> not otherwise defined in this Exhibit B have<br />

the meanings set forth elsewhere in this Commitment Letter.<br />

VI. Parties<br />

Borrower...............................................After giving effect to the Acquisition (as defined below),<br />

Clement Pappas <strong>and</strong> Company, Inc., a New Jersey<br />

corporation (the “Borrower”).<br />

Guarantors ...........................................Pomona Holdings, Inc., a Delaware corporation, a<br />

Delaware corporation, which is the direct parent<br />

company of the Borrower (the “Parent”), <strong>and</strong> each of its<br />

direct <strong>and</strong> indirect subsidiaries (other than any subsidiary<br />

that is a “controlled foreign corporation,” within the<br />

meaning of section 957 of the United States Tax Code (a<br />

“CFC”) to the extent making such CFC a guarantor<br />

would result in material adverse tax consequences to the<br />

Borrower) (collectively, the “Guarantors”; the Borrower<br />

<strong>and</strong> the Guarantors, collectively, the “Credit Parties”,<br />

with each being a “Credit Party”).<br />

Joint Lead Arrangers <strong>and</strong> Book Bank of Montreal (“BMO”) <strong>and</strong>/or one or more of its<br />

Runners .......................................... designees <strong>and</strong> Jefferies Finance LLC (“Jefferies<br />

Finance”) <strong>and</strong>/or one or more of its designees (in such<br />

capacities, each an “Arranger” <strong>and</strong>, together, the<br />

“Arrangers”). The Arrangers will perform the duties<br />

customarily associated with such role.<br />

Sole Syndication Agent........................Jefferies Finance <strong>and</strong>/or one or more of its designees (in<br />

such capacity, the “Syndication Agent”).<br />

Administrative Agent...........................BMO <strong>and</strong>/or one or more of its designees (in such<br />

capacity, the “Administrative Agent”). The<br />

Administrative Agent will perform the duties customarily<br />

associated with such role.<br />

Collateral Agent ...................................BMO <strong>and</strong>/or one or more of its designees (in such<br />

capacity, the “Collateral Agent”). The Collateral Agent<br />

will perform the duties customarily associated with such<br />

role.<br />

Lenders .................................................A syndicate of banks, financial institutions <strong>and</strong> other<br />

entities (the “Lenders”) arranged <strong>by</strong> the Administrative<br />

Agent in consultation with the Borrower.<br />

Closing Date..........................................The date, on or before the date on which the<br />

Commitments are terminated in accordance with Section


NYI-4378475v10 2<br />

15 of the Commitment Letter, on which the Acquisition<br />

is consummated <strong>and</strong> the funding of the Term Loans (as<br />

defined in Exhibit A) occurs (the “Closing Date”).<br />

Revolving Credit Documents ..............The definitive documentation governing or evidencing<br />

the Revolving Credit Facility (collectively, the<br />

“Revolving Credit Documents”).<br />

VII. Types <strong>and</strong> Amounts of Facilities<br />

Revolving Credit Facility ....................A five-year revolving credit facility (the “Revolving<br />

Credit Facility”) in an aggregate principal amount equal<br />

to $50.0 million (the loans thereunder, the “Revolving<br />

Loans”).<br />

Maturity...........................................The Revolving Credit Facility shall be available on a<br />

revolving basis during the period commencing on the<br />

Closing Date <strong>and</strong> ending on the fifth anniversary of the<br />

Closing Date (the “Revolving Credit Termination<br />

Date”). The Revolving Credit Facility will be undrawn<br />

on the Closing Date (other than up to an aggregate<br />

principal amount of not more than $25.0 million in<br />

addition to (i) any required “flex” original issue discount<br />

<strong>and</strong> upfront fees <strong>and</strong> (ii) to the extent necessary, the cash<br />

collateralization or the issuance of letters of credit to<br />

backstop, any existing outst<strong>and</strong>ing letters of credit of the<br />

Acquired Business which will remain outst<strong>and</strong>ing on the<br />

Closing Date). Amounts repaid under the Revolving<br />

Credit Facility may be reborrowed.<br />

Borrowing Base...............................The amount from time to time available under the<br />

Revolving Credit Facility, including any Letters of<br />

Credit, shall not exceed the sum of (i) 85% of eligible<br />

accounts receivable plus (ii) the lesser of (x) 65% of<br />

eligible inventory <strong>and</strong> (y) 85% of the net orderly<br />

liquidation value of eligible inventory minus (iii) such<br />

reserves the Administrative Agent may establish from<br />

time to time (in each case, to be reasonably determined<br />

<strong>by</strong> the Administrative Agent on the basis of periodic<br />

appraisals <strong>and</strong> collateral examinations) (collectively, the<br />

“Borrowing Base”). The advance rates <strong>and</strong> eligibility<br />

<strong>and</strong> reserve criteria to be utilized in the calculation of the<br />

Borrowing Base shall be determined (a) on or prior to the<br />

Closing Date, in the permitted discretion of the<br />

Administrative Agent after notice to the Borrower (<strong>and</strong> in<br />

any event shall require a valid first priority perfected<br />

security interest in all eligible assets included in the<br />

Borrowing Base), <strong>and</strong> (b) following the Closing Date, the<br />

advance rates, eligibility criteria <strong>and</strong> reserves for the<br />

Borrowing Base may reasonably be adjusted <strong>by</strong> the<br />

Administrative Agent based on the results of periodic


NYI-4378475v10 3<br />

appraisals <strong>and</strong> collateral examinations.<br />

“Eligible accounts receivable”, “eligible inventory” <strong>and</strong><br />

“net orderly liquidation value” will be fully defined in<br />

the Revolving Facility Documents in accordance with<br />

customary practices for transactions of this nature.<br />

Ineligible accounts will include (but not be limited to)<br />

accounts over 90 days past the original invoice date or<br />

over 60 days past the original due date, insolvent or<br />

bankrupt accounts, chargebacks/short-pays, customer<br />

accounts with cash in advance terms, discounts,<br />

allowances, rebates, <strong>and</strong> rebate accruals, contra accounts,<br />

foreign accounts not backed <strong>by</strong> letters of credit or<br />

acceptable credit insurance (Canadian accounts are<br />

eligible), consignment sale receivables, bill <strong>and</strong> holds,<br />

progress billings <strong>and</strong> pre billed accounts. Advance rate<br />

would be subject to a dilution test.<br />

Ineligible inventory will include (but not be limited to)<br />

inventory that is not located in the United States or<br />

Canada, in-transit with a common carrier from vendors,<br />

or suppliers, work in process, packaging <strong>and</strong> supplies,<br />

seasonings, processing plant parts <strong>and</strong> supplies,<br />

consignment, subject to recall or similar notice, samples,<br />

slow moving, damaged, aged, or obsolete inventory.<br />

Finished goods items located at locations with less than<br />

$100,000 of total inventory would be ineligible.<br />

Inventory located on leased facilities, mortgaged<br />

premises or at third-party warehouses will be eligible for<br />

a period of 60 days following the Closing Date <strong>and</strong>,<br />

thereafter, to the extent an acceptable waiver letter is<br />

executed <strong>and</strong> delivered to the Administrative Agent.<br />

Reserves shall include, but not be limited to, a reserve<br />

related to the Perishable Agricultural Commodities Act<br />

<strong>and</strong> associated outst<strong>and</strong>ing checks or accrued liabilities.<br />

Letters of Credit...............................A portion of the Revolving Credit Facility not in excess<br />

of an amount to be determined shall be available for the<br />

issuance of commercial <strong>and</strong> st<strong>and</strong><strong>by</strong> letters of credit (the<br />

“Letters of Credit”) <strong>by</strong> BMO <strong>and</strong>/or one or more of its<br />

affiliate designees <strong>and</strong>, if applicable, one or more other<br />

Lenders to be selected <strong>by</strong> the Administrative Agent in<br />

consultation with the Borrower (each such Lender in<br />

such capacity, an “Issuing Lender”). The face amount of<br />

any outst<strong>and</strong>ing Letters of Credit will reduce availability<br />

under the Revolving Credit Facility on a dollar-for-dollar<br />

basis. No Letter of Credit shall have an expiration date<br />

after the earlier of (i) one year after the date of issuance<br />

<strong>and</strong> (ii) 30 days prior to the Revolving Credit<br />

Termination Date; provided that any Letter of Credit with


NYI-4378475v10 4<br />

a one-year tenor may provide for the renewal thereof for<br />

additional one-year periods (which shall in no event<br />

extend beyond the date referred to in clause (ii) above).<br />

Drawings under any Letter of Credit shall be reimbursed<br />

<strong>by</strong> the Borrower (whether with its own funds or with the<br />

proceeds of Revolving Loans) on the same business day.<br />

To the extent that the Borrower does not so reimburse the<br />

Issuing Lender, the Lenders shall be irrevocably <strong>and</strong><br />

unconditionally obligated to reimburse the Issuing<br />

Lender on a pro rata basis.<br />

Swing Line Loans...................................A portion of the Revolving Credit Facility not in excess<br />

of an amount to be determined shall be available for<br />

swing line loans (the “Swing Line Loans”) from BMO or<br />

one of its designees (in such capacity, the “Swing Line<br />

Lender”) of small <strong>and</strong> late-day draws. Any such Swing<br />

Line Loans will reduce availability under the Revolving<br />

Credit Facility on a dollar-for-dollar basis. Each Lender<br />

shall acquire, under certain circumstances, an irrevocable<br />

<strong>and</strong> unconditional pro rata participation in each Swing<br />

Line Loan.<br />

Availability Block...................................Until such time a collateral audit <strong>and</strong> inventory appraisal<br />

are completed <strong>and</strong> satisfactorily reviewed <strong>by</strong><br />

Administrative Agent, an availability block of<br />

$10,000,000 will be in effect. Audit <strong>and</strong> appraisal to be<br />

completed no later than 90 days after closing.<br />

Use of Proceeds .....................................The proceeds of the Revolving Loans will be used to<br />

finance a portion of Purchase Price <strong>and</strong> other costs, fees<br />

<strong>and</strong> expenses with respect to the Transactions, including<br />

any required “flex” original issue discount or equivalent<br />

upfront fees, <strong>and</strong> for the general corporate purposes of<br />

the Borrower, including permitted acquisitions <strong>and</strong><br />

permitted restricted payments. Letters of Credit will be<br />

used to support payment <strong>and</strong> performance obligations<br />

incurred in the ordinary course of business <strong>by</strong> the<br />

Borrower <strong>and</strong> its subsidiaries.<br />

VIII. Certain Payment Provisions<br />

Fees <strong>and</strong> Interest Rates........................As set forth on Annex A hereto.<br />

Optional Prepayments <strong>and</strong><br />

Commitment Reductions ..............Optional prepayments of borrowings under the<br />

Revolving Credit Facility <strong>and</strong> optional reductions of the<br />

unutilized portion of the commitments under the<br />

Revolving Credit Facility will be permitted at any time,<br />

in minimum principal amounts to be agreed, without<br />

premium or penalty, subject to reimbursement of the<br />

Lenders’ redeployment costs in the case of a prepayment


NYI-4378475v10 5<br />

of Eurodollar Loans other than on the last day of the<br />

relevant interest period (which costs shall be computed<br />

without regard to the Applicable Margin).<br />

M<strong>and</strong>atory Prepayments <strong>and</strong><br />

Commitment Reductions ..............Subject to the terms of the Intercreditor Agreement, the<br />

following amounts will be applied to reduce the<br />

Revolving Loans:<br />

IX. Collateral <strong>and</strong> Guarantees.<br />

The Revolving Loans will be prepaid <strong>and</strong> the Letters<br />

of Credit will be cash collateralized or replaced if<br />

<strong>and</strong> to the extent that such extensions of credit at any<br />

time exceed the lesser of (i) the amount of the<br />

commitments in respect of the Revolving Credit<br />

Facility or (ii) the then-current Borrowing Base.<br />

50% of the net proceeds of any sale or issuance of<br />

equity <strong>by</strong>, or capital contribution to, the Parent (with<br />

exceptions to be agreed upon).<br />

100% of the net proceeds of any incurrence of<br />

indebtedness after the Closing Date <strong>by</strong> the Parent or<br />

any of its subsidiaries (other than purchase money<br />

indebtedness <strong>and</strong> other exceptions to be agreed<br />

upon).<br />

100% of the net proceeds of any non-ordinary course<br />

sale or other disposition of assets <strong>by</strong> the Parent or<br />

any of its subsidiaries (including (i) as a result of<br />

casualty or condemnation <strong>and</strong> (ii) any issuance or<br />

sale of equity <strong>by</strong> the Borrower or any of its<br />

subsidiaries), with certain exceptions <strong>and</strong><br />

reinvestment rights to be agreed upon.<br />

All such m<strong>and</strong>atory prepayments shall be (i) applied to<br />

the Revolving Credit Facility (including to cash<br />

collateralize Letters of Credit) with, during the existence<br />

of a default or event of default, at the election of the<br />

Administrative Agent, a concurrent <strong>and</strong> permanent<br />

reduction of the commitments thereunder <strong>and</strong> (ii) without<br />

premium or penalty, subject to reimbursement of the<br />

Lenders’ redeployment costs in the case of a prepayment<br />

of Eurodollar Loans other than on the last day of the<br />

relevant interest period (which costs shall be computed<br />

without regard to the Applicable Margin).<br />

Collateral ..............................................The obligations of each Credit Party in respect of (a) the<br />

Revolving Credit Facility, (b) any interest rate hedging<br />

obligations owed to an entity that was a Lender or an<br />

affiliate of a Lender at the time of such transaction


NYI-4378475v10 6<br />

(“Permitted Secured Hedging Obligations”), <strong>and</strong> (c) any<br />

liabilities resulting from funds transfer, deposit account<br />

<strong>and</strong> other cash management arrangements owed to an<br />

entity that was a Lender or an affiliate of a Lender at the<br />

time of such transaction (“Permitted Cash Management<br />

Obligations”) will be secured <strong>by</strong> a perfected security<br />

interest in substantially all of the Collateral (as defined in<br />

Exhibit A) provided that (i) the Revolving Credit<br />

Documents will waive the attachment or perfection of<br />

property if, in the reasonable discretion of the<br />

Administrative Agent, the costs of obtaining such<br />

attachment or perfection in such assets or perfection<br />

thereof are excessive in relation to the benefit to the<br />

Lenders of the security to be afforded there<strong>by</strong>, <strong>and</strong> (ii)<br />

equity interests in any person other than wholly owned<br />

subsidiaries will be pledged only to the extent permitted<br />

<strong>by</strong> the terms of such person’s organizational or joint<br />

venture documents.<br />

The Credit Parties <strong>and</strong> the Collateral Agent would enter<br />

into access agreements that would permit the Collateral<br />

Agent, subject to the Intercreditor Agreement, upon an<br />

Event of Default <strong>and</strong> exercise <strong>by</strong> Collateral Agent of its<br />

remedies under the Revolving Credit Documents, the<br />

right to use, at no cost, any pledged or unpledged<br />

equipment, real property, <strong>and</strong> intangible assets to<br />

process, finish out, collect or otherwise realize upon the<br />

assets so pledged to Collateral Agent.<br />

Each Credit Party shall cause all proceeds of its<br />

receivables (whether evidenced <strong>by</strong> accounts, instruments,<br />

chattel paper, payment intangibles or otherwise) to be<br />

deposited into a deposit account / lockbox under the sole<br />

control of the Collateral Agent subject to the terms of the<br />

Intercreditor Agreement. Any time Excess Availability<br />

(defined as the difference between the Borrowing Base<br />

<strong>and</strong> any Revolving Loans outst<strong>and</strong>ing <strong>and</strong> Letters of<br />

Credit issued under the Revolving Credit Facility) is less<br />

than $10,000,000 for three consecutive days, all proceeds<br />

shall in turn be applied on a daily basis to reduce the<br />

Revolving Loans to <strong>and</strong> other obligations of the<br />

Borrower then outst<strong>and</strong>ing under the Revolver Credit<br />

Facility (whether or not then due). The Borrower may<br />

spring out of cash dominion so long as the Borrower<br />

maintains Excess Availability exceeding $10,000,000 for<br />

60 consecutive days.<br />

The Credit Parties shall, within 90 days subsequent to the<br />

Closing Date <strong>and</strong> at all times thereafter prior to the<br />

Revolving Credit Termination Date, maintain all<br />

operating accounts (other than local convenience<br />

accounts carrying a balance <strong>and</strong> payroll accounts, in each


NYI-4378475v10 7<br />

case, not to exceed an amount to be agreed upon) at the<br />

Administrative Agent or its affiliates.<br />

The obligations of each Credit Party in respect of the<br />

Revolving Credit Facility <strong>and</strong> the Term Loan Facility<br />

will be secured <strong>by</strong> perfected liens having the priority<br />

described below under the caption “Lien Ranking.”<br />

Notwithst<strong>and</strong>ing anything herein to the contrary, the<br />

Collateral securing the Term Loan Facility will be the<br />

same as the collateral securing the Revolving Credit<br />

Facility.<br />

All such security interests will be created pursuant to<br />

documentation reasonably satisfactory in all respects to<br />

the Collateral Agent (including, in the case of real<br />

property, <strong>by</strong> customary items such as reasonably<br />

satisfactory title insurance, including endorsements,<br />

surveys <strong>and</strong> flood certificates) <strong>and</strong>, on the Closing Date,<br />

subject to the Certain Funds Provision, such security<br />

interests shall have become perfected <strong>and</strong> the Collateral<br />

Agent shall have received reasonably satisfactory<br />

evidence as to the enforceability <strong>and</strong> priority thereof.<br />

Guarantees............................................The Guarantors will unconditionally guarantee the<br />

obligations of each Credit Party in respect of the<br />

Facilities <strong>and</strong> the Permitted Secured Hedging Obligations<br />

<strong>and</strong> Permitted Cash Management Obligations (the<br />

“Guarantees”). Such Guarantees will be in form <strong>and</strong><br />

substance reasonably satisfactory to the Administrative<br />

Agent. All Guarantees shall be guarantees of payment<br />

<strong>and</strong> performance, <strong>and</strong> not of collection.<br />

Lien Ranking ........................................All indebtedness <strong>and</strong> other obligations under the<br />

Revolving Credit Facility <strong>and</strong> Permitted Secured<br />

Hedging Obligations <strong>and</strong> Permitted Cash Management<br />

Obligations <strong>and</strong> any guarantees of the foregoing<br />

(collectively, the “Revolving Facility Obligations”) will<br />

rank pari passu in right of payment to all of the<br />

indebtedness under the Term Loans <strong>and</strong> any guarantees<br />

thereof (collectively, the “Term Loan Obligations”), in<br />

each case, pursuant to the terms of an intercreditor<br />

agreement reasonably satisfactory to the Administrative<br />

Agent <strong>and</strong> the Lenders under the Revolving Credit<br />

Facility <strong>and</strong> the administrative agent <strong>and</strong> the lenders, in<br />

each case, in their reasonable discretion (the<br />

“Intercreditor Agreement”).<br />

Collateral Consisting of Non-Current Assets. The Term<br />

Loan Obligations will be secured <strong>by</strong> a first priority lien<br />

on the Collateral consisting of “non-current assets” (the<br />

definition of which is to be agreed upon), including a<br />

pledge of all the capital stock directly held <strong>by</strong> any Credit


X. Other Provisions<br />

NYI-4378475v10 8<br />

Party in any subsidiary (including the stock of the<br />

Borrower held <strong>by</strong> the Parent), <strong>and</strong> the Revolving Credit<br />

Obligations will be secured <strong>by</strong> a second priority lien on<br />

such Collateral, in each case, subject to the terms of the<br />

Intercreditor Agreement.<br />

Collateral Consisting of Current Assets. The Revolving<br />

Facility Obligations will be secured <strong>by</strong> a first priority<br />

lien on the Collateral consisting of “current assets” (the<br />

definition of which is to be agreed upon), including cash,<br />

accounts receivable, inventory <strong>and</strong> any proceeds thereof<br />

to the extent such foregoing assets do not constitute the<br />

proceeds of “non-current assets”, <strong>and</strong> the Term Loan<br />

Obligations will be secured <strong>by</strong> a second priority lien on<br />

such Collateral, in each case, subject to the terms of the<br />

Intercreditor Agreement.<br />

Representations <strong>and</strong> Warranties ........Customary for facilities <strong>and</strong> transactions of this type (as<br />

reasonably determined <strong>by</strong> the Administrative Agent, <strong>and</strong><br />

subject to customary materiality qualifications) <strong>and</strong><br />

others reasonably deemed appropriate <strong>by</strong> the<br />

Administrative Agent for this transaction in particular,<br />

including as to: organization <strong>and</strong> powers; authorization<br />

<strong>and</strong> enforceability of Revolving Credit Documents; no<br />

conflicts; financial statements, projections <strong>and</strong> other<br />

information; no material adverse effect; properties;<br />

intellectual property; equity interests <strong>and</strong> subsidiaries;<br />

litigation <strong>and</strong> compliance with laws <strong>and</strong> other regulatory<br />

matters; organizational documents, contractual<br />

obligations <strong>and</strong> material agreements; federal reserve<br />

regulations; Investment Company Act of 1940, as<br />

amended, <strong>and</strong> other laws restricting incurrence of debt;<br />

use of proceeds; taxes; accuracy <strong>and</strong> completeness of<br />

disclosure; labor matters; solvency; employee benefit<br />

plans <strong>and</strong> ERISA; environmental matters; insurance;<br />

security documents <strong>and</strong> validity, perfection <strong>and</strong> priority<br />

of security interests in the Collateral; acquisition<br />

documents; anti-terrorism laws, money laundering<br />

activities <strong>and</strong> dealing with embargoed persons <strong>and</strong>, if<br />

applicable, status as senior debt <strong>and</strong> as designated senior<br />

debt.<br />

Affirmative Covenants.........................Customary for facilities <strong>and</strong> transactions of this type (as<br />

reasonably determined <strong>by</strong> the Administrative Agent, <strong>and</strong><br />

subject to customary materiality qualifications) <strong>and</strong><br />

others reasonably deemed appropriate <strong>by</strong> the<br />

Administrative Agent for this transaction in particular,<br />

including as to: delivery of financial statements, reports,<br />

accountants’ letters, projections, officers’ certificates,<br />

borrowing base certificates, periodic collateral


NYI-4378475v10 9<br />

examinations, appraisals <strong>and</strong> other information; notices<br />

of litigation <strong>and</strong> other material events; existence;<br />

maintenance of business <strong>and</strong> properties; insurance;<br />

obligations <strong>and</strong> taxes; employee benefits <strong>and</strong> ERISA;<br />

maintaining records; access to properties <strong>and</strong> inspections;<br />

use of proceeds; compliance with environmental laws;<br />

environmental reports; interest rate protection; additional<br />

collateral <strong>and</strong> additional guarantors; security interests;<br />

further assurances; information regarding collateral;<br />

maintenance of corporate separateness, post-closing<br />

matters (if any); regulatory matters; holding an annual<br />

lenders’ meeting; <strong>and</strong> using commercially reasonable<br />

efforts to maintain monitored public corporate<br />

family/corporate credit ratings.<br />

Negative Covenants..............................Customary for facilities <strong>and</strong> transactions of this type (as<br />

reasonably determined <strong>by</strong> the Administrative Agent, <strong>and</strong><br />

subject to exceptions <strong>and</strong> baskets to be agreed upon) <strong>and</strong><br />

others reasonably deemed appropriate <strong>by</strong> the<br />

Administrative Agent for this transaction in particular,<br />

including limitations on indebtedness (including<br />

m<strong>and</strong>atorily redeemable equity interests, guarantees <strong>and</strong><br />

other contingent obligations); liens; sale <strong>and</strong> leaseback<br />

transactions; investments, loans <strong>and</strong> advances; asset<br />

sales; mergers, acquisitions, consolidations, liquidations<br />

<strong>and</strong> dissolutions; dividends <strong>and</strong> other payments in respect<br />

of equity interests <strong>and</strong> other restricted payments;<br />

transactions with affiliates; capital expenditures;<br />

prepayments of other indebtedness; modifications of<br />

organizational documents, acquisition documents <strong>and</strong><br />

certain other documents; limitations on certain<br />

restrictions on subsidiaries; limitations on issuance of<br />

capital stock <strong>and</strong> creation of subsidiaries; limitations on<br />

business activities; limitations on accounting changes;<br />

changes in fiscal year <strong>and</strong> fiscal quarter; lease<br />

obligations; no further negative pledges; anti-terrorism<br />

laws, money laundering activities <strong>and</strong> dealing with<br />

embargoed persons; <strong>and</strong> limitations on holding a material<br />

portion of the Collateral in non-US jurisdictions. Special<br />

purpose “holding company” covenants shall apply at all<br />

times to the Parent.<br />

The above limitation on restricted payments will permit<br />

restricted payments to the Parent, which will be permitted<br />

to make such restricted payments to its parent holding<br />

companies <strong>and</strong> ultimate shareholders, (i) in an aggregate<br />

amount not to exceed the “Cumulative Credit” (to be<br />

defined); provided that, both before <strong>and</strong> after giving pro<br />

forma effect to any such payment, (x) no default or event<br />

of default exists, (y) the unused availability under the<br />

Revolving Credit Facility shall be not less than<br />

$30,000,000 <strong>and</strong> (z) the total gross leverage ratio shall be


NYI-4378475v10 10<br />

less than 2.50 to 1.00; provided, further, that not more<br />

than $6,000,000 of such restricted payments may be paid<br />

in any 12-month period ending on or before the third<br />

anniversary of the Closing Date <strong>and</strong> (ii) to pay the<br />

reasonable <strong>and</strong> customary expenses of such parent<br />

holding companies, such as professional fees, taxes <strong>and</strong><br />

directors’ <strong>and</strong> officers’ liability insurance, not to exceed<br />

in any year an aggregate amount to be agreed upon.<br />

Financial Covenants.............................Minimum Fixed Charge Coverage Ratio (“FCCR”),<br />

measured on a consolidated basis in accordance with<br />

GAAP for the Borrower <strong>and</strong> its subsidiaries, defined as<br />

the ratio of EBITDA less unfinanced capital<br />

expenditures, to the sum of regularly scheduled principal<br />

payments, dividends, repurchases <strong>and</strong> other restricted<br />

payments, cash taxes, <strong>and</strong> cash interest expense for the<br />

same period of 1.10x.<br />

The Borrower will be required (subject to the conditions<br />

described in the two immediately following sentences) to<br />

maintain a minimum FCCR beginning the first quarter<br />

subsequent to the Closing Date <strong>and</strong> each quarter<br />

thereafter on a cumulative basis building to a most<br />

recently ended twelve month period. The FCCR will be<br />

calculated for the most recently ended quarter any time<br />

Excess Availability is less than $10,000,000 for three<br />

consecutive days. The FCCR will revert to nonreporting,<br />

so long as the Borrower maintains Excess<br />

Availability of greater than or equal to $10,000,000 for<br />

60 consecutive days.<br />

Reporting Requirements .....................Annual audited consolidated financial statements for the<br />

Borrower within 120 days of fiscal year end.<br />

Monthly company-prepared consolidated <strong>and</strong><br />

consolidating financial statements for the Borrower<br />

within 30 days of month end (except for quarter-end<br />

periods). Quarterly company-prepared consolidated <strong>and</strong><br />

consolidating financial statements for the Borrower<br />

within 45 days of quarter end.<br />

Monthly accounts receivable aging (including<br />

reconciliation of cash <strong>and</strong> receivables), accounts payable<br />

aging, <strong>and</strong> inventory status reports within 20 days of<br />

month end.<br />

Monthly covenant compliance certificates signed <strong>by</strong> the<br />

Borrower’s Chief Financial Officer or Director of<br />

Finance within 30 days of month end <strong>and</strong> 45 days of<br />

quarter end.<br />

Monthly borrowing base certificates signed <strong>by</strong> the


NYI-4378475v10 11<br />

Borrower’s chief financial officer within 20 days of<br />

month end. In the event Excess Availability is less than<br />

$10,000,000 for three consecutive days; then weekly<br />

(within 3 business days of week end) at the<br />

Administrative Agent’s request. Weekly borrowing base<br />

reporting will revert to monthly, so long as the Borrower<br />

maintains Excess Availability exceeding $10,000,000 for<br />

60 consecutive days. Weekly borrowing base certificates<br />

consist of rolling forward accounts receivable data <strong>by</strong><br />

reporting weekly sales, cash collections, <strong>and</strong> credits.<br />

Gross inventory, inventory ineligibles, <strong>and</strong> accounts<br />

receivable ineligibles are reported monthly.<br />

Collateral audits may be conducted <strong>by</strong> a firm acceptable<br />

to the Administrative Agent at the Borrower’s expense<br />

during the term of the Revolving Credit Facility of up to<br />

two (2) times annually, provided there is no default or<br />

event of default.<br />

Inventory appraisals may be conducted <strong>by</strong> a firm<br />

acceptable to the Administrative Agent at the Borrower’s<br />

expense during the term of the Revolving Credit Facility<br />

up to one time annually, provided there is no default or<br />

event of default.<br />

A copy of the Borrower’s operating budget for the<br />

following fiscal year no later than 30 days after the end<br />

of each fiscal year.<br />

Other information <strong>and</strong> reports as may be reasonably<br />

requested <strong>by</strong> any Lender. All reports <strong>and</strong> financial<br />

statements will be in form <strong>and</strong> scope reasonably<br />

acceptable to the Administrative Agent <strong>and</strong> the Required<br />

Lenders, including comparison to budget <strong>and</strong> prior<br />

comparable period.<br />

Notice of any change of control, Material Adverse Effect,<br />

incipient default or event of default, or material adverse<br />

litigation or governmental proceeding.<br />

Conditions Precedent...........................Conditions precedent to initial borrowings under the<br />

Revolving Credit Facility are set forth in Section 3 of the<br />

Commitment Letter <strong>and</strong> in Exhibit C hereto. Conditions<br />

precedent to each borrowing or issuance under the<br />

Revolving Credit Facility after the Closing Date will be<br />

(1) the absence of any continuing default or event of<br />

default, (2) the accuracy of all representations <strong>and</strong><br />

warranties, <strong>and</strong> (3) receipt of a customary borrowing<br />

notice or letter of credit request, as applicable.<br />

Events of Default..................................Customary for facilities <strong>and</strong> transactions of this type (as<br />

reasonably determined <strong>by</strong> the Administrative Agent) <strong>and</strong>


NYI-4378475v10 12<br />

others reasonably deemed appropriate <strong>by</strong> the<br />

Administrative Agent for this transaction in particular (in<br />

certain cases, subject to customary <strong>and</strong> appropriate grace<br />

<strong>and</strong> cure periods <strong>and</strong> materiality thresholds to be agreed)<br />

including as to: nonpayment of principal when due;<br />

nonpayment of interest, fees or other amounts when due;<br />

inaccuracy of representations <strong>and</strong> warranties in any<br />

material respect; violation of covenants; cross-defaults;<br />

bankruptcy <strong>and</strong> insolvency events; material judgments;<br />

ERISA events; actual or asserted invalidity or<br />

impairment of the Intercreditor Agreement, guarantees,<br />

security documents or any other Revolving Credit<br />

Documents (including the failure of any lien on any<br />

portion of the Collateral to remain perfected with the<br />

priority required under the Revolving Credit<br />

Documents); <strong>and</strong> a change of control or ownership (to be<br />

defined in a manner reasonably satisfactory to the<br />

Administrative Agent).<br />

Equity Cure Rights ..............................In the event that the Borrower fails to satisfy one or more<br />

financial maintenance covenants, the Revolving Credit<br />

Documents will contain certain equity cure rights<br />

pursuant to which, subject to the terms <strong>and</strong> conditions<br />

thereof (which shall be reasonably satisfactory in all<br />

respects to the Administrative Agent), the proceeds of<br />

common equity contributions <strong>by</strong> one or more<br />

shareholders of Pappas Lassonde Holdings, Inc., directly<br />

or indirectly, to Parent that are then contributed as cash<br />

common equity <strong>by</strong> Parent to the Borrower (“Equity Cure<br />

Contributions”) shall be treated on a dollar-for-dollar<br />

basis as EBITDA of the Borrower for purposes of<br />

retroactively curing the default(s) under such financial<br />

covenant(s); provided that (i) in each four fiscal quarter<br />

period, there shall be a period of at least two consecutive<br />

fiscal quarters in respect of which no Equity Cure<br />

Contributions are made, (ii) in each eight fiscal quarter<br />

period, there shall be a period of at least four consecutive<br />

fiscal quarters in respect of which no Equity Cure<br />

Contributions are made, (iii) no more than four Equity<br />

Cure Contributions may be made during the term of the<br />

Revolving Credit Facility; (iv) the amount of any Equity<br />

Cure Contributions in any fiscal quarter shall be no<br />

greater than the amount required to cause the Borrower to<br />

be in compliance with the financial covenant as at the<br />

end of such fiscal quarter, <strong>and</strong> (v) all Equity Cure<br />

Contributions shall be disregarded for all purposes other<br />

than retroactively curing defaults under the financial<br />

covenant, including being disregarded for purposes of<br />

determining any baskets with respect to the covenants<br />

contained in the Revolving Credit Documents.


Voting....................................................Amendments <strong>and</strong> waivers with respect to the Revolving<br />

Credit Documents will require the approval of Lenders<br />

holding not less than a majority of the aggregate principal<br />

amount of the Revolving Loans including participations<br />

in Letters of Credit <strong>and</strong> Swing Line Loans <strong>and</strong> unused<br />

commitments under the Revolving Credit Facility<br />

(provided that if there are only two Lenders, the approval<br />

of both Lenders will be required) (the “Required<br />

Lenders”), except that (i) the consent of each Lender<br />

directly affected there<strong>by</strong> shall be required with respect to<br />

(a) reductions in the amount or extensions of the final<br />

maturity of any Revolving Loan held <strong>by</strong> such Lender,<br />

(b) reductions in the rate of interest (other than a waiver<br />

of default interest) or any fee or other amount payable or<br />

extensions of any due date thereof, (c) increases in the<br />

amount or extensions of the expiration date of such<br />

Lender’s commitment or (d) modifications to the<br />

assignment provisions of the Revolving Credit<br />

Documents that further restrict assignments thereunder,<br />

(ii) the consent of 100% of the Lenders shall be required<br />

with respect to (a) reductions of any of the voting<br />

percentages or pro rata provisions, (b) releases of all or<br />

substantially all of the value of the guarantees of the<br />

Guarantors or of all or substantially all of the Collateral<br />

(other than in connection with permitted asset sales),<br />

other than releases of Guarantors (<strong>and</strong> their related<br />

Collateral) expressly permitted under the terms of the<br />

Revolving Credit Facility Documents, or (c) assignments<br />

<strong>by</strong> any Credit Party of its rights or obligations under the<br />

Revolving Credit Facility Documents <strong>and</strong> (iii) the<br />

consent of Lenders holding not less than 66-2/3% of the<br />

aggregate principal amount of the Revolving Loans<br />

including participations in Letters of Credit <strong>and</strong> Swing<br />

Line Loans <strong>and</strong> unused commitments under the<br />

Revolving Credit Facility shall be required with respect<br />

to any amendment or waiver that would have the effect<br />

of (A) changing eligibility criteria with respect to the<br />

Borrowing Base, (B) increasing the advance rates under<br />

the Borrowing Base or (C) otherwise increasing the<br />

availability under the Borrowing Base.<br />

NYI-4378475v10 13<br />

Unless as otherwise provided herein, the Revolving<br />

Credit Documents shall contain customary provisions<br />

relating to “defaulting” Lenders <strong>and</strong> agents (including for<br />

insolvency), including provisions relating to providing<br />

cash collateral to support Swing Line Loans or Letters of<br />

Credit, the suspension of voting rights, rights to receive<br />

certain fees, <strong>and</strong> termination or assignment of<br />

commitments or Revolving Loans of such Lenders.<br />

Assignments <strong>and</strong> Participations..........The Lenders shall be permitted to assign <strong>and</strong> sell<br />

participations in their loans <strong>and</strong> commitments subject, in


NYI-4378475v10 14<br />

the case of assignments (other than assignments to<br />

another Lender, an affiliate of a Lender or an approved<br />

fund (to be defined in the Revolving Credit Documents)),<br />

to the consent of (x) the Administrative Agent, (y) the<br />

Issuing Lender <strong>and</strong> the Swing Line Lender <strong>and</strong> (z) except<br />

in connection with the syndication of the Revolving<br />

Loans <strong>and</strong> the related commitments <strong>and</strong> so long as (i) no<br />

default or event of default has occurred <strong>and</strong> is then<br />

continuing, <strong>and</strong> (ii) such assignment is to an entity other<br />

than another Lender, an affiliate of a Lender or an<br />

approved fund, the Borrower (which consent shall not be<br />

unreasonably withheld, delayed or conditioned);<br />

provided that the Borrower shall be deemed to have<br />

consented to such assignment if the Borrower does not<br />

otherwise rejected in writing such assignment within five<br />

(5) business days of the date on which such assignment is<br />

requested; provided further that, the Revolving Credit<br />

Facility shall not be participated or assigned to any<br />

natural person, Parent, the Borrower or any of their<br />

respective affiliates. In the case of partial assignments<br />

(other than to another Lender, an affiliate of a Lender or<br />

an approved fund), the minimum assignment amount<br />

shall be $5.0 million with respect to Revolving Loans.<br />

Assignments will be <strong>by</strong> novation. The Administrative<br />

Agent shall receive an administrative fee of $3,500 in<br />

connection with each assignment unless otherwise agreed<br />

<strong>by</strong> the Administrative Agent.<br />

Participants shall have the same benefits as the Lenders<br />

with respect to yield protection <strong>and</strong> increased cost<br />

provisions, <strong>and</strong> will be subject to customary limitations<br />

on voting rights (as reasonably determined <strong>by</strong> the<br />

Administrative Agent). Pledges of Revolving Loans in<br />

accordance with applicable law shall be permitted<br />

without restriction. Promissory notes shall be issued<br />

under the Revolving Credit Facility only upon request.<br />

The Revolving Credit Documents shall contain<br />

customary provisions (as reasonably determined <strong>by</strong> the<br />

Administrative Agent) for replacing non-consenting<br />

Lenders in connection with amendments <strong>and</strong> waivers<br />

requiring the consent of all Lenders or of all Lenders<br />

directly affected there<strong>by</strong> so long as Lenders holding at<br />

least a majority of the aggregate principal amount of the<br />

loans including participations in Letters of Credit <strong>and</strong><br />

Swing Line Loans <strong>and</strong> unused commitments under the<br />

Revolving Credit Facility shall have consented thereto.<br />

Defaulting Lenders...............................The Senior Loan Documents shall contain customary<br />

provisions relating to “defaulting” Lenders, including<br />

provisions relating to providing cash collateral to support


NYI-4378475v10 15<br />

Swing Line Loans or Letters of Credit, the suspension of<br />

voting rights <strong>and</strong> of rights to receive certain fees, <strong>and</strong><br />

termination or assignment of commitments or Revolving<br />

Loans of such Lenders.<br />

Cost <strong>and</strong> Yield Protection ...................Each holder of Revolving Loans <strong>and</strong> the Issuing Lender<br />

will receive cost <strong>and</strong> interest rate protection customary<br />

for facilities <strong>and</strong> transactions of this type (as reasonably<br />

determined <strong>by</strong> the Administrative Agent), including<br />

compensation in respect of prepayments, taxes (including<br />

gross-up provisions for withholding taxes imposed <strong>by</strong><br />

any governmental authority <strong>and</strong> income taxes associated<br />

with all gross-up payments), changes in capital<br />

requirements, guidelines or policies or their interpretation<br />

or application, illegality, change in circumstances,<br />

reserves <strong>and</strong> other provisions reasonably deemed<br />

necessary <strong>by</strong> the Administrative Agent to provide<br />

customary protection for U.S. <strong>and</strong> non-U.S. financial<br />

institutions <strong>and</strong> other lenders.<br />

Expenses................................................The Borrower shall pay (i) all reasonable out-of-pocket<br />

expenses of the Administrative Agent, the Collateral<br />

Agent, the Syndication Agent <strong>and</strong> the Arrangers<br />

associated with the syndication of the Revolving Credit<br />

Facility <strong>and</strong> the preparation, negotiation, execution,<br />

delivery <strong>and</strong> administration of the Revolving Credit<br />

Documents <strong>and</strong> any amendment or waiver with respect<br />

thereto (including expenses arising from inventory<br />

appraisals <strong>and</strong> field exams incurred in connection with<br />

the closing <strong>and</strong> as otherwise provided for herein, the<br />

charges of IntraLinks, SyndTrak or a similar service <strong>and</strong><br />

the reasonable fees, disbursements <strong>and</strong> other charges of<br />

external counsel (but limited, in the case of legal fees <strong>and</strong><br />

expenses, to the reasonable <strong>and</strong> documented fees,<br />

disbursements <strong>and</strong> other charges of (a) one transaction<br />

counsel to the Administrative Agent, the Collateral<br />

Agent, the Syndication Agent <strong>and</strong> the Arrangers, taken as<br />

a whole, <strong>and</strong> (b) if necessary, one local counsel in any<br />

relevant jurisdiction (including Canada <strong>and</strong><br />

Luxembourg), in each case, to the Administrative Agent,<br />

the Collateral Agent, the Syndication Agent <strong>and</strong> the<br />

Arrangers, taken as a whole) <strong>and</strong> (ii) all out-of-pocket<br />

expenses of the Administrative Agent, the Collateral<br />

Agent, the Syndication Agent, the Arrangers, any other<br />

agent appointed in respect of the Revolving Credit<br />

Facility <strong>and</strong> the Lenders (including the fees,<br />

disbursements <strong>and</strong> other charges of external counsel <strong>and</strong><br />

consultants) in connection with the enforcement of the<br />

Revolving Credit Documents.


Indemnification ....................................The Revolving Credit Documents will contain customary<br />

indemnities (as reasonably determined <strong>by</strong> the<br />

Administrative Agent) for (i) the Arrangers, the<br />

Collateral Agent, the Administrative Agent <strong>and</strong> the<br />

Lenders, (ii) each affiliate of any of the foregoing<br />

persons <strong>and</strong> (iii) each of the respective officers, directors,<br />

partners, trustees, employees, affiliates, shareholders,<br />

advisors, agents, attorneys-in-fact <strong>and</strong> controlling persons<br />

of each of the foregoing persons referred to in clauses (i)<br />

<strong>and</strong> (ii) above (other than as a primary result of such<br />

entity’s or person’s gross negligence or willful<br />

misconduct as determined <strong>by</strong> a court of competent<br />

jurisdiction in a final <strong>and</strong> non-appealable ruling).<br />

Governing Law <strong>and</strong> Forum.................The Revolving Credit Documents will be governed <strong>by</strong><br />

New York law <strong>and</strong> will provide for the Credit Parties to<br />

submit to the exclusive jurisdiction <strong>and</strong> venue of the<br />

Federal <strong>and</strong> state courts of the State of New York.<br />

Counsel to BMO, as an Arranger,<br />

the Collateral Agent <strong>and</strong> the<br />

Administrative Agent ....................Goldberg Kohn Ltd.<br />

NYI-4378475v10 16


NYI-4378475v10<br />

ANNEX A<br />

Interest <strong>and</strong> Certain Fees<br />

Interest Rate Options .............................The Borrower may elect that the Revolving Loans<br />

comprising each borrowing bear interest at a rate per<br />

annum equal to:<br />

(i) the Base Rate plus the Applicable Margin; or<br />

(ii) the Eurodollar Rate plus the Applicable Margin;<br />

provided that all Swing Line Loans shall bear interest<br />

based upon the Base Rate for Revolving.<br />

The Borrower may elect interest periods of one, two,<br />

three or six months for Eurodollar Loans.<br />

As used herein:<br />

“Applicable Margin” means a percentage determined in<br />

accordance with the pricing grid attached hereto as<br />

Annex A-I.<br />

“Base Rate” means the highest of (i) the “U.S. Prime<br />

Lending Rate” as published in The Wall Street Journal<br />

(the “Prime Rate”), (ii) the federal funds effective rate<br />

from time to time, plus 0.50% <strong>and</strong> (iii) the Eurodollar<br />

Rate for a one-month interest period plus 1.00%.<br />

“Eurodollar Rate” means the rate per annum (adjusted<br />

for statutory reserve requirements for Eurocurrency<br />

liabilities) at which Eurodollar deposits are offered in the<br />

interbank Eurodollar market for the applicable interest<br />

period, as quoted on Reuters Screen LIBOR01 Page (or<br />

any successor page or service).<br />

Interest Payment Dates ..........................With respect to Revolving Loans bearing interest based<br />

upon the Base Rate (“Base Rate Loans”), quarterly in<br />

arrears on the last day of each calendar quarter <strong>and</strong> on the<br />

applicable maturity date.<br />

With respect to Revolving Loans bearing interest based<br />

upon the Eurodollar Rate (“Eurodollar Loans”), on the<br />

last day of each relevant interest period <strong>and</strong>, in the case of<br />

any interest period longer than three months, on each<br />

successive date three months after the first day of such<br />

interest period <strong>and</strong> on the applicable maturity date.<br />

Unutilized Commitment Fee .................The Borrower shall pay a commitment fee calculated at<br />

the applicable rate set forth in Annex A-I attached hereto<br />

on the average daily unused portion of the Revolving<br />

Credit Facility, payable quarterly in arrears. Swing Line<br />

Loans shall, for purposes of the commitment fee


NYI-4378475v10<br />

calculations only, not be deemed to be a utilization of the<br />

Revolving Credit Facility.<br />

Letter of Credit Fees..............................The Borrower shall pay a commission on all outst<strong>and</strong>ing<br />

Letters of Credit at a per annum rate equal to the<br />

Applicable Margin then in effect with respect to<br />

Revolving Loans made or maintained as Eurodollar<br />

Loans on the face amount of each such Letter of Credit.<br />

Such commission shall be shared ratably <strong>among</strong> the<br />

Lenders participating in the Revolving Credit Facility <strong>and</strong><br />

shall be payable quarterly in arrears.<br />

In addition to letter of credit commissions, a fronting fee<br />

calculated at a rate per annum of 0.375% on the face<br />

amount of each Letter of Credit shall be payable quarterly<br />

in arrears to the Issuing Lender for its own account. In<br />

addition, customary (as determined <strong>by</strong> the Issuing<br />

Lender) administrative, issuance, amendment, payment<br />

<strong>and</strong> negotiation charges shall be payable to the Issuing<br />

Lender for its own account.<br />

Default Rate...........................................At any time during a default or an event of default under<br />

the Revolving Credit Facility, at the election of the<br />

Administrative Agent or Required Lenders, outst<strong>and</strong>ing<br />

Revolving Loans <strong>and</strong> other amounts payable under the<br />

Revolving Credit Facility shall bear interest at 2.00%<br />

above the rates otherwise applicable to such Loans (or, in<br />

the case of other amounts, the rates otherwise applicable<br />

to Base Rate Loans) <strong>and</strong> shall be payable on dem<strong>and</strong>.<br />

Rate <strong>and</strong> Fee Basis.................................All per annum rates shall be calculated on the basis of a<br />

year of 360 days (or 365/366 days, in the case of Base<br />

Rate Loans the interest rate payable on which is then<br />

based on the Prime Rate) for the actual number of days<br />

elapsed (including the first day but excluding the last<br />

day).<br />

* * *


Average Excess<br />

Availability for Most<br />

Recently-Ended Quarter<br />

NYI-4378475v10<br />

ANNEX A-I TO EXHIBIT B<br />

TO COMMITMENT LETTER<br />

Pricing Grid - Revolving Loans<br />

Applicable Margin -<br />

Eurodollar Loans<br />

Unutilized<br />

Commitment Fee<br />

Applicable Margin -<br />

Base Rate Loans<br />

Greater than<br />

$30,000,000 1.75% 0.375% 0.75%<br />

Greater than<br />

$15,000,000, but less<br />

than or equal to<br />

$30,000,000 2.00% 0.375% 1.00%<br />

Less than or equal to<br />

$15,000,000 2.25% 0.375% 1.25%<br />

* * *


NYI-4378475v10<br />

EXHIBIT C TO COMMITMENT LETTER<br />

CLOSING CONDITIONS<br />

Capitalized terms used but not defined in this Exhibit C have the meanings assigned to them<br />

elsewhere in this Commitment Letter. The closing of the Facilities <strong>and</strong> the making of the initial loans <strong>and</strong><br />

other extensions of credit under the Facilities are conditioned upon satisfaction of , <strong>among</strong> other things, the<br />

conditions precedent contained in Section 3 of this Commitment Letter, including those summarized<br />

below. For purposes of this Exhibit C, references to the “Arrangers,” “we”, “us” or “our” means Jefferies<br />

Finance, Jefco, BMO <strong>and</strong> their respective affiliates.<br />

(i) GENERAL CONDITIONS<br />

1. Concurrent Financings. The Equity Contribution shall have been made <strong>and</strong> the Acquiror<br />

shall have received the proceeds thereof which, together with the proceeds on the Closing Date from the<br />

Debt Financing, shall be sufficient to pay the Purchase Price, the Refinancing <strong>and</strong> all related fees,<br />

commissions <strong>and</strong> expenses. The Definitive Debt Documents shall be prepared <strong>by</strong> our respective counsel<br />

(<strong>and</strong>, in the case of the Intercreditor Agreement, <strong>by</strong> Jones Day), shall be consistent with the Commitment<br />

Letter <strong>and</strong> Exhibit A, Exhibit B <strong>and</strong> this Exhibit C, shall have been executed <strong>and</strong> delivered <strong>by</strong> the<br />

Borrower <strong>and</strong> the Guarantors to the Administrative Agents under the Facilities <strong>and</strong> shall be in form <strong>and</strong><br />

substance reasonably satisfactory to each of us <strong>and</strong> you. The Arrangers shall be satisfied that, after giving<br />

effect to the Transactions, the Term Loans shall have been advanced under the Term Loan Facility <strong>and</strong> the<br />

Revolving Credit Facility shall be in full force <strong>and</strong> effect.<br />

2. Transactions. The Transactions (including the Acquisition) shall have been consummated<br />

or will be consummated concurrently with or immediately following the making of the Equity<br />

Contribution, the borrowing of the Term Loans, <strong>and</strong> the receipt <strong>by</strong> the Acquiror of the proceeds of the<br />

foregoing, in each case, in accordance with the Merger Agreement <strong>and</strong> the definitive documentation<br />

relating thereto (the “Definitive Acquisition Documents”) <strong>and</strong> the Merger Agreement shall not have been<br />

amended, modified or waived in any manner materially adverse to the Lenders or the Arrangers in their<br />

respective capacities as such without the consent of each of the Arrangers (it being understood <strong>and</strong> agreed<br />

that (1) any reduction in the purchase price in excess of 5% thereof or that does not result in a<br />

proportionate reduction in the aggregate principal amount of each of the Facilities, escrow of purchase<br />

price hold back amounts <strong>and</strong> any release or use of such escrowed proceeds shall be materially adverse to<br />

the interest of the Lenders <strong>and</strong>/or either of the Arrangers, (2) any change to the definition of “Material<br />

Adverse Effect” or any similar definition shall be deemed to be materially adverse to the interests of the<br />

Lenders <strong>and</strong> the Arrangers, <strong>and</strong> (3) any modifications to any of the provisions relating to any<br />

Administrative Agent’s, Collateral Agent’s, Arranger’s or Lender’s liability, jurisdiction or status as a<br />

third party beneficiary under the Merger Agreement shall be deemed to be materially adverse to the<br />

interest of the Lenders <strong>and</strong> the Arrangers). The Equity Contribution shall have been made in the manner<br />

<strong>and</strong> in at least the amount set forth in the Commitment Letter plus, if the consideration paid under the<br />

Definitive Acquisition Documents is increased after the date hereof, an amount equal to such increase.<br />

3. Refinancing of Existing Debt. Concurrently with the consummation of the Acquisition,<br />

the Refinancing of the Existing Debt of the Acquired Business shall have been consummated, all<br />

commitments relating thereto shall have been terminated, <strong>and</strong> all liens or security interests related thereto<br />

shall have been terminated or released. After giving effect to the Transactions, the Company shall have<br />

outst<strong>and</strong>ing no indebtedness or “Disqualified Stock” (as such term shall be defined in the Definitive Debt<br />

Documents) (or direct or indirect guarantee or other credit support in respect thereof) other than (i) the<br />

indebtedness in respect of the Debt Financing, (ii) capital lease obligations <strong>and</strong> purchase money<br />

indebtedness in an aggregate principal amount not exceeding $1.2 million <strong>and</strong> (iii) such other limited<br />

indebtedness as may be agreed to <strong>by</strong> each of the Arrangers.


4. Financial Statements; Financial Performance. Each Arranger shall have received (A)<br />

audited consolidated balance sheets <strong>and</strong> related statements of income, stockholders’ equity <strong>and</strong> cash flows<br />

of the Acquired Business for the last three full fiscal years ended at least 90 days prior to the Closing Date;<br />

it being acknowledged that such Arranger has received financial statements responsive to this clause (A)<br />

that are satisfactory to the such Arranger, (B) unaudited consolidated balance sheets <strong>and</strong> related statements<br />

of income, stockholders’ equity <strong>and</strong> cash flows of the Acquired Business for each subsequent interim<br />

quarterly period ended at least 45 days prior to the Closing Date (<strong>and</strong> the corresponding period for the<br />

prior fiscal year) <strong>and</strong> (C) a pro forma consolidated balance sheet <strong>and</strong> related pro forma consolidated<br />

statement of income (but not a pro forma statement of cash flows) of the Borrower (after giving effect to<br />

the Acquisition <strong>and</strong> the other Transactions) as of <strong>and</strong> for the twelve-month period ending on the last day of<br />

the most recently completed four-fiscal quarter period ended at least 90 days prior to the Closing Date (if<br />

such period is a fiscal year) or at least 45 days prior to the Closing Date (if such period is a fiscal quarter),<br />

prepared after giving effect to the Acquisition <strong>and</strong> other Transactions as if the Transactions had occurred<br />

as of such date (in the case of such balance sheet) or at the beginning of such period (in the case of the<br />

statement of income); provided that each such pro forma financial statement shall be prepared in good<br />

faith <strong>by</strong> the Borrower. Such financial statements shall show pro forma total leverage of the Parent <strong>and</strong> its<br />

consolidated subsidiaries after giving effect to the Transactions (calculated in a manner we agree is<br />

appropriate, but which will take into account any deleveraging resulting from increased Equity<br />

Contributions), for the twelve-month period ended on the Test Date of not greater than 4.5 to 1.0. As used<br />

in the preceding sentence, the term “Test Date” shall mean June 26, 2011; provided that if the Closing<br />

Date (as defined in the Merger Agreement) is extended to a date after August 15, 2011, the “Test Date”<br />

shall be the last day of the latest fiscal month for which financial statements are available.<br />

5. Business Plan; Projections. You shall have delivered to each Arranger a business plan of<br />

the Acquired Business for fiscal years 2011 through <strong>and</strong> including 2017, <strong>and</strong> satisfactory projections<br />

(including the assumptions on which such projections are based) for the Company for fiscal years 2011<br />

through <strong>and</strong> including 2017 (it being agreed that the business plan <strong>and</strong> projections received <strong>by</strong> Jefferies<br />

Finance on May 13, 2011 are satisfactory to each Arranger).<br />

6. Marketing Period. Each Arranger shall have been afforded a period (the “Marketing<br />

Period”) of at least 20 consecutive business days prior to the Closing Date (ending on the business day no<br />

later than the business day immediately prior to the Closing Date) following receipt of the Confidential<br />

Information Memor<strong>and</strong>um.<br />

7. Performance of Obligations. All costs, fees, expenses (including legal fees <strong>and</strong> expenses,<br />

title premiums, survey charges <strong>and</strong> recording taxes <strong>and</strong> fees) <strong>and</strong> other compensation <strong>and</strong> amounts<br />

contemplated <strong>by</strong> the Debt Financing Letters or otherwise payable to us, the Lenders or any of our or their<br />

respective affiliates, shall have been paid to the extent due. You shall have complied in all material<br />

respects with all of your covenants <strong>and</strong> obligations under the Debt Financing Letters <strong>and</strong> the Debt<br />

Financing Letters shall be in full force <strong>and</strong> effect.<br />

8. Customary Closing Documents. All documents required to be delivered under the<br />

Definitive Debt Documents, including delivery of a notice of borrowing, lien, litigation <strong>and</strong> tax searches,<br />

certificates of insurance <strong>and</strong> customary legal opinions, corporate records <strong>and</strong> documents from public<br />

officials <strong>and</strong> officers’ certificates shall have been delivered. Without limiting the foregoing, you shall<br />

have delivered (a) at least five business days prior to the Closing Date, all documentation <strong>and</strong> other<br />

information required <strong>by</strong> bank regulatory authorities under applicable “know-your-customer” <strong>and</strong> antimoney<br />

laundering rules <strong>and</strong> regulations, including the Patriot Act,(b) a certificate from the chief financial<br />

officer of the Borrower in the form set forth as Annex I hereto certifying that the Borrower <strong>and</strong> its<br />

subsidiaries on a consolidated basis after giving effect to the Transactions are solvent <strong>and</strong> (c) a customary<br />

borrowing base certificate<br />

9. Accuracy of Representations <strong>and</strong> Warranties. The Merger Agreement Representations<br />

<strong>and</strong> the Specified Representations shall be true <strong>and</strong> correct in all material respects.<br />

NYI-4378475v10


10. Absence of Default. No event of default that is expressly set forth opposite the “Events of<br />

Default” heading in Exhibit A or Exhibit B shall have occurred <strong>and</strong> be continuing, other than (i) any event<br />

of default that has occurred <strong>and</strong> is continuing <strong>by</strong> reference to a Credit Party’s breach of any covenant in the<br />

Definitive Debt Documents <strong>and</strong> (ii) any event of default that has occurred <strong>and</strong> is continuing <strong>by</strong> reference to<br />

the breach <strong>by</strong> any Credit Party of any representation or warranty that is not a Specified Representation or a<br />

Merger Agreement Representation.<br />

11. Security. The Collateral Agents, for the benefit of the Lenders under the Facilities, shall<br />

have been granted perfected security interests in all assets of the Credit Parties to the extent described in<br />

Exhibit A <strong>and</strong> Exhibit B to this Commitment Letter under the captions “Collateral” <strong>and</strong> with the priority<br />

described under the captions “Lien Ranking” in form <strong>and</strong> substance satisfactory to the Arrangers; provided<br />

that this condition is subject to the Certain Funds Provisions.<br />

NYI-4378475v10


NYI-4378475v10<br />

ANNEX I TO EXHIBIT C<br />

FORM <strong>OF</strong> SOLVENCY CERTIFICATE<br />

SOLVENCY CERTIFICATE<br />

of<br />

[<strong>CLEMENT</strong> PAPPAS <strong>AND</strong> COMPANY, INC.]<br />

<strong>AND</strong> ITS SUBSIDIARIES<br />

Pursuant to the Credit Agreement 1 , the undersigned here<strong>by</strong> certifies, solely in such undersigned's<br />

capacity as [chief financial officer] [specify other officer with equivalent duties] of the Borrower, <strong>and</strong> not<br />

individually, as follows:<br />

As of the date hereof, after giving effect to the consummation of the Transactions, including<br />

the making of the Loans under the Credit Agreement on the date hereof, <strong>and</strong> after giving effect<br />

to the application of the proceeds of such Loans:<br />

a. The fair value of the assets of the Borrower <strong>and</strong> its subsidiaries, on a<br />

consolidated basis, exceeds, on a consolidated basis, their debts <strong>and</strong><br />

liabilities, subordinated, contingent or otherwise;<br />

b. The present fair saleable value of the property of the Borrower <strong>and</strong> its subsidiaries,<br />

on a consolidated basis, is greater than the amount that will be required to pay the<br />

probable liability, on a consolidated basis, of their debts <strong>and</strong> other liabilities,<br />

subordinated, contingent or otherwise, as such debts <strong>and</strong> other liabilities become<br />

absolute <strong>and</strong> matured;<br />

c. The Borrower <strong>and</strong> its subsidiaries, on a consolidated basis, are able to pay their<br />

debts <strong>and</strong> liabilities, subordinated, contingent or otherwise, as such liabilities<br />

become absolute <strong>and</strong> matured; <strong>and</strong><br />

d. The Borrower <strong>and</strong> its subsidiaries, on a consolidated basis, are not engaged in, <strong>and</strong><br />

are not about to engage in, business for which they have unreasonably small capital.<br />

For purposes of this Certificate, the amount of any contingent liability at any time shall be<br />

computed as the amount that would reasonably be expected to become an actual <strong>and</strong> matured liability.<br />

Capitalized terms used but not otherwise defined herein shall have the meanings assigned to them in the<br />

Credit Agreement.<br />

1 Each Credit Agreement to be defined.<br />

[Signature Page Follows]


IN WITNESS WHERE<strong>OF</strong>, the undersigned has executed this Certificate in such undersigned's capacity<br />

as [chief financial officer] [specify other officer with equivalent duties] of the Borrower, on behalf of the<br />

Borrower, <strong>and</strong> not individually, as of the date first stated above.<br />

NYI-4378475v10<br />

[BORROWER]<br />

By: ___________________________<br />

Name:<br />

Title:<br />

Annex-B-I-1


JEFFERIES FINANCE LLC BANK <strong>OF</strong> MONTREAL<br />

520 Madison Avenue 115 South LaSalle Street, 35th Fl. West<br />

New York, New York 10022 Chicago, Illinois 60603<br />

Lassonde Industries Inc.<br />

755 Principale Street<br />

Rougemont, QC J0L 1M0<br />

CANADA<br />

Attention: Guy Blanchette, Vice-President<br />

<strong>and</strong> Chief Financial Officer<br />

NYI-4379771v1<br />

FEE LETTER<br />

Re: Clement Pappas <strong>and</strong> Company, Inc.<br />

Ladies <strong>and</strong> Gentlemen:<br />

June 17, 2011<br />

We refer to the commitment letter dated the date hereof (including the exhibits, schedules<br />

<strong>and</strong> annexes thereto, the “Commitment Letter”) <strong>among</strong> Jefferies Finance LLC (“Jefferies Finance”),<br />

Bank of Montreal (“BMO” <strong>and</strong> together with Jefferies Finance, the “Arrangers” “we” or “us”) <strong>and</strong><br />

Lassonde Industries Inc. (“Lassonde” or “you”). Terms used but not defined in this letter agreement (this<br />

“Fee Letter”) shall have the meanings assigned thereto in the Commitment Letter.<br />

1. Compensation.<br />

(a) REDACTED.<br />

(b) REDACTED.<br />

(c) REDACTED.<br />

(d) Expenses. In addition to the compensation that is to be paid to us hereunder,<br />

without regard to whether the Acquisition is consummated or the Commitment Letter expires or is<br />

terminated or otherwise, you shall pay, or cause the Acquired Business to pay, each Arranger promptly as<br />

billed, all reasonable disbursements <strong>and</strong> out-of-pocket expenses incurred <strong>by</strong> such Arranger or on behalf of<br />

such Arranger in connection with our services to be rendered hereunder <strong>and</strong> under the Commitment Letter<br />

<strong>and</strong> the Transactions (including, without limitation (i) expenses of our due diligence investigation,<br />

consultants’ fees, syndication expenses, travel expenses, fees, disbursements <strong>and</strong> other expenses of<br />

counsel (but limited, in the case of legal fees <strong>and</strong> expenses, to the reasonable <strong>and</strong> documented fees,<br />

disbursements <strong>and</strong> other charges of (a) one transaction counsel to the Administrative Agent, Collateral<br />

Agent, Syndication Agent <strong>and</strong> Arrangers for the Term Loan Facility taken as a whole, (b) one transaction<br />

counsel to the Administrative Agent, Collateral Agent, Syndication Agent <strong>and</strong> Arrangers for the<br />

Revolving Credit Facility taken as a whole, (c) one local counsel in any relevant jurisdiction (including


Canada <strong>and</strong> Luxembourg) <strong>and</strong> one additional counsel for each applicable specialty, in each case, to<br />

Administrative Agent, Collateral Agent, Syndication Agent <strong>and</strong> Arrangers for the Term Loan Facility<br />

taken as a whole <strong>and</strong> (d) one local counsel in any relevant jurisdiction (including Canada <strong>and</strong><br />

Luxembourg) <strong>and</strong> one additional counsel for each applicable specialty, in each case, to Administrative<br />

Agent, Collateral Agent, Syndication Agent <strong>and</strong> Arrangers for the Revolving Credit Facility taken as a<br />

whole) <strong>and</strong> rating agency fees <strong>and</strong> expenses, <strong>and</strong> (ii) the overnight cost of providing funds for the<br />

provision of loans under the Facilities if the closing does not occur on the date specified <strong>by</strong> the Sponsor as<br />

the closing date).<br />

(e) Fees Nonrefundable. All fees hereunder, once paid, are nonrefundable <strong>and</strong> not<br />

creditable against any other fee payable in connection with any Debt Financing Letter or otherwise. All<br />

fees payable hereunder shall be earned in full on the date on which they are payable hereunder <strong>and</strong> such<br />

fees shall be payable in immediately available funds in U.S. dollars free <strong>and</strong> clear of <strong>and</strong> without<br />

deduction for any <strong>and</strong> all present or future applicable taxes, levies, imposts, deductions, charges or<br />

withholdings, <strong>and</strong> all liabilities with respect thereto (with appropriate gross-up for withholding taxes).<br />

Without limiting the foregoing, your obligation to pay fees hereunder, or to cause such fees to be paid,<br />

shall be absolute <strong>and</strong> unconditional <strong>and</strong> shall not be subject to reduction <strong>by</strong> way of setoff or counterclaim<br />

or otherwise. Jefferies Finance reserves the right to allocate, in whole or in part, to Jefferies & Company,<br />

Inc. (“Jefco”) certain fees payable to it hereunder in such manner as it <strong>and</strong> Jefco shall agree in Jefferies<br />

Finance’s <strong>and</strong> Jefco’s sole discretion. BMO reserves the right, in its sole discretion, to share all or any<br />

portion of the fees payable to it hereunder with any of its affiliates or any of the other Lenders under the<br />

Revolving Credit Facility.<br />

2. Market Flex. REDACTED<br />

3. Hedging Program. As consideration for our services in connection with the Transactions,<br />

you here<strong>by</strong> agree to offer each of Jefco <strong>and</strong> BMO or any of their respective affiliates the opportunity to<br />

bid to provide all interest rate collars, swaps, hedges <strong>and</strong> other interest rate fixing financial services <strong>and</strong><br />

foreign currency hedges for the Parent <strong>and</strong> its subsidiaries for so long as the Facilities shall be in place,<br />

<strong>and</strong> on terms <strong>and</strong> conditions <strong>and</strong> pursuant to documentation satisfactory to Jefco or BMO or any of their<br />

respective affiliates, as applicable.<br />

4. Confidentiality. This Fee Letter is delivered to you with the underst<strong>and</strong>ing that neither<br />

this Fee Letter nor any of the terms hereof may be disclosed to any third party without each Arranger’s<br />

prior written consent except (a) as required <strong>by</strong> applicable law or compulsory legal process (in which case<br />

you agree to inform us thereof prior to such disclosure <strong>and</strong> to cooperate with us such that we may<br />

adequately secure a protective order in respect thereof), <strong>and</strong> (b) to your officers, directors, employees,<br />

attorneys, accountants <strong>and</strong> advisors on a confidential <strong>and</strong> need-to-know basis <strong>and</strong> only in connection with<br />

the Transactions.<br />

5. Notices. Notice given pursuant to any of the provisions of this Fee Letter shall be in<br />

writing <strong>and</strong> shall be mailed or delivered (a) if to you, at the address set forth above, (b) if to Jefferies<br />

Finance, at our offices, at 520 Madison Avenue, New York, New York 10022, Attention: General<br />

Counsel <strong>and</strong> (c) if to BMO, at our offices at 115 South LaSalle Street, 35th Fl. West, Chicago, Illinois<br />

60603, Attention Eric Schubert.<br />

6. Counterparts. This Fee Letter may be executed in one or more counterparts, each of<br />

which will be deemed an original, but all of which taken together will constitute one <strong>and</strong> the same<br />

instrument. Delivery of an executed signature page of this Fee Letter <strong>by</strong> facsimile, PDF or other<br />

electronic transmission shall be as effective as delivery of a manually executed counterpart thereof.<br />

NYI-4379771v1 2


7. Assignment. You may not assign any of your respective rights, or be relieved of any of<br />

your respective obligations, under this Fee Letter without the prior written consent of each Arranger,<br />

which may be given or withheld in the sole discretion of such Arranger (<strong>and</strong> any purported assignment<br />

without consent, at the Arrangers’ sole option, shall be null <strong>and</strong> void). Any <strong>and</strong> all obligations of, <strong>and</strong><br />

services to be provided <strong>by</strong>, us hereunder may be performed <strong>and</strong> any <strong>and</strong> all of our rights hereunder may<br />

be exercised <strong>by</strong> or through any of either Arranger’s affiliates or branches.<br />

8. Third Party Beneficiaries. This Fee Letter has been <strong>and</strong> is made solely for the benefit of<br />

you, each Arranger <strong>and</strong> each Arranger’s affiliates, including Jefco <strong>and</strong> its affiliates, <strong>and</strong> your, each<br />

Arranger’s <strong>and</strong> their respective successors <strong>and</strong> assigns, <strong>and</strong> nothing in this Fee Letter, express or implied,<br />

is intended to confer or does confer on any other person or entity any rights or reason under or <strong>by</strong> reason<br />

of this Fee Letter or your or our agreements contained herein.<br />

9. Entire Agreement. The Debt Financing Letters incorporate the entire underst<strong>and</strong>ing of<br />

the parties <strong>and</strong> supersede all previous agreements relating to the subject matter hereof should they exist.<br />

10. Choice of Law; Jurisdiction; Waivers. The Debt Financing Letters shall be governed <strong>by</strong>,<br />

<strong>and</strong> construed in accordance with, the laws of the State of New York without regard to conflict of interest<br />

principles (other than sections 5-1401 <strong>and</strong> 5-1402 of the New York General Obligations Law). To the<br />

fullest extent permitted <strong>by</strong> applicable law, you here<strong>by</strong> irrevocably submit to the exclusive jurisdiction of<br />

any New York State court or Federal court sitting in the County of New York of the Borough of<br />

Manhattan in respect of any claim, suit, action or proceeding arising out of or relating to the provisions of<br />

any Debt Financing Letter <strong>and</strong> irrevocably agree that all claims in respect of any such claim, suit, action<br />

or proceeding may be heard <strong>and</strong> determined in any such court. You <strong>and</strong> each of us here<strong>by</strong> waives, to the<br />

fullest extent permitted <strong>by</strong> applicable law, any objection that you or either of us may now or hereafter<br />

have to the laying of venue of any such claim, suit, action or proceeding brought in any such court, <strong>and</strong><br />

any claim that any such claim, suit, action or proceeding brought in any such court has been brought in an<br />

inconvenient forum. You <strong>and</strong> each of us here<strong>by</strong> waives, to the fullest extent permitted <strong>by</strong> applicable law,<br />

any right to trial <strong>by</strong> jury with respect to any claim, suit, action or proceeding arising out of or relating to<br />

the Debt Financing Letters, any of the Transactions or any of the other transactions contemplated here<strong>by</strong><br />

or there<strong>by</strong>. The provisions of this Section 10 are intended to be effective upon the execution of this Fee<br />

Letter without any further action <strong>by</strong> you, <strong>and</strong> the introduction of a true copy of this Fee Letter into<br />

evidence shall be conclusive <strong>and</strong> final evidence as to such matters.<br />

11. Headings. The section headings in this Fee Letter have been inserted as a matter of<br />

convenience of reference, are not part of this Fee Letter <strong>and</strong> shall not affect the interpretation of this Fee<br />

Letter.<br />

12. Amendment; Waiver. This Fee Letter may not be modified or amended except in a<br />

writing duly executed <strong>by</strong> you <strong>and</strong> each Arranger. No waiver <strong>by</strong> any party of any breach of, or any<br />

provision of, this Fee Letter shall be deemed a waiver of any similar or any other breach or provision of<br />

this Fee Letter at the same or any prior or subsequent time. To be effective, a waiver must be set forth in<br />

writing signed <strong>by</strong> each waiving party <strong>and</strong> must specifically refer to this Fee Letter <strong>and</strong> the breach or<br />

provision being waived.<br />

13. Credit Parties to Become Party. On the Closing Date, you shall cause the Borrower <strong>and</strong><br />

the other Credit Parties to assume from you, on a joint <strong>and</strong> several basis, effective upon the closing of the<br />

Acquisition, any <strong>and</strong> all liabilities <strong>and</strong> obligations relating to, or arising out of, any of your duties,<br />

responsibilities <strong>and</strong> obligations under this Fee Letter, following which you shall have no further rights,<br />

obligations or duties hereunder.<br />

NYI-4379771v1 3


[Remainder of page intentionally blank]<br />

NYI-4379771v1 4


If the foregoing correctly sets forth our underst<strong>and</strong>ing, please indicate your acceptance of the<br />

terms hereof <strong>by</strong> returning to us an executed counterpart hereof, whereupon this Fee Letter shall become a<br />

binding agreement <strong>among</strong> us.<br />

Accepted <strong>and</strong> agreed to as of the<br />

date first above written:<br />

LASSONDE INDUSTRIES INC.<br />

By:<br />

Name:<br />

Title:<br />

NYI-4379771v1 5<br />

Very truly yours,<br />

JEFFERIES FINANCE LLC<br />

By:<br />

Name:<br />

Title:<br />

BANK <strong>OF</strong> MONTREAL<br />

By:<br />

Name:<br />

Title:


Exhibit E<br />

[Intentionally Omitted]<br />

16439551.17.BUSINESS E-1


Exhibit F<br />

Forms of Key Employee Agreement<br />

16439551.17.BUSINESS F-1


Exhibit G<br />

Non-competition Agreements<br />

16439551.17.BUSINESS G-1


CLEVEL<strong>AND</strong>/1223796.6<br />

EXHIBIT G<br />

SHAREHOLDER NON-COMPETITION <strong>AGREEMENT</strong><br />

SALE <strong>OF</strong> BUSINESS<br />

FINAL EXHIBIT FORM<br />

This Shareholder Non-Competition Agreement, Sale of Business (this “Agreement”) is<br />

made <strong>and</strong> executed this [] day of [] 2011 (“Closing Date”), <strong>by</strong> <strong>and</strong> between POMONA<br />

HOLDINGS, INC., a Delaware corporation (“Parent”), <strong>CLEMENT</strong> PAPPAS <strong>AND</strong> COMPANY,<br />

INC., a New Jersey corporation (the “Company”) <strong>and</strong> [] (“Beneficiary Shareholder”), a<br />

beneficiary shareholder of the Company.<br />

WHEREAS, the Company, Parent, Pomona Merger Corp., a New Jersey corporation (a<br />

wholly-owned subsidiary of Parent) (“Newco”), <strong>and</strong>, solely for the purposes of Sections 2.7, 5.10,<br />

8.3, 8.4, 8.8, 8.9 <strong>and</strong> 9.1 <strong>and</strong> Article 10 thereof, Clement David Pappas <strong>and</strong> Clement Dimitri<br />

Pappas, as the Representatives, <strong>and</strong>, solely for the purposes of Article 10 thereof, Lassonde<br />

Industries, Inc., a Canadian corporation (“Lassonde Industries”), have entered into that certain<br />

Agreement <strong>and</strong> Plan of Merger (the “Merger Agreement”) pursuant to which Newco will merge<br />

with <strong>and</strong> into the Company <strong>and</strong> pursuant to which the Company will become a subsidiary of<br />

Parent (the “Merger”);<br />

WHEREAS, Beneficiary Shareholder is a beneficiary of [TRUST NAME] (the “Trust”),<br />

which is a shareholder of the Company <strong>and</strong> which will receive consideration for the shares of the<br />

Company owned <strong>by</strong> it in connection with the Merger;<br />

WHEREAS, it is a condition to Parent’s obligations to close the transactions<br />

contemplated <strong>by</strong> the Merger Agreement, that Beneficiary Shareholder enter into this Agreement<br />

<strong>and</strong> Beneficiary Shareholder is so willing to enter into this Agreement.<br />

NOW, THEREFORE, in consideration of the merger consideration to be paid to the Trust<br />

pursuant to the Merger Agreement, receipt of which consideration <strong>by</strong> the Trust Beneficiary<br />

Shareholder acknowledges <strong>and</strong> agrees will be a material <strong>and</strong> direct benefit to Beneficiary<br />

Shareholder, <strong>and</strong> ancillary to the disposition of shares of the Company <strong>by</strong> the Beneficiary<br />

Shareholder in the Merger, Beneficiary Shareholder here<strong>by</strong> agrees as follows:<br />

I. Restriction on Beneficiary Shareholder<br />

(a) Beneficiary Shareholder agrees that, from the date hereof until the fifth<br />

anniversary of the Closing Date, 1 Beneficiary Shareholder shall not, directly or indirectly, own,<br />

manage, operate, control, invest or acquire an interest in, or otherwise engage or participate in,<br />

whether as a proprietor, partner, stockholder, member, lender, director, officer, employee, joint<br />

venturer, investor, lessor, supplier, customer, agent, representative or other participant in any<br />

1 For Clement David Pappas <strong>and</strong> Clement Dimitri Pappas section I(a) will state: Beneficiary<br />

Shareholder agrees that while he is employed with the Company <strong>and</strong> until the later of the fifth<br />

anniversary of the Closing Date or the second anniversary of the date he ceases any <strong>and</strong> all<br />

employment with the Company,


Competitive Business (“Competitive Business” is defined as any business engaged in the<br />

manufacture, sale, supply, distribution or marketing of fruit juice, beverages containing fruit<br />

juice, beverages containing fruit concentrate, beverages containing tea, functional beverages<br />

(including, without limitation, fortified water) <strong>and</strong>/or cranberry sauce) in the United States or<br />

Canada; provided, however, that Beneficiary Shareholder may, directly or indirectly, in one or a<br />

series of transactions, own, invest or acquire an interest of up to two percent (2%) of the equity<br />

securities of any publicly-traded entity.<br />

(b) Beneficiary Shareholder agrees that, from the date hereof until the fifth<br />

anniversary of the Closing Date, 2 Beneficiary Shareholder shall not, without the express written<br />

approval of the Chairman of the Board of Directors of the Company, (A) directly or indirectly, in<br />

one or a series of transactions, recruit, solicit or otherwise induce or influence any employee,<br />

investor, customer or supplier of the Company or any Related Company to discontinue, reduce or<br />

modify such business relationship with the Company or such Related Company in the United<br />

States or Canada, or (B) employ or seek to employ or cause any person to employ or seek to<br />

employ any person or agent who is then (or was at any time within one (1) year prior to the date<br />

the Beneficiary Shareholder employs or seeks to employ such person) employed or retained <strong>by</strong><br />

the Company or any Related Company; provided that clauses (A) <strong>and</strong> (B) shall not prohibit<br />

general advertisements or other communications in any media not targeted specifically at<br />

employees or customers of the Company or any Related Company. For purposes of this<br />

Agreement, (i) “Related Company” means any company during any period in which it is a<br />

subsidiary of the Company or an Affiliate of the Company <strong>and</strong> (ii) “Affiliate” means, with<br />

respect to any person, any other person directly or indirectly controlling, controlled <strong>by</strong>, or under<br />

common control with such person, with “control” (including, with correlative meanings, the<br />

terms “controlling,” “controlled <strong>by</strong>” <strong>and</strong> “under common control with”), as used with respect to<br />

any Person, shall mean the possession, directly or indirectly, of the power to direct or cause the<br />

direction of the management or policies of such Person, whether through the ownership of voting<br />

securities, <strong>by</strong> agreement or otherwise.<br />

(c) Each of the parties hereto acknowledges that the time, scope, geographic area <strong>and</strong><br />

other provisions of this Agreement have been specifically negotiated <strong>by</strong> sophisticated parties <strong>and</strong><br />

agree that all such provisions are reasonable under the circumstances of the Merger Agreement.<br />

Beneficiary Shareholder acknowledges <strong>and</strong> agrees that the terms of this Agreement (i) are<br />

reasonable in light of all of the circumstances, (ii) are sufficiently limited to protect the<br />

legitimate interests of Parent <strong>and</strong> its Affiliates <strong>and</strong> (iii) impose no undue hardship on Beneficiary<br />

Shareholder. Beneficiary Shareholder acknowledges <strong>and</strong> agrees that the restrictive covenants<br />

<strong>and</strong> other agreements contained in this Agreement are an essential part of the Merger Agreement<br />

<strong>and</strong> the transactions contemplated here<strong>by</strong>, constitute a material inducement to Lassonde<br />

Industries, Parent <strong>and</strong> Newco entering into <strong>and</strong> performing its obligations under the Merger<br />

Agreement <strong>and</strong> are an essential part of the Parent’s willingness to pay the purchase price under<br />

the Merger Agreement. Without limiting the enforceability of the foregoing, it is the intention of<br />

the parties that if any of the restrictions or covenants contained in this Agreement is held to cover<br />

2 For Clement David Pappas <strong>and</strong> Clement Dimitri Pappas section I(a) will state: Beneficiary<br />

Shareholder agrees that while he is employed with the Company <strong>and</strong> until the later of the fifth<br />

anniversary of the Closing Date or the second anniversary of the date he ceases any <strong>and</strong> all<br />

employment with the Company,<br />

CLEVEL<strong>AND</strong>/1223796.6<br />

-2-


a geographic area or to be for a length of time that is not permitted <strong>by</strong> law, or is in any way<br />

construed to be too broad or to any extent invalid, such provision shall not be construed to be<br />

null, void <strong>and</strong> of no effect, but to the extent such provision would then be valid or enforceable<br />

under law, such provision shall be construed <strong>and</strong> interpreted or reformed to provide for a<br />

restriction or covenant having the maximum enforceable geographic area, time period <strong>and</strong> other<br />

provisions as shall be valid <strong>and</strong> enforceable under law.<br />

II. Governing Law<br />

This Agreement shall be governed <strong>and</strong> construed in accordance with the laws of the State of New<br />

Jersey.<br />

III. Entire Agreement/Severability<br />

This Agreement together with the Merger Agreement <strong>and</strong> each of the transaction documents<br />

entered into in connection with the Merger Agreement set forth the entire agreement between the<br />

parties with respect to the subject matter addressed herein <strong>and</strong> supersedes any previous oral or<br />

written agreements between the parties on this subject. Beneficiary Shareholder underst<strong>and</strong>s <strong>and</strong><br />

agrees that Parent may, at any time <strong>and</strong> without further action <strong>by</strong> Beneficiary Shareholder, assign<br />

this Agreement to a subsidiary or Affiliate or successor. In the event of such an assignment, the<br />

assignee company shall succeed to all of the rights held <strong>by</strong> Parent under this Agreement.<br />

Beneficiary Shareholder agrees that this Agreement applies from the date hereof, <strong>and</strong> shall inure<br />

to the benefit of Parent, its successors <strong>and</strong> assigns, <strong>and</strong> shall be binding upon his heirs, legal<br />

representatives <strong>and</strong> assigns. The provisions of this Agreement shall be severable, <strong>and</strong> in the<br />

event that any provision of it is found <strong>by</strong> any court to be unenforceable, in whole or in part, the<br />

remainder of this Agreement shall nevertheless be enforceable <strong>and</strong> binding on the parties.<br />

CLEVEL<strong>AND</strong>/1223796.6<br />

__________________________________________<br />

Name:[] Date<br />

<strong>CLEMENT</strong> PAPPAS <strong>AND</strong> COMPANY, INC.<br />

By:<br />

Name:<br />

Title:<br />

POMONA HOLDINGS, INC.<br />

By:<br />

Name:<br />

Title:<br />

-3-


Exhibit H<br />

P-L Holdings Stockholders’ Agreement<br />

16439551.17.BUSINESS H-1


Exhibit I<br />

Form of Stock Purchase Agreement<br />

16439551.17.BUSINESS I-1


COLUMBUS/795660.8<br />

EXHIBIT I<br />

STOCK PURCHASE <strong>AGREEMENT</strong><br />

FINAL EXHIBIT FORM<br />

THIS STOCK PURCHASE <strong>AGREEMENT</strong> (this “Agreement”) is made as of<br />

[__________, 2011] <strong>by</strong> <strong>and</strong> <strong>among</strong> the persons named on Schedule A hereto (the “Purchasers”)<br />

<strong>and</strong> Pomona Holdings, Inc., a Delaware corporation (“Pomona Holdings”), pursuant to Sections<br />

6.2(p) <strong>and</strong> 6.3(e) of the Agreement <strong>and</strong> Plan of Merger dated as of [June __, 2011] <strong>by</strong> <strong>and</strong> <strong>among</strong><br />

Clement Pappas <strong>and</strong> Company, Inc., Pomona Holdings, Pomona Merger Corp., a direct whollyowned<br />

subsidiary of Pomona Holdings (“Merger Sub”), <strong>and</strong>, solely for the purposes of Sections<br />

2.7, 5.10, 8.3, 8.4, 8.8, 8.9 <strong>and</strong> 9.1 <strong>and</strong> Article 10 thereof, Clement David Pappas <strong>and</strong> Clement<br />

Dimitri Pappas, as the Representatives, <strong>and</strong>, solely for the purposes of Article 10 thereof,<br />

Lassonde Industries, Inc. (the “Merger Agreement”).<br />

WHEREAS, in connection with the merger transaction contemplated <strong>by</strong> the Merger<br />

Agreement (the “Merger”), Pappas Lassonde Holdings, Inc., a Delaware corporation <strong>and</strong> the<br />

holder of all of the outst<strong>and</strong>ing capital stock of Pomona Holdings (“P-L Holdings”), will<br />

contribute [29,000] shares of the voting common stock, par value $0.001 per share (“Common<br />

Stock”), of P-L Holdings to Pomona Holdings (the “Stock Contribution”) for immediate resale<br />

<strong>by</strong> Pomona Holdings to the Purchasers; <strong>and</strong><br />

WHEREAS, each of the Purchasers desires to purchase from Pomona Holdings, <strong>and</strong><br />

Pomona Holdings desires to sell to each Purchaser, the number of shares of Common Stock set<br />

forth opposite such Purchaser’s name on Schedule A attached hereto (collectively, the<br />

“Securities”), immediately following the Stock Contribution.<br />

NOW, THEREFORE, in consideration of the premises <strong>and</strong> of the mutual representations,<br />

warranties <strong>and</strong> covenants contained herein, <strong>and</strong> intending to be legally bound, the parties hereto<br />

agree as follows:<br />

SECTION 1. DEFINITIONS. Capitalized terms used but not defined in this<br />

Agreement shall have the respective meanings assigned to such terms in the Merger Agreement.<br />

SECTION 2. SALE <strong>AND</strong> PURCHASE <strong>OF</strong> SECURITIES. Subject to the terms <strong>and</strong><br />

conditions of this Agreement <strong>and</strong> subject to the consummation of the Merger, at the Closing<br />

referred to below each of the Purchasers agrees to purchase from Pomona Holdings, <strong>and</strong> Pomona<br />

Holdings agrees to sell to each such Purchaser, the Securities set forth opposite such Purchaser’s<br />

name on Schedule A, at a purchase price of [$1,000.00] per share (the “Per Share Price”), for the<br />

aggregate purchase price set forth opposite such Purchaser’s name on Schedule A (with respect<br />

to each Purchaser, such aggregate purchase price, the “Purchase Price”).<br />

SECTION 3. CLOSING.<br />

3.1 Closing. The closing of the transactions contemplated <strong>by</strong> this Agreement (the<br />

“Closing”) shall take place at the offices of Dechert LLP, Cira Centre, 2929 Arch Street,<br />

Philadelphia, Pennsylvania 19104, immediately after the effectiveness of the Stock Contribution<br />

on the date of the Merger (the “Closing Date”).


3.2 Closing Deliveries. At the Closing:<br />

(a) Pomona Holdings shall cause P-L Holdings to deliver to each Purchaser a<br />

stock certificate representing the Securities purchased <strong>by</strong> such Purchaser, free <strong>and</strong> clear of any<br />

Lien <strong>and</strong> in the name of such Purchaser;<br />

(b) Each Purchaser shall pay to Pomona Holdings the Purchase Price payable<br />

<strong>by</strong> such Purchaser <strong>by</strong> wire transfer of immediately available funds to an account designated <strong>by</strong><br />

Pomona Holdings or <strong>by</strong> such other method of payment as Pomona Holdings <strong>and</strong> such Purchaser<br />

shall mutually agree;<br />

(c) The Purchasers shall execute <strong>and</strong> deliver the P-L Holdings Stockholders’<br />

Agreement to P-L Holdings <strong>and</strong> the other parties thereto; <strong>and</strong><br />

(d) Pomona Holdings shall cause the P-L Holdings Stockholders’ Agreement<br />

to be executed <strong>and</strong> delivered to the Purchasers <strong>by</strong> P-L Holdings, the Surviving Corporation, the<br />

Lassonde Investor (as defined in the P-L Holdings Stockholders’ Agreement) <strong>and</strong> Lassonde<br />

(U.S.A.) Inc.<br />

3.3 Condition to Pomona Holdings’ Obligation. The Purchasers acknowledge <strong>and</strong><br />

agree that the obligation of Pomona Holdings to sell any of the Securities to any such Purchaser<br />

is expressly conditioned on the payment <strong>by</strong> each Purchaser of the Purchase Price payable <strong>by</strong><br />

each Purchaser at the Closing <strong>and</strong> the execution <strong>by</strong> each Purchaser of the P-L Holdings<br />

Stockholders’ Agreement.<br />

3.4 Condition to Obligations of Each Party Hereto. Each party hereto acknowledges<br />

<strong>and</strong> agrees that the obligations hereunder of each Purchaser <strong>and</strong> Pomona Holdings are expressly<br />

conditioned upon the prior consummation on the Closing Date of the Merger. This Agreement<br />

shall terminate automatically (without any further action <strong>by</strong> any party hereto) <strong>and</strong> be of no<br />

further force <strong>and</strong> effect, with no liability on the part of any of the parties hereto, upon<br />

termination of the Merger Agreement if the Merger has not occurred.<br />

SECTION 4. REPRESENTATIONS <strong>AND</strong> WARRANTIES <strong>OF</strong> POMONA<br />

HOLDINGS. Pomona Holdings represents <strong>and</strong> warrants to each Purchaser that the statements<br />

contained in this Section 4 are correct <strong>and</strong> complete as of the Closing Date:<br />

4.1 Organization. Pomona Holdings is a corporation duly organized, validly existing<br />

<strong>and</strong> in good st<strong>and</strong>ing under the laws of the State of Delaware. P-L Holdings is a corporation<br />

duly organized, validly existing <strong>and</strong> in good st<strong>and</strong>ing under the laws of the State of Delaware.<br />

The certificate of incorporation <strong>and</strong> <strong>by</strong>laws of each of Pomona Holdings <strong>and</strong> P-L Holdings are<br />

attached hereto as Exhibit 1.<br />

4.2 Authorization. Pomona Holdings has the power <strong>and</strong> authority to execute <strong>and</strong><br />

deliver this Agreement <strong>and</strong> to perform its obligations hereunder, <strong>and</strong> P-L Holdings has the power<br />

<strong>and</strong> authority to effect the Stock Contribution, all of which have been duly authorized <strong>by</strong> all<br />

requisite action (including any required stockholder or director approvals). This Agreement has<br />

been duly authorized, executed <strong>and</strong> delivered <strong>by</strong> Pomona Holdings <strong>and</strong> constitutes a valid <strong>and</strong><br />

COLUMBUS/795660.8<br />

2


inding agreement of Pomona Holdings, enforceable against Pomona Holdings in accordance<br />

with its terms.<br />

4.3 Non-contravention. With respect to Pomona Holdings, the execution, delivery<br />

<strong>and</strong> performance <strong>by</strong> Pomona Holdings of this Agreement <strong>and</strong> the consummation of the sales of<br />

Securities contemplated here<strong>by</strong>, <strong>and</strong> with respect to P-L Holdings, the consummation of the<br />

Stock Contribution, do not (a) contravene any provision contained in such entity’s certificate of<br />

incorporation or <strong>by</strong>-laws, (b) conflict with, violate or result in a material breach (with or without<br />

the lapse of time, the giving of notice or both) of or constitute a material default (with or without<br />

the lapse of time, the giving of notice or both) under, or require the consent or approval of any<br />

third party under (i) any contract, agreement, commitment, indenture, mortgage, lease, pledge,<br />

note, bond, license, permit or other instrument or obligation or (ii) assuming satisfaction of the<br />

requirements set forth in Section 4.4, any judgment, order, decree, statute, law, rule or regulation<br />

or other restriction of any Governmental Authority, in each case to which such entity is a party or<br />

<strong>by</strong> which it is bound or to which any of its assets or properties are subject, or (iii) result in the<br />

acceleration of, or permit any Person to terminate, modify, cancel, accelerate or declare due <strong>and</strong><br />

payable prior to its stated maturity, any material obligation of such entity.<br />

4.4 No Consents. Except for any requirement to qualify for a registration exemption<br />

under the Securities Act of 1933, as amended, or the rules <strong>and</strong> regulations promulgated<br />

thereunder (collectively, the “Securities Act”) or any applicable state securities laws, no notice<br />

to, filing with, or authorization, registration, consent or approval of any Governmental Authority<br />

is necessary for the Stock Contribution or the execution, delivery or performance of this<br />

Agreement or the consummation of the transactions contemplated here<strong>by</strong> <strong>by</strong> Pomona Holdings<br />

or P-L Holdings, except for any consents, approvals, orders, permits, authorizations,<br />

registrations, declarations, notices <strong>and</strong> filings for which no material consequences will arise from<br />

the failure to make or obtain them.<br />

4.5 Capitalization of P-L Holdings; Subsidiaries.<br />

(a) The authorized, issued <strong>and</strong> outst<strong>and</strong>ing capital stock of P-L Holdings<br />

immediately after giving effect to the Stock Contribution <strong>and</strong> the transactions contemplated <strong>by</strong><br />

this Agreement <strong>and</strong> the Merger Agreement shall be as set forth on Schedule B. P-L Holdings<br />

does not <strong>and</strong> immediately after the Closing will not have any outst<strong>and</strong>ing options or warrants<br />

relating to its capital stock or any outst<strong>and</strong>ing securities or obligations convertible into or<br />

exchangeable for, or giving any Person any right to subscribe for or acquire from it, any shares<br />

of its capital stock. Except as set forth in the P-L Holdings Stockholders’ Agreement, there are<br />

no (a) outst<strong>and</strong>ing obligations of P-L Holdings to repurchase, redeem or otherwise acquire any<br />

capital stock of P-L Holdings or (b) voting trusts, proxies or other agreements <strong>among</strong> the<br />

stockholders of P-L Holdings with respect to the voting or transfer of the capital stock of P-L<br />

Holdings. The Per Share Price equals the per share purchase price paid <strong>by</strong> each of Lassonde<br />

Investor <strong>and</strong> Lassonde (U.S.A.) Inc. to P-L Holdings in consideration for each share of Common<br />

Stock held <strong>by</strong> Lassonde Investor <strong>and</strong> Lassonde (U.S.A.) Inc. as of the Closing.<br />

(b) All of the issued <strong>and</strong> outst<strong>and</strong>ing shares of capital stock of Pomona<br />

Holdings are directly or indirectly owned <strong>by</strong> P-L Holdings free <strong>and</strong> clear of all Liens. Pomona<br />

Holdings does not <strong>and</strong> immediately after the Closing will not have any outst<strong>and</strong>ing options or<br />

COLUMBUS/795660.8<br />

3


warrants relating to its capital stock or any outst<strong>and</strong>ing securities or obligations convertible into<br />

or exchangeable for, or giving any Person any right to subscribe for or acquire from it, any<br />

shares of its capital stock. There are no (i) outst<strong>and</strong>ing obligations of Pomona Holdings to<br />

repurchase, redeem or otherwise acquire any of its capital stock or (ii) voting trusts, proxies or<br />

other agreements <strong>among</strong> its stockholders with respect to the voting or transfer of the capital stock<br />

of Pomona Holdings. All of the issued <strong>and</strong> outst<strong>and</strong>ing shares of capital stock of Pomona<br />

Holdings have been duly authorized, validly issued, are fully paid <strong>and</strong> are nonassessable.<br />

4.6 Securities. The Securities have been validly authorized, duly issued <strong>and</strong> fully<br />

paid <strong>and</strong> are nonassessable. Pomona Holdings has (<strong>and</strong> upon payment of the Purchase Price<br />

therefor at the Closing, each Purchaser shall obtain) good <strong>and</strong> marketable title to the Securities<br />

purchased <strong>by</strong> such Purchaser, free <strong>and</strong> clear of all Liens.<br />

4.7 Conduct of Business; Liabilities. Other than in connection with (a) the formation<br />

<strong>and</strong> organization of P-L Holdings, Pomona Holdings <strong>and</strong> Merger Sub <strong>and</strong> (b) the negotiation,<br />

execution <strong>and</strong> delivery of this Agreement <strong>and</strong> the Merger Agreement <strong>and</strong> the other agreements<br />

contemplated there<strong>by</strong>, prior to the consummation of the transactions contemplated <strong>by</strong> the Merger<br />

Agreement, none of P-L Holdings, Pomona Holdings <strong>and</strong> Merger Sub has (i) conducted any<br />

business, (ii) incurred any expenses, obligations or liabilities (whether accrued, absolute,<br />

contingent, unliquidated or otherwise, whether or not known <strong>and</strong> whether due or to become due<br />

<strong>and</strong> regardless of when asserted), (iii) owned any assets, (iv) entered into any contracts or<br />

agreements or (v) assuming the accuracy of the representations <strong>and</strong> warranties of the Purchasers<br />

in this Agreement, violated any applicable laws or governmental rules or regulations.<br />

4.8 Commissions <strong>and</strong> Fees. No commission, fee or other remuneration is to be paid<br />

or given, directly or indirectly, to any Person <strong>by</strong> Pomona Holdings or its Affiliates for soliciting<br />

such Purchaser to purchase the Securities.<br />

SECTION 5. REPRESENTATIONS <strong>AND</strong> WARRANTIES <strong>OF</strong> THE<br />

PURCHASERS. Each Purchaser, severally but not jointly, represents <strong>and</strong> warrants to Pomona<br />

Holdings that the statements contained in this Section 5 are correct <strong>and</strong> complete with respect to<br />

such Purchaser as of the Closing Date:<br />

5.1 Authorization. Such Purchaser has the power <strong>and</strong> authority (including, as<br />

applicable, full corporate, limited liability company, limited partnership or trustee power <strong>and</strong><br />

authority), or in the case of an individual, the capacity, to execute <strong>and</strong> deliver this Agreement<br />

<strong>and</strong> to perform such Purchaser’s obligations hereunder, all of which have been duly authorized<br />

<strong>by</strong> all requisite action. This Agreement has been duly authorized, executed <strong>and</strong> delivered <strong>by</strong> such<br />

Purchaser <strong>and</strong> constitutes a valid <strong>and</strong> binding agreement of such Purchaser, enforceable against<br />

such Purchaser in accordance with its terms.<br />

5.2 Non-contravention. The execution, delivery <strong>and</strong> performance <strong>by</strong> such Purchaser<br />

of this Agreement <strong>and</strong> the consummation of the sales of Securities contemplated here<strong>by</strong> do not<br />

<strong>and</strong> will not (a) contravene any provision contained in such Purchaser’s organizational<br />

documents or trust documents (if applicable), (b) conflict with, violate or result in a material<br />

breach (with or without the lapse of time, the giving of notice or both) of or constitute a material<br />

default (with or without the lapse of time, the giving of notice or both) under, or require the<br />

COLUMBUS/795660.8<br />

4


consent or approval of any third party under (i) any contract, agreement, commitment, indenture,<br />

mortgage, lease, pledge, note, bond, license, permit or other instrument or obligation or (ii)<br />

assuming satisfaction of the requirements set forth in Section 5.3, any judgment, order, decree,<br />

statute, law, rule or regulation or other restriction of any Governmental Authority, in each case to<br />

which such Purchaser is a party or <strong>by</strong> which such Purchaser is bound or to which any of such<br />

Purchaser’s assets or properties are subject, or (iii) result in the acceleration of, or permit any<br />

Person to terminate, modify, cancel, accelerate or declare due <strong>and</strong> payable prior to its stated<br />

maturity, any material obligation of such Purchaser.<br />

5.3 No Consents. Except for any requirement to qualify for a registration exemption<br />

under the Securities Act or any applicable state securities laws, no notice to, filing with, or<br />

authorization, registration, consent or approval of any Governmental Authority is necessary for<br />

the execution, delivery or performance of this Agreement or the consummation of the<br />

transactions contemplated here<strong>by</strong> <strong>by</strong> such Purchaser, except for any consents, approvals, orders,<br />

permits, authorizations, registrations, declarations, notices <strong>and</strong> filings for which no material<br />

consequences will arise from the failure to make or obtain them.<br />

5.4 Investment.<br />

(a) The Securities are being acquired for such Purchaser’s own account <strong>and</strong><br />

not with a view to, or intention of, distribution thereof in violation of the Securities Act or any<br />

applicable state securities laws <strong>and</strong> will not be disposed of in contravention of the Securities Act<br />

or any applicable state securities laws.<br />

(b) Such Purchaser has knowledge of <strong>and</strong> has had access to information<br />

concerning the business, financial condition, properties, operations <strong>and</strong> prospects of P-L<br />

Holdings, is sophisticated in financial matters, is able to evaluate the risks <strong>and</strong> benefits of the<br />

investment in the Securities, <strong>and</strong> has determined that such investment in the Securities is suitable<br />

for such Purchaser, based upon such Purchaser’s financial situation <strong>and</strong> needs, as well as such<br />

Purchaser’s other securities holdings.<br />

(c) Such Purchaser is able to bear the economic risk of such Purchaser’s<br />

investment in the Securities for an indefinite period of time <strong>and</strong> such Purchaser underst<strong>and</strong>s that<br />

the Securities have not been registered under the Securities Act <strong>and</strong> cannot be sold unless<br />

subsequently registered under the Securities Act or an exemption from such registration is<br />

available. Such Purchaser further underst<strong>and</strong>s that the Securities are subject to certain restrictions<br />

set forth in the P-L Holdings Stockholders’ Agreement.<br />

(d) Such Purchaser has had an opportunity to ask questions <strong>and</strong> receive<br />

answers concerning the terms <strong>and</strong> conditions of the offering of Securities <strong>and</strong> has had full access<br />

to such other information concerning P-L Holdings as such Purchaser has requested.<br />

(e) Such Purchaser acknowledges that: (i) Rule 144 under the Securities Act<br />

is not available for resale of the Securities <strong>by</strong> such Purchaser because P-L Holdings does not<br />

satisfy certain conditions of that Rule; (ii) for so long as such Rule is not available, any resale or<br />

other transfer of such Securities under circumstances in which the seller or the person through<br />

whom the sale is made may be deemed to be an underwriter, as that term is used in the Securities<br />

COLUMBUS/795660.8<br />

5


Act, may require compliance with some other exemption under the Securities Act or the rules<br />

<strong>and</strong> regulations of the Securities <strong>and</strong> Exchange Commission; <strong>and</strong> (iii) any resale or other transfer<br />

of such Securities at such time in the future as Rule 144 may be available which is made in<br />

reliance upon Rule 144 can be made only in limited amounts in accordance with the terms <strong>and</strong><br />

conditions of said Rule (including the fact that such Securities must be held for minimum periods<br />

of time).<br />

(f) No commission, fee or other remuneration is to be paid or given, directly<br />

or indirectly, to any Person <strong>by</strong> such Purchaser for soliciting such Purchaser to purchase the<br />

Securities.<br />

(g) Such Purchaser is an “accredited investor” as defined in Rule 501(a) under<br />

the Securities Act. Such Purchaser is a resident of the state set forth opposite such Purchaser’s<br />

name on Schedule A attached hereto <strong>and</strong> is not acquiring the Securities as a nominee or agent or<br />

otherwise for any other person.<br />

5.5 Employee Relationship. As an inducement to Pomona Holdings to sell the<br />

Securities to the Purchaser, <strong>and</strong> as a condition thereto, each Purchaser acknowledges <strong>and</strong> agrees<br />

(with respect to such Purchaser) that neither the sale of the Securities to such Purchaser nor any<br />

provision contained herein shall entitle such Purchaser to remain in the employment of the<br />

Surviving Corporation or affect any rights of the Surviving Corporation to terminate such<br />

Purchaser’s employment. This Agreement shall not impair the rights of any Purchaser under any<br />

written employment contract between such Purchaser <strong>and</strong> the Surviving Corporation, or the<br />

rights of any Purchaser under the P-L Holdings Stockholders’ Agreement.<br />

SECTION 6. MISCELLANEOUS PROVISIONS.<br />

6.1 Notices. All notices or other communications required or permitted hereunder<br />

shall be in writing <strong>and</strong> shall be delivered personally, <strong>by</strong> facsimile or sent <strong>by</strong> certified, registered<br />

or express air mail, postage prepaid, <strong>and</strong> shall be deemed given when so delivered personally, or<br />

<strong>by</strong> facsimile upon electronic confirmation of receipt, or if mailed <strong>by</strong> overnight courier service<br />

guaranteeing next day delivery, one day after mailing, or if mailed in any other way, then upon<br />

receipt, as follows:<br />

If to Pomona Holdings:<br />

COLUMBUS/795660.8<br />

Lassonde Industries, Inc.<br />

755 Principale<br />

Rougemont, Quebec J0L 1M0<br />

Attention: Jean Gattuso<br />

with a copy to (which shall not constitute notice):<br />

Squire, S<strong>and</strong>ers & Dempsey (US) LLP<br />

4900 Key Tower<br />

127 Public Square<br />

Clevel<strong>and</strong>, OH 44114<br />

Attention: Laura D. Nemeth, Esq.<br />

6


If to a Purchaser:<br />

COLUMBUS/795660.8<br />

To the address for such Purchaser set forth on<br />

Schedule A attached hereto.<br />

or to such other address as any party hereto shall notify the other parties hereto (as provided<br />

above) from time to time.<br />

6.2 Governing Law; Jurisdiction. This Agreement shall be construed in accordance<br />

with <strong>and</strong> governed <strong>by</strong> the laws of the State of New York applicable to agreements made <strong>and</strong> to<br />

be performed wholly within that jurisdiction; provided, that the issuances of Securities shall be<br />

effected in accordance with the laws of the State of Delaware. In connection with any suit, action<br />

or other proceeding arising out of or relating to this Agreement, the events giving rise to this<br />

Agreement or any transaction contemplated here<strong>by</strong>, the parties hereto here<strong>by</strong> agree <strong>and</strong> consent<br />

to be subject to the exclusive jurisdiction of the United States District Court for the Southern<br />

District of New York, <strong>and</strong> in the absence of such Federal jurisdiction, the parties consent to be<br />

subject to the exclusive jurisdiction of the state courts located in New York, New York, <strong>and</strong><br />

here<strong>by</strong> waive the right to assert the lack of personal or subject matter jurisdiction or improper<br />

venue in connection with any such suit, action or other proceeding. In furtherance of the<br />

foregoing, each of the parties (a) waives the defense of inconvenient forum, (b) agrees not to<br />

commence, <strong>and</strong> agrees not to permit any Affiliate to commence, any suit, action or other<br />

proceeding arising out of or relating to this Agreement or any transaction contemplated here<strong>by</strong><br />

other than in any such court <strong>and</strong> (c) agrees that a final judgment in any such suit, action or other<br />

proceeding shall be conclusive <strong>and</strong> may be enforced in other jurisdictions <strong>by</strong> suit or judgment or<br />

in any other manner provided <strong>by</strong> law. Each party hereto further agrees that service of any<br />

process, summons, notice or document <strong>by</strong> U.S. registered mail to such party’s address set forth<br />

in Section 6.1 above shall be effective service of process for any claim, action or proceeding with<br />

respect to any matters to which it has submitted to jurisdiction in this Section 6.2 or otherwise.<br />

6.3 Assignment; Successors <strong>and</strong> Assigns; No Third-Party Rights. Except as<br />

otherwise provided herein, this Agreement may not, without the prior written consent of the<br />

other parties hereto, be assigned <strong>by</strong> operation of law or otherwise, <strong>and</strong> any attempted assignment<br />

shall be null <strong>and</strong> void. This Agreement shall be for the sole benefit of the parties to this<br />

Agreement <strong>and</strong> their respective heirs, successors, permitted assigns <strong>and</strong> legal representatives <strong>and</strong><br />

is not intended, nor shall be construed, to give any Person, other than the parties hereto <strong>and</strong> their<br />

respective heirs, successors, assigns <strong>and</strong> legal representatives, any legal or equitable right,<br />

remedy or claim hereunder.<br />

6.4 Counterparts. This Agreement may be executed in two or more counterparts for<br />

the convenience of the parties hereto, each of which shall be deemed an original <strong>and</strong> all of which<br />

together will constitute one <strong>and</strong> the same instrument. Delivery of an executed counterpart of a<br />

signature page to this Agreement <strong>by</strong> facsimile or portable document format shall be effective as<br />

delivery of a manually executed counterpart to this Agreement.<br />

7


6.5 Titles <strong>and</strong> Headings. The titles <strong>and</strong> captions in this Agreement are for reference<br />

purposes only, <strong>and</strong> shall not in any way define, limit, extend or describe the scope of this<br />

Agreement or otherwise affect the meaning or interpretation of this Agreement.<br />

6.6 Entire Agreement. This Agreement, including the Exhibit <strong>and</strong> Schedules attached<br />

hereto, constitutes the entire agreement <strong>among</strong> the parties with respect to the matters covered<br />

here<strong>by</strong> <strong>and</strong> supersedes all previous written, oral or implied underst<strong>and</strong>ings <strong>among</strong> them with<br />

respect to such matters. Notwithst<strong>and</strong>ing the foregoing, the Merger Agreement <strong>and</strong> the P-L<br />

Holdings Stockholders’ Agreement shall not be superseded <strong>by</strong> this Agreement <strong>and</strong> shall remain<br />

in full force <strong>and</strong> effect.<br />

6.7 Severability. The invalidity of any portion hereof shall not affect the validity,<br />

force or effect of the remaining portions hereof.<br />

6.8 No Strict Construction. Each of the parties hereto acknowledges that this<br />

Agreement has been prepared jointly <strong>by</strong> the parties hereto <strong>and</strong> shall not be strictly construed<br />

against either party. As a consequence, the parties do not intend that the presumptions of any<br />

laws or rules relating to the interpretation of contracts against the drafter of any particular clause<br />

should be applied to this Agreement <strong>and</strong> therefore waive their effects.<br />

6.9 Specific Performance. Each of the Purchasers <strong>and</strong> Pomona Holdings<br />

acknowledge that the rights of each party to consummate the transactions contemplated here<strong>by</strong><br />

are unique <strong>and</strong> recognize <strong>and</strong> affirm that in the event of a breach of this Agreement <strong>by</strong> any party,<br />

money damages would be inadequate <strong>and</strong> the non-breaching parties would have no adequate<br />

remedy at law. Accordingly, the parties agree that non-breaching parties shall have the right to<br />

specific performance, injunctive <strong>and</strong>/or other equitable relief (without the necessity of proving<br />

the inadequacy as a remedy of money damages or the posting of bond or other security), in<br />

addition to any other rights <strong>and</strong> remedies existing in their favor at law or in equity, to enforce<br />

their rights <strong>and</strong> the other parties’ obligations hereunder. Each party agrees that such party will<br />

not oppose the granting of an injunction, specific performance <strong>and</strong> other equitable relief on the<br />

basis that another party has an adequate remedy at law or an award of specific performance is not<br />

an appropriate remedy for any reason at law or equity.<br />

6.10 WAIVER <strong>OF</strong> JURY TRIAL. EACH <strong>OF</strong> THE PARTIES HERETO WAIVES<br />

ANY RIGHT IT MAY HAVE TO TRIAL BY JURY IN RESPECT <strong>OF</strong> ANY LITIGATION<br />

BASED ON, ARISING OUT <strong>OF</strong>, UNDER OR IN CONNECTION WITH THIS <strong>AGREEMENT</strong>.<br />

6.11 Failure or Indulgence not Waiver. No failure or delay on the part of any party<br />

hereto in the exercise of any right hereunder shall impair such right or be construed to be waiver<br />

of, or acquiescence in, any breach of any representation, warranty or agreement herein, nor shall<br />

any single or partial exercise of any such right preclude any other or further exercise thereof or<br />

any other right. All rights <strong>and</strong> remedies existing under this Agreement are cumulative to, <strong>and</strong> not<br />

exclusive of, any rights or remedies otherwise available.<br />

6.12 Amendments <strong>and</strong> Waivers. This Agreement may be amended, modified, waived<br />

<strong>and</strong> supplemented only <strong>by</strong> a written instrument authorized <strong>and</strong> executed <strong>by</strong> each party to this<br />

Agreement.<br />

COLUMBUS/795660.8<br />

8


COLUMBUS/795660.8<br />

[SIGNATURE PAGE FOLLOWS]<br />

9


IN WITNESS WHERE<strong>OF</strong>, the parties have executed this Agreement on the date first<br />

above written.<br />

POMONA HOLDINGS: PURCHASERS:<br />

POMONA HOLDINGS, INC.<br />

By:<br />

Name:<br />

Title:<br />

COLUMBUS/795660.8<br />

[Signature Page to Stock Purchase Agreement]<br />

<strong>CLEMENT</strong> DAVID PAPPAS 2009<br />

IRREVOCABLE TRUST<br />

By: __________________________<br />

Name: Clement David Pappas<br />

Title: Trustee<br />

EDWARD L.B. PAPPAS 2009<br />

IRREVOCABLE TRUST<br />

By: __________________________<br />

Name: Edward Pappas<br />

Title: Trustee<br />

ZACHARY P. PAPPAS 2009<br />

IRREVOCABLE TRUST<br />

By: __________________________<br />

Name: Zachary Pappas<br />

Title: Trustee<br />

<strong>CLEMENT</strong> DIMITRI PAPPAS 2009<br />

IRREVOCABLE TRUST<br />

By: __________________________<br />

Name: Clement Dimitri Pappas<br />

Title: Trustee<br />

T/U/A <strong>OF</strong> DEAN C. PAPPAS DATED<br />

FEBRUARY 3, 2009, AS AMENDED<br />

By: __________________________<br />

Name: Dean C. Pappas<br />

Title: Trustee


Name Address<br />

TRUSTEE <strong>OF</strong><br />

<strong>CLEMENT</strong><br />

DAVID PAPPAS<br />

2009<br />

IRREVOCABLE<br />

TRUST<br />

TRUSTEE <strong>OF</strong><br />

EDWARD L.B.<br />

PAPPAS 2009<br />

IRREVOCABLE<br />

TRUST<br />

TRUSTEE <strong>OF</strong><br />

ZACHARY P.<br />

PAPPAS 2009<br />

IRREVOCABLE<br />

TRUST<br />

TRUSTEE <strong>OF</strong><br />

<strong>CLEMENT</strong><br />

DIMITRI<br />

PAPPAS 2009<br />

IRREVOCABLE<br />

TRUST<br />

TRUSTEE <strong>OF</strong><br />

T/U/A <strong>OF</strong> DEAN<br />

C. PAPPAS<br />

DATED<br />

FEBRUARY 3,<br />

2009, AS<br />

AMENDED<br />

COLUMBUS/795660.8<br />

SCHEDULE A<br />

c/o Clement David Pappas<br />

One Collins Drive, Suite 200<br />

Carneys Point, NJ 08069<br />

c/o Edward Pappas<br />

One Collins Drive, Suite 200<br />

Carneys Point, NJ 08069<br />

c/o Zachary Pappas<br />

1016 Clinton St.<br />

Philadelphia, PA 19107<br />

c/o Clement Dimitri Pappas<br />

One Collins Drive, Suite 200<br />

Carneys Point, NJ 08069<br />

Attention: DIMITRI<br />

PAPPAS<br />

c/o Dean Pappas<br />

110 Compromise Rd<br />

Salem, NJ 08079<br />

A-1<br />

Shares of P-L<br />

Holdings<br />

Common Stock<br />

to be Purchased 1<br />

Aggregate Purchase<br />

Price 2<br />

9,000.00 $9,000,000.00<br />

6,500.00 $6,500,000.00<br />

4,500.00 $4,500,000.00<br />

7,000.00 $7,000,000.00<br />

2,000.00 $2,000,000.00<br />

TOTALS: 29,000.00 $29,000,000.00<br />

1 Assumes Per Share Price of $1,000.<br />

2 Such dollar <strong>and</strong> share amounts to be adjusted, on a pro rata basis, downwards if necessary to ensure<br />

ownership of less than 20% of P-L Holdings <strong>and</strong> may, as provided in the Merger Agreement at the option of the<br />

Pappas Group in connection with an Additional Equity Contribution, be adjusted upwards.


COLUMBUS/795660.8<br />

SCHEDULE B<br />

Post-Merger, Post-Stock Contribution <strong>and</strong> Post-Stock Purchase Capitalization of P-L Holdings<br />

Authorized capital stock: 1,000,000 shares of voting common stock, par value $0.001 per share<br />

Issued <strong>and</strong> outst<strong>and</strong>ing capital stock: 150,000.00 shares of voting common stock, par value<br />

$0.001 per share<br />

Stockholder Address<br />

LASSONDE (U.S.A.)<br />

INC.<br />

3346625 CANADA<br />

INC.<br />

TRUSTEE <strong>OF</strong><br />

<strong>CLEMENT</strong> DAVID<br />

PAPPAS 2009<br />

IRREVOCABLE<br />

TRUST<br />

TRUSTEE <strong>OF</strong><br />

EDWARD L.B.<br />

PAPPAS 2009<br />

IRREVOCABLE<br />

TRUST<br />

TRUSTEE <strong>OF</strong><br />

ZACHARY P.<br />

PAPPAS 2009<br />

IRREVOCABLE<br />

TRUST<br />

TRUSTEE <strong>OF</strong><br />

<strong>CLEMENT</strong> DIMITRI<br />

PAPPAS 2009<br />

IRREVOCABLE<br />

TRUST<br />

TRUSTEE <strong>OF</strong> T/U/A<br />

<strong>OF</strong> DEAN C.<br />

PAPPAS DATED<br />

FEBRUARY 3, 2009,<br />

AS AMENDED<br />

c/o Lassonde Industries Inc.<br />

755 Principale<br />

Rougemont, Quebec J0L 1M0<br />

c/o Lassonde Industries Inc.<br />

755 Principale<br />

Rougemont, Quebec J0L 1M0<br />

c/o Clement David Pappas<br />

One Collins Drive, Suite 200<br />

Carneys Point, NJ 08069<br />

c/o Edward Pappas<br />

One Collins Drive, Suite 200<br />

Carneys Point, NJ 08069<br />

c/o Zachary Pappas<br />

1016 Clinton St.<br />

Philadelphia, PA 19107<br />

c/o Clement Dimitri Pappas<br />

One Collins Drive, Suite 200<br />

Carneys Point, NJ 08069 Attention:<br />

DIMITRI PAPPAS<br />

c/o Dean Pappas<br />

110 Compromise Rd<br />

Salem, NJ 08079<br />

B-1<br />

Shares of Common Stock<br />

Owned of Record 3<br />

Percentage<br />

Ownership 4<br />

106,000.00 70.7%<br />

15,000.00 10.0%<br />

9,000.00 6.0%<br />

6,500.00 4.3%<br />

4,500.00 3.0%<br />

7,000.00 4.7%<br />

2,000.00 1.3%<br />

TOTALS: 150,000.00 100.0%<br />

3<br />

Assumes Per Share Price of $1,000 per share of Common Stock <strong>and</strong> Lassonde equity contribution of<br />

$121.0 million.<br />

4<br />

Such estimated amounts to be adjusted based on actual total equity funded to consummate the Merger <strong>and</strong><br />

as needed to ensure aggregate Pappas family ownership of less than 20% of P-L Holdings.


COLUMBUS/795660.8<br />

EXHIBIT 1<br />

[The certificate of incorporation of P-L Holdings, the <strong>by</strong>laws of P-L Holdings <strong>and</strong> the certificate<br />

of incorporation <strong>and</strong> <strong>by</strong>laws of Pomona Holdings shall be in a form reasonably agreed to <strong>by</strong><br />

Pomona Holdings <strong>and</strong> the Purchasers.]<br />

1-1

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!